<SEC-DOCUMENT>0001104659-22-053569.txt : 20220429
<SEC-HEADER>0001104659-22-053569.hdr.sgml : 20220429
<ACCEPTANCE-DATETIME>20220429161553
ACCESSION NUMBER:		0001104659-22-053569
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		6
CONFORMED PERIOD OF REPORT:	20220614
FILED AS OF DATE:		20220429
DATE AS OF CHANGE:		20220429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			uniQure N.V.
		CENTRAL INDEX KEY:			0001590560
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				000000000
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36294
		FILM NUMBER:		22875651

	BUSINESS ADDRESS:	
		STREET 1:		PAASHEUVELWEG 25A
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1105 BP
		BUSINESS PHONE:		1-339-970-7000

	MAIL ADDRESS:	
		STREET 1:		PAASHEUVELWEG 25A
		CITY:			AMSTERDAM
		STATE:			P7
		ZIP:			1105 BP

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	uniQure B.V.
		DATE OF NAME CHANGE:	20131030
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>tm223584d2_def14a.htm
<DESCRIPTION>DEF 14A
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0pt; font-size: 10pt"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 12pt; margin-bottom: 3pt; width: 100%"><DIV STYLE="border-top: Black 2pt solid; font-size: 1pt; border-bottom: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>UNITED STATES<BR>
SECURITIES AND EXCHANGE COMMISSION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Washington, D.C. 20549</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 14pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>SCHEDULE 14A</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>(RULE 14A-101)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Proxy Statement Pursuant to Section 14(a) of<BR>
the Securities Exchange Act of 1934 (Amendment No. &nbsp;&nbsp;&nbsp;&nbsp;)</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3.1pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    by the Registrant&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#120;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3.1pt; padding-left: 0.7pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3.1pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Filed
    by a Party other than the Registrant&nbsp;&nbsp;</FONT><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3.1pt; padding-left: 0.7pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3.1pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Check
    the appropriate box:</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 2.1pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Preliminary
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD>
    <TD STYLE="padding-right: 2.1pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Confidential,
    for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings">&#120;</FONT></TD>
    <TD STYLE="padding-right: 2.1pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Proxy Statement</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD>
    <TD STYLE="padding-right: 2.1pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Definitive
    Additional Materials</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.7pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD>
    <TD STYLE="padding-right: 2.1pt; padding-left: 0.7pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Soliciting
    Material under &sect;240.14a-12</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; width: 100%; padding-right: 3.1pt; padding-left: 0.7pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 14pt"><B>UNIQURE
    N.V.</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 3.1pt; padding-left: 0.7pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    of Registrant as Specified in Its Charter)</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="border-bottom: black 1pt solid; padding-right: 3.1pt; padding-left: 0.7pt; text-align: center; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3.1pt; padding-left: 0.7pt; text-align: center; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(Name
    of Person(s) Filing Proxy Statement, if other than the Registrant)</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3.1pt; padding-left: 0.7pt; font-size: 10pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD COLSPAN="2" STYLE="padding-right: 3.1pt; padding-left: 0.7pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Payment
    of Filing Fee (Check the appropriate box):</FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-left: 0.7pt; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#120;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 2.1pt; padding-left: 0.7pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">No
    fee required.</FONT></TD></TR>

<TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; font-size: 10pt"><FONT STYLE="font-family: Wingdings; font-size: 10pt">&#168;</FONT></TD>
    <TD STYLE="width: 95%; padding-right: 2.1pt; padding-left: 0.7pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Fee
    paid previously with preliminary materials.</FONT></TD></TR>

<TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 5%; text-align: left"><FONT STYLE="font-family: Wingdings">&#168;</FONT></TD><TD STYLE="text-align: justify; width: 95%">Fee
                                            computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a6(i)(1) and
                                            0-11</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="width: 100%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt; border-bottom: Black 2pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-align: center"><B>uniQure N.V.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Paasheuvelweg 25a</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>1105 BP Amsterdam</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>The Netherlands</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>+1-339-970-7000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: right">May&nbsp;17, 2022</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dear Shareholder:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On behalf of the Board of Directors of uniQure N.V. (the &ldquo;Company&rdquo;),&nbsp;I
invite you to attend our 2022 Annual General Meeting of Shareholders&nbsp;on June&nbsp;14, 2022, at 3:30 p.m., Central European Summer
Time (the &ldquo;2022 Annual Meeting&rdquo;).&nbsp;Considering the continuing coronavirus&nbsp;(COVID-19)&nbsp;pandemic, the 2022 Annual
Meeting will be held exclusively over the Internet via live audio webcast at meetnow.global/M79DCD7.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The matters to be voted upon at the 2022 Annual Meeting are listed
in the Notice of Annual General Meeting of Shareholders and are more fully described in the proxy statement accompanying this letter
(the &ldquo;Proxy Statement&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Registered Shareholders (as defined in the &lsquo;Notice of Annual
General Meeting of Shareholders&rsquo; below) are entitled to submit their questions regarding the agenda items ahead of the 2022 Annual
Meeting by email to <U>investors@uniQure.com</U> and during the 2022 Annual Meeting, in each case, as more particularly described in
the Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have opted to provide our materials in connection with the 2022
Annual Meeting pursuant to the full set delivery option. Under the full set delivery option, a company delivers all proxy materials to
its shareholders. Accordingly, you are receiving our proxy materials by mail or, if you previously agreed, by e-mail. These proxy materials
include the Notice of Annual General Meeting of Shareholders, the Proxy Statement, the proxy card, and the Annual Report on Form&nbsp;10-K
for the year ended December&nbsp;31, 2021. These materials are available free of charge at http://www.edocumentview.com/QURE. Further
instructions for accessing these proxy materials and voting at the 2022 Annual Meeting are described in the Notice of Annual General
Meeting of Shareholders and the Proxy Statement.&nbsp; Your vote is very important.&nbsp;Whether or not you plan to attend the 2022 Annual
Meeting over the Internet, please carefully review the enclosed Proxy Statement and then cast your vote, regardless of the number of
shares you hold.&nbsp; If you are a shareholder of record, you may vote over the Internet, by telephone or by completing, signing, dating,
and mailing the accompanying proxy card in the return envelope no later than 12:00 p.m.&nbsp;Central European Summer Time on June&nbsp;14,
2022. If you mail the proxy card within the United States, no additional postage is required.&nbsp; If your shares are held in street
name (held for your account by a broker or other nominee), you will receive instructions from your broker or other nominee explaining
how to vote your shares and, you will have the option to cast your vote in the manner provided in the voting instructions you receive
from your broker or other nominee.&nbsp; You will not be able to vote your shares at the 2022 Annual Meeting. Accordingly, to be sure
that your vote will be received on time, please cast your vote by your choice of available means at your earliest convenience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Thank you for your continuing interest in the Company. We look forward
to you attending the 2022 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you have any questions about the Proxy Statement, please contact
investor relations at investors@uniQure.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">Sincerely,</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">/s/ Matthew Kapusta</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Matthew Kapusta</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer and Executive Director</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>uniQure N.V.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>June 14, 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To the Shareholders of uniQure N.V.:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Notice is hereby given that the 2022 Annual General Meeting of Shareholders
(the &ldquo;2022 Annual Meeting&rdquo;) of uniQure N.V., a public company with limited liability (<I>naamloze vennootschap</I>) under
the laws of the Netherlands (the &ldquo;Company,&rdquo; &ldquo;uniQure,&rdquo; or &ldquo;we&rdquo;), will be held on June&nbsp;14, 2022,
at 3:30 p.m., Central European Summer Time, exclusively over the Internet via live audio webcast for the following purposes:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt">I.</TD>
    <TD STYLE="width: 95%; padding-right: 5.4pt; padding-left: 5.4pt">Opening and announcements</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">II.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Board Report on the financial year 2021 (for discussion only)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">III.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Explanation of the application of the remuneration policy (for discussion only)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">IV.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Adoption of the 2021 Dutch statutory annual accounts and treatment of the results
    (Voting Proposal No.&nbsp;1)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">V.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Discharge of liability of the members of the Board of Directors (the &ldquo;Board&rdquo;)
    (Voting Proposal No.&nbsp;2)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">VI.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board Appointment:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>reappointment of Matthew Kapusta as executive director (Voting Proposal No.&nbsp;3)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>reappointment of Robert Gut as non-executive director (Voting Proposal No.&nbsp;4)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">VII.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Renew the designation of the Board as the competent body to issue Ordinary
    Shares and grant rights to subscribe for Ordinary Shares (Voting Proposal No.&nbsp;5)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">VIII.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Reauthorize the Board to exclude or limit preemptive rights upon the issuance
    of Ordinary Shares and granting of rights to subscribe for Ordinary Shares (Voting Proposal No.&nbsp;6)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">IX.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Reauthorize the Board to repurchase Ordinary Shares (Voting Proposal No.&nbsp;7)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">X.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Appointment of KPMG Accountants N.V. as external auditors of the Company for
    the financial year 2022 (Voting Proposal No.&nbsp;8)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">XI.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">To approve, on an advisory basis, the compensation of the named executive officers
    of the Company (Voting Proposal No.&nbsp;9)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">XII.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Any other business</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">XIII.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Closing of the meeting</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Board of Directors (our &ldquo;Board&rdquo;) recommends that you
vote &ldquo;<B>FOR</B>&rdquo; each of the voting proposals noted above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Several of the agenda items are presented to the 2022 Annual Meeting
because we are organized under the laws of the Netherlands. Several matters that are within the authority of the Board under the corporate
laws of most U.S. states require shareholder approval under Dutch law. Additionally, Dutch corporate governance provisions require certain
discussion topics for an annual general meeting of shareholders upon which shareholders do not vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board has fixed the close of business Eastern Time on May&nbsp;17,
2022 as the record date and, therefore, only the Company&rsquo;s shareholders of record (&ldquo;Registered Shareholders&rdquo;) at 10:05
p.m.&nbsp;Central European Summer Time on May&nbsp;17, 2022 are entitled to receive this notice (the &ldquo;Notice&rdquo;) and to vote
at the 2022 Annual Meeting and any adjournment thereof.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Only Registered Shareholders who have given notice in writing to the
Company by June&nbsp;13, 2022 of their intention to attend the 2022 Annual Meeting over the Internet via live audio webcast are entitled
to so attend the 2022 Annual Meeting. The conditions for attendance at the 2022 Annual Meeting are as follows. Registered Shareholders
must:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>notify
                                            the Company by June&nbsp;13, 2022 of their intention to attend the 2022 Annual Meeting over
                                            the Internet via the live audio webcast in accordance with the instructions as set out in
                                            the Proxy Statement (as defined below);</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>vote
                                            their shares in advance of the 2022 Annual Meeting by Internet, by telephone or by mail in
                                            accordance with the instructions as set out in the Proxy Statement, and to ensure that their
                                            votes are received no later than 12:00 noon Central European Summer Time on June&nbsp;14,
                                            2022;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>submit
                                            their questions regarding the agenda items in advance of the 2022 Annual Meeting by email
                                            to investors@uniQure.com and ensure that their questions are received no later than 11:59
                                            p.m.&nbsp;Central European Summer Time on June&nbsp;13, 2022. We intend to answer all questions
                                            so submitted, and, time permitting, there will be an opportunity to ask follow-up questions
                                            during the 2022 Annual Meeting in accordance with our rules&nbsp;of conduct and procedure;
                                            and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Times New Roman, Times, Serif">o</FONT></TD><TD>listen
to the 2022 Annual Meeting over the Internet via the live audio webcast at meetnow.global/M79DCD7.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A proxy statement more fully describing the matters to be considered
at the 2022 Annual Meeting (the &ldquo;Proxy Statement&rdquo;) is attached to this Notice.&nbsp;Copies of our Annual Report on Form&nbsp;10-K
for the year ended December&nbsp;31, 2021 (the &ldquo;Annual Report on Form&nbsp;10-K&rdquo;), including our financial statements and
notes thereto, as filed with the Securities and Exchange Commission, accompany this Notice, but are not deemed to be part of the Proxy
Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 3 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We have opted to provide our materials in connection with the 2022
Annual Meeting pursuant to the full set delivery option. Under the full set delivery option, a company delivers all proxy materials to
its shareholders. This delivery can be by mail or, if a shareholder has previously agreed, by e-mail. Accordingly, you are receiving
our proxy materials by mail or, if you previously agreed, by e-mail. These proxy materials include this Notice, the Proxy Statement,
the proxy card, and the Annual Report on Form&nbsp;10-K. In addition to delivering proxy materials to shareholders, a company must also
post all proxy materials on a publicly accessible website and provide information to shareholders about how to access that website. These
materials are available free of charge at <I>http://www.edocumentview.com/QURE</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our 2021 Dutch Statutory Annual Accounts and our 2021 Dutch
Statutory Board Report are available on our website at <I>www.uniqure.com</I>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The 2022 Annual Meeting is an important event in our corporate calendar
and provides an opportunity to engage with shareholders and for shareholders to pass the necessary resolutions for the conduct of the
business and affairs of the Company. Considering the continuing coronavirus&nbsp;(COVID-19)&nbsp;pandemic and public health concerns,
we have decided to hold an all-virtual meeting instead of a physical meeting such that the 2022 Annual Meeting can only be attended over
the Internet via live audio webcast.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The health and well-being of our colleagues, shareholders, and the
communities in which we operate is a priority for us. However, we are also committed to ensuring that shareholders can exercise their
right to vote and ask questions at the upcoming 2022 Annual Meeting. In particular, the proxy voting methods set out below and the ability
to vote by internet, telephone, or mail in advance of the 2022 Annual Meeting and to ask questions via the Internet in advance of and
during the 2022 Annual Meeting, which ensure that shareholders can participate in the 2022 Annual Meeting remotely instead of attending
in person. Any questions asked via the Internet in advance of the 2022 Annual Meeting must be submitted to investors@uniQure.com no later
than 11:59 p.m.&nbsp;Central European Summer Time on June&nbsp;13, 2022. The aim is to answer all questions so submitted during the 2022
Annual Meeting, time permitting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Due to the potential risks of aiding the spread of coronavirus&nbsp;(COVID-19)&nbsp;by
gathering at the 2022 Annual Meeting and on how the meeting itself is held and conducted, shareholders <U>cannot</U> attend the 2022
Annual Meeting in person. We believe that the safest way to ensure all shareholders can exercise their rights at the 2022 Annual Meeting
is by participating online and by voting your shares in advance, e.g., by returning the proxy card (if you received one) prior to the
2022 Annual Meeting.&nbsp;You are encouraged to vote your shares as early as possible.</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Whether or not you plan to attend the 2022 Annual Meeting over
the Internet, please vote via the Internet prior to the 2022 Annual Meeting. You also may vote by telephone or by submitting a proxy
card by mail prior to the 2022 Annual Meeting.&nbsp; If your shares are held in street name, you will receive instructions from your
broker or other nominee explaining how to vote your shares, and you also may have the choice of instructing the record holder as to the
voting of your shares by proxy, over the Internet or by telephone.&nbsp; Follow the instructions on the voting instruction form you receive
from your broker or other nominee.&nbsp; If you are submitting a proxy card by mail, you do not need to affix postage to the enclosed
reply envelope if you mail it within the United States.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All proxies submitted to us will be tabulated by Computershare.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">All shareholders are extended an invitation to attend the 2022 Annual
Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%">&nbsp;</TD>
    <TD STYLE="width: 45%">By Order of the Board of Directors,</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">/s/ Matthew Kapusta</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Matthew Kapusta</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer and Executive Director</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<!-- Field: Page; Sequence: 4 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Important Notice Regarding the Availability
of Proxy Materials for the 2022 Annual General Meeting of Shareholders to Be Held on June&nbsp;14, 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">The Proxy Statement, Proxy Card, and our Annual
Report on Form&nbsp;10-K are available at</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">http://www.edocumentview.com/QURE</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt">and, together with our 2021
Dutch Statutory Annual Accounts and our 2021 Dutch Statutory Board Report, on our website at http://www.uniqure.com.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 5 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>TABLE OF CONTENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; width: 0.5in; font-size: 10pt; text-align: left"><A HREF="#a_001">1.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#a_001">NOTE REGARDING FORWARD-LOOKING STATEMENTS</A></TD>
    <TD STYLE="vertical-align: bottom; width: 0.5in; font-size: 10pt; text-align: right"><A HREF="#a_001">1</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#a_002">2.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#a_002">PROXY STATEMENT FOR THE 2022 ANNUAL GENERAL MEETING OF SHAREHOLDERS</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#a_002">2</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_001">3.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#b_001">AGENDA ITEM I&mdash;OPENING AND ANNOUNCEMENTS</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_001">5</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#fa_001">4.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#fa_001">AGENDA ITEM II&mdash;REPORT ON THE FINANCIAL YEAR 2021</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#fa_001">5</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_002">5.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#b_002">AGENDA ITEM III&mdash;EXPLANATION OF THE APPLICATION OF THE REMUNERATION POLICY</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_002">5</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_003">6.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#b_003">AGENDA ITEM IV&mdash;VOTING PROPOSAL NO. 1 - ADOPTION OF THE 2021 DUTCH STATUTORY ANNUAL
    ACCOUNTS AND TREATMENT OF THE RESULTS</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_003">5</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_004">7.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#b_004">AGENDA ITEM V&mdash;VOTING PROPOSAL NO. 2 - DISCHARGE OF LIABILITY FOR THE MEMBERS
    OF THE BOARD</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_004">6</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_005">8.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#b_005">AGENDA ITEM VI&mdash;VOTING PROPOSAL NO. 3 AND NO. 4- BOARD APPOINTMENTS</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_005">6</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; vertical-align: top; text-align: left"><A HREF="#b_006">9.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#b_006">AGENDA ITEM VII&mdash;VOTING PROPOSAL NO. 5 - RENEW THE DESIGNATION OF THE BOARD AS
    THE COMPETENT BODY TO ISSUE ORDINARY SHARES AND GRANT RIGHTS TO SUBSCRIBE FOR ORDINARY SHARES</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_006">8</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_007">10.</A></TD>
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_007">AGENDA ITEM VIII&mdash;VOTING PROPOSAL NO. 6 - REAUTHORIZE THE BOARD TO EXCLUDE OR
    LIMIT PREEMPTIVE RIGHTS UPON THE ISSUANCE OF ORDINARY SHARES AND GRANTING OF RIGHTS TO SUBSCRIBE FOR ORDINARY SHARES</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_007">8</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_008">11.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#b_008">AGENDA ITEM IX&mdash;VOTING PROPOSAL NO. 7 - REAUTHORIZE THE BOARD TO REPURCHASE ORDINARY
    SHARES</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_008">9</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_009">12.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#b_009">REPORT OF THE AUDIT COMMITTEE</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_009">10</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_010">13.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#b_010">AGENDA ITEM X&mdash;VOTING PROPOSAL NO. 8 - APPOINTMENT OF KPMG ACCOUNTANTS N.V. AS
    EXTERNAL AUDITORS OF THE COMPANY FOR THE FINANCIAL YEAR 202<U>2</U></A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_010">11</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_011">14.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#b_011">AGENDA ITEM XI&mdash;VOTING PROPOSAL NO. 9 &mdash;TO APPROVE, ON AN ADVISORY BASIS,
    THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS OF THE COMPANY</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_011">12</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_012">15.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#b_012">AGENDA ITEM XII&mdash; ANY OTHER BUSINESS</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_012">12</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_013">16.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#b_013">AGENDA ITEM XIII - CLOSING OF THE MEETING</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_013">12</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#b_014">17.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#b_014">CORPORATE GOVERNANCE</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#b_014">12</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#a_003">18.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#a_003">CERTAIN RELATIONSHIPS AND RELATED PERSONS TRANSACTIONS</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#a_003">21</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#a_004">19.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#a_004">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#a_004">22</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#a_005">20.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#a_005">COMPENSATION COMMITTEE REPORT</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#a_005">25</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#v_001">21.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#v_001">SUMMARY COMPENSATION TABLE</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#v_001">44</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#v_002">22.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#v_002">OUTSTANDING EQUITY AWARDS AT FISCAL YEAR END 2021</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#v_002">46</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#v_003">23.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#v_003">GRANTS OF PLAN-BASED AWARDS FOR 2021</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#v_003">47</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#v_004">24.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#v_004">OPTION EXERCISES AND STOCK VESTED IN 2021</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#v_004">48</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#va_002">25.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#va_002">DIRECTOR COMPENSATION</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#va_002">54</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#a_006">26.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#a_006">DIRECTOR COMPENSATION TABLE</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#a_006">55</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#a_007">27.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#a_007">GENERAL MATTERS</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#a_007">56</A></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="vertical-align: top; font-size: 10pt; text-align: left"><A HREF="#va_001">28.</A></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><A HREF="#va_001">ANNUAL MEETING PROXY CARD</A></TD>
    <TD STYLE="vertical-align: bottom; font-size: 10pt; text-align: right"><A HREF="#va_001">58</A></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 6 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_001"></A><B>NOTE REGARDING FORWARD-LOOKING STATEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">Certain statements in the following proxy statement
for the 2022 Annual General Meeting of Shareholders are &ldquo;forward-looking statements&rdquo; within the meaning of Section&nbsp;27A
of the Securities Act of 1933, as amended, and Section&nbsp;21E of the Securities Exchange Act of 1934, as amended (the &ldquo;Exchange
Act&rdquo;), and are subject to the safe harbor created by those sections. Forward-looking statements are based on our current assumptions,
projections and expectations of future events, and are generally identified by words such as &ldquo;may,&rdquo; &ldquo;will,&rdquo; &ldquo;should,&rdquo;
 &ldquo;could,&rdquo; &ldquo;would,&rdquo; &ldquo;expects,&rdquo; &ldquo;plans,&rdquo; &ldquo;anticipates,&rdquo; &ldquo;believes,&rdquo;
 &ldquo;estimates,&rdquo; &ldquo;projects,&rdquo; &ldquo;predicts,&rdquo; &ldquo;potential&rdquo; and similar expressions, or the negatives
thereof, or future dates. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ
materially from those projected or implied. The most significant factors known to us that could materially adversely affect our business,
operations, industry, financial position or future financial performance are described in &ldquo;<I>Part&nbsp;I,&nbsp;Item 1A, Risk Factors</I>&rdquo;
in our most recent Annual Report on Form&nbsp;10-K filed with the Securities and Exchange Commission (the &ldquo;SEC&rdquo;) on February&nbsp;25,
2022 (the &ldquo;Annual Report on Form&nbsp;10-K&rdquo;), which is being provided to you together with this proxy statement. You should
not place undue reliance on any forward-looking statement, which speaks only as of the date made, and should recognize that forward-looking
statements are predictions of future results, which may not occur as anticipated. Actual results could differ materially from those anticipated
in the forward-looking statements and from historical results due to the risks and uncertainties described in our Annual Report on Form&nbsp;10-K,
including in &ldquo;<I>Part&nbsp;I,&nbsp;Item 1A. Risk Factors</I>,&rdquo; as well as others that we may consider immaterial or do not
anticipate at this time. The risks and uncertainties described in our Annual Report on Form&nbsp;10-K are not exclusive and further information
concerning our company and our business, including factors that could materially affect our operating results or financial condition,
may emerge from time to time. We undertake no obligation to update forward-looking statements to reflect actual results or changes in
factors or assumptions affecting such forward-looking statements. We advise you, however, to consult any further disclosures we make
on related subjects in our future Annual Reports on Form&nbsp;10-K, Quarterly Reports on Form&nbsp;10-Q and Current Reports on Form&nbsp;8-K
that we file with or furnish to the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 7; Options: NewSection; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->1<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>uniQure N.V.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>Paasheuvelweg 25a</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>1105 BP Amsterdam</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>The Netherlands</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><B>+1-339-970-7000</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_002"></A><B>PROXY STATEMENT FOR THE 2022 ANNUAL GENERAL
MEETING OF SHAREHOLDERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>To Be Held on June&nbsp;14, 2022, at 3:30 p.m.,
Central European Summer Time</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This proxy statement (the &ldquo;Proxy Statement&rdquo;), which includes
the explanatory notes to the agenda for the 2022 Annual General Meeting of Shareholders (the &ldquo;2022 Annual Meeting&rdquo;), and
the accompanying proxy card (the &ldquo;Proxy Card&rdquo;), are being furnished with respect to the solicitation of proxies by the Board
of Directors (the &ldquo;Board&rdquo;) of uniQure N.V., a public company with limited liability (<I>naamloze vennootschap</I>) under
the laws of the Netherlands (the &ldquo;Company,&rdquo; &ldquo;uniQure&rdquo; or &ldquo;we&rdquo;), for the 2022 Annual Meeting.&nbsp;
The 2022 Annual Meeting will be held at 3:30 p.m.&nbsp;Central European Summer Time on June&nbsp;14, 2022, and at any adjournment thereof,
exclusively over the Internet via live audio webcast.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The approximate date on which the Proxy Statement and Proxy Card are
first being sent or given to the Company&rsquo;s shareholders (each a &ldquo;Shareholder and collectively, the &ldquo;Shareholders&rdquo;)
is May&nbsp;18, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The purposes of the 2022 Annual Meeting are to discuss and/or vote
on the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 5%; padding-right: 5.4pt; padding-left: 5.4pt">I.</TD>
    <TD STYLE="width: 95%; padding-right: 5.4pt; padding-left: 5.4pt">Opening and announcements</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">II.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Report on the financial year 2021 (for discussion only)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">III.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Explanation of the application of the remuneration policy (for discussion only)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">IV.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Adoption of the 2021 Dutch statutory annual accounts and treatment of the results
    (Voting Proposal No.&nbsp;1)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">V.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Discharge of liability of the members of the Board of Directors (the &ldquo;Board&rdquo;)
    (Voting Proposal No.&nbsp;2)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">VI.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Board Appointment:</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>reappointment of Matthew Kapusta as executive director (Voting Proposal No.&nbsp;3)</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">b)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>reappointment of Robert Gut as non-executive director (Voting Proposal No.&nbsp;4)</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">VII.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Renew the designation of the Board as the competent body to issue Ordinary
    Shares and grant rights to subscribe for Ordinary Shares (Voting Proposal No.&nbsp;5)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">VIII.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Reauthorize the Board to exclude or limit preemptive rights upon the issuance
    of Ordinary Shares and granting of rights to subscribe for Ordinary Shares (Voting Proposal No.&nbsp;6)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">IX.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Reauthorize the Board to repurchase Ordinary Shares (Voting Proposal No.&nbsp;7)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">X.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Appointment of KPMG Accountants N.V. as external auditors of the Company for
    the financial year 2022 (Voting Proposal No.&nbsp;8)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">XI.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">To approve, on an advisory basis, the compensation of the named executive officers
    of the Company (Voting Proposal No.&nbsp;9)</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">XII.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Any other business</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">XIII.</TD>
    <TD STYLE="padding-right: 5.4pt; padding-left: 5.4pt">Closing of the meeting</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Who May&nbsp;Vote</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Holders of record of our ordinary shares (the &ldquo;Ordinary Shares&rdquo;)
at the close of business Eastern Time on May&nbsp;17, 2022 (the &ldquo;Record Date&rdquo;) are entitled to receive notice of and to vote
at the 2022 Annual Meeting and any adjournment thereof.&nbsp;We expect that we will have approximately 46,644,109 Ordinary Shares outstanding
as of the Record Date.&nbsp;We have no other securities entitled to vote at the 2022 Annual Meeting.&nbsp;Each Ordinary Share is entitled
to one vote on each matter. There is no cumulative voting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A list of Shareholders entitled to vote at the 2022 Annual Meeting
will be available at the 2022 Annual Meeting and will also be available for ten (10)&nbsp;days prior to the 2022 Annual Meeting, during
regular office hours, at the principal executive offices of the Company, located at Paasheuvelweg 25a, 1105 BP Amsterdam, the Netherlands,
by contacting Investor Relations at uniQure N.V., Paasheuvelweg 25a, 1105 BP Amsterdam, the Netherlands, by telephone at +1-339-970-7000,
or by email to investors@uniQure.com.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the Company&rsquo;s Articles of Association and the rules&nbsp;of
the Nasdaq Global Select Market, the presence at the 2022 Annual Meeting of 33 1/3% of the issued share capital, present in person or
represented by proxy, is required for a quorum. &ldquo;Abstentions&rdquo; and &ldquo;broker non-votes,&rdquo; if any, will be counted
as present and entitled to vote for purposes of determining whether a quorum is present for the transaction of business at the 2022 Annual
Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Broker non-votes&rdquo; are shares represented at the 2022
Annual Meeting held by brokers, bankers, or other nominees (i.e., in &ldquo;street name&rdquo;) that are not voted on a particular proposal
because the nominee does not have discretionary voting power with respect to that item and has not received instructions from the beneficial
owner. Generally, brokerage firms may vote to ratify the selection of independent auditors and on other &ldquo;discretionary&rdquo; or
 &ldquo;routine&rdquo; items. In contrast, brokerage firms may not vote to appoint directors, because those proposals are considered &ldquo;non-discretionary&rdquo;
items. Accordingly, if you do not instruct your broker how to vote your shares on &ldquo;non-discretionary&rdquo; matters, your broker
will not be permitted to vote your shares on these matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 8; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->2<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each matter proposed by the Board, other than with respect to the
appointment of directors and the exclusion or limitation of preemptive rights upon the issuance of Ordinary Shares and granting of rights
to subscribe for Ordinary Shares, shall be adopted by a simple majority of the votes cast at the 2022 Annual Meeting. Brokers will have
discretion to vote only with respect to Voting Proposal No.&nbsp;8 (Appointment KPMG Accountants N.V. as external auditors).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Consistent with Dutch law and the Company&rsquo;s Articles of Association,
executive directors and non-executive directors are appointed by the general meeting from a binding nomination by the non-executive directors.
The proposed candidate specified in the binding nomination shall be appointed, provided that the requisite quorum is present or represented
at the general meeting, unless the nomination is overruled by the general meeting (which would result if a majority of at least two-thirds
of the votes cast, which majority represents more than half of the issued share capital, vote &ldquo;against&rdquo; the appointment of
such director, with abstentions, &ldquo;blank votes&rdquo;, &ldquo;broker non-votes&rdquo; and invalid votes not considered votes cast),
in which case he or she will not be appointed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Methods of Voting</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">If you are a record holder of Ordinary Shares
at the close of business Eastern Time on May&nbsp;17, 2022, you may vote as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>By
Internet</B>.&nbsp; Access the website of the Company&rsquo;s tabulator, Computershare, at: http://www.investorvote.com/QURE<I>, </I>using
the voter control number printed on the furnished proxy card.&nbsp; Your shares will be voted in accordance with your instructions.&nbsp;
You must specify how you want your shares voted or your Internet vote cannot be completed, and you will receive an error message.&nbsp;
If you vote on the Internet, you also may request electronic delivery of future proxy materials.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>By
                                            Telephone</B>.&nbsp; Call 1-800-652-8683 toll-free from the U.S., U.S. territories and Canada
                                            and follow the instructions on the enclosed proxy card.&nbsp; Your shares will be voted in
                                            accordance with your instructions.&nbsp; You must specify how you want your shares voted
                                            or your telephone vote cannot be completed. You must have the control number that is included
                                            on the proxy card when voting.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>By
                                            Mail</B>.&nbsp; Complete and mail a proxy card in the enclosed postage prepaid envelope to
                                            the address provided.&nbsp; Your shares will be voted in accordance with your instructions.&nbsp;
                                            If you are mailed or otherwise receive or obtain a proxy card, and you choose to vote by
                                            telephone or by Internet, you do not have to return your proxy card.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you attend the 2022 Annual Meeting over the Internet via live audio
webcast, you will not be able to vote the shares you hold in real time over the Internet via live audio webcast, so please ensure that
you vote in advance of the 2022 Annual Meeting by Internet, by telephone or by mail, in accordance with the above instructions. To be
sure that your vote will be received in time (and no later than 12:00 p.m.&nbsp;Central European Summer Time on June&nbsp;14, 2022),
please cast your vote by your choice of available means at your earliest convenience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If Ordinary Shares are held in street name (held for your account
by a broker or other nominee) at the close of business Eastern Time on May&nbsp;17, 2022, you may vote:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>By
                                            Internet or By Telephone.</B> You will receive instructions from your broker or other nominee
                                            if you are permitted to vote by internet or telephone.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><B>By
                                            Mail.</B> You will receive instructions from your broker or other nominee explaining how
                                            to vote your shares.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you attend the 2022 Annual Meeting over the Internet via live audio
webcast, you will not be able to vote the shares you hold in street name in real time over the Internet via live audio webcast, so please
ensure that you vote in advance of the 2022 Annual Meeting by Internet, by telephone or by mail, such in accordance with the above instructions.
To be sure that your vote will be received in time (and no later than 12:00 noon&nbsp;Central European Summer Time on June&nbsp;14, 2022),
please cast your vote by your choice of available means at your earliest convenience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Board&rsquo;s Recommendations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board recommends a vote:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-size: 10pt">(1)</FONT></TD><TD>Voting Proposal No.&nbsp;1:
                                            &ldquo;<B>FOR</B>&rdquo; adoption of the 2021 Dutch Statutory Annual Accounts and treatment
                                            of the results.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Voting Proposal No.&nbsp;2: &ldquo;<B>FOR</B>&rdquo; discharge of
                                            liability of the members of the Board.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>Voting Proposal No.&nbsp;3: &ldquo;<B>FOR</B>&rdquo; reappointment
                                            of Matthew Kapusta as an executive director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 9; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->3<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(4)</TD><TD>Voting Proposal No.&nbsp;4: &ldquo;<B>FOR</B>&rdquo; reappointment
                                            of Robert Gut as a non-executive director.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>




<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(5)</TD><TD>Voting Proposal No.&nbsp;5: &ldquo;<B>FOR</B>&rdquo; renewing the
                                            designation of the Board as the competent body to issue Ordinary Shares and grant rights
                                            to subscribe for Ordinary Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(6)</TD><TD>Voting Proposal No.&nbsp;6: &ldquo;<B>FOR</B>&rdquo; reauthorizing
                                            the Board to exclude or limit preemptive rights upon the issuance of Ordinary Shares and
                                            granting of rights to subscribe for Ordinary Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(7)</TD><TD>Voting Proposal No.&nbsp;7: &ldquo;<B>FOR</B>&rdquo; reauthorization
                                            of the Board to repurchase Ordinary Shares.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(8)</TD><TD>Voting Proposal No.&nbsp;8: &ldquo;<B>FOR</B>&rdquo; appointment
                                            of KPMG Accountants N.V. as external auditors of the Company for the financial year 2022.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(9)</TD><TD>Voting Proposal No.&nbsp;9: &ldquo;<B>FOR</B>&rdquo; on an advisory
                                            basis, the compensation of the named executive officers of the Company.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Voting by Proxy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Ordinary Shares represented by any proxy duly given will be voted
at the 2022 Annual Meeting in accordance with the instructions of the Shareholder.&nbsp; You may vote &ldquo;<B>FOR</B>&rdquo; or &ldquo;<B>AGAINST</B>&rdquo;
or &ldquo;<B>ABSTAIN</B>&rdquo; from each of the voting proposals. If no specific&nbsp;instructions are given, the shares will be voted
 &ldquo;<B>FOR</B>&rdquo; the voting proposals described in this Proxy Statement.&nbsp; In addition, if any other matters come before
the 2022 Annual Meeting, the persons named in the accompanying Proxy Card will vote in accordance with their best judgment with respect
to such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If we receive a signed and dated proxy card or receive your instructions
by Internet or by telephone and your instructions do not specify how your shares are to be voted, your shares will be voted with the Board&rsquo;s recommendations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Revoking Your Proxy</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Even if you execute a proxy, you retain the right to revoke it and
to change your vote.&nbsp; You must notify us of your intention to revoke your proxy no later than 12:00 noon p.m.&nbsp;Central European
Summer Time on June&nbsp;14, 2022. Such revocation may be effected in writing by execution of a subsequently dated proxy, or by a written
notice of revocation, sent to the attention of Investor Relations at the address of our principal executive offices set forth above.&nbsp;Unless
so revoked, the shares represented by a proxy, if received in time, will be voted in accordance with the directions given therein.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If the 2022 Annual Meeting is postponed or adjourned for any reason,
at any subsequent reconvening of the 2022 Annual Meeting, all proxies will be voted in the same manner as the proxies would have been
voted at the original convening of the 2022 Annual Meeting (except for any proxies that have at that time effectively been revoked or
withdrawn).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">You are requested, regardless of the number of shares you own or your
intention to attend the 2022 Annual Meeting over the Internet via live audio webcast, to vote by proxy as soon as possible.&nbsp;You
do not need to affix postage to the enclosed reply envelope if you mail it within the United States.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Solicitation of Proxies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The expenses of solicitation of proxies will be paid by the Company.
We may solicit proxies by mail, by electronic mail or by phone through agents of the Company.&nbsp; Additionally, the employees of the
Company, who will receive no extra compensation therefor, may solicit proxies personally, by telephone, electronic mail, or mail.&nbsp;
The Company will also reimburse banks, brokers or other institutions for their expenses incurred in sending proxies and proxy materials
to the beneficial owners of shares held by them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Delivery of Proxy Materials to Households</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Only one copy of the Company&rsquo;s Annual Report on Form&nbsp;10-K
and this Proxy Statement will be delivered to an address where two or more Shareholders reside unless we have received contrary instructions
from a Shareholder residing at such address.&nbsp; Upon written or oral request from a Shareholder, we will promptly deliver a separate
copy of the Annual Report on Form&nbsp;10-K, the Proxy Statement, Notice of Internet Availability of Proxy Materials, and Proxy Card
to each Shareholder at the shared address.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you are a Shareholder who lives at a shared address and you would
like additional copies of the Annual Report on Form&nbsp;10-K, the Proxy Statement, or any future annual reports or proxy statements,
please contact Investor Relations, uniQure N.V., Paasheuvelweg 25a, 1105 BP Amsterdam, the Netherlands, by telephone at +1-339-970-7000
or by email at investors@uniQure.com, and we will promptly mail you copies.&nbsp; This Proxy Statement and the Annual Report on Form&nbsp;10-K
are also available at http://www.edocumentview.com/QURE.&nbsp; If you are receiving multiple copies of this Proxy Statement and the
Annual Report on Form&nbsp;10-K at your household and wish to receive only one, please contact Investor Relations at the mailing address,
phone number or email address listed above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 10; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->4<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Voting Results</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The preliminary voting results will be announced at the 2022 Annual
Meeting. The final results will be disclosed in a Current Report on Form&nbsp;8-K within four business days after the meeting date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Contact for Additional Questions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If you hold your shares directly, please contact Investor Relations
at uniQure N.V., Paasheuvelweg 25a, 1105 BP Amsterdam, the Netherlands, by telephone at +1-339-970-7000, or by email at investors@uniQure.com.
If your shares are held in street name, please use the contact information provided on your voting instruction form or contact your broker
or other nominee directly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_001"></A>AGENDA ITEM I</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OPENING AND ANNOUNCEMENTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Chair will open the 2022 Annual Meeting and make any announcements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="fa_001"></A>AGENDA ITEM II</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BOARD REPORT ON THE FINANCIAL YEAR
2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This item is for discussion only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Under this agenda item, the Board will discuss the
business and results of operations of the Company as contained in the Dutch statutory board report for the year ended December 31, 2021
(the &ldquo;2021 Dutch Statutory Board Report&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">The contents of the corporate governance chapter in
the 2021 Dutch Statutory Board Report, including our compliance with the Dutch Corporate Governance Code, will also be submitted for discussion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">A copy of our 2021 Dutch Statutory Board Report is
available on our website at www.uniqure.com or may be obtained by contacting Investor Relations at investors@uniQure.com or by telephone
at +1-339-970-7000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Due to the international nature of our business and pursuant to a prior
shareholder authorization, our 2021 Dutch Statutory Board Report has been prepared in the English language.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_002"></A>AGENDA ITEM III</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>EXPLANATION OF THE APPLICATION OF THE REMUNERATION
POLICY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This item is for discussion only.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under this agenda item, an explanation will be provided on how the
Company&rsquo;s remuneration policy was applied in fiscal year 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_003"></A>AGENDA ITEM IV</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTING PROPOSAL NO. 1 - ADOPTION OF THE 2021
DUTCH STATUTORY ANNUAL ACCOUNTS<BR>
 &nbsp;AND TREATMENT OF THE RESULTS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">As a public company with limited liability (naamloze vennootschap)
incorporated under the laws of the Netherlands, we are required by both Dutch law and our Articles of Association to prepare the Dutch
statutory annual accounts and submit them to our Shareholders for adoption. Our 2021 Dutch statutory annual accounts include our consolidated
financial statements for the year ended December 31, 2021, for the uniQure N.V. group, which are comprised of the consolidated statements
of financial position, consolidated statements of profit and loss and other comprehensive income, consolidated statements of changes in
equity and consolidated statements of cash flows with explanatory notes thereto prepared in accordance with International Financial Reporting
Standards (&ldquo;IFRS&rdquo;) as adopted by the European Union, as well as stand-alone Company-only financial statements of uniQure N.V.
for the year ended December 31, 2021, comprising uniQure N.V.&rsquo;s Company-only statement of financial position and the Company-only
statement of profit and loss with explanatory notes thereto prepared in accordance with Book 2 of the Dutch Civil Code (together the &ldquo;2021
Dutch Statutory Annual Accounts&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our 2021 Dutch Statutory Annual Accounts differ from the consolidated financial statements contained in our Annual
Report on Form 10-K, which was prepared in accordance with U.S. generally accepted accounting principles (&ldquo;U.S. GAAP&rdquo;), and
filed with the SEC. Our 2021 Dutch Statutory Annual Accounts contain some disclosures
that are not required under U.S. GAAP and that are therefore not contained in our Annual Report on Form&nbsp;10-K.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A copy of our 2021 Dutch Statutory Annual Accounts is available on
our website at <I>www.uniqure.com</I> or may be obtained by contacting Investor Relations at investors@uniQure.com or by telephone at
+1-339-970-7000.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Due to the international nature of our business and pursuant to a
prior shareholder authorization, our 2021 Dutch Statutory Annual Accounts have been prepared in the English language.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 11; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->5<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: 1 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>VOTE REQUIRED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The affirmative vote of a majority of our Ordinary Shares represented
by proxy at the 2022 Annual Meeting and entitled to vote, is required to approve Voting Proposal No.&nbsp;1. Abstentions and broker non-votes
will have no effect on the outcome of this vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUR BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS
VOTE &ldquo;FOR&rdquo; THE ADOPTION OF OUR DUTCH STATUTORY ANNUAL ACCOUNTS FOR THE FISCAL YEAR ENDED DECEMBER 31, 2021.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_004"></A>AGENDA ITEM V</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTING PROPOSAL NO. 2 - DISCHARGE OF LIABILITY
OF THE MEMBERS OF THE BOARD OF DIRECTORS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the 2022 Annual Meeting, as contemplated by Dutch law and as is
typical for Dutch registered companies, our Shareholders will be asked to grant discharge of liability of the members of our Board in
office for the management and conducted policy during the 2021 financial year insofar as the exercise of such duties is reflected in
the 2021 Dutch Statutory Annual Report or otherwise disclosed to the 2022 Annual Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">If our Shareholders approve to grant discharge of liability,
the members of our Board will not be liable to our Company for actions that such directors took on behalf of our Company in the exercise
of their duties in 2021 and as reflected in the 2021 Dutch Statutory Annual Accounts and the 2021 Dutch Statutory Annual Board Report
or otherwise disclosed to the 2022 Annual Meeting. Therefore, this release does not apply to matters that were not previously disclosed
to our Shareholders. This release also is subject to the provisions of Dutch law relating to liability upon commencement of bankruptcy
or other insolvency proceedings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>VOTE REQUIRED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The affirmative vote of a majority of our Ordinary Shares represented
by proxy at the 2022 Annual Meeting and entitled to vote, is required to approve Voting Proposal No.&nbsp;2. Abstentions and broker non-votes
will have no effect on the outcome of this vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUR BOARD UNANIMOUSLY RECOMMENDS THAT
SHAREHOLDERS VOTE &ldquo;FOR&rdquo; THE GRANT OF DISCHARGE OF LIABILITY OF THE MEMBERS OF OUR BOARD IN OFFICE DURING THE FISCAL YEAR
ENDED DECEMBER 31, 2021 FOR THE MANAGEMENT AND CONDUCTED POLICY DURING OUR FISCAL YEAR ENDED DECEMBER 31, 2021 INSOFAR AS THE
EXERCISE OF SUCH DUTIES IS REFLECTED IN THE 2021 DUTCH STATUTORY ANNUAL ACCOUNTS AND THE 2021 DUTCH STATUTORY BOARD REPORT OR
DISCLOSED TO THE 2022 ANNUAL MEETING.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_005"></A>AGENDA ITEM VI</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTING PROPOSAL NO. 3 AND NO. 4 - BOARD APPOINTMENT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board is responsible for establishing broad corporate policies
and monitoring the overall performance of the Company.&nbsp; It selects the Company&rsquo;s senior management, delegates authority for
the conduct of the Company&rsquo;s day-to-day operations to those senior managers and monitors their performance.&nbsp;Members of the
Board are kept informed of the Company&rsquo;s business by, among other things, participating in Board and Committee meetings, by attending
certain meetings with (senior) management of the Company, and by reviewing analyses and reports provided to them.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board is currently made up of nine directors.&nbsp;The terms of
office of one executive director, Matthew Kapusta and one non-executive director, Robert Gut, are scheduled to expire on the date of
the 2022 Annual Meeting. The terms of office for four non-executive directors, Madhavan Balachandran, Jack Kaye, Leonard Post, and Jeremy
Springhorn, are schedule to expire on the date of the 2023 annual general meeting of shareholders. The terms of office of three non-executive
directors, Rachelle Jacques, David Meek, and Paula Soteropoulos, are schedule to expire on the date of the 2024 annual general meeting
of shareholders. Under our Articles of Association, all directors hold office for a maximum term of four years, or until their earlier
death, resignation, suspension, or dismissal. However, the current practice of the Board is to nominate all directors, both executive
and non-executive, for terms of office of three years.&nbsp;The Board has implemented staggered terms to provide for a retirement schedule
as required by our Articles of Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Board has nominated Matthew Kapusta, our Chief Executive Officer
(&ldquo;Chief Executive Officer&rdquo; or &ldquo;CEO&rdquo;), for reappointment to the Board, to serve as an executive director until
the 2025 annual general meeting of shareholders or until his earlier death, resignation, suspension, or dismissal. The Board has nominated
Robert Gut for reappointment to the Board, to serve as a non-executive director until the 2025 annual general meeting of shareholders
or until his earlier death, resignation, suspension, or dismissal. Each of Matthew Kapusta and Robert Gut have consented to being named
in this Proxy Statement and to serve if appointed.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The name, position with the Company and age as of the Record Date
of each individual who is our nominee for appointment as a director is:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Name</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Age</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font-size: 10pt; font-weight: bold; text-align: center">Position</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Director&nbsp;Since</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 50%; font-size: 10pt; text-align: left">Matthew Kapusta</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 15%; font-size: 10pt; text-align: center">49</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; width: 15%; font-size: 10pt; text-align: left">Executive Director</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; font-size: 10pt; text-align: center">2015</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Robert Gut</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: center">57</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left">Non-Executive Director</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: center">2018</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 12; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->6<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>MATTHEW KAPUSTA</B>. Matthew Kapusta, age 49, has been Chief Executive
Officer of uniQure since December&nbsp;2016, and currently serves on the Company&rsquo;s Board of Directors. Mr.&nbsp;Kapusta also served
as our Chief Financial Officer from joining uniQure in January&nbsp;2015 until June&nbsp;2021. Prior to joining uniQure, Mr.&nbsp;Kapusta
was Senior Vice President at AngioDynamics (NASDAQ: ANGO) from 2011 to 2014, responsible for corporate development, strategic planning,
and national accounts. Prior to AngioDynamics, he served as Vice President, Finance and Strategic Planning and Analysis for Smith&nbsp;&amp;
Nephew Orthopaedics. Mr.&nbsp;Kapusta&rsquo;s career also includes more than a decade of investment banking experience focused on emerging
life sciences companies. Mr.&nbsp;Kapusta was Managing Director, Healthcare Investment Banking at Collins Stewart, and held various positions
at Wells Fargo Securities, Robertson Stephens, and PaineWebber. Mr.&nbsp;Kapusta holds a Master of Business Administration from New York
University&rsquo;s Stern School of Business, a Bachelor of Business Administration from University of Michigan&rsquo;s Ross School of
Business and earned his Certified Public Accountant license in 1996 while at Ernst&nbsp;&amp; Young. We believe that Mr.&nbsp;Kapusta
is qualified to serve as our Chief Executive Officer and an Executive Director due to his broad expertise in the biotechnology and finance
industries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ROBERT GUT, M.D., Ph.D.</B> Dr. Robert Gut, age
57, was elected to his current term as a Non-Executive Director in December 2020. Dr Gut first joined our Board in June 2018, and previously
served as both a Non-Executive and an Executive Director. He also served as our Chief Medical Officer from August 2018 until October 2020.
During his time as our Chief Medical Officer, Dr. Gut led clinical development, clinical operating and medical-team-activities that successfully
initiated and executed our HOPE-B pivotal trial of etranacogene dezaparvovec for hemophilia B and our Phase 1/2 clinical trial of AMT-130
for the treatment of Huntington&rsquo;s Disease. In October 2020, he resigned as Chief Medical Officer and as executive director (because
under Dutch law our executive directors must hold an executive position with the Company), and in December 2020, he was reappointed to
the Board as a non-executive director. Dr. Gut has more than 23 years of experience in the biopharmaceutical industry-leading clinical
development and medical affairs activities in rare disorders and other therapeutic areas. For most of his career, Dr. Gut worked at Novo
Nordisk Inc. (NYSE: NVO), where he headed the company&rsquo;s U.S. Biopharm Medical organization with leading products in hemophilia,
endocrinology, and women&rsquo;s health (NovoSeven&reg;, Norditropin&reg; and Vagifem&reg;), totaling approximately $1.6 billion in U.S.
revenue. Over his career, Dr. Gut&rsquo;s contributions have helped achieve six FDA product approvals and three additional new product
indications. Dr. Gut has supported the launch of nine new products, overseeing medical activities including medical science liaison and
health economics and outcomes research team building. He has also served for the FDA&rsquo;s Center for Drug Evaluation and Research as
a member of the Advisory Committees for Reproductive Health Drugs and Drug Safety and Risk Management. Dr. Gut was appointed the Chief
Medical Officer of Versartis, Inc. in September 2017 and received his Doctor of Medicine degree from the Medical University of Lublin,
and his Doctorate degree from Lublin Institute of Medicine, Poland. He attended numerous postgraduate programs at Wharton, Stanford, and
Harvard Business School. We believe Dr. Gut is qualified to serve as a Non-Executive Director due to his extensive experience in the biotechnology
industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If reappointed, the term of office for each of Mr.&nbsp;Kapusta and
Dr.&nbsp;Gut will expire on the date of the 2025 annual general meeting of shareholders. Pursuant to the Company&rsquo;s Articles of
Association, the Board plans to appoint a chair of the Board and any new committee members at the first meeting of the Board following
the 2022 Annual Meeting, which is currently scheduled for June&nbsp;14, 2022. We currently expect that Dr.&nbsp;Gut will continue to
serve on our Research&nbsp;&amp; Development Committee of the Board. We do not currently expect any changes to the position of chair
of the Board, which presently is held by David Meek, or to any of our existing Committee assignments.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For information as to the Ordinary Shares held by Mr.&nbsp;Kapusta
and Dr.&nbsp;Gut see &ldquo;Security Ownership of Certain Beneficial Owners and Management.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">There are no arrangements or understandings between the nominees,
directors or executive officer and any other person pursuant to which our nominee, directors or executive officer have been selected
for their respective positions.&nbsp;However, the Company has entered into indemnification agreements with its existing non-executive
directors pursuant to which the Company agrees to indemnify such directors in certain circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>VOTE REQUIRED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Consistent with Dutch law and our Articles of Association, executive
directors and non-executive directors are appointed by a general meeting from a binding nomination by the non-executive directors. The
proposed candidate specified in the binding nomination shall be appointed, provided that the requisite quorum is represented by a proxy
at the 2022 Annual Meeting, unless the nomination is overruled by the general meeting, which resolution requires at least a two-third
majority of the votes cast at the 2022 Annual Meeting, provided that such majority represents at least half of the issued share capital.
Each Ordinary Share confers the right to cast one vote at the 2022 Annual Meeting. Blank votes and invalid votes shall be regarded as
not having been cast.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 13; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->7<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE
 &ldquo;FOR&rdquo; EACH OF THE NOMINEES FOR DIRECTOR.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_006"></A>AGENDA ITEM VII<BR>
VOTING PROPOSAL NO. 5 &mdash; RENEW THE DESIGNATION OF THE BOARD AS THE COMPETENT BODY TO ISSUE <BR>
ORDINARY SHARES AND GRANT RIGHTS TO SUBSCRIBE FOR ORDINARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the 2022 Annual Meeting, as contemplated by Dutch law and as is
typical for Dutch registered companies, our Shareholders will be asked to renew the designation of our Board as the competent body to
issue Ordinary Shares and to grant rights to subscribe for Ordinary Shares up to a maximum of (i)&nbsp;our authorized share capital in
the event of an underwritten public offering, or (ii)&nbsp;19.9% of our aggregate issued share capital at the time of issuance in connection
with any other single issuance (or series of related issuances), for a term of 18 months with effect from the date of the 2022 Annual
Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Our current authorized share capital consists of eighty
million (80,000,000) Ordinary Shares, each with a nominal value per share of &euro;0.05. Under Dutch law and our Articles of Association,
we are required to seek the approval of our Shareholders each time we wish to issue shares of our authorized share capital unless our
Shareholders have authorized our Board to issue shares. This authorization may not continue for more than five years but may be given
on a rolling basis. We currently have authorization from our Shareholders to issue Ordinary Shares, or grant rights to subscribe for Ordinary
Shares, up to a maximum of (i) our authorized share capital in the event of an underwritten public offering or (ii) 19.9% of our aggregate
issued share capital at the time of issuance in connection with any other single issuance (or series of related issuances). This existing
authorization expires on December 16, 2022, and it is common practice for Dutch companies to seek to renew this authorization annually
on a rolling basis. The approval of this voting proposal will maintain our flexibility to allow our Board to issue Ordinary Shares and
to grant rights to subscribe for Ordinary Shares without the delay and expense of calling extraordinary general meetings of shareholders.
The designation can be used for all purposes, including any issuance under our employee share purchase plan, subject to statutory limitations,
and except for awards granted under the 2014 Restated Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">We also currently issue Ordinary Shares from our authorized
share capital to satisfy our obligations under awards granted under our equity compensation plans, and the Shareholders separately authorized
such plans. Other than ordinary share issuances in connection with our equity compensation plans (including plans for inducement grants
to newly hired employees), our employee share purchase plan, and any sales deemed to be &ldquo;at-the-market offerings&rdquo; pursuant
to our supplemental prospectus filed on March 2, 2021 with the United States Securities and Exchange Commission, we do not have any specific
plans, proposals, or arrangements to issue any of our authorized Ordinary Shares for any purpose. However, in the ordinary course of our
business, our Board may determine from time to time that the issuance of authorized and unissued shares is in the best interests of our
Company, including in connection with equity compensation or future acquisitions or financings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">This authority to issue shares is similar to that afforded
under state law to the boards of directors of public companies domiciled in the United States. Management believes that retaining the
flexibility to allow our Board to issue our Ordinary Shares for acquisitions, financings, or other business purposes in a timely manner
without first obtaining specific shareholder approval is important to our continued growth. Furthermore, our Ordinary Shares are listed
on the Nasdaq Global Select Market, and the issuance of additional shares will remain subject to Nasdaq rules. For example, one of the
Nasdaq rules requires shareholder approval for the issuance of shares in a private placement of more than 20% of the shares outstanding,
with several exceptions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If our Shareholders do not renew the designation of our Board as the
competent body to issue Ordinary Shares and to grant rights to subscribe for Ordinary Shares, then the previous authorization would remain
in place, and our Board would continue to retain authority to issue Ordinary Shares and to grant rights to subscribe for Ordinary Shares
pursuant to that authorization until it expires on December&nbsp;16, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>VOTE REQUIRED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The affirmative vote of a majority of our Ordinary Shares represented
by proxy at the 2022 Annual Meeting and entitled to vote, is required to approve Voting Proposal No.&nbsp;5. Abstentions and broker non-votes
will have no effect on the outcome of this vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUR BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS
VOTE &ldquo;FOR&rdquo; THE RENEWAL OF THE AUTHORITY OF OUR BOARD TO ISSUE OUR ORDINARY SHARES AND GRANT RIGHTS TO SUBSCRIBE FOR OUR ORDINARY
SHARES UP TO A MAXIMUM OF (I)&nbsp;OUR AUTHORIZED SHARE CAPITAL IN THE EVENT OF AN UNDERWRITTEN PUBLIC OFFERING OR (II)&nbsp;19.9% OF
OUR AGGREGATE ISSUED SHARE CAPITAL AT THE TIME OF ISSUANCE IN CONNECTION WITH ANY OTHER SINGLE ISSUANCE (OR SERIES OF RELATED ISSUANCES),
FOR A TERM OF 18 MONTHS WITH EFFECT FROM THE DATE OF THE 2022 ANNUAL MEETING.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_007"></A>AGENDA ITEM VIII</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTING PROPOSAL NO. 6 - REAUTHORIZE THE BOARD
TO EXCLUDE OR LIMIT PREEMPTIVE RIGHTS UPON THE ISSUANCE OF ORDINARY SHARES AND GRANTING OF RIGHTS TO SUBSCRIBE FOR ORDINARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under Dutch law, holders of our Ordinary Shares would have
a pro rata pre-emptive right of subscription to any of our Ordinary Shares issued for cash. A pre-emptive right of subscription is the
right of our current Shareholders to maintain their percentage ownership of our Ordinary Shares by buying a proportional number of any
new Ordinary Shares that we issue. However, Dutch law and our Articles of Association permit our Shareholders to authorize our Board
to exclude or limit these pre-emptive rights. This authorization may not continue for more than five years, but it may be given on a
rolling basis. We currently have authorization from our Shareholders to exclude or limit these pre-emptive rights, which authorization
expires on December&nbsp;16, 2022, and it is common practice for Dutch companies to seek to renew this authorization annually on a rolling
basis.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the 2022 Annual Meeting, we are asking our Shareholders to renew
the authority of our Board to exclude or limit pre-emptive rights in relation to our Ordinary Shares and rights to subscribe for our
Ordinary Shares in connection with the issuance or granting thereof for a term of 18 months with effect from the date of the 2022 Annual
Meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 14; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->8<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If our Shareholders do not renew the authority of our Board to exclude
or limit preemptive rights in relation to our Ordinary Shares and rights to subscribe for our Ordinary Shares on the terms set forth
above, then the previous authorization would remain in place, and our Board would continue to retain authority to exclude or limit preemptive
rights to subscribe for our Ordinary Shares pursuant to that authorization until it expires on December&nbsp;16, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>VOTE REQUIRED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The affirmative vote of a majority of our Ordinary Shares represented
by proxy at the 2022 Annual Meeting and entitled to vote, or the affirmative vote of a two-thirds majority of our Ordinary Shares represented
by proxy at the 2022 Annual Meeting and entitled to vote if only less than half of the issued share capital is so represented at the
2022 Annual Meeting, is required to approve Voting Proposal No.&nbsp;6. Abstentions and broker non-votes will have no effect on the outcome
of this vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUR BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS
VOTE &ldquo;FOR&rdquo; THE AUTHORITY OF THE BOARD TO EXCLUDE OR LIMIT PRE-EMPTIVE RIGHTS FROM TIME TO TIME, FOR A TERM OF 18 MONTHS WITH
EFFECT FROM THE DATE OF THE 2022 ANNUAL MEETING.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_008"></A>AGENDA ITEM IX</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTING PROPOSAL NO. 7 - REAUTHORIZE THE BOARD
TO REPURCHASE ORDINARY SHARES</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">At the 2022 Annual Meeting, as contemplated by Dutch
law and as is typical for Dutch registered companies, our Shareholders will be asked to authorize our Board to acquire the Company&rsquo;s
own fully paid-up Ordinary Shares up to a maximum of 10% of the issued share capital of the Company for a period of 18 months from the
date of the 2022 Annual Meeting in open market purchases, through privately negotiated transactions, or by means of self-tender offer
or offers, at prices per share ranging from the nominal value up to 110% of the market price per share at the time of the transaction.
This authority to repurchase shares is similar to that afforded under state law to public companies domiciled in the United States. For
purposes of this authorization, &ldquo;market price&rdquo; means the highest price officially quoted for the Ordinary Shares on any of
the official stock markets on which the Ordinary Shares are listed during any of the thirty (30) banking days preceding the date the repurchase
is effected or proposed. Our Ordinary Shares are currently listed on the Nasdaq Global Select Market. The current authorization of our
Board to repurchase Ordinary Shares is scheduled to expire on December 16, 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">Under Dutch law and our Articles of Association,
our Board may, subject to certain Dutch statutory provisions, be authorized to repurchase our issued Ordinary Shares on our behalf in
an amount, at prices and in the manner authorized by the general meeting of shareholders. Adoption of this voting proposal will allow
us to have the flexibility to repurchase our Ordinary Shares without the expense of calling an extraordinary general meeting of shareholders.
Such authorization may not continue for more than 18 months, but it may be given on a rolling basis. Although our Board has no present
intention to commence an open market or other share repurchase program, our Board believes that we will benefit by authorizing our Board
to repurchase our Ordinary Shares if the Board believes such repurchases would be in our and our Shareholders&rsquo; best interests.
For example, to the extent our Board believes that our Ordinary Shares may be undervalued at the market levels at which they are then
trading, repurchases of our share capital may represent an attractive investment for us. Such Ordinary Shares could be used for any valid
corporate purpose, including use under our equity compensation plans, or for acquisitions, mergers, or similar transactions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">However, the number of Ordinary Shares repurchased,
if any, and the timing and manner of any repurchases would be determined by our Board, considering prevailing market conditions, our available
resources and other factors that cannot be predicted now. The nominal value of the Ordinary Shares in our issued share capital that we
acquire, hold, hold as pledgee or which are acquired or held by one of our subsidiaries, may never exceed 50% of our issued share capital.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In order to provide us with sufficient flexibility, our Board proposes
that our Shareholders authorize our Board for an 18-month period from the date of the 2022 Annual Meeting to acquire the Company&rsquo;s
own fully paid-up Ordinary Shares up to a maximum of 10% of the issued share capital of the Company in open market purchases, through
privately negotiated transactions or by means of self-tender offer or offers, at prices ranging from the nominal value up to 110% of
the market price per share at the time of the transaction, within the limits set by Dutch law and our Articles of Association.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>VOTE REQUIRED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The affirmative vote of a majority of our Ordinary Shares represented
by proxy at the 2022 Annual Meeting and entitled to vote, is required to approve Voting Proposal No.&nbsp;7. Abstentions and broker non-votes
will have no effect on the outcome of this vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>OUR BOARD UNANIMOUSLY RECOMMENDS THAT SHAREHOLDERS
VOTE &ldquo;FOR&rdquo; THE AUTHORIZATION OF THE BOARD TO REPURCHASE FULLY PAID-UP ORDINARY SHARES UP TO 10% OF THE ISSUED SHARE CAPITAL
FOR A PERIOD OF 18 MONTHS FROM THE DATE OF THE 2022 ANNUAL MEETING AT A REPURCHASE PRICE BETWEEN THE NOMINAL VALUE OF THE ORDINARY SHARES
CONCERNED AND AN AMOUNT EQUAL TO 110% OF THE MARKET PRICE PER SHARE AT THE TIME OF THE PURCHASE.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 15; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->9<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_009"></A>REPORT OF THE AUDIT COMMITTEE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: 0.5in"><I>The report of the Audit Committee
is not &ldquo;soliciting material,&rdquo; is not deemed &ldquo;filed&rdquo; with the SEC and is not to be incorporated by reference into
any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934, both as amended.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Audit Committee of our Board (the &ldquo;Audit
Committee&rdquo;) is responsible for assisting the Board in fulfilling its oversight responsibilities regarding the Company&rsquo;s financial
accounting and reporting processes, system of internal control, audit process, and process for monitoring compliance with laws and regulations.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Management of the Company has the primary responsibility
for preparing the Company&rsquo;s consolidated financial statements, as well as establishing and maintaining the integrity of the Company&rsquo;s
financial reporting process, accounting principles and internal controls.&nbsp;KPMG Accountants N.V., the Company&rsquo;s independent
registered public accounting firm for the 2021 financial year, was responsible for performing an audit of the Company&rsquo;s consolidated
financial statements and expressing an opinion as to the conformity of such financial statements with U.S. generally accepted accounting
principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In this context, the Audit Committee reviewed
and discussed the audited financial statements of the Company as of and for the year ended December&nbsp;31, 2021 with the Company&rsquo;s
management and KPMG Accountants N.V.&nbsp; To ensure independence, the Audit Committee met separately with KPMG Accountants N.V. and
members of the Company&rsquo;s management.&nbsp;These reviews included discussion with the independent registered public accounting firm
of matters required to be discussed pursuant to Statement on Auditing Standards No.&nbsp;61, as amended (AICPA, <I>Professional Standards</I>,
Vol. 1, AU section 380), as adopted by the Public Company Accounting Oversight Board (&ldquo;PCAOB&rdquo;) in Rule&nbsp;3200T.&nbsp;
In addition, the Audit Committee received the written disclosures and the letter from the independent registered public accounting firm
required by Rule&nbsp;3526 of the PCAOB requiring independent registered public accounting firms to annually disclose in writing all
relationships that, in their professional opinion may reasonably be thought to bear on independence, to confirm their perceived independence
and to engage in a discussion of independence, and it has discussed with KPMG Accountants N.V. its independence from the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based on the reviews and discussions described
above, the Audit Committee recommended to the Board the inclusion of the audited financial statements in the Company&rsquo;s Annual Report
on Form&nbsp;10-K for the fiscal year ended December&nbsp;31, 2021, for filing with the Securities and Exchange Commission.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">The Audit Committee</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid">/s/ Jack Kaye</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Jack Kaye, Chair</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid">/s/ Rachelle Jacques</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Rachelle Jacques</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid">/s/ Jeremy Springhorn</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Jeremy Springhorn</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 16; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->10<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_010"></A>AGENDA ITEM X</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTING PROPOSAL NO. 8 - APPOINTMENT OF KPMG
ACCOUNTANTS N.V. AS EXTERNAL AUDITORS OF THE <BR>
COMPANY FOR THE FINANCIAL YEAR 2022</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">For the fiscal year ending December&nbsp;31, 2022,
the Board has selected KPMG Accountants N.V. (&ldquo;KPMG&rdquo;) to serve as our auditor and independent registered public accounting
firm who will (i)&nbsp;audit the Dutch statutory annual accounts to be prepared in accordance with the International Financial Reporting
Standards, as adopted by the European Union (&ldquo;IFRS&rdquo;) and (ii)&nbsp;serve as our independent registered public accounting
firm for purposes of reporting pursuant to U.S. law.&nbsp;As required by Dutch law, shareholder approval must be obtained for the selection
of KPMG to serve as our auditor and independent registered public accounting firm.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">KPMG has served as our independent registered
public accounting firm since June&nbsp;2019.&nbsp;The fees for the services provided to us by KPMG during the years ended December&nbsp;31,
2021 and 2020 are described below under &ldquo;Principal Accountant Fee Information.&rdquo;&nbsp;We expect that representatives of KPMG
will be present at the 2022 Annual Meeting and will be available to answer appropriate questions. The representatives will also have
the opportunity to make a statement if they desire to do so.&nbsp;KPMG&rsquo;s report on the financial statements for the fiscal year
ended December&nbsp;31, 2021, which is the only such report issued for these financial statements, does not contain an adverse opinion
or a disclaimer of opinion, and it was not qualified or modified as to uncertainty, audit scope, or accounting principles.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Audit Committee annually reviews the independent
registered public accounting firm&rsquo;s independence, including reviewing all relationships between the independent registered public
accounting firm and us and any disclosed relationships or services that may impact the objectivity and independence of the independent
registered public accounting firm, and the independent registered public accounting firm&rsquo;s performance. We do not believe that
any relationships exist which would interfere with KPMG&rsquo;s independence.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>Principal Accountant Fees and Services</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We regularly review the services and fees of our
independent registered public accounting firms. These services and fees are also reviewed by the Audit Committee on an annual basis.
The following table shows the fees accrued by the Company for audit and other services provided by KPMG for the fiscal year ended December&nbsp;31,
2021:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="CENTER" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2021($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">2020($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; font-weight: bold"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="font-size: 10pt; font-weight: bold; text-align: center">(in thousands)</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font-size: 10pt; text-align: left; text-indent: -10.1pt; padding-left: 10.1pt">Audit fees of KPMG</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,392</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,029</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10.1pt; padding-left: 10.1pt">Audit-related fees</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">114</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">85</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10.1pt; padding-left: 10.1pt">Tax fees</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">Total</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,506</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,114</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Pre-Approval Policies and Procedures</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Audit Committee pre-approves all auditing
services, internal control related services and permitted non-audit services (including the fees and terms thereof) to be performed,
subject to the de minimis exception for non-audit services that are approved by the Audit Committee prior to the completion of an audit.&nbsp;
The Audit Committee has adopted policies and procedures relating to the approval of all audit and non-audit services that are to be performed
by the Company&rsquo;s independent registered public accounting firm. This policy generally provides that the Company will not engage
its independent registered public accounting firm to render audit or non-audit services unless the service is specifically approved in
advance by the Audit Committee, or the engagement is entered into pursuant to the pre-approval procedure described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">From time to time, the Audit Committee may pre-approve
specified types of services that are expected to be provided to the Company by its independent registered public accounting firm during
the next 12 months.&nbsp;Any such pre-approval is detailed as to the particular service or type of services to be provided and is also
generally subject to a maximum dollar amount.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Audit Committee pre-approved all services
performed since the pre-approval policy was adopted.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 17; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->11<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>VOTE REQUIRED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The affirmative vote of a majority of our Ordinary
Shares represented by proxy at the 2022 Annual Meeting and entitled to vote, is required to approve Voting Proposal No.&nbsp;8. Brokers
will have discretion to vote on this item.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE
 &ldquo;FOR&rdquo; THE APPOINTMENT OF KPMG ACCOUNTANTS N.V.&nbsp; AS THE COMPANY&rsquo;S EXTERNAL AUDITORS AND INDEPENDENT REGISTERED
PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING DECEMBER 31, 2021.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_011"></A>AGENDA ITEM XI</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>VOTING PROPOSAL NO. 9 &mdash; TO APPROVE, ON
AN ADVISORY BASIS, THE COMPENSATION OF THE NAMED <BR>
EXECUTIVE OFFICERS OF THE COMPANY</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As required by Section&nbsp;14A of the Exchange
Act, the Company&rsquo;s shareholders have the opportunity to approve, on an advisory basis, the compensation of the Company&rsquo;s
named executive officers (&ldquo;NEOs&rdquo;) as disclosed in this Proxy Statement in accordance with the SEC rules, which we also have
referred to herein as the Say-on-Pay vote.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our executive compensation program is designed
to align compensation metrics with our strategic imperatives, align the interests of management with our shareholders, and attract and
retain talented executives. Please see the Compensation Discussion and Analysis beginning on page&nbsp;26 of this Proxy Statement for additional
details, including information about the fiscal year 2021 compensation of our NEOs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We believe that Shareholders have benefitted from
the continued development of our product candidates and research pipeline over the past year. Given the Company&rsquo;s development and
growth under the leadership of the NEOs, the Board recommends that shareholders vote &ldquo;FOR&rdquo; the following resolution at our
2022 Annual Meeting:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&ldquo;RESOLVED, that the Company&rsquo;s
shareholders approve, on an advisory basis, the compensation of the NEOs, as disclosed on pages&nbsp;26 to 56 of the Proxy Statement
for the 2022 Annual Meeting pursuant to Item 402 of Regulation S-K, including the Compensation Discussion and Analysis, the 2021
Summary Compensation Table, and the other related tables and disclosure.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">It is expected that the next say-on-pay vote will
occur at our 2023 annual general meeting of shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in"><B>VOTE REQUIRED</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Although advisory and not binding, the Compensation
Committee of the Board (the &ldquo;Compensation Committee&rdquo;) and the Board will consider the outcome of this vote on Voting Proposal
No.&nbsp;9 when considering future compensation arrangements for the Company&rsquo;s NEOs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>THE BOARD UNANIMOUSLY RECOMMENDS THAT YOU VOTE
 &ldquo;FOR&rdquo; THE APPROVAL, ON AN ADVISORY BASIS, OF THE COMPENSATION OF THE NAMED EXECUTIVE OFFICERS, AS STATED IN THE ABOVE RESOLUTION.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_012"></A>AGENDA ITEM XII - ANY OTHER
BUSINESS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The 2022 Annual Meeting will review and discuss
any other business brought to its attention.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_013"></A>AGENDA ITEM XIII - CLOSING
OF THE MEETING</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Chair will conclude the meeting.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="b_014"></A>CORPORATE GOVERNANCE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Board of Directors (the &ldquo;Board&rdquo;) Leadership Structure
and Composition</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have a one-tier board structure under Dutch
law, meaning that executive and non-executive directors are members of the same board of directors.&nbsp; Our Articles of Association
provide that the number of members of our Board will be determined by our Board, provided that the Board shall be comprised of at least
one executive director and at least one non-executive director and provided further that the number of executive directors shall at all
times be less than the number of non-executive directors.&nbsp; Our Board currently consists of nine directors, one of whom is an executive
director and eight of whom are non-executive directors. If a director is to be appointed, the non-executive directors make a binding
nomination, which is approved by the general meeting of shareholders pursuant to the procedure described in Voting Proposal Numbers 3
and 4. Under our Articles of Association, a general meeting of shareholders may suspend or dismiss a director by at least a two-thirds
majority of votes cast, provided that such majority represents more than half of the issued share capital. The Board may suspend (but
may not dismiss) an executive director. In the event of an absence or inability to act with respect to one or more of the directors,
our Articles of Association provide that the non-executive directors shall be authorized to temporarily fill the vacant position for
a period up to the first general meeting, or in the case of a director unable to act, up to the moment he is no longer unable to act.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 18; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->12<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 30.55pt">Under our Articles of Association
and Dutch law, the members of our Board are collectively responsible for our management, general and financial affairs, and policy and
strategy. Our executive director is primarily responsible for managing our day-to-day affairs. Our non-executive directors supervise our
executive director and our general affairs and provide general advice to him. In performing their duties, our directors are guided by
the interest of our Company and, with the boundaries set by relevant Dutch law, must consider the relevant interests of our stakeholders.
In consultation with the Nominating and Corporate Governance Committee of the Board (the &ldquo;Nominating and Corporate Governance Committee&rdquo;),
the Board has determined that the current board structure is appropriate for the Company. Having staggered, multiple-year terms for our
directors provides for stability, continuity, and experience among our Board. Further, the Board believes that building a cohesive board
of directors is an important goal. In our industry in particular, long-term focus is critical. The time horizon required for successful
development of gene therapies makes it vital that we have a board that understands the implications of this process and has the ability
to develop and implement long-term strategies while benefiting from an in-depth knowledge of our business and operations. Our current
board structure helps to ensure that there will be the continuity, and stability of leadership required to resist the pressure to focus
on short-term results at the expense of the long-term value and success of the Company. Our future success depends in significant part
on the ability to attract and retain capable and experienced directors. In this regard, we believe that longer terms for our directors
will enhance director independence from both management and stockholder special interest groups.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Under our Articles of Association and consistent
with Dutch corporate governance principles, the Board appoints an executive director as Chief Executive Officer and appoints a non-executive
director as Chair of the Board. We believe that the separation of these roles serves our Shareholders and us well. David Meek currently
serves as our Chair, and we expect he will continue in that capacity following the 2022 Annual Meeting.&nbsp; The duties and responsibilities
of the Chair include, among others: determining the agenda and chairing the meetings of the Board, monitoring our Board to ensure that
it operates effectively, ensuring that the directors receive accurate, timely, and clear information, encouraging active engagement by
all directors, promoting effective relationships and open communication between the non-executive directors and the executive directors,
and monitoring effective implementation of our Board decisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There are no arrangements or understandings between
the directors or senior management and any other person pursuant to which our directors or senior management have been selected for their
respective positions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Directors and Senior Management</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Set forth below are the names of our current directors
and executive officers, their ages (as of March&nbsp;31, 2022), all positions and offices that they hold with us, the period during which
they have served as such, and their business experience during at least the last five years.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: Black 1pt solid; width: 36%"><FONT STYLE="font-size: 10pt"><B>Name</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 10%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Age</B></FONT></TD>
    <TD STYLE="padding-bottom: 1pt; width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; width: 50%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Position</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Matthew Kapusta</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">49</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer, Executive Director</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>David Meek</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">58</TD>
    <TD>&nbsp;</TD>
    <TD>Chair, Non-Executive Director</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Madhavan Balachandran</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">71</TD>
    <TD>&nbsp;</TD>
    <TD>Non-Executive Director</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Robert Gut, M.D., Ph.D.</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">57</TD>
    <TD>&nbsp;</TD>
    <TD>Non-Executive Director, former Chief Medical Officer</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Rachelle Jacques</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">50</TD>
    <TD>&nbsp;</TD>
    <TD>Non-Executive Director</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Jack Kaye</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">78</TD>
    <TD>&nbsp;</TD>
    <TD>Non-Executive Director</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Leonard Post, Ph.D.</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">69</TD>
    <TD>&nbsp;</TD>
    <TD>Non-Executive Director</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Paula Soteropoulos</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">54</TD>
    <TD>&nbsp;</TD>
    <TD>Non-Executive Director</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Jeremy Springhorn, Ph.D.</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">59</TD>
    <TD>&nbsp;</TD>
    <TD>Non-Executive Director</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Pierre Caloz</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">50</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Operations Officer</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Ricardo Dolmetsch</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">53</TD>
    <TD>&nbsp;</TD>
    <TD>President, Research&nbsp;&amp; Development</TD></TR>
  <TR STYLE="vertical-align: top; background-color: White">
    <TD>Christian Klemt</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">49</TD>
    <TD>&nbsp;</TD>
    <TD>Chief Financial Officer</TD></TR>
  <TR STYLE="vertical-align: top; background-color: rgb(204,238,255)">
    <TD>Alexander Kuta, Ph.D.</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="text-align: center">62</TD>
    <TD>&nbsp;</TD>
    <TD>Executive Vice President, Quality &amp; Regulatory Affairs</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 19; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->13<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 80%; border-collapse: collapse">
  <TR STYLE="vertical-align: top; background-color: #D9E1F2">
    <TD COLSPAN="5" STYLE="border: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Board Diversity
    Matrix (As of April&nbsp;18, 2022)</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Total
    Number of Directors</B></TD>
    <TD COLSPAN="4" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>9</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D9E1F2">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; width: 45%; padding-right: 5.4pt; padding-left: 5.4pt">&nbsp;</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; width: 10%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Female</B></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; width: 9%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Male</B></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; width: 15%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Non-Binary</B></TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; width: 21%; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"><B>Did
    Not <BR>
    Disclose <BR>
    Gender</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD COLSPAN="5" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Part&nbsp;I:
    Gender Identity</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D9E1F2">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Directors</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">7</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD COLSPAN="5" STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt"><B>Part&nbsp;II:
    Demographic Background</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D9E1F2">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">African
    American or Black</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Alaskan
    Native or Native American</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D9E1F2">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Asian</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">1</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD></TR>

<TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Hispanic
    or Latinx</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D9E1F2">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Native
    Hawaiian or Pacific Islander</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">White</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">2</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">6</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D9E1F2">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Two
    or More Races or Ethnicities</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD></TR>
  <TR STYLE="vertical-align: top; background-color: white">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">LGBTQ+</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #D9E1F2">
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; border-left: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">Did
    Not Disclose Demographic Background</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center">0</TD>
    <TD STYLE="border-right: black 1pt solid; border-bottom: black 1pt solid; padding-right: 5.4pt; padding-left: 5.4pt; text-align: center"></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>MATTHEW KAPUSTA</B>. Matthew Kapusta, age 49, has been Chief Executive
Officer of uniQure since December&nbsp;2016, and currently serves on the Company&rsquo;s Board of Directors. Mr.&nbsp;Kapusta also served
as our Chief Financial Officer from joining uniQure in January&nbsp;2015 until June&nbsp;2021. Prior to joining uniQure, Mr.&nbsp;Kapusta
was Senior Vice President at AngioDynamics (Nasdaq: ANGO) from 2011 to 2014, responsible for corporate development, strategic planning,
and national accounts. Prior to AngioDynamics, he served as Vice President, Finance and Strategic Planning and Analysis for Smith&nbsp;&amp;
Nephew Orthopaedics. Mr.&nbsp;Kapusta&rsquo;s career also includes more than a decade of investment banking experience focused on emerging
life sciences companies. Mr.&nbsp;Kapusta was Managing Director, Healthcare Investment Banking at Collins Stewart, and held various positions
at Wells Fargo Securities, Robertson Stephens, and PaineWebber. Mr.&nbsp;Kapusta holds a Master of Business Administration from New York
University&rsquo;s Stern School of Business, a Bachelor of Business Administration from University of Michigan&rsquo;s Ross School of
Business and earned his Certified Public Accountant license in 1996 while at Ernst&nbsp;&amp; Young. We believe that Mr.&nbsp;Kapusta
is qualified to serve as our Chief Executive Officer and an Executive Director due to his broad expertise in the biotechnology and finance
industries.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>DAVID MEEK</B>. David Meek, age 58, has served as a member of our
Board since June&nbsp;2018 and as Chair of our Board since June&nbsp;2021. Mr.&nbsp;Meek has&nbsp;more than 30 years of experience in
the biopharma industry, where he has held various global executive positions in major pharmaceutical and biotechnology companies. Mr.&nbsp;Meek
was appointed CEO and Director of Mirati Therapeutics (Nasdaq: MRTX), a public clinical stage oncology biotech company, in September&nbsp;2021.
From January&nbsp;2020 to March&nbsp;2021, Mr.&nbsp;Meek was President&nbsp;&amp; CEO, Director of FerGene, a gene therapy biotech focused
on the treatment of cancer. From July&nbsp;2016 to December&nbsp;2020, Mr.&nbsp;Meek was CEO and a member of the Board of Ipsen, a French
public biopharma company. From July&nbsp;2014 to June&nbsp;2016, he was Executive Vice-President and President of the oncology division
of Baxalta prior to being acquired by Shire. He spent two years as the Chief Commercial Officer of Endocyte from August&nbsp;2012 to
July&nbsp;2014. Mr.&nbsp;Meek also spent eight years at Novartis as a global franchise head from January&nbsp;2005 to June&nbsp;2007,
CEO of Novartis Canada from July&nbsp;2007 to December&nbsp;2009, and region head of oncology for northern, central and Eastern Europe
from January&nbsp;2010 to August&nbsp;2012. He began his biopharma career at Johnson&nbsp;&amp; Johnson and Janssen Pharmaceuticals where
he worked from July&nbsp;1989 to December&nbsp;2004 and where he held increasingly senior levels of executive roles. Mr.&nbsp;Meek serves
as a Director for Entasis Therapeutics (Nasdaq: ETTX). &nbsp;Mr.&nbsp;Meek holds a B.A. from the University of Cincinnati. We believe
Mr.&nbsp;Meek is qualified to serve as a Non-Executive Director due to his extensive experience in the biotechnology industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>MADHAVAN BALACHANDRAN</B>. Mr.&nbsp;Balachandran, age 71, has served
as a member of our Board since September&nbsp;2017. Mr.&nbsp;Balachandran has been a director of Catalent (NYSE: CTLT) since May&nbsp;2017.
Mr.&nbsp;Balachandran was Executive Vice President, Operations of Amgen Inc., a global biotechnology company, from August&nbsp;2012 until
July&nbsp;2016 and retired as an Executive Vice President in January&nbsp;2017. Mr.&nbsp;Balachandran joined Amgen in 1997 as Associate
Director, Engineering. He became Director, Engineering in 1998, and, from 1999 to 2001, he held the position of Senior Director, Engineering
and Operations Services before moving to the position of Vice President,&nbsp;Information Systems from 2001 to 2002. Thereafter, Mr.&nbsp;Balachandran
was Vice President, Puerto Rico Operations from May&nbsp;2002 to February&nbsp;2007. From February&nbsp;2007 to October&nbsp;2007, Mr.&nbsp;Balachandran
was Vice President, Site Operations, and from October&nbsp;2007 to August&nbsp;2012, he held the position of Senior Vice President, Manufacturing.
Prior to his tenure at Amgen, Mr.&nbsp;Balachandran held leadership positions at Copley Pharmaceuticals, now a part of Teva Pharmaceuticals
Industries Ltd., and Burroughs Wellcome Company, a predecessor before mergers of GlaxoSmithKline plc. Mr.&nbsp;Balachandran holds a Master
of Science degree in Chemical Engineering from The State University of New York at Buffalo and an MBA from East Carolina University.
We believe Mr.&nbsp;Balachandran is qualified to serve as a Non-Executive Director due to his extensive experience in the biotechnology
industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 20; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->14<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ROBERT GUT, M.D., Ph.D.</B> Dr. Robert Gut,
age 57, was elected to his current term as a Non-Executive Director in December 2020. Dr Gut first joined our Board in June 2018,
and previously served as both a Non-Executive and an Executive Director. He also served as our Chief Medical Officer from August
2018 until October 2020. During his time as our Chief Medical Officer, Dr. Gut led clinical development, clinical operation and
medical team activities that successfully initiated and executed our HOPE-B pivotal trial of etranacogene dezaparvovec for
hemophilia B and our Phase 1/2 clinical trial of AMT-130 for the treatment of Huntington&rsquo;s Disease. In October 2020, he
resigned as Chief Medical Officer and as executive director (because under Dutch law our executive directors must hold an executive
position with the Company), and in December 2020, he was reappointed to the Board as a non-executive director. Dr. Gut has more than
23 years of experience in the biopharmaceutical industry-leading clinical development and medical affairs activities in rare
disorders and other therapeutic areas. For most of his career, Dr. Gut worked at Novo Nordisk Inc. (NYSE: NVO), where he headed the
company&rsquo;s U.S. Biopharm Medical organization with leading products in hemophilia, endocrinology, and women&rsquo;s health
(NovoSeven&reg;, Norditropin&reg; and Vagifem&reg;), totaling approximately $1.6 billion in U.S. revenue. Over his career, Dr.
Gut&rsquo;s contributions have helped achieve six FDA product approvals and three additional new product indications. Dr. Gut has
supported the launch of nine new products, overseeing medical activities including medical science liaison and health economics and
outcomes research teams building. He has also served for the FDA&rsquo;s Center for Drug Evaluation and Research as a member of the
Advisory Committees for Reproductive Health Drugs and Drug Safety and Risk Management. Dr. Gut was appointed the Chief Medical
Officer of Versartis, Inc. in September 2017 and received his Doctor of Medicine degree from the Medical University of Lublin, and
his Doctorate degree from Lublin Institute of Medicine, Poland. He attended numerous postgraduate programs at Wharton, Stanford, and
Harvard Business School. We believe Dr. Gut is qualified to serve as a Non-Executive Director due to his extensive experience in the
biotechnology industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>RACHELLE JACQUES</B>. Rachelle Jacques, age 50, has more than 25
years of industry experience, with strong global experience in strategic, cross-functional leadership roles spanning finance, business
operations, manufacturing, and commercial, including the successful launches of several novel therapies for rare diseases. In March&nbsp;2022,
Ms.&nbsp;Jacques was appointed President and Chief Executive Officer of Akari Therapeutics, a late-stage biopharmaceutical company focused
on innovative therapeutics to treat orphan autoimmune and inflammatory diseases. From February&nbsp;2019 to March&nbsp;2022, Ms.&nbsp;Jacques
has served as the Chief Executive Officer of Enzyvant Therapeutics Inc, focusing on the development of transformative regenerative therapies
for rare diseases. From August&nbsp;2017 to February&nbsp;2019, she served as the Senior Vice President and Global Complement Franchise
Head at Alexion Pharmaceuticals,&nbsp;Inc., where she was responsible for global franchise strategy development and execution across
the therapeutic areas of hematology, nephrology, and neurology. From January&nbsp;2016 to June&nbsp;2017, she was Vice President of U.S.
Hematology Marketing at Baxalta Inc. and then Shire plc, following Shire&rsquo;s acquisition of Baxalta in 2016. From July&nbsp;2015
to June&nbsp;2016, she served as Vice President of Business Operations at Baxalta Inc. after its spinoff from Baxter International Inc.
Ms.&nbsp;Jacques held multiple leadership positions at Baxter, including Vice President of Finance, U.S. BioScience Business. Earlier
in her career, Ms.&nbsp;Jacques served in various roles at Dow Corning Corporation, including operational management positions in the
U.S., Europe, and China. Ms.&nbsp;Jacques received her B.A. degree in business administration from Alma College. She has also served
as a financial auditor for Ernst&nbsp;&amp; Young and Deloitte and Touche. Since April&nbsp;2019, Ms.&nbsp;Jacques has served on the
Board of Directors of Corbus Pharmaceuticals (Nasdaq: CRBP), and from April&nbsp;2020 to February&nbsp;2021, she served on the Board
of Directors of Viela Bio. She is a founding member of the Alliance for Regenerative Medicine (ARM) Action for Equality Task Force.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>JACK KAYE</B>. Jack Kaye, age 78, has served as
a member of our Board since 2016. Mr. Kaye has also served as Chairman of the Audit Committee of Keryx Biopharmaceuticals, Inc. (Nasdaq:
KERX) from 2006 to 2016, is currently chairman of the Audit Committee and a member of the Compensation Committee of Dyadic International,
Inc. (OTC: DYAI), and chairman of the Audit Committee of DiaCarta Ltd. Mr. Kaye began his career at Deloitte LLP, an international accounting,
tax and consulting firm, in 1970, and was a partner in the firm from 1978 until May 2006. At Deloitte, he was responsible for servicing
a diverse client base of public and private, global, and domestic companies in a variety of industries. Mr. Kaye has extensive experience
consulting with clients on accounting and reporting matters, private and public debt financings, SEC rules and regulations, corporate
governance, and Sarbanes-Oxley matters. Prior to retiring, Mr. Kaye served as Partner-in-Charge of Deloitte&rsquo;s Tri-State Core Client
practice, a position he held for more than 20 years. Mr. Kaye has a Bachelor of Business Administration from Baruch College and is a Certified
Public Accountant. We believe that Mr. Kaye is qualified to serve as a Non- Executive Director due to his extensive accounting and financial
experience.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>LEONARD POST, PH.D. </B>Dr.&nbsp;Post, age 69, has over 35 years
of experience in the pharmaceutical industry where he has held various global executive positions and has extensive experience in research
and development of product candidates. Since July&nbsp;2016, Dr.&nbsp;Post has served as Chief Scientific Officer of Vivace Therapeutics,
an oncology company working on small molecules targeting the hippo pathway and is also Chief Scientific Officer of its sister company
Virtuoso Therapeutics, a company working on bispecific antibodies for oncology. From February&nbsp;2010 until June&nbsp;2016, Dr.&nbsp;Post
worked at BioMarin (Nasdaq: BMRN), in various positions including Chief Scientific Officer. During that time, he oversaw the initiation
of BioMarin&rsquo;s first gene therapy project for hemophilia A. Prior to that, Dr.&nbsp;Post served as Chief Scientific Officer of LEAD
Therapeutics, Senior Vice President of Research&nbsp;&amp; Development at Onyx Pharmaceuticals, and Vice President of Discovery Research
at Parke-Davis Pharmaceuticals. He is also currently an advisor to Canaan Partners. Dr.&nbsp;Post is a virologist by training and did
early work on engineering of herpes simplex virus as a postdoctoral fellow. He has a Bachelor of Science degree in Chemistry from the
University of Michigan, and a Doctorate degree in Biochemistry from the University of Wisconsin. We believe Dr.&nbsp;Post is qualified
to serve as a Non-Executive Director due to his extensive experience in the biotechnology industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 21; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->15<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PAULA SOTEROPOULOS</B>. Paula Soteropoulos, age 54, has served
as a member of our Board since July&nbsp;2013. Ms.&nbsp;Soteropoulos is an executive leader with more than 30 years of experience in
the biopharma industry in areas of drug development, manufacturing, business development, global commercialization and company building.
She currently serves as the Executive Chairman of Ensoma, a private venture-backed company. Since November&nbsp;2020, she has served
on the Board of Directors of Rallybio, LLC. Since March&nbsp;2020 she also has served as a Strategic Advisor to 5AM Ventures. From January&nbsp;2015
through September&nbsp;2019, she served as President and Chief Executive Officer of Akcea Therapeutics (Nasdaq: AKCA). From July&nbsp;2013
to December&nbsp;2014, she served as Senior Vice President and General Manager, Cardiometabolic Business and Strategic Alliances at Moderna
Therapeutics Inc. Prior to this, Ms.&nbsp;Soteropoulos worked at Genzyme Corporation, a biotechnology company, from 1992 to 2013, most
recently as Vice President and General Manager, Cardiovascular, Rare Diseases. Ms.&nbsp;Soteropoulos holds a Bachelor of Science degree
in chemical engineering and a Master of Science degree in chemical and biochemical engineering, both from Tufts University, and holds
an executive management certificate from the University of Virginia, Darden Graduate School of Business Administration. Ms.&nbsp;Soteropoulos
serves on the Advisory Board for the Chemical and Biological Engineering Department of Tufts University. We believe Ms.&nbsp;Soteropoulos
is qualified to serve as a Non-Executive Director due to her extensive experience in the biotechnology industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>JEREMY SPRINGHORN. Ph.D. </B>Dr.&nbsp;Springhorn, age 59, has served
as a member of our Board since September&nbsp;2017. Since April&nbsp;2021, Dr.&nbsp;Springhorn has been Chief Executive Officer of Nido
Biosciences. Prior to taking his position at Nido, Dr.&nbsp;Springhorn was Chief Business Officer of Syros Pharmaceuticals,&nbsp;Inc.
(Nasdaq: SYRS) from November&nbsp;2017 until April&nbsp;2021. Prior to taking his position at Syros, Dr.&nbsp;Springhorn served as Partner,
Corporate Development at Flagship Pioneering from March&nbsp;2015 until June&nbsp;2017 where he worked with VentureLabs in helping companies
in various strategic and corporate development capacities, creating next generation startups, and working with Flagship&rsquo;s Corporate
Limited Partners. Prior to joining Flagship, Dr.&nbsp;Springhorn was one of the original scientists at Alexion Pharmaceuticals,&nbsp;Inc.
(Nasdaq: ALXN) and was one of the original inventors of the drug Soliris&reg;. At Alexion Pharmaceuticals, Dr.&nbsp;Springhorn was Vice
President of Corporate Strategy and Business Development from 2006 until March&nbsp;2015. Dr.&nbsp;Springhorn started at Alexion in 1992
where he served in various leadership roles in R&amp;D before switching to Business Development in 2006. Prior to 1992, Dr.&nbsp;Springhorn
received his Ph.D. from Louisiana State University Medical Center in New Orleans and his BA from Colby College. Dr.&nbsp;Springhorn currently
serves on the Board of Directors for NMD Pharma, Board of Advisors for Mythic Therapeutics, and the Board of Visitors for Colby College.
We believe Dr.&nbsp;Springhorn is qualified to serve as a Non-Executive Director due to his extensive experience in the biotechnology
industry.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>PIERRE CALOZ</B>. Mr.&nbsp;Pierre Caloz, age 50, joined
uniQure as Chief Operations Officer in May&nbsp;2021. Mr. Caloz oversees manufacturing, supply chain, engineering as well as product
development and analytical development. Mr.&nbsp;Caloz oversees Manufacturing Operations, Product Development and Analytical
Development, and he is responsible for the development of uniQure&rsquo;s global commercial manufacturing capability. Mr.&nbsp;Caloz
has nearly 25 years of global operations experience in the biopharma industry, including at CSL Behring, Merck-Serono, and Abgenix. Most recently, Mr. Caloz served as Senior Vice President and General Manager of EU and Asia Pacific
Operations at CSL Behring. Mr. Caloz earned a B.Sc. degree from the University of Geneva, a M.Sc. degree from Swiss Federal
Institute of Technology, and an E.M.B.A. from the Ashridge Business School.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>RICARDO DOLMETSCH, Ph.D. </B>Dr.&nbsp;Ricardo Dolmetsch, age 53,
joined uniQure in September&nbsp;2020 as our President, Research&nbsp;&amp; Development. He is responsible for uniQure&rsquo;s research,
nonclinical and clinical development activities.&nbsp; Prior to joining uniQure, Dr.&nbsp;Dolmetsch served as the Global Head of Neuroscience
at the Novartis Institutes for Biomedical Research (NIBR) the research and early development arm of Novartis. There, he built the team
and led the development of treatments for neurodegenerative and neuropsychiatric diseases, including rare genetically defined disorders.
During his tenure, Dr.&nbsp;Dolmetsch played an instrumental role in Novartis&rsquo; acquisition of AveXis in 2018 and the successful
development of the Novartis gene therapy pipeline. Prior to NIBR, Dr.&nbsp;Dolmetsch was a Professor at Stanford Medical School and a
Senior Director at the Allen Institute for Brain Science in Seattle, Washington.&nbsp; He obtained his bachelor&rsquo;s degree with honors
from Brown University, earned his Ph.D. in neuroscience from Stanford University and conducted his postdoctoral training at Harvard University
Medical School and Children&rsquo;s Hospital Boston.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CHRISTIAN KLEMT.</B> Christian Klemt, age 49, has served as our
Chief Financial Officer since June&nbsp;2021 and since September&nbsp;2020 serves as general manager of our Amsterdam site. Previously,
Mr.&nbsp;Klemt served as our Chief Accounting Officer from August&nbsp;2017 to June&nbsp;2021, and as our Global Controller from September&nbsp;2015
until August&nbsp;2017. While serving as our Global Controller, Mr.&nbsp;Klemt oversaw our transition to a domestic U.S. filer and conversion
to U.S. Generally Accepted Accounting Principles. Mr.&nbsp;Klemt joined us from CGG SA (NYSE: CGG) where he held the position of Regional
Finance Director and Country Manager. Prior to this, he held various senior finance roles including Group Finance Manager at Basell Polyolefines
N.V. (now LyondellBasell N.V.) (NYSE: LBI) where he led the conversion to U.S. Generally Accepted Accounting Principles following the
acquisition of Lyondell and was involved in the acquisition of various petrochemical assets. Mr.&nbsp;Klemt holds a master&rsquo;s degree
in Business Administration from the University of Muenster, Germany and qualified as a German Certified Public Accountant and Tax Advisor
while employed at KPMG.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><B>ALEXANDER KUTA, PH.D.</B> Dr. Kuta, age 62,
joined uniQure in January 2017 and has served as our Executive Vice President, Quality &amp; Regulatory Affairs since May 2021. He served
as our Executive Vice President, Operations from May 2021 to August 2019 and as our Senior Vice President, Regulatory Affairs from January
2017 to August 2019. Prior to joining uniQure, he was Vice President of Research &amp; Development Global Regulatory Affairs for EMD
Serono, responsible for immune-mediated diseases, oncology, and biologics regulatory CMC, from January 2016 to September 2016. He joined
EMD Serono in April 2013 as Vice President, Head of US Regulatory Affairs. While at EMD Serono he served on the US Leadership Team. From
April 2012 to March 2013, Dr. Kuta was Vice President of Global Regulatory Affairs and a member of the Executive Leadership Team at Lantheus
Medical Imaging. His previous industry experience includes senior regulatory leadership roles at AMAG Pharmaceuticals (Nasdaq: AMAG)
from August 2010 to April 2012 as well as Genzyme Corporation from August 1995 to July 2010 where he worked in the areas of rare diseases,
cell, and gene therapy, therapeutic proteins, and biomaterials. Prior to joining industry, he was Chief of the Cytokine and Gene Therapy
Branch in the Center for Biologics at FDA from January 1993 to August 1995 and a Scientific Reviewer from January 1990 to January 1993.
Dr. Kuta has served on the BIO Regulatory Affairs Leadership Committee - Cell and Gene Therapy Working Group, as reviewer for the National
Gene Vector Laboratories program, on the ICH (M6) Gene Therapy Working Group and is currently on the scientific review board of the Gene
Therapy Resource Program of NHLBI/NIH. Dr. Kuta holds a Bachelor of Science degree from Saint John&rsquo;s University, Collegeville,
MN, and a Ph.D. from the Chicago Medical School at Rosalind Franklin U-Med &amp; Science. He conducted his post-doctoral studies at the
National Cancer Institute/National Institutes of Health.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 22; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->16<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risk Oversight</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board, in its advisory capacity,
and the Company&rsquo;s management regularly review the Company&rsquo;s strategic plan which includes, among other things, the various
business, clinical, developmental, financial, and other market risks confronting, and opportunities available to, the Company at any given
time. Specifically, pursuant to the Company&rsquo;s Corporate Governance Guidelines and Board Rules, the Board is charged with assessing
major risks facing the Company and reviewing options to mitigate such risks. The Board performs this oversight role by using several
different levels of review. In connection with its reviews of the operations and corporate functions of the Company, the Board addresses
the primary risks associated with those operations and corporate functions. In addition, the Board reviews the risks associated with
the Company&rsquo;s business strategies periodically throughout the year as part of its consideration of undertaking any such business
strategies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board has delegated certain risk oversight
responsibilities to its committees (the &ldquo;Committees&rdquo;). Each of our Board&rsquo;s Committees also oversees the management
of the Company&rsquo;s risk that falls within each Committee&rsquo;s areas of responsibility. In performing this function, each Committee
has full access to management, as well as the ability to engage advisors. For example, the Audit Committee is required to regularly review
and discuss with management the Company&rsquo;s major financial risk exposures and the steps management has taken to monitor and control
such exposures. The Nominating and Corporate Governance Committee is required to regularly review the corporate governance principles
of the Company and recommend to the Board any proposed changes it may deem appropriate.&nbsp; The Compensation Committee considers risks
related to the attraction and retention of professional talent and the implementation and administration of compensation and benefit
plans affecting the Company&rsquo;s employees.&nbsp; All Committees are required, pursuant to their respective charters, to report regularly
to the Board.&nbsp; The activities of the Audit, Compensation, Nominating and Corporate Governance and Research&nbsp;&amp; Development
Committees are more fully described below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Board Determination of Director Independence</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 30.55pt">Our securities are listed on
the Nasdaq Global Select Market (&ldquo;Nasdaq&rdquo;), and we use the standards of &ldquo;independence&rdquo; prescribed by rules set
forth by Nasdaq. Under Nasdaq rules, a majority of a listed company&rsquo;s board of directors must be comprised of independent directors.
In addition, Nasdaq rules require that, subject to specified exceptions, each member of a listed company&rsquo;s audit committee and compensation
committee be independent and, in the case of audit committees, satisfy additional independence criteria set forth in Rule 10A-3, under
the Exchange Act. Under Nasdaq rules, a director will only qualify as an &ldquo;independent director&rdquo; if, in the opinion of that
company&rsquo;s board of directors, that person does not have a relationship that would interfere with the exercise of independent judgment
in fulfilling the responsibilities of a director.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Based upon information requested from and provided
by each director concerning their background, employment and affiliations, including family relationships, our Board has determined that
each of Madhavan Balachandran, Rachelle Jacques, Jack Kaye, David Meek, Leonard Post, Paula Soteropoulos, and Jeremy Springhorn has no
relationship that would interfere with the exercise of independent judgment in carrying out the responsibilities of a director and is
independent within the meaning of the director independence standards of the Nasdaq rules&nbsp;and the SEC. Our Board has determined
that each of Matthew Kapusta and Robert Gut do not qualify as &ldquo;independent&rdquo; under the Nasdaq rules.&nbsp;Our Board has also
determined that each of the current members of our Audit Committee and our Compensation Committee satisfies the independence standards
for such committee established by Rule&nbsp;10A-3 under the Exchange Act, the SEC rules,&nbsp;and the Nasdaq rules, as applicable, and
that the current members of the Nominating and Corporate Governance Committee are also independent.&nbsp; In making these determinations,
the directors reviewed and discussed information provided by the directors and the Company regarding each director&rsquo;s business and
personal activities as they may relate to the Company and the Company&rsquo;s management.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Board Meetings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board met six (6)&nbsp;times during the calendar
year ended December&nbsp;31, 2021. Each of our directors attended at least 75% of the meetings of the Board and the Committees on which
he or she served during the year ended December&nbsp;31, 2021 (in each case, which was held during the period for which he or she was
a director and/or a member of the applicable Committee). Except for two absences during 2021, each of the directors attended all meetings
of the Board. Philip Astley-Sparke, Madhavan Balachandran, Robert Gut, Matt Kapusta, Jack Kaye, David Meek, Leonard Post and Paula Soteropoulos
attended our 2021 Annual General Meeting of Shareholders held on June&nbsp;16, 2021.&nbsp;Mr.&nbsp;Meek, Mr.&nbsp;Balachandran, Dr.&nbsp;Gut,
Mr.&nbsp;Kapusta, Mr.&nbsp;Kaye, and Dr.&nbsp;Post attended our 2021 Extraordinary General Meeting of Shareholders held on October&nbsp;21,
2021.&nbsp; The Company encourages its directors to attend the annual and extraordinary general meetings of shareholders. Executive sessions,
or meetings of the independent directors without management present, are held regularly.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Committees and Committee Meetings</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 30.55pt">The Board has a
standing Audit Committee, Nominating and Corporate Governance Committee, Compensation Committee, and Research &amp; Development
Committee. Each of the committees except for the Research &amp; Development Committee is comprised solely of independent directors
and is described more fully below. The Research &amp; Development Committee includes three independent directors and one director
that is not independent (Dr. Gut). The members of each Committee are appointed by our Board. From time to time, the Board may
establish other committees. Below is a description of the four principal Committees of our Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 23; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->17<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Audit Committee and Audit Committee Financial Expert</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Audit Committee is currently comprised of
Jack Kaye, Rachelle Jacques, and Jeremy Springhorn. Mr.&nbsp;Kaye serves as the Chair of the Audit Committee.&nbsp; The Audit Committee
has determined that Mr.&nbsp;Kaye is an &ldquo;audit committee financial expert&rdquo; within the meaning of the SEC&rsquo;s rules&nbsp;and
regulations and has the level of financial sophistication required by Nasdaq Rule&nbsp;5605(c)(2)(A).&nbsp; Each of Mr.&nbsp;Kaye, Ms.&nbsp;Jacques,
and Dr.&nbsp;Springhorn satisfies the director independence standards and the independence standards for members of the Audit Committee
established by SEC and Nasdaq. Following the 2021 Annual Meeting, Ms.&nbsp;Paula Soteropoulos, who also satisfied the director independence
standards and the independence standards for members of the Audit Committee established by SEC and Nasdaq, joined the committee to succeed
Mr.&nbsp;Astley-Sparke (who did not stand for reelection at the June&nbsp;2021 general meeting of shareholders) on an interim basis until
Ms.&nbsp;Jacques joined the Audit Committee following her appointment to the Board in October&nbsp;2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">As noted above, the Audit Committee
is governed by the Audit Committee Charter. A copy of this Charter is available on our website at www.uniqure.com under &ldquo;Investors
 &amp; Newsroom &mdash; Corporate Governance &mdash; uniQure Audit Committee Charter.&rdquo; In addition to the risk oversight responsibilities
discussed above, the Audit Committee&rsquo;s other responsibilities include recommending the selection of our independent registered public
accounting firm; reviewing with the Company&rsquo;s independent registered public accounting firm the procedures for and results of their
audits; reviewing with the independent accountants and management our financial reporting, internal controls and internal audit procedures;
reviewing and approving related party transactions; and reviewing matters relating to the relationship between the Company and our independent
registered public accounting firm, including the selection of and engagement fee for our independent registered public accounting firm,
and assessing the independence of the independent registered public accounting firm. The Audit Committee has the authority to engage independent
legal, accounting, and other advisers, as it determines necessary to perform its duties.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Audit Committee met five (5)&nbsp;times during
2021, and each member attended all the meetings during the period for which they were a member of the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Compensation Committee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Compensation Committee is currently comprised
of Madhavan Balachandran, Jack Kaye, and David Meek.&nbsp; Mr.&nbsp;Balachandran serves as the Chair of the Compensation Committee. Each
of Mr.&nbsp;Balachandran, Mr.&nbsp;Kaye, and Mr.&nbsp;Meek satisfies the director independence standards and the independence standards
for members of the Compensation Committee established by the SEC and Nasdaq. The Compensation Committee is governed by the Compensation
Committee Charter. A copy of this Charter is available on our website at www.uniqure.com under &ldquo;Investors&nbsp;&amp; Newsroom &mdash;
Corporate Governance &mdash;&nbsp;uniQure Compensation Committee Charter.&rdquo;&nbsp;In addition to the risk oversight responsibilities
discussed above, the Compensation Committee&rsquo;s other responsibilities include reviewing&nbsp;and approving or recommending to the
Board for approval, as appropriate, the compensation of our executive officers following consideration of corporate goals and objectives
relevant to such executive officers; overseeing the evaluation of the Company&rsquo;s senior executives; reviewing and making recommendations
to the Board regarding incentive compensation and equity-based plans; and administering our stock option plans.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Without further action from the
Board, the Compensation Committee has the authority to retain compensation consultants and other outside advisors to assist in the evaluation
of executive officer compensation and is empowered to pay compensation to such consultants and other outside advisors. The Compensation
Committee retained WTW (formerly Willis Towers Watson) to act as a compensation consultant during the year ended December 31, 2021 to
assist in designing and reviewing our management and director compensation programs. For further information, please refer to &ldquo;Compensation
Discussion and Analysis,&rdquo; below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Compensation Committee met seven (7)&nbsp;times
during 2021, and the members attended all meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Nominating and Corporate Governance Committee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Nominating and Corporate Governance Committee
is currently comprised of Jeremy Springhorn, David Meek, and Paula Soteropoulos.&nbsp;Dr.&nbsp;Springhorn currently serves as the Chair
of the Nominating and Corporate Governance Committee. Each of Dr.&nbsp;Springhorn, Ms.&nbsp;Soteropoulos and Mr.&nbsp;Meek satisfy the
independence standards established by SEC and Nasdaq. The Nominating and Corporate Governance Committee is governed by the Nominating
and Corporate Governance Committee Charter. A copy of this Charter is available on our website at www.uniqure.com under &ldquo;Investors&nbsp;&amp;
Newsroom &mdash; Corporate Governance &mdash; uniQure Nominating and Corporate Governance Committee Charter.&rdquo;&nbsp; In addition
to the risk oversight responsibilities discussed above, the Nominating and Corporate Governance Committee&rsquo;s other responsibilities
include identifying individuals qualified to become Board members and to recommend to the Board the nominees for director at annual general
meetings of shareholders; recommending to the Board nominees for each Committee; developing and recommending to the Board corporate governance
principles applicable to the Company; and leading the Board in its annual review of the Board&rsquo;s performance. Following the 2021
Annual Meeting, Mr.&nbsp;Meek joined the committee to succeed Mr.&nbsp;Astley-Sparke.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Nominating and Corporate Governance Committee
met six (6)&nbsp;times during 2021, and each member attended all the meetings during the period for which they were a member of the Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 24; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->18<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Research&nbsp;&amp; Development Committee</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Research&nbsp;&amp; Development Committee
is currently comprised of Leonard Post, Robert Gut, Paula Soteropoulos and Jeremy Springhorn.&nbsp;Dr.&nbsp;Post currently serves as
the Chair of the Research and Development Committee. Although neither the SEC nor Nasdaq require that the member of the Research&nbsp;&amp;
Development Committee be independent, each of Dr.&nbsp;Post, Ms.&nbsp;Soteropoulos and Dr.&nbsp;Springhorn satisfy the independence standards
established by SEC and Nasdaq. Dr.&nbsp;Gut does not currently satisfy the independence standards established by the SEC and Nasdaq.
The Research&nbsp;&amp; Development Committee is governed by the Research&nbsp;&amp; Development Committee Charter. A copy of this Charter
is available on our website at www.uniqure.com under &ldquo;Investors&nbsp;&amp; Newsroom &mdash; Corporate Governance &mdash; uniQure
Research&nbsp;&amp; Development Committee Charter.&rdquo;&nbsp; In addition to the risk oversight responsibilities discussed above, the
Research&nbsp;&amp; Development Committee&rsquo;s other responsibilities include: serving as an advisory body to the Board in matters
related to the Company&rsquo;s technology, research and development activities, product pipeline, and manufacturing platform (the &ldquo;Company&rsquo;s
Technology&rdquo;); advising the Board on the strategic direction of the Company with respect to the Company&rsquo;s technology; and
evaluating the function and effectiveness of the Company&rsquo;s research, development, manufacturing operations, clinical operations,
and other technical, scientific and medical operations. Dr.&nbsp;Gut was added to the committee in February&nbsp;2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Research&nbsp;&amp; Development Committee
met nine (9)&nbsp;times during 2021, and the members attended all meetings.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Polices Governing Director Nominations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Director Nomination Process</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Our Board is responsible for selecting its own
members for appointment. The Board delegates the selection and nomination process to the Nominating and Corporate Governance Committee,
with the expectation that other members of the Board, and of management, will be requested to take part in the process as appropriate.
The Nominating and Corporate Governance Committee makes recommendations to the Board regarding the size and composition of the Board.
The Nominating and Corporate Governance Committee is responsible for ensuring that the composition of the Board accurately reflects the
needs of the Company&rsquo;s business and, in furtherance of this goal, for proposing the addition of members for purposes of obtaining
the appropriate members and skills. The Nominating and Corporate Governance Committee recommends, and the non-executive directors nominate,
candidates to stand for appointment as directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">Our Nominating and Corporate
Governance Committee identifies candidates for director nominees in consultation with management, through the use of other advisors, through
the recommendations submitted by shareholders or through such other methods as the Nominating and Corporate Governance Committee deems
to be helpful to identify candidates. Candidates recommended by shareholders and other stakeholders are given appropriate consideration
in the same manner as other candidates. Once candidates have been identified, our Nominating and Corporate Governance Committee confirms
that the candidates meet all the minimum qualifications for director nominees established by the Nominating and Corporate Governance Committee.
The Nominating and Corporate Governance Committee may gather information about the candidates through interviews, detailed questionnaires,
background checks or any other means that the Nominating and Corporate Governance Committee deems to be appropriate in the evaluation
process. The Nominating and Corporate Governance Committee then meets as a group to discuss and evaluate the qualifications and skills
of each candidate, both on an individual basis and considering the overall composition and needs of the Board. Based on the results of
the evaluation process, the Nominating and Corporate Governance Committee recommends candidates as director nominees for appointment to
the Board for the Board&rsquo;s approval.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Qualifications</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">The Nominating and Corporate
Governance Committee may receive from shareholders and other recommendations for nominees for appointment to the Board and recommend to
the Board candidates for Board membership for consideration by the shareholders at the annual general meeting of shareholders. In recommending
candidates to the Board, the Nominating and Corporate Governance Committee takes into consideration the Board&rsquo;s criteria for selecting
new directors, including, but not limited to, integrity, past achievements, judgment, intelligence, relevant experience and a commitment
to understanding the Company&rsquo;s business and its industry and the ability of the candidate to devote adequate time to Board duties.
The Nominating and Corporate Governance Committee does not assign specific weights to particular criteria, and no particular criterion
is a prerequisite for any Board candidate. We do however consider diversity in reviewing director candidates and do not discriminate based
on race, religion, sexual orientation, sex or national origin. For the Board to fulfill its responsibilities, our Nominating and Corporate
Governance Committee believes that the Board should include directors possessing a blend of experience, knowledge and ability, regardless
of other characteristics.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Any Shareholder wishing to recommend a candidate
for Board membership should submit the recommendation in writing to Investor Relations at uniQure N.V., Paasheuvelweg 25a, 1105 BP Amsterdam,
the Netherlands. The written submission should set forth the candidate&rsquo;s qualifications as specified in the uniQure Nominating
and Corporate Governance Committee Charter. The Nominating and Corporate Governance Committee will consider all candidates recommended
by Shareholders who satisfy the minimum qualifications for director nominees and Board member attributes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 25; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->19<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Code of Business Conduct and Ethics and Corporate Governance Guidelines
and Board Rules</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; text-indent: 0.5in">We have adopted a code of
business conduct and ethics that is applicable to all our employees, officers, and directors, including our Chief Executive Officer
and Chief Financial Officer. The code of business conduct and ethics is available on our website at www.uniqure.com under
 &ldquo;Investors &amp; Newsroom &mdash;<FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&nbsp; </FONT>Corporate
Governance &mdash; uniQure Code of Business Conduct and Ethics.&rdquo; We have also adopted corporate governance guidelines and
board rules which are applicable to the Company&rsquo;s management and are available on our website at www.uniqure.com under
 &ldquo;Investors &amp; Newsroom &mdash; Corporate Governance &mdash; uniQure Corporate Governance Guidelines and Rules for the Board
of Directors.&rdquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In addition to the Listing Rules&nbsp;of the Nasdaq
Global Select Stock Market and rules&nbsp;and regulations as promulgated by the SEC, as a Dutch company, our governance practices are
governed by the Dutch Corporate Governance Code.&nbsp; The Dutch Corporate Governance Code (as amended) contains several principles and
best practices, with an emphasis on integrity, transparency, and accountability as the primary means of achieving good governance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">There is considerable overlap between the requirements
we must meet under U.S. rules&nbsp;and regulations and the provisions of the Dutch Corporate Governance Code.&nbsp; Although we apply
several provisions of the Dutch Corporate Governance Code, as a &ldquo;domestic&rdquo; issuer, we comply with the Nasdaq corporate governance
requirements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">In accordance with the Dutch Corporate
Governance Code&rsquo;s compliance principle of &ldquo;apply-or-explain,&rdquo; which permits Dutch companies to be fully compliant
with the Dutch Corporate Governance Code by either applying the Dutch practices or explaining why the Company has chosen to apply
different practices, we disclose in our Dutch Statutory Board Report that accompanies our Dutch Statutory Annual Accounts to what
extent we do not apply provisions of the Dutch Corporate Governance Code, together with the reasons for those deviations.&nbsp; Our
Dutch Statutory Board Report may be found on the &ldquo;Investors&nbsp;&amp; Newsroom &mdash; Events and Presentations&rdquo;
section of our website at <U>http://www.uniqure.com/investors-newsroom/events-presentations.php</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Environmental, Social and Governance Practices</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">As a company driven by its mission to transform
patients' lives, we take our responsibility to patients, employees, the medical community, and the communities in which we live and work
very seriously. As we grow, we are enhancing our focus on a variety of ESG considerations. In December 2021, the Company adopted its ESG
Plan (the &ldquo;ESG Plan&rdquo;), and, as part of that, the Company has launched an ESG Steering Committee (the &ldquo;ESG Committee&rdquo;).
The ESG Committee, which is composed of a cross-functional group of senior employees in our Company, works closely with our Nominating
and Governance Committee and across the organization in addressing ESG initiatives. While we continue to expand our ESG strategy, we have
already focused on the following areas:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Patient Community Outreach</I>: Patients are at the center of our mission.
We operate a robust patient support program, partake in regular, compliant interaction with patient advocacy groups and invite patients
to share their experiences in-person and virtually. Our community engagement activities are focused on seeking to better understand the
lives of people living with rare disease and identifying opportunities to support the rare disease community. We believe that partnering
with and understanding the lives of patients and their families differentiates us and enhances our ability to discover and develop potential
therapies. As part of our recently adopted ESG Plan, we are actively addressing additional initiatives that will both leverage the many
things we do now and create new programs to continue to develop who we are as an organization and to foster positive effects our patient
community. Finally, we continue to monitor product safety in our clinical development programs and via our pharmacovigilance program.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Diversity, Equity, and Inclusion</I>: We are committed to promoting diversity
in our workforce and to taking steps to support equity and inclusion for all. We believe that a diverse workforce positively impacts performance,
fosters innovation, strengthens culture, and inspires. As a highly diverse organization with employees from many nations across the globe,
we embrace diversity as part of our culture, and have taken active steps to improve the diversity of our board, executive team, and extended
leadership team within the Company. We will continue to measure and share our diversity statistics in the future. We expect to continue
to enhance our Board, leadership, and workforce diversity, advance the development of diverse talent, and ensure diverse succession plans
in our employee workforce, leadership, and our Board. In addition, we are committed to equitable pay for all employees and use industry
benchmarks and annual compensation reviews to ensure a fair and bias-free compensation system.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Employee Wellness</I>: We are dedicated to investing in our employees
and workplace culture. As part of this effort, we have put in place several financial wellness programs for the benefit of our workforce,
including an Employee Stock Purchase Plan and 401(k) match program. We have also taken several actions to promote the physical and mental
wellbeing of our employees, including employee recognition programs, regular employee surveys, regular townhall and site meetings, recent
office space designs focusing on employee well-being, resources for assisting with the care of family members, and online resources for
addressing stress and anxiety. Our employees (other than our manufacturing and laboratory personnel) have been provided the ability to
work virtually to flexibly manage business and home responsibilities. We have enhanced our internal communications and touch points to
ensure connectivity to our workforce. For those who choose to work from our offices, all our facilities have been appropriately evaluated
and are compliant with applicable guidelines related to COVID-19. We will continue to manage this situation with a focus on the safety
of our employees, physicians, caregivers, and patients.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Environmental Impact</I>: We are cognizant of our responsibility to our
broader environment and have supported several green measures at our headquarters in an effort to reduce our Company&rsquo;s carbon footprint,
including recycling efforts at all facilities, energy conservation using low voltage LED lighting, lighting sensors, heating and cooling
systems schedules, energy recovery systems in our manufacturing facility, and a waste management program to convert manufacturing waste
to plastic lumber. In our research laboratories and manufacturing facility, hazardous and chemical waste are responsibly managed and tracked
in line with regulatory requirements. We continue to explore ways to improve our sustainability efforts.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif"><I>Corporate Governance</I>: Our Board is committed to establishing strong
corporate governance practices with the goals of promoting strategies for long-term value creation, helping the company consider the best
interests of all stakeholders, improving management systems, minimizing risks of mismanagement and instilling trust with our investors.
Our Board adheres to our Corporate Governance Guidelines and Rules of the Board of Directors, which present a framework for good corporate
governance practices. We are focused on creating meaningful strategic direction, responsible oversight, and management of the Company.
In December 2021, we adopted our ESG Plan under the purview of our Nominating and Corporate Governance Committee, which will work closely
with our ESG Steering Committee on a regular basis. The Nominating and Corporate Governance Committee has established our ESG initiatives
and strategy as a standing item for its regularly scheduled meetings and will actively seek to continually improve our company by systematically
addressing initiatives for each of environmental stewardship, social stewardship, and improved corporate governance.</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 26; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->20<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<!-- Field: Split-Segment; Name: 2 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_003"></A><B>CERTAIN RELATIONSHIPS AND RELATED PERSON TRANSACTIONS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Pre-Approval Policy Regarding Related Person Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The Board has adopted a related party transactions
policy, pursuant to which the Chief Financial Officer and the Audit Committee are charged with reviewing and approving or disapproving
related party transactions.&nbsp; A &ldquo;Related Party Transaction&rdquo; under the policy means any transaction, arrangement or relationship
(or any series of similar transactions, arrangements or relationships) where the amount involved or proposed to be involved exceeds $120,000
(or its equivalent in any currency), in which the Company or any of its controlled subsidiaries was, is or will be a participant (i.e.,
not necessarily a party) and in which any Related Party, as defined below, had, has or will have a direct or indirect material interest.
The &ldquo;Related Party Transactions Policy&rdquo; supplements the provisions in the Company&rsquo;s Code of Business Conduct and Ethics
concerning potential conflict of interest situations. Pursuant to the policy, compensation of directors and senior management are reviewed
and approved by the Compensation Committee.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">This written policy covers transactions or series
of transactions in which the Company or any subsidiary participates, and a &ldquo;Related Party&rdquo; has or will have a direct or indirect
material interest. For purposes of this policy, a &ldquo;Related Party&rdquo; is:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 5%"></TD><TD STYLE="width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="vertical-align: top; text-align: left; width: 92%">Each
                                            director and executive officer of the Company and any person who was serving as a director
                                            and/or executive officer at any time since the beginning of the Company&rsquo;s last fiscal
                                            year;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 5%"></TD><TD STYLE="width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; width: 92%">Any
                                            nominee for appointment as a director of the Company;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 5%"></TD><TD STYLE="width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify; width: 92%">Any
                                            security holder who is the beneficial owner or record holder of more than 5% of any class
                                            of the Company&rsquo;s voting securities;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 5%"></TD><TD STYLE="width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="vertical-align: top; text-align: left; width: 92%">Any
                                            immediate family member of any of the foregoing persons. An &ldquo;immediate family member&rdquo;
                                            includes the spouse, parents, stepparents, children, stepchildren, siblings, mothers- and
                                            fathers-in-law, sons- and daughters-in-law, brothers- and sisters-in-law, and any person
                                            (other than a tenant or employee) sharing the household of a director, executive officer,
                                            director nominee or greater than 5% security holder of the Company; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 5%"></TD><TD STYLE="width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="vertical-align: top; text-align: left; width: 92%">Any
                                            entity that employs any person identified in the above or in which any person identified
                                            in the above directly or indirectly owns or has a material interest.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Pursuant to the Related Party Transactions Policy,
each Company executive officer, director or nominee for director or any other officer or employee who intends to cause the Company to
enter into a related party transaction must fully disclose to the Chief Financial Officer all material facts concerning a prospective
transaction or arrangement involving the Company in which such person may have an interest. The Chief Financial Officer will review the
information and make a preliminary, written conclusion as to whether the transaction is a related party transaction.&nbsp; If the preliminary
conclusion is that the transaction would be a related party transaction, the Chief Financial Officer will present the information and
his conclusion to the Audit Committee for review. If a member of the Audit Committee is involved in the transaction, that member will
not participate in determining whether the related party transaction is approved or ratified by the Audit Committee. Annually, the Audit
Committee will review any previously approved or ratified related party transactions that are continuing and determine based on then-existing
facts and circumstances.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Before any related person transaction is approved,
the following factors are to be considered:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="vertical-align: top; width: 5%; text-align: left"></TD><TD STYLE="vertical-align: top; width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="vertical-align: top; text-align: left; width: 92%">The
                                            Related Party&rsquo;s interest in the transaction;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="vertical-align: top; width: 5%; text-align: left"></TD><TD STYLE="vertical-align: top; width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="vertical-align: top; text-align: left; width: 92%">The
                                            approximate value of the aggregate amount involved in the transaction;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="vertical-align: top; width: 5%; text-align: left"></TD><TD STYLE="vertical-align: top; width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="vertical-align: top; text-align: left; width: 92%">The
                                            approximate value of the amount of the Related Party&rsquo;s interest in the transaction;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="vertical-align: top; width: 5%; text-align: left"></TD><TD STYLE="vertical-align: top; width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="vertical-align: top; text-align: left; width: 92%">A
                                            summary of the material terms of and facts relating to the transaction, including any documentation
                                            or proposed documentation for the transaction, and identification of the area(s)&nbsp;of
                                            the Company&rsquo;s business directly relevant to the transaction;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="vertical-align: top; width: 5%; text-align: left"></TD><TD STYLE="vertical-align: top; width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="vertical-align: top; text-align: left; width: 92%">Where
                                            the transaction involves the purchase or sale of products, property, or services, the availability
                                            of comparable products, property or services from or to (as applicable) unrelated third-party
                                            sources;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="vertical-align: top; width: 5%; text-align: left"></TD><TD STYLE="vertical-align: top; width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="vertical-align: top; text-align: left; width: 92%">Whether
                                            the transaction was undertaken in the ordinary course of business of the Company;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="vertical-align: top; width: 5%; text-align: left"></TD><TD STYLE="vertical-align: top; width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="vertical-align: top; text-align: left; width: 92%">An
                                            assessment of whether the transaction&rsquo;s terms are comparable to terms available from
                                            or to (as applicable) unrelated third parties in an arms-length transaction;</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="vertical-align: top; width: 5%; text-align: left"></TD><TD STYLE="vertical-align: top; width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="vertical-align: top; text-align: left; width: 92%">The
                                            purpose of, and the potential benefits to the Company of the transaction; and</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="vertical-align: top; width: 5%; text-align: left"></TD><TD STYLE="vertical-align: top; width: 3%; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="vertical-align: top; text-align: left; width: 92%"><FONT STYLE="font-family: Times New Roman, Times, Serif">Any other information regarding the
transaction or the Related Party in the context of the proposed transaction that would be material to investors</FONT> considering the
circumstances of the particular transaction.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 27; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->21<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Approval of a transaction under the policy will
be granted only if it is determined that, under all of the circumstances, the transaction is in, or not inconsistent with, the best interests
of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Review of Related Person Transactions</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">Between January&nbsp;1, 2021 and December&nbsp;31,
2021, the Company has engaged in the following transactions with the members of our Board, senior management, parties that held more
than 5% of our Ordinary Shares during that period, and their affiliates, which we refer to as our related parties. Each of these transactions
was approved in accordance with our Related Transactions Policy.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Compensation of and Grants of Options to Certain Related Parties</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 41.55pt 0pt 5.55pt; text-indent: 30.55pt">In the period ended December
31, 2021, executive directors received regular salaries, post-employment benefits and share-based payments. Additionally, non-executive
directors received compensation for their services in the form of cash compensation and equity grants. We grant options and restricted
share units (&ldquo;RSUs&rdquo;), to members of the Board and senior management. We also granted performance share units (&ldquo;PSUs&rdquo;)
to senior management and certain other employees. Details of equity granted are included within the beneficial ownership table below.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_004"></A><B>SECURITY OWNERSHIP OF CERTAIN&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>BENEFICIAL OWNERS AND MANAGEMENT</B></P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt">Based on information publicly filed and
provided to us by certain holders, the following table shows the number of our Ordinary Shares beneficially owned as of April 8,
2022 by (i) each person known by us to beneficially own more than five percent of our voting securities, (ii) each named executive
officer, (iii) each of our directors, (iv) each of our director nominees, and (v) all of our current NEOs and directors as a
group.&nbsp; Beneficial ownership is determined in accordance with the rules of the SEC and includes voting or investment power with
respect to securities. In computing the number of Ordinary Shares beneficially owned by a person and the percentage ownership of
that person, Ordinary Shares that could be issued upon the exercise of outstanding equity awards and warrants held by that person
that are currently exercisable or exercisable within 60 days of April 8, 2022 are considered outstanding.&nbsp;As of April 8, 2022,
we had 46,644,109 Ordinary Shares outstanding. Unless otherwise stated in a footnote, each of the beneficial owners listed below has
direct ownership of and sole voting power and investment power with respect to our Ordinary Shares.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt">Unless otherwise noted below, the address of each
director and named executive officer is c/o uniQure N.V., Paasheuvelweg 25a, 1105 BP Amsterdam, the Netherlands.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif">Name&nbsp;and&nbsp;Address&nbsp;of</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="6" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Ordinary&nbsp;Shares&nbsp;Beneficially&nbsp;Owned</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif">Beneficial&nbsp;Owner</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Number</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Percent</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: italic bold 10pt Times New Roman, Times, Serif; text-align: left">5% or Greater Shareholders (&ldquo;Major Shareholders&rdquo;):</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 72%; text-align: left">Nantahala Capital Management, LLC (1)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">4,469,213</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">9.58</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">FMR, LLC (2)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,340,063</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9.30</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Blackrock Inc. (3)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,293,805</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9.21</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Federated Hermes Inc (4)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,855,615</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8.27</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Point72 Asset Management Ltd. (5)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,609,384</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7.74</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Coller Investment Management Ltd. (6)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,840,365</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6.09</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Bristol-Myers Squibb Company (7)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,388,108</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5.12</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Investco Ltd (8)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,374,235</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5.09</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: italic bold 10pt Times New Roman, Times, Serif; text-align: left">Directors and Named Executive Officers (9)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Matthew Kapusta</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">835,630</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1.76</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Alexander E Kuta, Ph.D.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">145,461</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.31</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Christian Klemt</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">112,236</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.24</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Robert Gut, M.D., Ph.D.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">102,712</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.22</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jack Kaye</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">57,879</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.12</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Paula Soteropoulos</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">49,180</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.11</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Ricardo Dolmetsch, Ph.D.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">42,466</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.09</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Madhavan Balachandran</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">38,755</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.08</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jeremy P. Springhorn, Ph.D.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">38,755</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.08</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">David Meek</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">28,175</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.06</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Leonard Post, Ph.D.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">11,527</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.02</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Rachelle Jacques</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.00</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Pierre Caloz</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">0.00</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Directors, Director Nominees, and Named Executive Officers Total (9)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,462,776</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">3.10</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">Major Shareholders, Directors, Director Nominees, and Named Executive Officers Total</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">29,633,564</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right">63.50</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt"></P>

<!-- Field: Page; Sequence: 28; Options: NewSection; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->22<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The registered office of Nantahala Capital Management, LLC is 130 Main St.
2nd&nbsp;Floor, New Canaan, Connecticut 06840, United States. The number of Ordinary Shares reported is based solely on a Schedule 13G/A filed
with the Securities and Exchange Commission by Nantahala Capital Management, LLC on February 14, 2022.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The registered office of FMR, LLC is 245 Summer Street, Boston, Massachusetts
02210, United States. The number of Ordinary Shares reported is based solely on a Schedule 13G/A filed with the Securities and Exchange Commission
by FMR, LLC on February 9, 2022.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The registered office of Blackrock, Inc. is 55 East 52<SUP>nd</SUP> Street,
New York, New York, 10055 United States. The number of Ordinary Shares reported is based solely on a Schedule 13G filed with the Securities and
Exchange Commission by Blackrock, Inc. on February 7, 2022.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(4)</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The registered office of Federated Hermes Inc. is 1001 Liberty Avenue, Pittsburgh,
Pennsylvania 15222-3770, United States. The number of Ordinary Shares reported is based solely on a Schedule 13G/A filed with the Securities and
Exchange Commission by Federated Hermes Inc on February 12, 2021.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(5)</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The registered office of Point72 Asset Management, L.P. is 72 Cummings Point
Road, Stamford, Connecticut, 06902 United States. The number of Ordinary Shares reported is based solely on a Schedule 13G jointly filed with the
Securities and Exchange Commission by Point72 Asset Management, L.P., Point72 Capital Advisors Inc., Cubist Systematic Strategies and
Steven A. Cohen on February 11, 2022.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(6)</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The registered office of Coller Investment Management Ltd. is c/o Coller
Investment Management Limited, PO Box 255, Trafalgar Court, Les Banques, St Peter Port, Guernsey, Channel Islands GY1 3QL. The number
of Ordinary Shares reported is based solely on the Schedule 13G/A filed with the Securities and Exchange Commission by Coller Investment Management
Limited, Coller International General Partner V. L.P and Coller International Partners V-A, L.P on April 30, 2021.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(7)</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The registered office of Bristol-Myers Squibb Company is 345 Park Avenue,
New York, New York 10154, United States. The number of Ordinary Shares reported is based solely on a Schedule 13G filed with the Securities and
Exchange Commission by Bristol-Myers Squibb Company on August 17, 2015.</FONT></TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(8)</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The registered office of Invesco Ltd. is 1555 Peachtree NE, Suite 1800, Atlanta,
Georgia 30309, United States. The number of Ordinary Shares reported is based solely on a Schedule 13G/A filed with the Securities and Exchange
Commission by Invesco Ltd on February 10, 2022.</FONT></TD></TR></TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(9)</TD><TD><FONT STYLE="font-family: Times New Roman, Times, Serif">The persons listed below hold options to purchase the number of Ordinary
Shares shown that are currently exercisable or become exercisable within 60 days of April 8, 2022, as well as the number of outstanding
Ordinary Shares shown:</FONT></TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 29; Value: 22 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->23<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: left">Name</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Options to<BR> Purchase<BR> Ordinary<BR> Shares</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt; text-align: center">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt; text-align: center">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Outstanding<BR> Ordinary&nbsp;Shares</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; padding-bottom: 1pt; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 72%; text-align: left">Matthew Kapusta</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">641,120</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 2%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">194,510</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Alexander E. Kuta, Ph.D.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">106,415</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">39,046</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Christian Klemt</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">72,713</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">39,523</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Robert Gut, Ph.D.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">74,408</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">28,304</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Ricardo Dolmetsch, Ph.D.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">19,981</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">22,485</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jack Kaye</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">40,412</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">17,467</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Madhavan Balachandran</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">29,412</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9,343</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jeremy Springhorn, Ph.D.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">29,412</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9,343</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Paula Soteropoulos</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">43,412</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,768</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">David Meek</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">23,022</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5,153</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Leonard Post, Ph.D.</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">9,940</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,587</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Pierre Caloz</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Rachelle Jacques</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left; padding-bottom: 1pt">Directors and Named Executive Officers Total</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">1,090,247</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: right">372,529</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Securities Authorized for Issuance under Equity Compensation Plans
</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 30.05pt">The table below provides information about our
Ordinary Shares that may be issued under our 2014 Amended and Restated Share Option Plan (the &ldquo;2014 Restated Plan&rdquo;), our predecessor
plans and outside these plans as of April 8, 2022:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">Plan&nbsp;Category</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(a)&nbsp;Number&nbsp;of&nbsp;securities<BR>
    to&nbsp;be<BR> issued&nbsp;upon&nbsp;exercise&nbsp;of<BR> outstanding&nbsp;options,<BR> warrants&nbsp;and&nbsp;rights</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(b)&nbsp;Weighted-average<BR>
    exercise&nbsp;price&nbsp;of&nbsp;outstanding<BR> options,&nbsp;warrants&nbsp;and&nbsp;rights (1)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">(c)&nbsp;Number&nbsp;of&nbsp;securities<BR>
    remaining&nbsp;available&nbsp;for<BR> future&nbsp;issuance&nbsp;under<BR> equity<BR> compensation&nbsp;plans<BR>
    (excluding&nbsp;securities reflected<BR> in&nbsp;column&nbsp;(a))</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="text-indent: -0.125in; padding-left: 0.125in; font: 10pt Times New Roman, Times, Serif; width: 42%; text-align: left"><FONT STYLE="font-size: 8pt">2012
    Equity Incentive Plan (Equity Compensation Plan Approved by Security Holders)</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">10,000</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="width: 16%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">11.00</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">(2)</FONT></TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 18%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-size: 8pt">2014
    Restated Plan (Equity Compensation Plan Approved by Security Holders)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">6,369,324</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">17.82</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">2,216,072</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-indent: -0.125in; padding-left: 0.125in; text-align: left"><FONT STYLE="font-size: 8pt">Equity
    Compensation Plans Not Approved by Security Holders (3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">44,000</FONT></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">5.31</FONT></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="border-bottom: Black 1pt solid; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">(4)</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">Total</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">6,423,324</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">$</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">17.73</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">2,216,072</FONT></TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>The exercise price for our RSU and PSU awards is $0.00 and is included in the weighted-average exercise price of outstanding options,
warrants and rights.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>The exercise price of outstanding options is denominated in euro and translated to US$ at the foreign exchange rate as of April 8,
2022.</TD></TR></TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>These awards include inducement grants entered into by the Company outside of the 2014 Restated Plan and the predecessor plans.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the 2021 Annual General Meeting, our Board was granted the authority
to issue a maximum of 19.9% of the Company&rsquo;s aggregate issued capital at the time of issuance in connection with any other single
issuance (or series of related issuances).&nbsp;Ordinary Shares may be issued as part of inducement or other option grants but are not
restricted to that purpose.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 1pt">&nbsp;</FONT></P>





<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 30; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->24<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_005"></A><B>COMPENSATION COMMITTEE REPORT</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-indent: 0.5in"><I>The Compensation Committee Report
is not &ldquo;soliciting material,&rdquo; is not deemed &ldquo;filed&rdquo; with the SEC and is not to be incorporated by reference into
any filing of the Company under the Securities Act of 1933 or the Securities Exchange Act of 1934, both as amended.</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">We have reviewed and discussed the Compensation
Discussion&nbsp;&amp; Analysis contained in this Proxy Statement with uniQure&rsquo;s management, and based upon such review and discussion,
we recommended to the Board that the Compensation Discussion&nbsp;&amp; Analysis be included in this Proxy Statement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Compensation Committee</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid; width: 50%">/s/ Madhavan Balachandran</TD>
    <TD STYLE="width: 50%">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Madhavan Balachandran, Chair</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid">/s/ Jack Kaye</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>Jack Kaye</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="border-bottom: black 1pt solid">/s/ David Meek</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>David Meek</TD>
    <TD>&nbsp;</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 31; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->25<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>COMPENSATION DISCUSSION&nbsp;&amp; ANALYSIS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Compensation Discussion and Analysis (the &ldquo;CD&amp;A&rdquo;)
explains our compensation philosophy, policies, and decisions for 2021 for the following executives, whom we refer to in this CD&amp;A
and in the following tables as our NEOs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; width: 33%"><FONT STYLE="font-size: 10pt"><B>Named&nbsp;Executive&nbsp;Officer</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 65%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Title</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><B>Matthew Kapusta</B></TD>
    <TD>&nbsp;</TD>
    <TD>Chief Executive Officer and Executive Director</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><B>Ricardo Dolmetsch</B></TD>
    <TD>&nbsp;</TD>
    <TD>President, Research and Development</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><B>Alexander Kuta</B></TD>
    <TD>&nbsp;</TD>
    <TD>Executive Vice President, Quality and Regulatory</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><B>Christian Klemt </B><SUP>(1)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Chief Financial Officer</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><B>Pierre Caloz </B><SUP>(2)</SUP></TD>
    <TD>&nbsp;</TD>
    <TD>Chief Operations Officer</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">(1)&nbsp;Mr.&nbsp;Klemt was promoted from Chief
Accounting Officer to Chief Financial Officer on June&nbsp;15, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in">(2)&nbsp;Mr.&nbsp;Caloz was hired as Chief Operations Officer
on May&nbsp;17, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Executive Summary</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Our Business</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We are a leader in the field of gene therapy and seek to deliver to
patients suffering from rare and other devastating diseases single treatments with potentially curative results. We are advancing a focused
pipeline of innovative gene therapies, including product candidates for the treatment of Hemophilia B, which effective May&nbsp;6, 2021,
we licensed to CSL Behring pursuant to the CSL Behring Agreement (as defined below), and Huntington&rsquo;s disease. We believe our technology
platform and manufacturing capabilities provide us distinct competitive advantages, including the potential to reduce development risk,
cost, and time to market. We produce our Adeno-associated virus (&ldquo;AAV&rdquo;) -based gene therapies in our own facilities with
a proprietary, commercial-scale, current good manufacturing practices (&ldquo;cGMP&rdquo;)-compliant, manufacturing process. We believe
our Lexington, Massachusetts-based facility is one of the world&rsquo;s most versatile gene therapy manufacturing facilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>2021 Performance and Achievements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In 2021, our NEOs played critical roles in the achievement of our
goals to advance and expand our pipeline of leading gene therapy product candidates.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>CSL Behring commercialization and license agreement</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On May&nbsp;6, 2021, our commercialization and license agreement with
CSL Behring pursuant to which CSL Behring will receive exclusive global rights to etranacogene dezaparvovec, became fully effective.
Upon closing this transaction, we collected $462 million, including a $450.0 million upfront cash payment. In addition, the agreement
also entitles us to receive more than $0.3 billion in regulatory, development, and first commercial sale milestones, $1.3 billion in
additional commercial milestones, and tiered double-digit royalties of up to a low-twenties percentage of net product sales arising from
the collaboration. </P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Hemophilia B program &ndash; Etranacogene dezaparvovec (AMT-061)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In June 2021, we completed 18-month follow-up visits
for all patients in our pivotal Phase III HOPE-B trial (the &ldquo;HOPE-B Study) of etranacogene dezaparvovec. The HOPE-B Study is a multinational,
open-label, single-arm study to evaluate the safety and efficacy of etranacogene dezaparvovec. Fifty-four adult Hemophilia B patients
classified as severe or moderately severe and requiring prophylactic FIX replacement therapy were enrolled in the study.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On December&nbsp;9, 2021, we announced the achievement of the pre-specified
primary endpoint of non-inferiority in annualized bleeding rate (&ldquo;ABR&rdquo;) 18-months following administration compared to baseline
Factor IX (&ldquo;FIX&rdquo;) prophylactic therapy in the HOPE-B Study. The study also achieved a secondary endpoint demonstrating statistical
superiority in reduction of ABR compared to baseline FIX prophylactic therapy. ABR for all bleeds after stable FIX expression, assessed
at 18 months, was 1.51 compared with the ABR of 4.19 for the lead-in period of at least six months, achieving the primary non-inferiority
endpoint and a secondary superiority endpoint (p=0.0002) in the HOPE-B Study. ABR for investigator-adjudicated FIX-treated bleeds was
0.83 compared with lead-in ABR of 3.65 (p&lt;0.0001). All participants continued to demonstrate durable, sustained increases in FIX activity
at 18-months post-infusion with a mean FIX activity of 36.9 percent of normal, as measured by a one-stage activated partial thromboplastin
time-based (&ldquo;aPTTbased&rdquo;) clotting assay, compared to a mean FIX activity of 39.0 percent of normal at 26-weeks of follow-up.
Etranacogene dezaparvovec was generally well-tolerated with over 80% of adverse events considered mild.</P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 32; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->26<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Huntington&rsquo;s disease program (AMT-130)</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On April 5, 2021, we announced the completion of enrollment
of the low-dose cohort of the U.S. Phase I/II study of AMT-130. The low-dose cohort includes 10 patients, of which six patients received
treatment with AMT-130 and four patients received sham surgery. The U.S. Phase I/II clinical trial is a randomized, controlled, double-blinded,
dose escalation study of AMT-130. We completed enrollment of the high-dose cohort of 16 patients, of which 10 patients will receive treatment
with AMT-130 and six patients will receive sham surgery in March 2022.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On December&nbsp;16, 2021, we announced initial 12-month observations
on the first four patients enrolled in the low-dose cohort of the U.S. Phase I/II study. Two of the four enrolled patients received AMT-130,
and two patients received Sham surgery as a control. AMT-130 was generally well tolerated in the treated patients, with no serious adverse
events related to AMT-130. NfL, a biomarker of injury in the brain, increased as expected immediately following the surgical procedure
and returned to baseline in the treated patients. NfL remained relatively constant in the two untreated control patients. Structural
magnetic resonance imaging did not reveal any clinically meaningful safety findings in either treated or control patients at one year
of follow-up. Measurements of total and mutant HTT protein in the cerebral spinal fluid of the four patients were highly variable and
inconclusive. As of December&nbsp;31, 2021, 19 patients have been enrolled in the clinical trial to date, including nine of 16 in the
high-dose cohort.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Also on December&nbsp;16, 2021, we announced the initiation of patient
screening in our 15 patient, open-label, Phase Ib/II study of AMT-130 in the EU, as well our plans to initiate a third cohort in the
ongoing U.S. Phase I/II clinical trial. The third cohort, which will include up to 18 additional randomized patients receiving the higher
dose, will explore the use of alternative stereotactic navigation systems to simplify placement of catheters for infusions of AMT-130.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Acquisition of Corlieve Therapeutics</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 5.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Times New Roman, Times, Serif">In
July 2021 we completed the acquisition of Corlieve Therapeutics SAS (</FONT>&ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif">Corlieve</FONT>&rdquo;<FONT STYLE="font-family: Times New Roman, Times, Serif">),
a privately held French gene therapy company. Through this acquisition we added Corlieve</FONT>&rsquo;<FONT STYLE="font-family: Times New Roman, Times, Serif">s
gene therapy program, AMT-260, employing micro ribonucleic acid (</FONT>&ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif">miRNA</FONT>&rdquo;<FONT STYLE="font-family: Times New Roman, Times, Serif">)
silencing technology to target suppression of aberrantly expressed kainate receptors in the hippocampus of patients with temporal lobe
epilepsy (</FONT>&ldquo;<FONT STYLE="font-family: Times New Roman, Times, Serif">TLE</FONT>&rdquo;<FONT STYLE="font-family: Times New Roman, Times, Serif">)
to our pipeline. TLE affects approximately 1.3 million people in the U.S. and Europe alone, of which approximately 0.8 million patients
are unable to adequately control acute seizures with currently approved anti-epileptic therapies. Patients with refractory TLE experience
increased morbidity, excess mortality, and poor quality of life.</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Financing</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of December&nbsp;31, 2021, we had cash, cash equivalents and restricted
cash of $559.4 million, which include payments received from CSL Behring following the closing of the transaction. Until such time, if
ever, as we can generate substantial cash flows from successfully commercializing our proprietary product candidates, we expect to finance
our cash needs through a combination of equity offerings, debt financings, collaborations, strategic alliances and marketing, distribution,
and licensing arrangements. We believe that our cash and cash equivalents will fund our operations into the first half of 2025 assuming
achievement of $230.0 million related to BLA and MAA submissions as well as first commercial sales milestones under the CSL Behring commercialization
and license agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On January&nbsp;29, 2021, we and Hercules amended the 2018 Amended
Facility (&ldquo;2021 Amended Facility&rdquo;). Pursuant to the 2021 Amended Facility, Hercules agreed to an additional Facility of $100.0
million (&ldquo;Tranche B&rdquo;) increasing the aggregate principal amount of the term loan facilities from $35.0 million to up to $135.0
million. On January&nbsp;29, 2021, we drew down $35.0 million of the Tranche B. Advances under Tranche B bore interest at a rate equal
to the greater of (i)&nbsp;8.25% or (ii)&nbsp;8.25% plus the prime rate, less 3.25% per annum. The principal balance of $70.0 million
and all accrued but unpaid interest on advances under Tranche B was due on June&nbsp;1, 2023. The back-end fee in respect of advances
under the 2021 Amended Facility ranged from 1.65% to 6.85%, depending on the repayment date. In addition to Tranche B, the 2021 Amended
Facility also extended the interest only payment period of the previously funded $35.0 million term loan (&ldquo;Tranche A&rdquo;) from
January&nbsp;1, 2022 to June&nbsp;l, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On December&nbsp;15, 2021, we and Hercules amended and restated the
2021 Amended Facility (&ldquo;2021 Restated Facility&rdquo;). Pursuant to the 2021 Restated Facility, Tranche A and Tranche B of the
2021 Amended Facility with a total outstanding balance of $70.0 million were consolidated into one tranche with a total commitment of
$100.0 million. We drew down an additional $30.0 million, resulting in total principal outstanding as of December&nbsp;31, 2021 of $100.0
million. The 2021 Restated Facility extended the loan&rsquo;s maturity date from June&nbsp;1, 2023 until December&nbsp;1, 2025. The interest-only
period is extended from January&nbsp;1, 2023 to December&nbsp;1, 2024, or December&nbsp;1, 2025 if, prior to June&nbsp;30, 2024, either
(a)&nbsp;the BLA for AMT-061 is approved by the FDA or (b)&nbsp;AMT-130 is advanced into a pivotal trial. The interest rate is adjustable
and is the greater of (i)&nbsp;7.95% and (ii)&nbsp;7.95% plus the prime rate less 3.25% per annum. Under the 2021 Restated Facility,
we owe a back-end fee of 4.85% of the outstanding debt. We are required to repay the facility in equal monthly installments of principal
and interest between the end of the interest-only period and the maturity date. We continue to owe a $2.5 million back-end fee related
to the 2021 Amended Facility which is due on June&nbsp;1, 2023.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">On March&nbsp;1, 2021, we entered into a Sales Agreement with SVB
Leerink LLC (&ldquo;SVB Leerink&rdquo;) with respect to an at-the-market (&ldquo;ATM&rdquo;) offering program, under which we may, from
time to time in our sole discretion, offer and sell through SVB Leerink, acting as agent, our ordinary shares, up to an aggregate offering
price of $200.0 million. We pay SVB Leerink a commission equal to 3% of the gross proceeds of the sales price of all ordinary shares
sold through it as a sales agent under the Sales Agreement.</P>




<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In March&nbsp;and April&nbsp;of 2021, we issued 921,730 ordinary shares
at a weighted average price of $33.52 per ordinary share, with net proceeds of $29.6 million, after deducting underwriting discounts
and net of offering expenses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 33; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->27<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><U>Compensation Philosophy and Principles</U></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We operate in a competitive, rapidly changing and heavily regulated
industry. The long-term success of our business requires us to be resourceful, adaptable, and innovative. The skills, talent, and dedication
of our executive officers are critical components to our success and the future growth of the company. Therefore, our compensation program
for our executive officers, including our NEOs, is designed to attract, retain, and incentivize the best possible talent.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Compensation Committee has established core objectives for our
compensation programs, which are underpinned by a focus on elements that attract and retain the talent we believe is necessary to successfully
lead uniQure and our employees globally.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Pay for performance</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Motivate and reward our senior management to achieve
established business and individual objectives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Align interests with our shareholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Align compensation with the value realized by
our shareholders</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Use &ldquo;at risk&rdquo; compensation to incentivize
executives</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Use &ldquo;at risk,&rdquo; or variable, compensation
to align the interests with those of our shareholders over time and contribute to the achievement of both short- and long-term goals</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B>Attract and retain talented executives</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">Provide compensation opportunities and policies
that are competitive with similarly sized biotechnology companies</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>How We Determine Executive Compensation</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Compensation Oversight</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Compensation Committee is composed solely of independent directors,
who at the end of 2021 were Madhavan Balachandran, Jack Kaye, and David Meek, with Mr. Balachandran serving as the Compensation Committee
Chair.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Details of the Compensation Committee&rsquo;s duties are fully set
out in the Compensation Committee&rsquo;s charter, which can be found on our website: http://uniqure.com/investors-newsroom/corporate-governance.php.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The overarching purpose of the Compensation Committee
is to oversee the way the Board discharges its responsibilities relating to uniQure&rsquo;s compensation policies, plans and programs
for uniQure&rsquo;s executive officers and directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Compensation Committee is wholly accountable for any changes in
compensation for the Chief Executive Officer, and the Chief Executive Officer is not included in any discussions regarding changes to
his own compensation. For other NEOs, recommendations are made by the Chief Executive Officer and subsequently reviewed and approved
by the Compensation Committee. Overall compensation for our NEOs may increase or decrease year-to-year based upon, among other things,
his or her annual performance or changes in his or her responsibilities.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>The Annual Committee Process</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Compensation Committee typically meets 6 (six) or more times a
year to consider the following items:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; width: 18%"><FONT STYLE="font-size: 10pt"><B>Quarter</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 80%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Typical&nbsp;Meeting&nbsp;Topics</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center">Q1</TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>Determine the Company&rsquo;s performance against their goals for the previous year;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>Determine corporate goals for current year;</P>
    <P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>Determine executive compensation for current year, including base salary, target bonus and long-term equity incentive grants,
    as well as earned annual cash bonus for prior year; and</P>
    <P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    Determine non-executive employee compensation for current year, including merit pool for base salary increases, bonus pool for prior
    year performance, and annual equity grants.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 27pt; text-indent: -27pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center">Q2</TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>Assess prior year activities and Compensation Committee performance;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>Determine director compensation, including cash and equity compensation; and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>Plan compensation cycle through remainder of current year and into following year.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 27pt; text-indent: -27pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center">Q3</TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>Review Compensation Committee Charter;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>Review with compensation consultant best practices related to disclosure and director and executive compensation;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>Review compensation peer group; and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    Engage compensation consultant for work associated with upcoming compensation cycle.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 27pt; text-indent: -27pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="text-align: center">Q4</TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Review
    information provided by compensation consultant, including comparable data related to director and executive compensation based on
    the peer group reviewed in Q3;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    </FONT>Perform initial compensation evaluations for the coming year (including executive cash and equity compensation), director
    compensation (including cash and equity compensation), employee equity grants, and terms of annual incentive bonus plan for upcoming
    year; and</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
    Perform initial evaluations of the Company&rsquo;s performance against their corporate goals.</P></TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 34; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->28<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<!-- Field: Split-Segment; Name: 3 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In 2021, the Compensation Committee, in consultation with WTW (formerly Willis Towers Watson),
also determined to award key leaders within the organization, inclusive of the NEOs a one-time performance share unit grant to
support the retention of employees and to align the organization around key value drivers for the company. See 2021 Performance
Share Unit Award section below for more detail.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Additional meetings are scheduled on an as needed basis, and in 2021
the Compensation Committee met 7 (seven) times.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Use of an Independent Advisor</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As set out in its Charter, the Compensation Committee has the authority
to retain outside consultants to provide independent advice to the Compensation Committee.&nbsp;In 2021 the Compensation Committee retained
WTW as its independent compensation consultant.&nbsp; WTW reported directly to the Compensation Committee and took direction from the
Chair of the Compensation Committee.&nbsp; Having assessed WTW&rsquo;s independence pursuant to SEC rules&nbsp;and Nasdaq listing rules,
the Compensation Committee concluded that the work of WTW did not raise any conflicts of interest.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">During the year, WTW provided assistance in designing and reviewing
our management and director compensation programs, including reviewing the compensation peer group, providing market data on all aspects
of compensation, reviewing long-term incentive grant practices, and attended Compensation Committee meetings and provided general advice.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Compensation Committee considered the analysis and advice from
WTW, as well as support and insight from management when making compensation decisions.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Managing Compensation-Related Risk</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">uniQure operates in a highly regulated and competitive sector, and
managing risk is embedded in the way the Company is run and operates.&nbsp;The Board has delegated to the Compensation Committee
responsibility to oversee compensation-related risk.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Compensation Committee annually evaluates whether there are potential
risks arising from the Company&rsquo;s compensation policies and practices as part of our annual risk assessment performed by management
and reported to and discussed with the Board.&nbsp; The Compensation Committee has determined that uniQure&rsquo;s compensation policies
and practices do not encourage executives to take excessive risks given that the various elements of the policies and practices diversify
the risks associated with any single element of the executives&rsquo; compensation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Compensation Peer Group</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto">The Compensation Committee, with support of WTW, conducts
an annual review of the peer group used for benchmarking compensation levels, with a detailed review every two years. A full review of
the peer group was performed in 2020 and approved in September 2020 to inform 2021 compensation decisions (the &ldquo;2021 Peer Group&rdquo;).
The 2021 Peer Group comprises of 18 similar, publicly traded, biopharmaceutical companies based on multiple factors, including number
of employees, market capitalization, R&amp;D expense, revenue, and pipeline profile.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto">The table below depicts the 2021 Peer Group:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 34%; padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Adverum
Biotechnologies</TD>
<TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Editas
Medicine</TD>
<TD STYLE="width: 33%; padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;MyoKardia</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Arena
Pharmaceuticals</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Epizyme</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Regenxbio</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Arrowhead
Pharmaceuticals</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Fate Therapeutics</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Revance
Therapeutics</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Blueprint
Medicines</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Intellia
Therapeutics</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Sangamo
Therapeutics</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Denali
Therapeutics</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Invitae</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Voyager
Therapeutics</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Dynavax
Technologies</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;MeiraGTx</TD>
<TD STYLE="padding-right: 5.4pt; padding-left: 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Wave
Life Science</TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 35; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->29<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The 2021 Peer Group reflects the following changes from the 2020 peer
group:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 30%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Removed&nbsp;Companies<BR>
    (n=2)</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 66%; text-align: center"><FONT STYLE="font-size: 10pt"><B>New&nbsp;Companies<BR>
    (n=3)</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-left: 0.5in; text-indent: -0.25in"></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 35.85pt; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;Alder
    BioPharmaceuticals</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;Spark
    Therapeutics</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt">&nbsp;</P></TD>
    <TD STYLE="padding-left: 0.5in">&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;
    </FONT>&#8239;&#8239;&#8239;&#8239;&#8239;Adverum Biotechnologies</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;
    Fate Therapeutics</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;
    </FONT>&#8239;&#8239;&#8239;&#8239;&#8239;MeiraGTx</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 17.85pt; text-indent: -17.85pt"></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the time of approval, 2021 Peer Group had:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Trailing twelve-month
                                            average market capitalizations that ranged from approximately $477 million to $4.01 billion,
                                            with uniQure ranked at the 79<SUP>th</SUP> percentile;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Spot market capitalizations
                                            that ranged from approximately $306 million to $4.68 billion, with uniQure ranked at the
                                            59<SUP>th</SUP> percentile;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Employee headcounts
                                            that ranged from 114 to 1,500, with uniQure ranked at the 80<SUP>th</SUP> percentile;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>R&amp;D expense that
                                            ranged from $40 million to $331 million, with uniQure ranked at the 47<SUP>th</SUP> percentile;
                                            and</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.5in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Revenues that ranged
                                            from $0 to $806 million, with uniQure ranked at the 14<SUP>th</SUP> percentile.</TD></TR>
                                                                                                                                     </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Compensation Committee determined that uniQure&rsquo;s size relative
to the peer group was appropriate for the purpose of compensation comparisons.&nbsp; For executive roles where insufficient proxy statement
data was available to inform market comparisons, the Compensation Committee additionally referenced survey data provided by WTW and Radford
for similarly sized biotech and biopharma companies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 36; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->30<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Compensation Elements</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the 2016 Annual General Meeting, uniQure shareholders approved
our Remuneration Policy, which sets out the structure for the compensation granted to our senior managers, including the Chief Executive
Officer and other NEOs. The full policy can be found on our website: http://uniqure.com/investors-newsroom/corporate-governance.php.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In summary, our compensation program is designed to be straightforward
in nature with five core elements, the first three of which are compensation related and the last two are benefits reflecting local market
practices for each named executive officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: black 1pt solid; width: 13%"><FONT STYLE="font-size: 10pt"><B>Element</B></FONT></TD>
    <TD STYLE="width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 29%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Purpose</B></FONT></TD>
    <TD STYLE="width: 2%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; width: 55%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Key&nbsp;Features</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD>Base Salary</TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Provide market-competitive fixed compensation</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attract exceptional talent in the relevant market</P></TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in">&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol; font-size: 10pt">&middot;
</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Fixed
cash compensation</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Reviewed
    annually</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&#8239;Value
    informed by market levels for executives with comparable qualifications, experience, and responsibility, coupled with the nature,
    scope and impact of the role</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Target
    approximately 50<FONT STYLE="font-size: 10pt">th</FONT>&nbsp;percentile of market peers, considering the factors noted above</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in">&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Short-Term Incentive</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Annual Cash Bonus)</P></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Reward for achievement of pre-defined criteria in areas of
strategic importance to uniQure Align compensation with Company performance</P></TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in">&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 27pt; text-indent: -27pt"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Subject
    to the approval of the Board in its discretion</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Discretionary
    variable cash compensation ranging from 40% to 60% of annual Base Salary in 2021</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Maximum
    opportunity capped at 150% of target</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Weighting
    is based solely on performance against corporate goals for the Chief Executive Officer, and a combination of performance against
    corporate goals (80%) and individual goals (20%) for the other named executive officers</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Corporate
    and individual targets established in the beginning of each year</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Assessment
    against the predetermined goals informs actual cash bonus that is awarded</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Target
    bonuses informed by levels in the market, with reference to the 50th&nbsp;percentile</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in">&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Long-Term Incentives</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">(Equity Awards)</P></TD>
    <TD>&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Align long-term interests with shareholders</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Reward sustainable value creation Encourage retention</P></TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in">&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Annual
    awards subject to the approval of the Board in its discretion</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Annual
    awards in 2021 were a mix of stock options and restricted stock units</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Stock
    options have a ten-year term, with 25% vesting after one year and then ratably on a quarterly basis</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>Restricted
    stock units vest ratably on an annual basis over three years</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&#8239;Target
    opportunity informed by prior year performance and levels in the market with reference to the 50th&nbsp;percentile</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;
    </FONT><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&#8239;One-time
    PSU award provided in 2021 with goals tied to the pipeline milestones and relative total shareholder return.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in">&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD>Pension and Retirement Savings Plans</TD>
    <TD>&nbsp;</TD>
    <TD>Provide market-competitive retirement benefits</TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in">&nbsp;</TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&#8239;Based
    on local market practice</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&#8239;U.S.-based
    named executive officers are eligible to participate in a qualified 401(k)&nbsp;Plan with matching of up to 3% of base salary</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&#8239;Netherlands-based
    named executive officers are eligible to participate in a defined contribution pension plan</P></TD></TR>

<TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in">&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="width: 13%">Other Benefits</TD>
    <TD STYLE="width: 2%">&nbsp;</TD>
    <TD STYLE="width: 31%">Provide market competitive benefits focused on well-being</TD>
    <TD STYLE="width: 3%; padding-left: 0.25in; text-indent: -0.25in">&nbsp;</TD>
    <TD STYLE="width: 51%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&#8239;An
    Employee Share Purchase Plan (&ldquo;ESPP&rdquo;) is offered to all eligible employees, which includes eligible named executive officers</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;ESPP
    allows for purchase of discounted Ordinary Shares through accumulated payroll deductions</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Medical,
    dental and vision health care plans with premiums paid by the company for U.S.-based named executive officers</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&#8239;Up
    to four weeks of paid time off for U.S.-based named executive officers and six weeks for Netherlands-based executive officers</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;</FONT>&#8239;Company-paid
    life insurance and short-term and long-term disability, with some employee contribution for U.S.-based named executive officers</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Tuition
    reimbursement</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 22.5pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Fitness
    membership reimbursement</P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 37; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->31<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Target Pay Mix</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">A significant portion of our NEOs&rsquo; target compensation is variable and at-risk, short-term incentives (&ldquo;STI&rdquo;) and long-term
incentives (&ldquo;LTI&rdquo;) maximizing alignment with our shareholders and long-term value creation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto">The 2021 target compensation mix for the Chief Executive
Officer is detailed below. Of the total target compensation, 89% was at risk (the STI and LTI components) and 11% was not at risk (the
salary component).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><IMG SRC="tm223584d1_pre14aimg0001.jpg" ALT=""></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We do not specify a target mix of salary, STI and LTI compensation
for our other NEOs, but we target a range of approximately 75% - 80% for the at-risk components.&nbsp; The overall compensation structure
is adjusted to determine an appropriate mix on a position-by-position basis based on peer group data and other comparable compensation
data for each position.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>2021 Compensation Decisions and Outcomes</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Base Salary</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As described below, our NEOs receive a base salary, the terms of which
are subject to each of their individual employment agreements. The Compensation Committee annually reviews each named executive officer&rsquo;s
base salary and may adjust such individual&rsquo;s base salary after considering his or her responsibilities, performance and contributions
to the Company and the Company&rsquo;s overall performance. Additionally, the Compensation Committee will consider market data, with
a view to ensuring base salary is set competitively, with a philosophy of targeting approximately the 50<FONT STYLE="font-size: 10pt">th</FONT>&nbsp;percentile,
taking into consideration the above factors.&nbsp; Based on that analysis and the recommendation of our Compensation Committee, the Board
made adjustments from the prior year to the base salaries of our executive officers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 38; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->32<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The 2021 base salary for our NEOs are described below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Named&nbsp;Executive&nbsp;Officer</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Base&nbsp;Salary</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Effective&nbsp;Date</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt"><B>Matthew Kapusta
    </B><FONT STYLE="font-style: normal; font-weight: normal"><SUP>1)</SUP></FONT></TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">$</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">583,495</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">January&nbsp;2021</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-indent: -10pt; padding-left: 10pt"><B>Ricardo Dolmetsch</B><FONT STYLE="font-style: normal; font-weight: normal"><SUP>2)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">506,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">January&nbsp;2021</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt"><B>Alexander E. Kuta </B><FONT STYLE="font-style: normal; font-weight: normal"><SUP>1)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">444,813</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">January&nbsp;2021</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt"><B>Christian Klemt </B><FONT STYLE="font-style: normal; font-weight: normal"><SUP>3)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&euro;</TD><TD STYLE="font-size: 10pt; text-align: right">325,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">June&nbsp;2021</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-indent: -10pt; padding-left: 10pt"><B>Pierre Caloz</B><FONT STYLE="font-style: normal; font-weight: normal"><SUP>4)</SUP></FONT></TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">CHF</TD><TD STYLE="font-size: 10pt; text-align: right">463,760</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">May&nbsp;2021</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#9;Mr.&nbsp;Kapusta&rsquo;s
                                            and Dr.&nbsp;Kuta&rsquo;s base salaries were increased in alignment with the rate of increase
                                            with the broader employee population. Increases ranged from 2.0% to 3.0%.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#9;Dr.&nbsp;Dolmetsch
                                            joined uniQure as our President Research and Development on September&nbsp;14, 2020. He received
                                            a 1.2% increase in 2021 that reflects a pro-rated increase based on his 2020 hire date.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>(3)&#8239;&#8239;&#8239;&#8239;&#8239;&#9;Mr.&nbsp;Klemt
                                            base salary was increased 4.5% as of January&nbsp;1, 2022, and 29.6% in relation to his promotion
                                            to Chief Financial Officer on June&nbsp;15, 2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>(4)&#8239;&#8239;&#8239;&#8239;&#8239;&#9;Mr.&nbsp;Caloz&rsquo;s
                                            base salary was effective upon his hire date of May&nbsp;17, 2021.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Short-term Incentive</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s short-term incentives to NEOs provide an opportunity
for our NEOs to earn an annual cash bonus, contingent on the successful achievement of goals with various program areas aligned to our
strategic objectives. The award of any annual bonuses shall be subject to the approval of the Board in its discretion.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any annual cash bonus for the Chief Executive Officer is based solely
on the assessment of company-wide performance.&nbsp;For the other NEOs 80% of their opportunity is based on the same company-wide performance,
with the remaining 20% based on individual performance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 39; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->33<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Bonus opportunities for the NEOs in 2021 were as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 90%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Named&nbsp;Executive&nbsp;Officer</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Target&nbsp;Bonus<BR>
    (%&nbsp;of&nbsp;salary)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Maximum&nbsp;Bonus<BR>
    (%&nbsp;of&nbsp;salary)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 74%; font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10.1pt; padding-left: 10.1pt">Matthew
    Kapusta</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">60.0</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">%</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">90.0</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Ricardo Dolmetsch</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50.0</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">75.0</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Alexander E. Kuta</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">40.0</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60.0</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Christian Klemt</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">40.0</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">60.0</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Pierre Caloz</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">50.0</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">75.0</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr.&nbsp;Kapusta, Dr.&nbsp;Dolmetsch, and Dr.&nbsp;Kuta&rsquo;s
target bonus rate remained the same from the prior year. Mr.&nbsp;Klemt&rsquo;s target bonus was increased from 35% to 40% as of
June&nbsp;2021 in recognition of his promotion to Chief Financial Officer. Mr.&nbsp;Caloz joined uniQure in May&nbsp;2021 with a target bonus of 50% of base salary.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Annually, we evaluate and establish performance targets based on the
corporate goals that are adopted by the Board.&nbsp;Our performance targets are generally based on the achievement of a key set of core
objectives considered essential to our successful performance over a given calendar year.&nbsp; These core objectives are designed across
the range of functions of the Company, including clinical, research and technology, regulatory, manufacturing, finance, and other general
and administrative functions.&nbsp; Our performance against targets is reviewed periodically with the Board throughout the year.&nbsp;
At the end of the calendar year, we assess the overall performance, which is then used for compensation decisions, including the payment
of annual incentive bonuses.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In early 2021, the Board approved the following corporate objectives.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Corporate Objectives</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighting
    at Target</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Corporate Sub-Objectives</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighting
    at Target</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="text-align: left; vertical-align: top; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; width: 26%; font-size: 10pt; text-align: left; text-indent: -10.1pt; padding-left: 10.1pt">Focused
    Execution</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 22%; font-size: 10pt; text-align: right">55</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">%</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 24%; font-size: 10pt; text-align: left; text-indent: -0.25in; padding-left: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;<FONT STYLE="font-family: Symbol"></FONT>&#8239;&#8239;Support
    BLA Submission and Commercial Preparation for Hemophilia B (EtranaDez)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 22%; font-size: 10pt; text-align: right">35</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; padding-left: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Execute
    Clinical Development Plan for Huntington&rsquo;s Disease (AMT-130)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">20</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left">Strategic Expansion&nbsp;&amp; Growth</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">30</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; padding-left: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Advance
    SCA3 Towards the Clinic (AMT-150)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">5</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; padding-left: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Build
    Early and Sustainable Pipeline and Invest in Enabling Technologies</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">15</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; padding-left: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Increase
    Manufacturing Capacity&nbsp;&amp; Invest in Innovation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">10</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left">Strengthen the Organization</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; padding-left: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Improve
    Culture</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">7.5</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; padding-left: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Recruit&nbsp;&amp;
    Retain Talent</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">5</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -0.25in; padding-left: 0.5in"><FONT STYLE="font-family: Symbol">&middot;</FONT>&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Manage
    Financials</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: right">2.5</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">We believe these corporate objectives were critical
to the successful execution of our long-term strategy and the achievement of sustainable shareholder value creation.&nbsp; In approving
the targets, each goal within a program area has an associated level of achievement and time frame.&nbsp;The extent to which the goal
is achieved, and whether it is on time, informs the rating assigned at year-end. Each objective had at least two goals associated with
it, such as program advancement or pipeline milestones. When it set them, the Compensation Committee believed that the goals associated
with these corporate objectives were challenging but attainable, and that attainment was uncertain.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="text-align: left; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">To achieve the annual cash bonus, the total performance
related to all key goals must exceed a minimum threshold of 50%.&nbsp;The maximum total performance related to all key goals cannot exceed
150%. The total performance is determined by taking the weighted average of each of the goals. If overall performance is assessed at below
50%, no annual cash bonus is paid, and if overall performance assessed at above 150%, the annual cash bonus is capped at 150% of the target
bonus.</P>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 40; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->34<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt auto">While the specific goals are not disclosed for each
objective given their potential competitive sensitivity, the following achievements in 2021 were factors taken into consideration when
assessing Company performance:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 15%; border-bottom: black 1pt solid; padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key&nbsp;Goal</B></FONT></TD>
    <TD STYLE="width: 3%; padding-right: 0.8pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 82%; border-bottom: black 1pt solid; padding-right: 0.8pt; text-align: center"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Key Achievements</B></FONT></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Support BLA Submission and Commercial Preparation for Hemophilia B (etranacogene dezaparvovec)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">Clinical / Regulatory</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Conducted last patient 52-week and 18-month visits.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Completed investigation of clinical hold event and achieved lifting of clinical hold.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Held pre-BLA and MAA meetings.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Presented 52-week and 18-month follow-up data from HOPE-B pivotal study.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Met primary endpoint of HOPE-B pivotal study</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Supported preparation of BLA and MAA by CSL Behring.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">CMC / Operations</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Achieved Certificate of Analysis for successful 200L process validation.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Completed mock inspections.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">Commercial / Medical Affairs</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Initiated value dossier.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">CSL Behring Collaboration</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Established integration plan with CSL Behring.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Closed CSL Behring transaction.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Execute Clinical Development Plan for Huntington&rsquo;s Disease (AMT-130)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">Clinical / Regulatory</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Completed multiple data safety monitoring board meetings.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Achieved additional clinical trial approvals for EU Phase Ib/II study.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Completed dosing of Cohort 1 of U.S. Phase I/II study.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Initiated dosing of Cohort 2 of U.S. Phase I/II study</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Presented 12-month data on initial patients in U.S. Phase I/II study.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Completed 19 patient procedures in U.S. Phase I/II study.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
Initiated patient screening in EU Phase Ib/II study.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">CMC / Operations</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Completed release of all clinical trial material.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Developed 500L process/potency assay.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">Medical Affairs</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Completed manuscript of burden of illness.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Advance SCA3 Towards the Clinic (AMT-150)</FONT></TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239; &#8239;Deprioritized program.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Build Early and Sustainable Pipeline and Invest in Enabling Technologies </FONT></TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">Fabry Disease</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Initiated cGMP seed production.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Completed dose-range finding mouse study.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">Early-Stage Research</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Designated two lead candidates.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Initiated four new research programs.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">Enabling Technology</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Completed studies of AAV and other novel capsids.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Presented enabling technology plan and priorities to Board.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">Business Development</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Held R&amp;D / Investor Day.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Completed acquisition of Corlieve.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Increase Manufacturing Capacity &amp; Invest in Innovation </FONT></TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Completed multi-site capacity build-out (i.e., office, labs, cleanroom).</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Increased Lexington manufacturing capacity.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Completed Lexington pilot plant start-up.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Increased analytical and process development capacity.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Presented innovation plan and priorities to Board.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Improve Culture</FONT></TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Implemented baseline ESG self-study.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Implemented multi-level leadership development initiative.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Implemented employee and new hire learning program.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Recruit &amp; Retain Talent</FONT></TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Recruited critical new hires.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Met regrettable turnover goals.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Met total annual turnover goals.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 0.8pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">Manage Financials</FONT></TD>
    <TD STYLE="padding-right: 0.8pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Achieved cash burn budget.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 38.6pt; text-indent: -22.5pt"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Executed amendments to debt facility.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0">&nbsp;</P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 41; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->35<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table provides a breakdown of how the Board, with respect
to our CEO, and the Compensation Committee, with respect to our remaining named executive officers, determined that we performed against
each of these corporate objectives during 2021:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Corporate Objectives</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Weighting at Target</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Actual Performance</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: right; border-bottom: Black 1pt solid">Actual % Earned</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 58%; font: 10pt Times New Roman, Times, Serif; text-align: left">Support BLA Submission and Commercial Preparation for Hemophilia B</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">35</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">70</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">24.5</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Execute Clinical Development Plan for Huntington&rsquo;s Disease</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">125</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">25</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Advance SCA3 Program Towards the Clinic</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">40</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Build Early and Sustainable Pipeline and Invest in Enabling Tech</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">15</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">135</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20.25</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Increase Manufacturing Capacity &amp; Invest in Innovation</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">10</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">120</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">12</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Improve Culture</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7.5</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7.5</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Recruit &amp; Retain Talent</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">5</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Manage Financials</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2.5</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">150</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3.75</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Total</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD></TR>
  </TABLE>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In consultation with our named executive officers, Mr. Kapusta established
individual goals for each of our other named executive officers at the beginning of 2021 that (i) were specific to each named executive
officer&rsquo;s area of responsibility and (ii) were intended to support our corporate objectives for 2021. At the time these goals were
established, Mr. Kapusta believed they were challenging but attainable, and attainment was uncertain. The individual goals for each named
executive officer, other than Mr. Kapusta, for 2021 included the following:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 88%; font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; margin-right: 2in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="width: 23%; border-bottom: black 1pt solid; padding-right: 0.8pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Named&nbsp;Executive&nbsp;Officer</B></FONT></TD>
    <TD STYLE="width: 3%; padding-right: 0.8pt; font-size: 10pt; text-align: center">&nbsp;</TD>
    <TD STYLE="width: 74%; border-bottom: black 1pt solid; padding-right: 0.8pt; font-size: 10pt; text-align: center"><B>Considerations</B></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 0.8pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr. Ricardo Dolmetsch</B></FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Champion acquisition of Corlieve (TLE program).</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Successfully resolve AMT-061 clinical hold.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Strong clinical operational execution of Huntington and HOPE-B studies.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Advance four new research programs.</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Dr. Alexander Kuta</B></FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Significant contributions to successful process validation campaign.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Advance pre-approval inspection readiness, including mock inspection / CSL audits.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Spearhead pre-BLA preparations and meetings with FDA.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.35in; text-indent: -0.35in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Achieve clinical trial approvals for EU clinical study of AMT-130 for Huntington&rsquo;s disease in Poland, United Kingdom, and Germany.</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top; background-color: #CCEEFF">
    <TD STYLE="padding-right: 0.8pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Christian Klemt</B></FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Provide significant support of Corlieve and CSL Behring transaction and integration.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Successfully negotiate/complete two amendments of Hercules debt facilities</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Achieve cash budget targets; no significant accounting deficiencies.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Provide interim leadership of HR organization.</FONT></P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="padding-right: 0.8pt; font-size: 10pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><B>Pierre Caloz</B></FONT></TD>
    <TD STYLE="padding-right: 0.8pt; font-size: 10pt">&nbsp;</TD>
    <TD>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Complete process validation campaign.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Define platform innovation plan and presented to R&amp;D Committee.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0.8pt 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-family: Times New Roman, Times, Serif">&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;
    Complete rigorous review of long-term capacity plans.</FONT></P></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">With input from Mr. Kapusta, the Compensation Committee made a qualitative
determination following the end of the year as to the level of achievement by each of our named executive officers other than our CEO
about his or her respective individual performance objectives. The combination of corporate and individual performance resulted in the
following 2021 actual bonus pay-outs:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font-size: 10pt; text-align: center">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Allocation of Bonus</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="10" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Actual Bonus Achievement</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Named&nbsp;Executive&nbsp;Officer</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Base Salary</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>Target </B></P> <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 1.8pt 0pt 0; text-align: center"><B>Bonus %</B></P></TD><TD STYLE="padding-bottom: 1pt; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Corporate Goals Weighting</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Individual Goals Weighting</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Corporate Goal Achievement</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">Individual Goal Achievement</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid">2021 Cash&nbsp;Bonus</TD><TD STYLE="padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt">Matthew Kapusta</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">583,495</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">60</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">--</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">--</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 2%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">350,097</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt">Ricardo Dolmetsch</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">506,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">50</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">80</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">253,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Alexander E. Kuta</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">$</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">444,813</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">40</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">80</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">90</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">$</TD><TD STYLE="font-size: 10pt; text-align: right">174,367</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt">Christian Klemt (1)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&euro;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">325,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">40</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">80</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">115</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&euro;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">120,004</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; text-indent: -10pt; padding-left: 10pt">Pierre Caloz (2)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">CHF</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">463,760</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">50</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">80</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">20</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">110</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">%</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">CHF</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">147,743</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(1)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Mr.
Klemt&rsquo;s bonus was pro-rated based on his 2021 time as Chief Accounting Officer and Chief Financial Officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">(2)&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;&#8239;Mr.
Caloz&rsquo;s bonus was pro-rated based on his May 17, 2021 hire date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 42; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->36<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: 4 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>2021 Long-Term Incentive Awards</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company&rsquo;s 2014 Restated Plan provides that the Board may
grant equity awards to its employees.&nbsp;These grants include annual and periodic equity awards linked to continued employment and,
at the Board&rsquo;s discretion, the achievement of certain performance targets. Such grants as they apply to our NEOs are described
below. Pursuant to the 2014 Restated Plan, employees may be granted options, restricted share units or performance share units. By awarding
long-term incentive awards via a combination of different vehicles, the Compensation Committee can balance the objectives of driving
sustainable long-term performance and shareholder value creation, encouraging retention while remaining market competitive.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">For 2021, the Compensation Committee determined that annual long-term
incentive awards would be granted in the form of share options and restricted share units. This combination of vehicles balances our
objectives of long-term performance and shareholder value creation with executive retention and market competitiveness. Options require
our stock price to increase, and to do so in a sustainable way, for the awards to have and retain value. The Compensation Committee believes
these provide a compelling performance orientation.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Awards are generally made annually in the first calendar quarter,
considering the impact on achieving our corporate goals, performance in the prior year and market data for the compensation peer
group. The key features of each award type are as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 23%"><IMG SRC="tm223584d1_pre14asp4img02.jpg" ALT=""></TD>
    <TD STYLE="width: 77%"><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;</FONT>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Options
    vest over a period of four years, with 25% of options granted becoming exercisable on the first anniversary, with the remaining options
    becoming exercisable pro-rata on a quarterly basis over the remaining three years.</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Awards
    expire after ten years.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT>Share
    options cannot be repriced, reset, or exchanged for cash if underwater without shareholder approval.</P></TD></TR>
  <TR STYLE="vertical-align: top">
    <TD STYLE="text-align: center">&nbsp;</TD>
    <TD STYLE="padding-left: 0.25in; text-indent: -0.25in">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD><IMG SRC="tm223584d1_pre14asp4img03.jpg" ALT=""></TD>
    <TD><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Restricted
    Share Units vest pro-rata on an annual basis over three years.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Dividends
    do not accrue until shares are free from restrictions, unless expressly stated in the applicable award agreement.</FONT></P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>
    <P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT><FONT STYLE="font-size: 10pt">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares
    are issued to the participant upon vesting of the award but may be subject to a nondiscretionary sale of a portion of the shares
    to cover tax withholding requirements.</FONT></P></TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Target equity awards are approved each year by the Compensation Committee,
based on a combination of factors including performance against corporate and individual goals, granting history in prior years, impact
on share utilization and dilution, impact of the individual on achieving the Company&rsquo;s corporate goals, relative grant levels among
executives, market practices and other relevant factors. In determining and approving award values, the Compensation Committee reviews
data for our peer group and the overall total compensation of our executive officers.&nbsp;Considering the overall corporate performance
and individual achievement in 2020, our Compensation Committee recommended that the Board grant long-term incentive equity awards that
were commensurate with reference to the 25<SUP>th</SUP>-75<SUP>th</SUP> percentile of our peer group.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 43; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->37<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In establishing the mix of long-term incentives to award our NEOs,
the Compensation Committee referenced market data for our peers, which found that most competitors grant awards in either stock options
or a combination of stock options and restricted stock units.&nbsp; These awards had the following fair values as of the February 25, 2021 grant date
(rounded to the nearest thousand):</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; width: 57%"><FONT STYLE="font-size: 10pt"><B>Named&nbsp;Executive&nbsp;Officer</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 3%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Stock
    Options (USD)</B></FONT></TD>
    <TD STYLE="vertical-align: bottom; width: 3%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid; vertical-align: bottom; width: 12%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Restricted
    Stock Units (USD)</B></FONT></TD>
    <TD STYLE="vertical-align: top; width: 1%; text-align: center">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; vertical-align: bottom; width: 12%; text-align: center"><FONT STYLE="font-size: 10pt"><B>Total
    (USD)</B></FONT></TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; padding-left: 10.1pt; text-indent: -10.1pt"><B>Matthew Kapusta</B></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">2,065,000</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">2,065,000</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: right">4,130,000</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><B>Dr.&nbsp;Ricardo Dolmetsch (1)</B></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">471,000</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">471,000</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: right">942,000</TD></TR>
  <TR STYLE="background-color: #CCEEFF">
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><B>Dr.&nbsp;Alexander Kuta</B></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">693,000</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">693,000</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: right">1,386,000</TD></TR>
  <TR>
    <TD STYLE="vertical-align: top; padding-left: 10pt; text-indent: -10pt"><B>Christian Klemt (2)</B></TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">604,000</TD>
    <TD STYLE="vertical-align: bottom">&nbsp;</TD>
    <TD STYLE="vertical-align: bottom; text-align: right">604,000</TD>
    <TD STYLE="vertical-align: top">&nbsp;</TD>
    <TD STYLE="text-align: right">1,208,000</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Dr.&nbsp;Dolmetsch was appointed in September&nbsp;2020 and his
                                            2021 annual equity grant value was pro-rated based on his service.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Mr.&nbsp;Klemt&rsquo;s annual grant was based on his role as a Chief
                                            Accounting Officer. Mr.&nbsp;Klemt also received a promotional grant upon his promotion to
                                            Chief Financial Officer in June&nbsp;2021. The fair value of the promotional grant is not
                                            included in the above table. Details of these awards are provided below in the section titled
                                            &ldquo;Christian Klemt.&rdquo;</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr.&nbsp;Caloz did not receive an annual equity grant, as he was hired
in May&nbsp;2021. The Compensation Committee approved equity grants to secure his appointment and to align him immediately with the other
executives and the interests of our shareholders. Details of these awards are provided below in the section titles &ldquo;Pierre Caloz.&rsquo;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>2021 Performance Share Unit Award</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Compensation Committee, in consultation with WTW, determined to
award key leaders within the organization, inclusive of NEOs a one-time performance share unit grant to support the retention of employees
and to align the organization around key value drivers for the company. The Performance Share Unit grant is based on the following key
performance criteria, which is presented with certain information omitted:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 80%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Milestone Performance</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Weighting</TD><TD STYLE="font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 87%; font-size: 10pt; text-align: left">Regulatory approval milestone for Hemophilia B</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">25</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Second regulatory approval milestone for Hemophilia B</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Clinical study milestone for Huntington&rsquo;s Disease</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">35</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Pipeline candidate milestone #1</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Pipeline candidate milestone #2</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">15</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Total Weighting</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">100</TD><TD STYLE="font-size: 10pt; text-align: left">%</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 44; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->38<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Performance vesting for each of these measures is based both on achieving
the milestone and the timeframe under which the milestone is achieved. Based on this performance criteria, the number of units that vests
can range from a minimum of 0% to a maximum of 100%. In addition, for the last three milestones, the vesting outcome will be modified
based on the company&rsquo;s 3-year relative total shareholder return performance compared against the Nasdaq Biotechnology Index:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Above 75<SUP>th</SUP> percentile
                                            of the Nasdaq Biotechnology Index &ndash; 150% earned milestone.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Between the 25<SUP>th</SUP>
                                            and 50<SUP>th</SUP> percentile of the Nasdaq Biotechnology Index &ndash; 100% earned milestone.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD>Below the 25<SUP>th</SUP>
                                            percentile of the Nasdaq Biotechnology Index &ndash; 50% earned milestone.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The core design aspects of the performance share unit award (i.e.,
broader leader participation beyond the NEOs, fully at-risk performance-based milestone, as well as linkage to relative total shareholder
return) were put in place to ensure close alignment between shareholders, NEOs, and the broader leadership population.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Employee Share Purchase Plan</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Employee Share Purchase Plan is designed to allow eligible employees
of uniQure and its designated subsidiaries to purchase discounted Ordinary Shares at designated intervals through their accumulated payroll
deductions. The purpose of the Plan is to provide employees with a convenient method to invest in uniQure Ordinary Shares which will
increase the equity stake of our employees and will benefit shareholders by aligning more closely the interests of our participating
employees with those of our shareholders.&nbsp;We believe that this will help to motivate and retain highly qualified employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the Plan, the number of Ordinary Shares initially reserved for
issuance was 150,000. The purchase price of the Ordinary Shares acquired on each purchase date will be the lesser of (a)&nbsp;85% of
the closing price of an Ordinary Share on the first day of the offering period or (b)&nbsp;85% of the closing price of an Ordinary Share
on the purchase date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>CEO Pay Ratio</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under Item 402(u)&nbsp;of Regulation S-K adopted by the SEC pursuant
to the Dodd-Frank Wall Street Reform and Consumer Protection Act of 2010, we are required to disclose the ratio of the annual total compensation
of our Chief Executive Officer to the annual total compensation of our median compensated employee, excluding our CEO.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 87%; font-size: 10pt; text-align: left; text-indent: -10.1pt; padding-left: 10.1pt">Matthew Kapusta (a)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">5,100,101</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">Median Employee 2021 Annual Total Compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">143,299</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 10pt">CEO to Median Employee Pay Ratio</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">36 to 1</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>



<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: left">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.5in; text-indent: -0.25in">(a)<FONT STYLE="font-size: 10pt">&nbsp;&nbsp;
</FONT>This annual total compensation is the Total Compensation from the Summary Compensation Table.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 45; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->39<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Methodology</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our methodology for determining our CEO pay ratio relies on estimates
and assumptions calculated in a manner consistent with SEC rules&nbsp;and guidance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B><I>Calculating Median Employee Compensation</I></B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To identify the median employee in 2021, we used the same median employee
identified in 2020 through the following methodology. We used total wages earned as our consistently applied compensation measure (&ldquo;CACM&rdquo;),
which we obtained from our payroll records across our global employee population. We calculated the total wages earned in the 2020 calendar
year and adjusted the pay of employees in Europe from Euros to U.S. Dollars using the average exchange rate that we applied in our financial
statements. For employees that started their employment during the year (i.e., after January&nbsp;1, 2020), we adjusted the total wages
earned to reflect annualized wages earned. We did not annualize the total wages earned for any of our temporary or seasonal workers.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">We then calculated our median employee&rsquo;s compensation in 2021
and determined that the total annual compensation of our median employee was $143,299 as of December&nbsp;31, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our CEO to median employee pay ratio is 36 to 1.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The SEC&rsquo;s rules&nbsp;for identifying the median compensated
employee and calculating the pay ratio based on that employee&rsquo;s annual total compensation allow companies to adopt a variety of
methodologies, to apply certain exclusions, and to make reasonable estimates and assumptions that reflect their employee populations
and compensation practices. As a result, the pay ratio reported by other companies, including our compensation peer group, may not be
comparable to the pay ratio reported above, as other companies have different employee populations and compensation practices and may
utilize different methodologies, exclusions, estimates and assumptions in calculating their own pay ratios.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Employment Agreements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Matthew Kapusta</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prior to becoming our Chief Executive Officer, Mr.&nbsp;Kapusta served
as our Chief Financial Officer. On December&nbsp;9, 2014, the Company entered into an employment agreement with Mr.&nbsp;Kapusta for
the role of Chief Financial Officer&rdquo;), which was subsequently amended on a several occasions, including in connection with Mr.&nbsp;Kapusta&rsquo;s
appointment as Chief Executive Officer (as amended, the &ldquo;Kapusta Employment Agreement&rdquo;).&nbsp; The Kapusta Employment Agreement
provides that Mr.&nbsp;Kapusta will earn a base salary equal to $450,000 per year effective January&nbsp;1, 2017, plus reimbursement
of expenses incurred on the Company&rsquo;s behalf. In February&nbsp;2022, the Board approved Mr.&nbsp;Kapusta&rsquo;s 2022 salary and
long-term equity incentive awards, as well as his annual cash bonus for performance in 2021. The Board awarded Mr.&nbsp;Kapusta a 2022
base salary of $610,000 and a 2021 performance bonus of $350,097. Mr.&nbsp;Kapusta is also eligible for a cash bonus based on performance
in 2022 with a target of 60% of his base salary. The Board also awarded Mr.&nbsp;Kapusta 2022 long-term incentive equity grants of 125,073
restricted share units and an option to purchase 215,643 ordinary shares in the Company each pursuant to the Company&rsquo;s equity incentive
plan. The termination provisions of the Kapusta Employment Agreements are further discussed below. The term of the Kapusta Employment
Agreement will run through December&nbsp;31, 2022 (subject to an automatic renewal provision if no notice of termination is provided
at least ninety days prior to the end of a renewal term) or until terminated by either us or by Mr.&nbsp;Kapusta. Copies of the Kapusta
Employment Agreement and its amendments are filed as Exhibits&nbsp;10.6, 10.7 and 10.8 to the Company&rsquo;s Annual Report on Form&nbsp;10-K
filed with the SEC on March&nbsp;1, 2021, respectively. The foregoing are not complete descriptions of the Kapusta Employment Agreement
and are qualified in their entirety by reference to the full text of such agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 46; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->40<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Pierre Caloz</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr.&nbsp;Caloz entered into an employment agreement with the Company
effective May&nbsp;17, 2021, for the role of Chief Operations Officer (the &ldquo;Caloz Employment Agreement&rdquo;). The Caloz Employment
Agreement provides that Mr.&nbsp;Caloz will receive a base salary of CHF (Swiss Francs) 463,760 per year, subject to review at the sole
discretion of the Company, a one-time signing bonus of CHF 180,103 and a discretionary bonus of up to 50% of annual base salary. Under
the Caloz Employment Agreement, Mr.&nbsp;Caloz is also entitled to expenses and reimbursements.&nbsp; He was also entitled to a grant
of an option to purchase 75,000 ordinary shares in the Company (subject to a four-year vesting period), a grant of 25,000 restricted
share units (subject to a three-year vesting period), and a grant of 10,000 restricted share units (subject to a one-year vesting period)
each pursuant to the Company&rsquo;s equity incentive plan and would be eligible for future grant awards. The Caloz Employment Agreement
also provides for severance benefits, including an increase in severance payments: (1)&nbsp;to 150% of base salary plus target bonus
for a termination in association with a change of control of the Company and (2)&nbsp;to 100% of base salary plus target bonus for other
qualifying terminations; as well as a pro-rata cash bonus for the current (interrupted) year in which any qualifying termination occurs.
In March&nbsp;2022, Mr.&nbsp;Caloz received a letter (the &ldquo;Caloz 2022 Letter&rdquo;), which provides that his 2022 base salary
will be CHF 475,000 and his 2021 bonus will be CHF 147,743. The Caloz 2022 Letter also provides that Mr.&nbsp;Caloz will be entitled
to participate in the 2022 equity grants of 37,086 restricted share units and an option to purchase 63,941 ordinary shares in the Company
each pursuant to the Company&rsquo;s equity incentive plan. The termination provisions of the Caloz Employment Agreement are further
discussed below. The Caloz Employment Agreement is to continue in force from year to year unless terminated in accordance with its terms.
A copy of the Caloz Employment Agreement is filed as Exhibit&nbsp;10.61 to the Company&rsquo;s Annual Report on Form&nbsp;10-K filed
with the SEC on February&nbsp;25, 2022. The foregoing are not complete descriptions of the Caloz Employment Agreement and are qualified
in their entirety by reference to the full text of such agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Ricardo Dolmetsch</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dr.&nbsp;Dolmetsch entered into an employment agreement with the Company
effective September&nbsp;14, 2020, for the role of President, Research and Development (the &ldquo;Dolmetsch Employment Agreement&rdquo;).
The Dolmetsch Employment Agreement provides that Dr.&nbsp;Dolmetsch will receive a base salary of $500,000 per year, subject to review
at the sole discretion of the Company, a one-time signing bonus of $250,000 and a discretionary bonus of up to 50% of annual base salary.
Under the Dolmetsch Employment Agreement, Dr.&nbsp;Dolmetsch is also entitled to expenses and reimbursements.&nbsp; He was also entitled
to a grant of an option to purchase 35,000 ordinary shares in the Company (subject to a four-year vesting period), a grant of 55,000
restricted share units (subject to a three-year vesting period), and a grant of 10,000 restricted share units (subject to a one-year
vesting period) each pursuant to the Company&rsquo;s equity incentive plan and would be eligible for future grant awards. The Dolmetsch
Employment Agreement also provides for severance benefits, including payments of: (1)&nbsp;to 150% of base salary plus target bonus and
COBRA coverage for 18 months for a termination in association with a change of control of the Company and (2)&nbsp;to 100% of base salary
plus target bonus and COBRA coverage for 12 months for other qualifying terminations; as well as a pro-rata cash bonus for the current
(interrupted) year in which any qualifying termination occurs. In March&nbsp;2022, Dr.&nbsp;Dolmetsch received a letter (the &ldquo;Dolmetsch
2022 Letter&rdquo;), which provides that his 2022 base salary will be $ 525,000 and his 2021 bonus will be $ 253,000. The Dolmetsch 2022
Letter also provides that Dr.&nbsp;Dolmetsch will be entitled to participate in the 2022 equity grants of 54,683 restricted share units
and an option to purchase 94,281 ordinary shares in the Company each pursuant to the Company&rsquo;s equity incentive plan. The termination
provisions of the Dolmetsch Employment Agreement are further discussed below. The Dolmetsch Employment Agreement is to continue in force
from year to year unless terminated in accordance with its terms. A copy of the Dolmetsch Employment Agreement is filed as Exhibit&nbsp;10.56
to the Company&rsquo;s Annual Report on Form&nbsp;10-K filed with the SEC on March&nbsp;1, 2021. The foregoing are not complete descriptions
of the Dolmetsch Employment Agreement and are qualified in their entirety by reference to the full text of such agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 47; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->41<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Alexander E. Kuta</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Dr.&nbsp;Kuta entered into an employment agreement with the Company
on January&nbsp;23, 2017, for the role of Senior Vice President, Regulatory Affairs (the &ldquo;Kuta Employment Agreement&rdquo;). The
Kuta Employment Agreement provides that Dr.&nbsp;Kuta will receive a base salary of $375,000 per year, subject to review at the sole
discretion of the Company and a discretionary bonus of up to 35% of annual base salary (with any such bonus for 2017 being pro-rated
for length of service). Under the Kuta Employment Agreement, Dr.&nbsp;Kuta is also entitled to expenses and reimbursements.&nbsp; He
was also entitled to a grant of an option to purchase 150,000 ordinary shares in the Company pursuant to the Company&rsquo;s equity incentive
plan and would be eligible for future grant awards. Effective August&nbsp;20, 2019, the Kuta Employment Agreement was amended and restated
to, among other things, provide for a promotion to the position of Executive Vice President, Operations, a base salary of $429,646 annually,
an additional equity grant of 15,000 restricted share units pursuant to the Company&rsquo;s equity incentive plan, and additional severance
benefits, including an increase in severance payments: (1)&nbsp;to 150% of base salary plus target bonus and COBRA coverage for 18 months
for a termination in association with a change of control of the Company and (2)&nbsp;to 100% of base salary plus target bonus and COBRA
coverage for 12 months for other qualifying terminations; as well as a pro-rata cash bonus for the current (interrupted) year in which
any qualifying termination occurs.&nbsp;In March&nbsp;2022, Dr.&nbsp;Kuta received a letter (the &ldquo;Kuta 2022 Letter&rdquo;), which
provides that his 2022 base salary will be $460,000 and his 2021 bonus will be $ 174,367. The Kuta 2022 Letter also provides that Dr.&nbsp;Kuta
will be entitled to participate in the 2022 equity grants of 34,904 restricted share units and an option to purchase 60,179 ordinary
shares in the Company each pursuant to the Company&rsquo;s equity incentive plan. The termination provisions of the Kuta Employment Agreement
are further discussed below. The Kuta Employment Agreement is to continue in force from year to year unless terminated in accordance
with its terms. A copy of the Kuta Employment Agreement is filed as Exhibit&nbsp;10.44 to the Company&rsquo;s Annual Report on Form&nbsp;10-K
filed with the SEC on March&nbsp;1, 2021. The foregoing are not complete descriptions of the Gut Employment Agreement and are qualified
in their entirety by reference to the full text of such agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><U>Christian Klemt</U></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Mr.&nbsp;Klemt entered into an employment agreement with the Company
effective September&nbsp;1, 2015, for the role of Global Controller. Effective July&nbsp;15, 2017, Mr.&nbsp;Klemt was promoted to Chief
Accounting Officer and entered into an amended employment agreement with the Company (the &ldquo;Klemt Employment Agreement&rdquo;).
The Klemt Employment Agreement provided that Mr.&nbsp;Klemt will receive a base salary of &euro;200,000 per year, subject to review at
the sole discretion of the Company and a discretionary bonus of up to 35% of his annual base salary. Under the Klemt Employment Agreement,
Mr.&nbsp;Klemt was also entitled to expenses and reimbursements.&nbsp;Effective March&nbsp;1, 2020, the Klemt Employment Agreement was
amended and restated to, among other things, to provide additional severance benefits, including an increase in severance payments: (1)&nbsp;to
150% of base salary plus target bonus for a termination in association with a change of control of the Company and (2)&nbsp;to 100% of
base salary plus target bonus for other qualifying terminations; as well as a pro-rata cash bonus for the current (interrupted) year
in which any qualifying termination occurs.&nbsp;Effective June&nbsp;15, 2021 Mr.&nbsp;Klemt was promoted to Chief Financial Officer
and entered into an amended employment agreement with the Company (the &ldquo;Klemt Amended Employment Agreement&rdquo;). The Klemt Amended
Employment Agreement provided that Mr.&nbsp;Klemt will receive a base salary of &euro;325,000 per year, subject to review at the sole
discretion of the Company and a discretionary bonus of up to 40% of his annual base salary. Under the Klemt Employment Agreement, Mr.&nbsp;Klemt
was also entitled to expenses and reimbursements. In March&nbsp;2022, Mr.&nbsp;Klemt received a letter (the &ldquo;Klemt 2022 Letter&rdquo;),
which provides that his 2022 base salary will be &euro;340,000 and his 2021 bonus will be &euro;120,004. The Klemt 2022 Letter also provides
that Mr.&nbsp;Klemt will be entitled to participate in the 2022 equity grants of 43,630 restricted share units and an option to purchase
75,224 ordinary shares in the Company each pursuant to the Company&rsquo;s equity incentive plan. The termination provisions of the Klemt
Employment Agreement are further discussed below. The Klemt Amended Employment Agreement is to continue in force until he reaches the
legal retirement age in the Netherlands, unless terminated earlier. A copy of the Klemt Amended Employment Agreement is filed as Exhibit&nbsp;10.49
to the Company&rsquo;s Annual Report on Form&nbsp;10-K filed with the SEC on March&nbsp;1, 2021. The foregoing are not complete descriptions
of the Klemt Employment Agreement and are qualified in their entirety by reference to the full text of such agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Other Executive Compensation Policies</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Tax and Accounting Considerations for named executive officer subject
to US tax legislation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Prior to the passage of the Tax Cuts and Jobs Act of 2017, Section&nbsp;162(m)&nbsp;of
the Internal Revenue Code of 1986, as amended (the &ldquo;Internal Revenue Code&rdquo;), had  disallowed a tax deduction for
compensation in excess of $1.0 million paid to a company&rsquo;s NEOs, other than its chief financial officer.&nbsp; Historically, qualifying
performance-based compensation was not subject to the deduction limitation if specified requirements were met.&nbsp;However, effective
for taxable years beginning after December&nbsp;31, 2017, the exemption for qualified performance-based compensation from the deduction
limitation of Section&nbsp;162(m)&nbsp;has been repealed, such that compensation paid to our NEOs more than $1 million will not be
deductible unless it qualifies for the limited transition relief applicable to certain compensation arrangements in effect as of November&nbsp;2, 2017.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Nonqualified deferred compensation&rdquo; is required by Section&nbsp;409A
of the Internal Revenue Code to be paid under plans or arrangements that satisfy certain statutory requirements regarding timing of deferral
elections, timing of payments and certain other matters.&nbsp;Employees and service providers who receive compensation that fails to
satisfy these requirements may be subject to accelerated income tax liabilities, a 20% excise tax, penalties, and interest on their compensation
under such plans.&nbsp;The Company seeks to design and administer our compensation and benefits plans and arrangements for all our
employees and service providers, including our NEOs, to keep them either exempt from or in compliance with the requirements of Section&nbsp;409A.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 48; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->42<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Sections 280G and 4999 of the Internal Revenue Code impose certain
adverse tax consequences on compensation treated as excess parachute payments. An executive is treated as having received excess parachute
payments if such executive receives compensatory payments or benefits that are contingent on a change in control, and the aggregate amount
of such payments and benefits equal or exceeds three times the executive&rsquo;s base salary amount. The portion of the payments and
benefits more than one times base salary amount is treated as excess parachute payments and are subject to a 20% excise tax, in addition
to any applicable federal income and employment taxes.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Deferred Compensation and Retirement Plans</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company operates a qualified 401(k)&nbsp;Plan for all employees
at its Lexington facility in the USA. The uniQure,&nbsp;Inc. 401(k)&nbsp;Plan is an employee contribution plan only, and there are no
employer contributions currently being made.&nbsp;The uniQure Inc. 401(k)&nbsp;Plan offers both a before tax and after tax (Roth) component,
which are subject to IRS statutory limits for each calendar year.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company operates a defined contribution pension plan for all employees
at its Amsterdam facility in the Netherlands, which is funded by the Company through payments to an insurance company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Equity Incentive Plan</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The 2014 Restated Plan enables the Board to grant equity awards, including
options, restricted share unites (RSUs) and performance share units (PSUs).&nbsp;The purpose of the 2014 Restated Plan is to advance
the interests of the Company&rsquo;s shareholders by enhancing the Company&rsquo;s ability to attract, retain and motivate persons who
are expected to make important contributions to the group and by providing such persons with equity ownership opportunities and performance-based
incentives that are intended to better align the interests of such persons with those of the Company&rsquo;s shareholders.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The terms of the PSUs are further discussed above. For RSUs the shares
are automatically issued to the grantee upon the vesting of the award.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the 2014 Restated Plan, the maximum number of Ordinary Shares
available is currently limited to 12,601,471. As of March&nbsp;31, 2022, 2,171,353 Ordinary Shares remain available for grant under the
2014 Restated Plan.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Employee Share Purchase Plan</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Employee Share Purchase Plan (&ldquo;ESPP&rdquo;) is designed
to allow eligible employees of the Company and its designated subsidiaries to purchase discounted Ordinary Shares at designated intervals
through their accumulated payroll deductions. The purpose of the ESPP is to provide employees with a convenient method to invest in the
Company&rsquo;s Ordinary Shares which will increase the equity stake of the Company&rsquo;s employees and will benefit shareholders by
aligning more closely the interests of participating employees with those of the Company&rsquo;s shareholders.&nbsp;The Company believes
that this will help to motivate and retain highly qualified employees.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Under the ESPP, the number of Ordinary Shares initially reserved for
issuance is 150,000. The purchase price of the Ordinary Shares acquired on each purchase date will be the lesser of (a)&nbsp;85% of the
closing price of an Ordinary Share on the first day of the offering period or (b)&nbsp;85% of the closing price of an Ordinary Share
on the purchase date. As of March&nbsp;31, 2022, a total of 123,744 Ordinary Shares remain available for issuance under the ESPP.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Role of Executive Officer in Determining Executive Compensation</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Compensation Committee and Board approve all compensation decisions
related to our Named Executive Offices. Such decisions by the Compensation Committee regarding compensation were made independently from
our NEOs.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Stock Ownership Requirements and Hedging Policies</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Effective December&nbsp;2021, the Company adopted stock ownership
guidelines to further align the interests of its executive officers with the interests of the Company&rsquo;s stockholders. The
executive officers are expected to hold ordinary shares of the Company and other equity rights commensurate with their respective
roles with the Company. The policy applies to the &ldquo;Executive Officers,&rdquo; which includes the Chief Executive Officer, the
Chief Financial Officer, the President of Research and Development, the Chief Operations Officer, the Chief Legal Officer, the Chief
People and Culture Officer, the Chief Business Officer, the Chief Corporate Affairs Officer, and the Executive Vice President of
Regulatory Affairs and Quality Affairs. The policy requires that, within five years of adoption of the policy or their date of
appointment to their position, the Executive Officers are required to have a stock ownership position in the Company in an amount no
less than the multiple of their base salary set forth below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" ALIGN="RIGHT" STYLE="border-collapse: collapse; width: 90%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 20%">Chief Executive Officer</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 5%">3</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in; width: 10%">&nbsp; x</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 65%">annual base salary</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Other Covered Persons</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">1</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; padding-left: 0.25in">&nbsp; x</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">annual base salary</TD></TR>
  </TABLE><P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 49; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->43<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the event of an increase in an Executive Officer&rsquo;s base salary
or other compensation, an Executive Officer will have one year from the time of such increase to acquire any additional Ordinary Shares
needed to meet these guidelines. The ownership requirement will be measured as to each Executive Officer as of the first trading day
in January&nbsp;of each year. All Directors and Executive Officers have satisfied, or are on track to satisfy within the five-year grace
period, the Board&rsquo;s stock ownership guidelines. This description of the stock ownership guidelines does not purport to be complete,
and it is qualified in its entirety by reference to the full text of the guidelines, which can be viewed on our website at <U>https://www.uniqure.com/investors-newsroom/corporate-governance.php</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Clawback Policy </I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 9.25pt 0pt 5.55pt">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Also effective December&nbsp;2021, the Company adopted a Compensation
Clawback Policy (the &ldquo;Clawback Policy&rdquo;). Under the policy, in the event the Company is required to prepare an accounting
restatement due to material noncompliance of the Company with any financial reporting requirement under the United States federal securities
laws, the Board will take, in its discretion, such action it deems necessary to recover from its executive officers who received incentive-based
compensation, based on performance in a year for which the Company is required to prepare restated financial statements, the excess of
what would have been paid to the executive officer under the accounting restatement. This applies during a lookback period of three years,
and the amounts to be reclaimed are as determined by the Board in its sole discretion. For purposes of the Clawback Policy, an executive
officer is any of the Company&rsquo;s officers who are required, or who have been required during the immediately preceding three calendar
years, to file reports pursuant to Section&nbsp;16 of the Securities Exchange Act of 1934 as well as the Company&rsquo;s Chief Legal
Officer, if not included. This policy may, in certain circumstances, be applied to other current or former employees whose actions or
omissions contributed to the circumstances requiring the restatement and also involved willful misconduct or a willful violation of any
of the Company&rsquo;s rules. Additionally, if the Board determines that detrimental conduct has occurred that results in a material
adverse impact, any incentive compensation paid during the prior year may be subject to clawback. Incentive compensation excludes base
salary and other compensation but includes equity compensation and bonuses. The full Clawback Policy is available on our website at <U>https://www.uniqure.com/investors-newsroom/corporate-governance.php</U>.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Risk Considerations</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Compensation Committee annually evaluates whether there are potential
risks arising from the Company&rsquo;s compensation policies and practices.&nbsp; Based on such evaluation, the Compensation Committee
believes that the Company&rsquo;s compensation policies and practices do not encourage executives to take excessive risks because the
various elements of the Company&rsquo;s executive compensation policies and practices diversify the risks associated with any single
element of the executive&rsquo;s compensation.&nbsp; Instead, the elements of the Company&rsquo;s executive compensation policy are,
collectively, designed to achieve the Company&rsquo;s annual and long-term corporate objectives and strategies.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="v_001"></A>SUMMARY COMPENSATION TABLE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table summarizes the annual compensation paid to our
named executive officers for the three fiscal years ended December&nbsp;31, 2021, 2020 and 2019.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif">Name</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Year</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Salary&nbsp;(1)<BR>
    ($)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Stock<BR>
    Award(3)<BR> ($)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option<BR>
    Awards(3)<BR> ($)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Non-Equity<BR>
    Incentive<BR> Plan<BR> Compensation(4)<BR> ($)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Medicare<BR>
    benefits<BR> ($)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">All&nbsp;other<BR>
    compensation<BR> ($)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total<BR>
    ($)</TD><TD STYLE="font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left; text-indent: -10pt; padding-left: 10pt">Matthew
    Kapusta</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">2021</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">583,495</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">2,065,081</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">2,065,074</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">350,097</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">27,654</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">8,700</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 10%; text-align: right">5,100,101</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 1%; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">584,527</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,750,608</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,749,294</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">348,398</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">24,752</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,798</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,465,377</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2019</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">547,885</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,612,454</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,564,705</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">329,725</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">22,620</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8,400</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">4,085,789</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left; text-indent: -10pt; padding-left: 10pt">Ricardo
    Dolmetsch</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2021</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">506,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">470,973</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">470,983</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">253,000</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">27,654</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8,700</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,737,309</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(5)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">144,231</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,513,550</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">724,550</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">75,452</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">6,359</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">49,767</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,513,909</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left; text-indent: -10pt; padding-left: 10pt">Alexander
    E. Kuta</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2021</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">444,813</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">692,566</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">692,557</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">174,367</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">21,378</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8,700</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,034,382</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">452,579</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">641,408</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">640,928</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">172,692</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">18,754</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8,550</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,934,911</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2019</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">405,912</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,112,678</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">373,204</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">179,657</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">16,638</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">8,400</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,096,489</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left; text-indent: -10pt; padding-left: 10pt">Christian
    Klemt (2)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2021</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">344,628</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">934,487</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">928,907</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">141,986</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">18,410</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2,368,418</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-indent: -10pt; padding-left: 10pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2020</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">274,296</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">427,588</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">427,275</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">100,804</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">17,498</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,247,461</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-indent: -10.1pt; padding-left: 10.1pt">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2019</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">241,116</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">360,796</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">350,079</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">92,115</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">15,058</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,059,563</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left; text-indent: -10pt; padding-left: 10pt">Pierre
    Caloz (2)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">2021</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">(6)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">316,981</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,206,100</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">1,499,010</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">161,661</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">43,901</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">3,227,653</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-right: 0; margin-bottom: 0pt; text-align: left"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(1)</TD><TD STYLE="text-align: justify">Salary is determined
                                            based on actual salary during the fiscal years 2019 - 2021.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 50; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->44<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(2)</TD><TD STYLE="text-align: left">Mr.&nbsp;Klemt receives
                                            his salary, non-equity incentive plan compensation and other compensation in euros. Amounts
                                            were translated to $ using an average exchange rate for the 12-month period ended December&nbsp;31,
                                            2021 of 1.18 $/euro (2020 of 1.14 $/euro; 2019: 1.12 $/euro). Mr Caloz receives his salary,
                                            non-equity incentive compensation and other compensation in Swiss francs. Amounts were translated
                                            to dollars using an average exchange rate for the 12-month period ended December&nbsp;31,
                                            2021 of 1.09 $/Swiss franc.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(3)</TD><TD STYLE="text-align: left">The value of stock awards
                                            and stock options as reported in their respective columns above represent the aggregate grant
                                            date fair value of the stock and options awards granted to such named officers during 2019,
                                            2020 and 2021 as determined in accordance with Accounting Standards Codification 718, Compensation-Stock
                                            Compensation (&ldquo;ASC 718&rdquo;) not including estimates of forfeitures related to service-based
                                            vesting conditions. Amounts reflected in the stock awards column are comprised of the accounting
                                            value of both the time-vested RSUs and PSUs granted in the years reflected. PSUs have only
                                            been included in the stock awards column to the extend accomplishment of an underlying milestone
                                            is considered probable in accordance with ASC 718. The grant date fair value of the PSU award
                                            assuming the highest level of achievement of the performance conditions are as follows: Matthew
                                            Kapusta: $1,711,105, Ricardo Dolmetsch $857,020, Alexander E. Kuta $598,740, Pierre Caloz
                                            $857,020 and Christian Klemt $598,740.&nbsp; For assumptions and estimates used in determining
                                            these values, see Management&rsquo;s Discussion and Analysis of Financial Condition and Results
                                            of Operations &mdash; Share-based Payments and Note 2.3.18 of the Consolidated Financial
                                            Statements in our 2021 Annual Report on Form&nbsp;10-K. Note that the amounts reported in
                                            these columns reflect the accounting cost for these stock and option awards, and do not correspond
                                            to the actual economic value that may be received by the NEOs. The number of RSUs and stock
                                            options granted is established using a 30-day average share price, to mitigate for any short-term
                                            volatility, applied to the approved target value. Grant date fair values are calculated on
                                            the date of grant in accordance with accounting rules. This can result in differences between
                                            the target values approved by the Compensation Committee and the disclosed grant date fair
                                            value. In 2021 this resulted in the grant date fair value being approximately 0.7% higher
                                            than the target value.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(4)</TD><TD STYLE="text-align: left">These amounts reflect the
                                            annual cash bonus awards granted to the named executive officers pursuant to the Company&rsquo;s
                                            Short-term Incentive program.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(5)</TD><TD STYLE="text-align: justify">Dr.&nbsp;Dolmetsch&rsquo;s
                                            employment commenced on September&nbsp;14, 2020.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0in"></TD><TD STYLE="width: 0.25in; text-align: left">(6)</TD><TD STYLE="text-align: justify">Mr.&nbsp;Caloz&rsquo;s
                                            employment commenced on May&nbsp;17, 2021.</TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 51; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->45<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="v_002"></A>OUTSTANDING EQUITY AWARDS
AT FISCAL YEAR END 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The following table contains information concerning exercisable stock
options with respect to our Ordinary Shares, RSUs and PSUs granted to our named executive officers that were outstanding as of December&nbsp;31,
2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 7pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="font-size: 7pt; vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 7pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font-size: 7pt; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: center"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="14" STYLE="border-bottom: Black 1pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 7pt">Option&nbsp;Awards&nbsp;(1)</FONT></TD><TD STYLE="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="11" STYLE="border-bottom: Black 1pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 7pt">Stock&nbsp;Awards&nbsp;(2)</FONT></TD><TD STYLE="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 7pt Times New Roman, Times, Serif; white-space: nowrap"><FONT STYLE="font-size: 7pt">Name</FONT></TD><TD STYLE="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 7pt">Type&nbsp;of<BR>
    Equity<BR> Award</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 7pt">Number&nbsp;of<BR>
    Securities<BR> Underlying<BR> Unexercised<BR> Options<BR> Exercisable<BR> (#)</FONT></TD><TD STYLE="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 7pt">Number&nbsp;of<BR>
    securities<BR> underlying<BR> unexercised<BR> options<BR> Unexercisable<BR> (#)</FONT></TD><TD STYLE="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 7pt">Equity<BR>
    incentive<BR> plan<BR> awards:<BR> Number&nbsp;of<BR> securities<BR> underlying<BR> unexercised<BR> unearned<BR> options<BR> (#)</FONT></TD><TD STYLE="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 7pt">Option<BR>
    Exercise<BR> Price<BR> ($)</FONT></TD><TD STYLE="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 7pt">Option<BR>
    Expiration<BR> Date</FONT></TD><TD STYLE="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 7pt">Number<BR>
    of<BR> Shares<BR> or&nbsp;Units<BR> of&nbsp;Stock<BR> That<BR> Have<BR> Not&nbsp;Yet<BR> Vested<BR> (#)</FONT></TD><TD STYLE="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 7pt">Market<BR>
    Value&nbsp;of<BR> Shares&nbsp;or<BR> Units&nbsp;of<BR> Stock<BR> That<BR> Have&nbsp;Not<BR> Vested<BR> ($)</FONT></TD><TD STYLE="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 7pt">Equity<BR> Incentive<BR> Plan<BR> Awards:<BR> Number&nbsp;of<BR> Unearned</FONT></P>
                                                                                <P STYLE="margin-top: 0; margin-bottom: 0"><FONT STYLE="font-size: 7pt">PSUs,<BR> Shares,<BR>
Other<BR> Units&nbsp;or<BR> Rights<BR> That&nbsp;Have<BR> Not&nbsp;Yet<BR> Vested&nbsp;(10)<BR> (#)</FONT></P></TD><TD STYLE="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font: bold 7pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 7pt">Equity<BR>
    Incentive<BR> Plan<BR> Awards:<BR> Market&nbsp;or<BR> Payout<BR> Value&nbsp;of<BR> Unearned<BR> Shares<BR> Units&nbsp;or<BR> Other<BR>
    Rights<BR> That&nbsp;Have<BR> Not&nbsp;Vested<BR> ($)</FONT></TD><TD STYLE="font: bold 7pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; white-space: nowrap; width: 20%; text-align: left; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">Matthew
    Kapusta</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 6%; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="width: 1%; font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 6%; text-align: right"><FONT STYLE="font-size: 7pt">100,000</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 6%; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 6%; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 6%; text-align: right"><FONT STYLE="font-size: 7pt">14.71</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 6%; text-align: right"><FONT STYLE="font-size: 7pt">2025</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 6%; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 6%; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 6%; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 6%; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; width: 1%; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">100,000</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">23.60</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2025</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">51,316</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">7.53</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2026</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">175,000</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">6.22</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2027</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">78,434</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">5,229</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">19.39</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2028</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">57,311</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">26,051</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">31.71</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2029</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">25,931</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">33,347</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">51.81</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2030</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">96,229</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">37.00</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2031</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; vertical-align: middle; text-align: left"><FONT STYLE="font-size: 7pt">(3)</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">8,475</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">175,772</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(4</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">22,527</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">467,210</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(5</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">55,813</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">1,157,562</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">PSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(9</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">27,713</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">574,768</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">PSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(10)</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">58,300</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">1,209,142</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">Ricardo
    Dolmetsch</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">10,937</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">24,063</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">38,67</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2030</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">21,947</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">37,00</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2031</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(6</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">36,667</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">760,474</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(5</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">12,729</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">263,999</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">PSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(10</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">29,200</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">605,608</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">Alexander
    E. Kuta</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">44,000</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">5.31</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2027</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">22,264</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">1,498</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">19.39</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2028</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">13,669</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">6,214</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">31.71</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2029</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">9,500</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">12,219</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">51.81</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2030</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">32,272</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">37.00</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2031</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(3</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2,021</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">41,916</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(4</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">5,000</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">103,700</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(4</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">8,254</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">171,188</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(5</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">18,718</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">388,211</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">PSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(9</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">6,610</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">137,091</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">PSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(10</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">20,400</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">423,096</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">Christian
    Klemt</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">3,000</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">7.53</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2026</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">15,000</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">6.22</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2027</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">21,206</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">1,414</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">19.39</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2028</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">12,822</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">5,829</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">31.71</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2029</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">6,331</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">8,148</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">51.81</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2030</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">28,165</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">37.00</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2031</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">16,235</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">34.46</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2031</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(3</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">1,896</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">39,323</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(4</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">5,503</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">114,132</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(5</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">16,335</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">338,788</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(8</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">9,579</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">198,668</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">PSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(9</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">6,201</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">238,819</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">PSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(10</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">20,400</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">423,396</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; white-space: nowrap; text-align: left"><FONT STYLE="font-size: 7pt">Pierre Caloz</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">Options</FONT></TD>
    <TD STYLE="font-size: 7pt; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">75,000</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">34.46</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">2031</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">RSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(8</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">35,000</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">725,900</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="font-size: 7pt; vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 7pt; text-indent: -10.1pt; padding-left: 10.1pt"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">PSUs</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">(10</FONT>)</TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">&mdash;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">29,200</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 7pt">605,608</FONT></TD><TD STYLE="font: 7pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 7pt">&nbsp;</FONT></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>The option grants typically vest over four years; 25% on the anniversary
                                            of the grant date and in equal quarterly instalments thereafter.</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Market values of RSU and PSU awards are valued based on the closing stock
                                            price of the Company on December&nbsp;31, 2021 ($20.74 per Ordinary Share).</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>2019 RSU awards granted on January&nbsp;25, 2019, vest  one-third after each
                                            of one year, two years and three years after the grant date.</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(4)</TD><TD>2020 RSU awards granted on February&nbsp;27, 2020, vest one-third after each
                                            of one year, two years and three years after the grant date.</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(5)</TD><TD>2021 RSU awards granted on February&nbsp;25, 2021, vest one-third after each
                                            of one year, two years and three years after the grant date.</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(6)</TD><TD>RSU award granted on September&nbsp;15, 2020, vests one-third after each of
                                            one year, two years and three years after the grant date.</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(7)</TD><TD>RSU awards granted on September&nbsp;17, 2019, vest one-third after each of
                                            one year, two years and three years after the grant date.</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(8)</TD><TD>RSU awards granted on June&nbsp;15, 2021, vest one-third after each of one
                                            year, two years and three years after the grant date.</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(9)</TD><TD>2019 PSU awards granted on January&nbsp;25, 2019, were earned in February&nbsp;2020
                                            and vest on January&nbsp;25, 2022.</TD></TR>
<TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0"></TD><TD STYLE="width: 0.25in">(10)</TD><TD>2021 PSU awards granted on December&nbsp;8, 2021, are subject to milestones and are not yet earned.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 52; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->46<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="v_003"></A>GRANTS OF PLAN-BASED AWARDS
FOR 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font-size: 10pt; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font-size: 10pt; text-align: center"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="10" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Estimated&nbsp;Possible<BR>
    Payouts&nbsp;under<BR> Non-Equity&nbsp;Incentive<BR> Plan&nbsp;Awards(1)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="10" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Estimated&nbsp;Future&nbsp;Payouts<BR>
    Under&nbsp;Equity&nbsp;Incentive<BR> Plan&nbsp;Awards(4)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-size: 8pt">All&nbsp;Other<BR>
    stock<BR> Awards:<BR> Number&nbsp;of<BR> shares&nbsp;of<BR> stock&nbsp;or</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-size: 8pt">All&nbsp;Other<BR>
    option<BR> awards:<BR> Number&nbsp;of<BR> securities<BR> underlying</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-size: 8pt">Exercise&nbsp;or<BR>
    Base&nbsp;price<BR> of&nbsp;Option</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="font: bold 10pt Times New Roman, Times, Serif; white-space: nowrap; text-align: center"><FONT STYLE="font-size: 8pt">Grant<BR>
    Date&nbsp;Fair<BR> Value&nbsp;of<BR> Stock<BR> and<BR> Option</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Name</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="border-bottom: Black 1pt solid; white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 8pt">Award</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Grant<BR>
    Dates</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Threshold<BR>
    ($)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Target<BR>
    ($)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Maximum<BR>
    ($)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Threshold<BR>
    (#)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Target<BR>
    (#)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Maximum<BR>
    (#)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">units<BR>
    ($)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Option<BR>
    (#)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Awards<BR>
    ($/sh)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; text-align: center; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 8pt">Awards<BR>
    ($)</FONT></TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 12%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">Matthew Kapusta</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; width: 6%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">IC(1)</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">175,049</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">350,097</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">525,146</FONT></TD><TD STYLE="width: 0%; font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 0%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 0%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 0%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 0%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 5%; font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">Option(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">02/25/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">96,229</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">37.00</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">2,065,074</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">RSU(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">02/25/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">55,813</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">2,065,081</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">PSU (4)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">12/08/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">58,300</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">58,300</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">1,711,105</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">Ricardo Dolmetsch</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">IC(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">126,500</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">253,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">379,500</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">Option(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">02/25/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">21,947</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">37.00</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">470,983</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">RSU(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">02/25/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">12,729</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">470,973</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">PSU (4)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">09/15/20</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">29,200</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">29,200</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">857,020</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">Alexander E. Kuta</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">IC(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">88,963</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">177,925</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">266,888</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">Option(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">02/25/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">32,272</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">37.00</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">692,557</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">RSU(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">02/25/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">18,718</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">692,566</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">PSU (4)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">12/08/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">20,400</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">20,400</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">598,740</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">Christian Klemt (5)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">IC(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">76,907</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">153,813</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">230,720</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">Option(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">02/25/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">28,165</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">37.00</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">604,421</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">Option (2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">06/15/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">16,235</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">34.46</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">324,486</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">RSU(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">02/25/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">16,335</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">604,395</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">RSU (3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">06/15/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">9,579</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">330,092</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">PSU (4)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">12/08/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">20,400</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">20,400</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">598,740</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">Pierre Caloz (6)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">IC(1)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">126,862</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">253,724</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">380,586</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: right"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font-size: 10pt; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">Option(2)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">06/15/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">75,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">34.46</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">1,499,010</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">RSU(3)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">06/15/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">35,000</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">1,206,100</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="white-space: nowrap; text-align: right; font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">PSU (4)</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 8pt">12/08/21</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">29,200</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">29,200</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">&mdash;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right"><FONT STYLE="font-size: 8pt">857,020</FONT></TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left"><FONT STYLE="font-size: 8pt">&nbsp;</FONT></TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.55pt"></TD><TD STYLE="width: 15.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(1)</FONT></TD><TD STYLE="padding-right: 35.55pt">Represents 2021 annual cash bonus granted under the Company&rsquo;s Short-Term Incentive Plan. For
additional information, please see &ldquo;Compensation Discussion and Analysis&mdash;2021 Short-Term Incentive Plan&rdquo;.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.55pt"></TD><TD STYLE="width: 15.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(2)</FONT></TD><TD STYLE="padding-right: 25.05pt">Time-vested stock options granted under the Company&rsquo;s 2014 Restated Plan. Grant date values are
determined in accordance with ASC Topic 718. See &ldquo;Compensation Discussion and Analysis&mdash;2021 Long-term Incentive Awards&rdquo;.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.55pt"></TD><TD STYLE="width: 15.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(3)</FONT></TD><TD STYLE="padding-right: 50.25pt">Time-vested RSUs granted under the Company&rsquo;s 2014 Restated Plan. Grant date values are determined
in accordance with ASC Topic 718. See &ldquo;Compensation Discussion and Analysis&mdash;2021 Long-term Incentive</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.55pt"></TD><TD STYLE="width: 15.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(4)</FONT></TD><TD STYLE="padding-right: 25.05pt">PSUs granted in 2021 under the Company&rsquo;s 2014 Restated Plan for the 2021-2024 performance period
were unearned as per December 31, 2021. Grant date values are determined in accordance with ASC Topic 718. See &ldquo;Compensation Discussion
and Analysis&mdash;2021 Long-term Incentive Awards&rdquo;.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.55pt"></TD><TD STYLE="width: 15.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(5)</FONT></TD><TD>Mr. Klemt receives a salary in euros. Amounts were translated to dollars using an average exchange rate for the 12-month period ended
December 31, 2021 of</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.85pt">1.18 $/euro.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 20.85pt">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" WIDTH="100%" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 5.55pt"></TD><TD STYLE="width: 15.3pt"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt">(6)</FONT></TD><TD>Mr. Caloz receives his salary in Swiss francs. Amounts were translated to dollars using an average exchange rate for the 12-month
period ended December 31, 2021 of 1.09 $/Swiss franc.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 53; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->47<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="v_004"></A>OPTION EXERCISES AND STOCK
VESTED IN 2021</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table discloses information for
each of our named executive officers regarding the exercise of stock option awards and the vesting of certain stock awards for the 12-month
period ended December&nbsp;31, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD COLSPAN="5" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Option&nbsp;Awards</B></FONT></TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD COLSPAN="5" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><P STYLE="margin-top: 0; margin-bottom: 0"></P>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;<FONT STYLE="font-size: 10pt"><B>Stock&nbsp;Awards</B></FONT></P>

</TD><TD STYLE="padding-bottom: 1pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="text-align: center; font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number&nbsp;of<BR>
                                            shares<BR> Acquired&nbsp;on<BR> Exercise<BR> (#)</B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Value&nbsp;Realized<BR>
                                            on&nbsp;Exercise<BR> ($)</B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Number&nbsp;of<BR>
                                            Shares<BR> Acquired<BR> on&nbsp;Vesting<BR> (#)</B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="text-align: center; font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center"><FONT STYLE="font-size: 10pt"><B>Value&nbsp;Realized<BR>
                                            on&nbsp;Vesting(1)</B></FONT></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: center">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font-size: 10pt; text-align: left">Matthew Kapusta</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">-</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">74,119</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">2,827,882</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Alexander E. Kuta</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">54,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,422,627</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">26,723</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,010,973</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Christian Klemt</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">19,349</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">738,100</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Ricardo Dolmetsch</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">28,333</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,030,755</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Pierre Caloz</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">-</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-left: 0.25in; margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Value realized equals number of Ordinary Shares vested multiplied
                                            by the closing price of our Ordinary Shares on the Nasdaq Global Select Market on the day
                                            the Ordinary Shares vested, respectively the closing price on the last trading day if such
                                            vesting occurs on a day that our Ordinary Shares are not traded on the Nasdaq Global Select
                                            Market.</TD></TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Potential Payments upon Termination or Change of Control</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the terms of their respective employment agreements with
the Company, each of our NEOs is eligible for potential payments and benefits in connection with a termination, including for Cause or
for Good Reason, or in connection with a Change of Control. The following narrative and tables set forth the potential payments and value
of additional benefit that each of our NEOs would receive in the scenarios contemplated. The tables below assume that employment terminated
and/or the Change of Control occurred on December&nbsp;31, 2021 and reflect the stock price of the Company on December&nbsp;31, 2021
of  $20.74 per Ordinary Share.&nbsp;Except as otherwise provided, the following definitions apply to the potential payments upon termination.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Accrued Benefit&rdquo; means (a)&nbsp;payment of base salary
through the termination date, (b)&nbsp;payment of any bonus for performance periods completed prior to the termination date, (c)&nbsp;any
payments or benefits under the Company&rsquo;s benefit plans that are vested, earned or accrued prior to the termination date (including,
without limitation, earned but unused vacation); and (d)&nbsp;payment of unreimbursed business expenses incurred by the named executive
officer.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Cause&rdquo; means the good faith determination by the Company,
after written notice from the Board to the named executive officer that one or more of the following events has occurred and stating
with reasonable specificity the actions that constitute Cause and the specific reasonable cure (related to sections (a)&nbsp;and (h)&nbsp;below):
(a)&nbsp;the named executive officer has willfully or repeatedly failed to perform his or her material duties, and such failure has not
been cured after a period of thirty (30) days&rsquo; notice; (b)&nbsp;any reckless or grossly negligent act by the named executive officer
having the foreseeable effect of injuring the interest, business or reputation of the Company, or any of its parent, subsidiaries or
affiliates in any material respect and which did in fact cause such material injury; (c)&nbsp;the named executive officer&rsquo;s evidenced
use of any illegal drug, or illegal narcotic, or excessive amounts of alcohol (as determined by the Company in its reasonable discretion)
on Company property or at a function where the named executive officer is working on behalf of the Company; (d)&nbsp;the indictment on
charges or conviction for (or the procedural equivalent or conviction for), or entering of a guilty plea or plea of no contest with respect
to a felony; (e)&nbsp;the conviction for (or the procedural equivalent or conviction for), or entering of a guilty plea or plea of no
contest with respect to a misdemeanor which, in the Board&rsquo;s reasonable judgment, involves moral turpitude deceit, dishonesty or
fraud, except that, in the event that the named executive officer is indicted on charges for a misdemeanor set forth above, the Board
may elect, in its sole discretion, to place the named executive officer on administrative garden leave with continuation of full compensation
and benefits under this Agreement during the pendency of the proceedings; (f)&nbsp;conduct by or at the direction of the named executive
officer constituting misappropriation or embezzlement of the property of the Company, or any of its parents or affiliates (other than
the occasional, customary and de minimis use of Company property for personal purposes); (g)&nbsp;a breach by the named executive officer
of a fiduciary duty owing to the Company, including the misappropriation of (or attempted misappropriation of) a corporate opportunity
or undisclosed self-dealing; (h)&nbsp;a material breach by the named executive officer of any material provision of this Agreement, any
of the Company&rsquo;s written employment policies or the named executive officer&rsquo;s fiduciary duties to the Company, which breach,
if curable, remains uncured for a period of thirty (30) days after receipt by the named executive officer of written notice of such breach
from the Board, which notice shall contain a reasonably specific description of such breach and the specific reasonable cure requested
by the Board; and (i)&nbsp;any breach of their respective employment agreements.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 54; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->48<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Change of Control&rdquo; means any of the following: (a)&nbsp;any
 &ldquo;person,&rdquo; as such term is used in Sections 13(d)&nbsp;and 14(d)&nbsp;of the Securities Exchange Act of 1934, as amended (the
 &ldquo;Act&rdquo;) (other than the Company, any of its subsidiaries, or any trustee, fiduciary or other person or entity holding securities
under any employee benefit plan or trust of the Company or any of its subsidiaries), together with all &ldquo;affiliates&rdquo; and &ldquo;associates&rdquo;
(as such terms are defined in Rule&nbsp;12b-2 under the Act) of such person, shall become the &ldquo;beneficial owner&rdquo; (as such
term is defined in Rule&nbsp;13d-3 under the Act), directly or indirectly, of securities of the Company representing forty (40) percent
or more of the combined voting power of the Company&rsquo;s then outstanding securities having the right to vote in an election of the
Board (&ldquo;Voting Securities&rdquo;) (in such case other than as a result of an acquisition of securities directly from the Company);
or (b)&nbsp;the date a majority of the members of the Board is replaced during any 12-month period by directors whose appointment or
election is not endorsed by a majority of the members of the Board before the date of the appointment or election; or (c)&nbsp;the consummation
of (1)&nbsp;any consolidation or merger of the Company where the stockholders of the Company, immediately prior to the consolidation
or merger, would not, immediately after the consolidation or merger, beneficially own (as such term is defined in Rule&nbsp;13d-3 under
the Act), directly or indirectly, shares representing in the aggregate more than 50 percent of the voting shares of the Company issuing
cash or securities in the consolidation or merger (or of its ultimate parent corporation, if any), or (2)&nbsp;any sale or other transfer
(in one transaction or a series of transactions contemplated or arranged by any party as a single plan) of all or substantially all of
the assets of the Company.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Change of Control Termination&rdquo; means (i)&nbsp;any termination
by the Company of the named executive officer&rsquo;s employment other than for Cause that occurs within 12 months after the Change of
Control; or (ii)&nbsp;any resignation by the named executive officer for Good Reason that occurs within 12 months after the Change of
Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Disability&rdquo; means an incapacity by accident, illness
or other circumstances which renders the named executive officer mentally or physically incapable of performing the duties and services
required of him or her on a full-time basis for a period of at least 120 days.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Good Reason&rdquo; means that the named executive officer has
complied with the Good Reason Process (hereinafter defined) following the occurrence of any of the following events: (a)&nbsp;a material
diminution in the named executive officer&rsquo;s responsibilities, authority or duties (excluding any duties associated with any position
that the named executive officer may hold at the Company); (b)&nbsp;a diminution in the named executive officer&rsquo;s base salary,
except for across-the-board salary reductions, based on the Company&rsquo;s financial performance, similarly affecting all or substantially
all other senior management employees of the Company, which reduction does not reduce the named executive officer&rsquo;s base salary
(in the aggregate with any similar reductions during the term of employment) by more than 20% from the named executive officer&rsquo;s
highest base salary; (c)&nbsp;a material change in the geographic location at which the named executive officer provides services to
the Company (i.e., outside a radius of fifty (50) miles from their primary business location); or (d)&nbsp;the material breach of their
respective employment agreements by the Company (each a &ldquo;Good Reason Condition&rdquo;).</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Good Reason Process&rdquo; means that (a)&nbsp;the named executive
officer reasonably determines in good faith that a Good Reason Condition has occurred; (b)&nbsp;the named executive officer notifies
the Board in writing of the first occurrence of the Good Reason Condition within sixty (60) days of the first occurrence of such condition;
(c)&nbsp;the named executive officer cooperates in good faith with the Company&rsquo;s efforts, for a period not less than thirty (30)
days following such notice (the &ldquo;Cure Period&rdquo;), to remedy the Good Reason Condition; (d)&nbsp;notwithstanding such efforts,
the Good Reason Condition continues to exist; and (e)&nbsp;the named executive officer terminates the employment within sixty (60) days
after the end of the Cure Period. If the Company cures the Good Reason Condition during the Cure Period, Good Reason shall be deemed
not to have occurred.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 55; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->49<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Matthew Kapusta</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table discloses information about
the benefits the named executive officer would receive as of December&nbsp;31, 2021, at a share price of $20.74 per Ordinary Share upon
termination in certain circumstances, including in the event of a change in control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Termination<BR> without&nbsp;Cause<BR>
    or&nbsp;Resignation<BR> for Good<BR> Reason<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Termination&nbsp;in<BR>
    Connection&nbsp;with<BR> a&nbsp;Change&nbsp;in<BR> Control<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Death<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Disability(5)<BR>
    ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Retirement(5)<BR>
    ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-indent: -10.1pt; padding-left: 10.1pt">Compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 35%; font-size: 10pt; text-align: left; text-indent: -10.1pt; padding-left: 20.2pt">Cash severance (1)</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">583,495</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,867,184</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10.1pt; padding-left: 20.2pt">Pro-rata bonus (1), (2)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">350,097</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">350,097</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">350,097</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">350,097</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10.1pt; padding-left: 10.1pt">Long term incentive</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10.1pt; padding-left: 20.2pt">Restricted share units &mdash;
    unvested&nbsp;&amp; accelerated</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,800,543</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,800,543</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: -10.1pt; padding-left: 20.2pt">Performance share units &mdash;
    unvested&nbsp;&amp; accelerated (3)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">574,768</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">574,768</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">574,768</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">574,768</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10.1pt; padding-left: 20.2pt">Stock options &mdash; unvested&nbsp;&amp;
    accelerated</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,059</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,059</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,059</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,059</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">7,059</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10.1pt; padding-left: 10.1pt">Benefits and perquisites</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left; text-indent: -10.1pt; padding-left: 20.2pt">Health insurance (4)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">30,435</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,653</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt; text-indent: -10.1pt; padding-left: 10.1pt"><B>Total</B></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"><B>&nbsp;</B></TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right"><B>3,346,397</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"><B>&nbsp;</B></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"><B>&nbsp;</B></TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right"><B>4,645,304</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"><B>&nbsp;</B></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"><B>&nbsp;</B></TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right"><B>931,924</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"><B>&nbsp;</B></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"><B>&nbsp;</B></TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right"><B>931,924</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"><B>&nbsp;</B></TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt"><B>&nbsp;</B></TD>
    <TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"><B>&nbsp;</B></TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right"><B>7,059</B></TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left"><B>&nbsp;</B></TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 3%">(1)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%">Cash severance and pro-rata bonus are paid as a lump sum, except
    in the case of base salary paid on termination without cause or for good reason, which is paid over the course of the severance period.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(2)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Pro-rata bonus amounts under the &ldquo;Termination without Cause or Resignation
    for Good Reason&rdquo; and &ldquo;Death&rdquo; columns are based on actual 2021 annual short-term incentive pay out.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(3)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">PSU amounts reflect actual earned awards for all completed tranches.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(4)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Health costs are based on individual elections and budgeted rates for 2021.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(5)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">The disclosure assumes the Compensation Committee did not exercise its discretion
    to award pro-rata short-term incentive amounts in the event of disability or retirement.</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Kapusta Employment Agreement requires us to provide compensation
and/or other benefits to Mr.&nbsp;Kapusta during his employment and in the event of that executive&rsquo;s termination of employment
under certain circumstances and in the event of termination because of a change in control. Those arrangements are described in greater
detail below. All severance payments and benefits described below (except for Accrued Benefits (defined below)) are conditioned upon
the execution and delivery to the Company of a General Release of Claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Other than in the event of a Change of Control Termination (defined
below), pursuant to the terms of the Kapusta Employment Agreement, if the Company terminates Mr.&nbsp;Kapusta&rsquo;s employment (or
fails to renew the Kapusta Employment Agreement) without Cause or if Mr.&nbsp;Kapusta resigns or opts not to renew the Kapusta Employment
Agreement for Good Reason, then Mr.&nbsp;Kapusta is entitled to Accrued Benefits (defined below), twelve months of base salary, a lump
sum bonus payment, accelerated vesting of options and restricted share unit awards which remain unvested as of the termination date,
accelerated vesting of performance share unit awards to the extent then earned which remain unvested as of the termination date, and
the continuation of certain other benefits.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If Mr.&nbsp;Kapusta&rsquo;s employment with the Company terminates
due to his death or disability, he will be entitled to Accrued Benefits and a lump sum bonus payment.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">In the event of a Change of Control Termination (defined below), Mr.&nbsp;Kapusta
will be entitled in such circumstances to a lump sum payment equal to two times Mr.&nbsp;Kapusta&rsquo;s then-current base salary to
be paid no later than sixty days after the termination date, his bonus for the year of termination pro-rated based upon Mr.&nbsp;Kapusta&rsquo;s
termination date, and a lump sum representing and additional two times Mr.&nbsp;Kapusta&rsquo;s bonus, to be paid no later than sixty
days following the termination date.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If Mr.&nbsp;Kapusta incurs excise tax liability pursuant to section
4999 of the Internal Revenue Code, as amended, he will be entitled to certain reductions in his severance payments which will have the
result of providing him certain tax relief, all pursuant to the Kapusta Employment Agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 56; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->50<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<!-- Field: Split-Segment; Name: 5 -->
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If Mr.&nbsp;Kapusta&rsquo;s employment with the Company is terminated
voluntarily without Good Reason by Mr.&nbsp;Kapusta, for Cause by the Company, upon a vote of the general meeting of the Company&rsquo;s
shareholders to dismiss him or upon a vote of the Board to recommend dismissal from his positions at the Company to the general meeting
of the Company&rsquo;s shareholders and /or to suspend Mr.&nbsp;Kapusta from his positions, then Mr.&nbsp;Kapusta is not entitled to
any severance.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Accrued Benefit&rdquo; means (a)&nbsp;payment of base salary
through the termination date, (b)&nbsp;payment of any bonus for performance periods completed prior to the termination date, (c)&nbsp;any
payments or benefits under the Company&rsquo;s benefit plans that are vested, earned or accrued prior to the termination date (including,
without limitation, earned but unused vacation); (d)&nbsp;payment of unreimbursed business expenses incurred by Mr.&nbsp;Kapusta; and
(e)&nbsp;rights to indemnification and directors&rsquo; and officers&rsquo; liability insurance coverage, under any agreement between
the Company and Mr.&nbsp;Kapusta, and/or under any of the Company&rsquo;s organizational documents.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&ldquo;Change of Control Termination&rdquo; means (a)&nbsp;any termination
by the Company of Mr.&nbsp;Kapusta&rsquo;s employment, other than for Cause, that occurs within the period that starts ninety (90) days
preceding the Change of Control and ends on the one-year anniversary of the Change in Control; or (b)&nbsp;any resignation by Mr.&nbsp;Kapusta
for Good Reason, that occurs within the period that starts ninety (90) days preceding the Change of Control and ends on the one-year
anniversary of the Change in Control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing descriptions of the Kapusta Employment Agreement do
not purport to be complete and are qualified in their entirety by reference to the full text of such agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Pierre Caloz</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table discloses information about
the benefits the named executive officer would receive as of December&nbsp;31, 2021, at a share price of $20.74 per Ordinary Share upon
termination in certain circumstances, including in the event of change in control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Termination<BR> without<BR>
    Cause<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Resignation<BR> for&nbsp;Good<BR>
    Reason<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Termination<BR> in&nbsp;Connection<BR>
    with&nbsp;a&nbsp;Change<BR> in&nbsp;Control<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Death<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Disability(3)<BR>
    ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Retirement(3)<BR>
    ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-indent: -10.1pt; padding-left: 10.1pt">Compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 22%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Cash severance</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">475,472</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">475,472</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">713,208</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Pro-rata bonus(1)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">161,661</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">161,661</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">161,661</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Long term incentive</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Restricted share units &mdash; unvested&nbsp;&amp;
    accelerated</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">725,900</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Performance share units &mdash; unvested&nbsp;&amp;
    accelerated(2)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Stock options &mdash;
    unvested&nbsp;&amp; accelerated</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Total</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">637,133</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">637,133</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">1,600,769</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 3%">(1)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%">Pro-rata bonus amount under the &ldquo;Termination without Cause
    or Resignation for Good Reason&rdquo; column is based on actual 2021 annual short-term incentive pay-out.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(2)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">PSU amounts reflect actual earned awards for all completed tranches.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(3)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">The disclosure assumes the Compensation Committee did not exercise its discretion
    to award pro-rata short-term incentive amounts in the event of disability or retirement.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Caloz Employment Agreement requires us to provide compensation
and/or other benefits to Mr.&nbsp;Caloz during his employment and in the event of that executive&rsquo;s termination of employment under
certain circumstances and in the event of termination because of a change in control. Those arrangements are described in greater detail
below. All severance payments and benefits described below (except for Accrued Benefits) are conditioned upon the execution and delivery
to the Company of a General Release of Claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the terms of the Caloz Employment Agreement, if Mr.&nbsp;Caloz&rsquo;s
employment is terminated due to the death or Disability of Mr.&nbsp;Caloz, then Mr.&nbsp;Caloz is entitled to Accrued Benefits. If the
Company terminates Mr.&nbsp;Caloz&rsquo;s&nbsp;employment without Cause or if Mr.&nbsp;Caloz resigns for Good Reason, then Mr.&nbsp;Caloz
is entitled to Accrued Benefits, twelve months of base salary plus target bonus and a bonus pro-rated to the date of termination and
based on the target bonus amount set by the Board (50% as of December&nbsp;31, 2021). In the event of a change of control termination
then Mr.&nbsp;Caloz is entitled to Accrued Benefits, 18 months of base salary plus target bonus and a bonus pro-rated to the date of
termination and based on the target bonus amount set by the Board (50% as of December&nbsp;31, 2021). In the event of a termination of
Mr.&nbsp;Caloz&rsquo;s&nbsp;employment due to death or disability or if Mr.&nbsp;Caloz resigns for Good Reason or upon a Change of Control
Termination, Mr.&nbsp;Caloz is entitled to accelerated vesting of options and performance share unit awards that remain unvested as of
the termination date. Furthermore, in the event of a Change of Control Termination, Mr.&nbsp;Caloz is entitled to accelerated vesting
of restricted share unit awards, and, to avoid duplication of severance payments, any amount to be paid per the above will be offset
by severance amounts paid pursuant to the Company&rsquo;s change of control guidelines</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 57; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->51<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Ricardo Dolmetsch</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table discloses information about
the benefits the named executive officer would receive as of December&nbsp;31, 2021, at a share price of $20.74 per Ordinary Share upon
termination in certain circumstances, including in the event of change in control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Termination<BR> without<BR>
    Cause<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Resignation<BR> for&nbsp;Good<BR>
    Reason<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Termination&nbsp;in<BR>
    Connection<BR> with&nbsp;a&nbsp;Change<BR> in&nbsp;Control<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Death<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Disability(4)<BR>
    ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Retirement(4)<BR>
    ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-indent: -10.1pt; padding-left: 10.1pt">Compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 22%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Cash severance</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">759,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">759,000</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">1,138,500</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Pro-rata bonus(1)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">253,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">253,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">253,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Long term incentive</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Restricted share units &mdash;
    unvested&nbsp;&amp; accelerated</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">1,024,473</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Performance share units &mdash; unvested&nbsp;&amp;
    accelerated (2)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Stock options &mdash; unvested&nbsp;&amp; accelerated</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 20pt">Benefits and perquisites</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">#</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">#</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">#</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Health insurance (3)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">30,435</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">30,435</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">45,653</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Total</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">1,042,435</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">1,042,435</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; text-align: right">2,461,626</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">#</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">#</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">#</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center">&nbsp;&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 3%">(1)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%">Pro-rata bonus amount under the &ldquo;Termination without Cause
    or Resignation for Good Reason&rdquo; column is based on actual 2021 annual short-term incentive pay-out.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(2)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">PSU amounts reflect actual earned awards for all completed tranches.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(3)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Health costs are based on individual elections and budgeted rates for 2021.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(4)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">The disclosure assumes the Compensation Committee did not exercise its discretion
    to award pro-rata short-term incentive amounts in the event of disability or retirement.</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">As of December&nbsp;31, 2021, the Dolmetsch Employment Agreement required
us to provide compensation and/or other benefits to Dr.&nbsp;Dolmetsch during his employment and in the event of that executive&rsquo;s
termination of employment under certain circumstances and in the event of termination due to of a change in control. Those arrangements
are described in greater detail below. All severance payments and benefits described below (except for Accrued Benefits) are conditioned
upon the execution and delivery to the Company of a General Release of Claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the terms of the Dolmetsch Employment Agreement, if Dr.&nbsp;Dolmetsch&rsquo;s
employment is terminated due to the death or Disability of Dr.&nbsp;Dolmetsch, then Dr.&nbsp;Dolmetsch is entitled to Accrued Benefits.
If the Company terminates Dr.&nbsp;Dolmetsch&rsquo;s employment without Cause or if Dr.&nbsp;Dolmetsch resigns for Good Reason, then
Dr.&nbsp;Dolmetsch is entitled to Accrued Benefits, twelve months of base salary plus target bonus, a bonus pro-rated to the date of
termination and based on the target bonus amount set by the Board (currently 50%), and continued coverage through COBRA for a period
of 12 months. In the event of a change of control termination then Dr.&nbsp;Dolmetsch is entitled to Accrued Benefits, 18 months of base
salary plus target bonus, a bonus pro-rated to the date of termination and based on the target bonus amount set by the Board (currently
50%), and continued coverage through COBRA for a period of 18 months. In the event of a termination of Dr.&nbsp;Dolmetsch&rsquo;s employment
due to death or disability or if Dr.&nbsp;Dolmetsch resigns for Good Reason or upon a Change of Control Termination, Dr.&nbsp;Dolmetsch
is entitled to accelerated vesting of options that remain unvested as of the termination date. Furthermore, in the event of a Change
of Control Termination, Dr.&nbsp;Dolmetsch is entitled to accelerated vesting of restricted share unit awards, and, to avoid duplication
of severance payments, any amount to be paid per the above will be offset by severance amounts paid pursuant to the Company&rsquo;s change
of control guidelines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The foregoing descriptions of the Dolmetsch Employment Agreement do
not purport to be complete and are qualified in their entirety by reference to the full text of such agreement.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 58; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->52<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Christian Klemt</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table discloses information about
the benefits the named executive officer would receive as of December&nbsp;31, 2021, at a share price of $20.74 per Ordinary Share upon
termination in certain circumstances, including in the event of change in control.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Termination<BR> without<BR>
    Cause<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Resignation<BR> for&nbsp;Good<BR>
    Reason<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Termination<BR> in&nbsp;Connection<BR>
    with&nbsp;a&nbsp;Change<BR> in&nbsp;Control<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Death<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Disability(3)<BR>
    ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Retirement(3)<BR>
    ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-indent: -10.1pt; padding-left: 10.1pt">Compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 22%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Cash severance</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">482,480</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">482,480</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">723,720</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-indent: -10pt; padding-left: 20pt">Pro-rata bonus(1)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">141,986</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">141,986</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">141,986</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Long term incentive</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Restricted share units &mdash; unvested&nbsp;&amp;
    accelerated</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">690,912</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Performance share units &mdash; unvested&nbsp;&amp;
    accelerated(2)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">128,609</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">128,609</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">128,609</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">128,609</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">128,609</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Stock options &mdash;
    unvested&nbsp;&amp; accelerated</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,909</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,909</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,909</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,909</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">1,909</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Total</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">753,075</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">754,984</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">1,687,135</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">130,518</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">130,518</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">1,909</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0pt 0.25in; text-indent: -0.25in"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 3%">(1)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%"><P STYLE="margin-top: 0; margin-bottom: 0">Pro-rata bonus amount under the &ldquo;Termination without Cause or Resignation for Good Reason&rdquo; column is based on actual 2020 annual short-term incentive pay-out.</P>
                                                                     <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(2)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif"><P STYLE="margin-top: 0; margin-bottom: 0">PSU amounts reflect actual earned awards for all completed tranches.</P>
                                                         <P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P></TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(3)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">The disclosure assumes the Compensation Committee did not exercise its discretion
    to award pro-rata short-term incentive amounts in the event of disability or retirement.</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Klemt Employment Agreement requires us to provide compensation
and/or other benefits to Mr.&nbsp;Klemt during his employment and in the event of that executive&rsquo;s termination of employment under
certain circumstances and in the event of termination due to a change in control. Those arrangements are described in greater
detail below. All severance payments and benefits described below (except for Accrued Benefits) are conditioned upon the execution and
delivery to the Company of a General Release of Claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the terms of the Klemt Employment Agreement, if Mr.&nbsp;Klemt&rsquo;s
employment is terminated due to the death or Disability of Mr.&nbsp;Klemt, then Mr.&nbsp;Klemt is entitled to Accrued Benefits. If the
Company terminates Mr.&nbsp;Klemt&rsquo;s&nbsp;employment without Cause or if Mr.&nbsp;Klemt resigns for Good Reason, then Mr.&nbsp;Klemt
is entitled to Accrued Benefits, twelve months of base salary plus target bonus and a bonus pro-rated to the date of termination and
based on the target bonus amount set by the Board (40% as of December&nbsp;31, 2021). In the event of a change of control termination
then Mr.&nbsp;Klemt is entitled to Accrued Benefits, 18 months of base salary plus target bonus and a bonus pro-rated to the date of
termination and based on the target bonus amount set by the Board (40% as of December&nbsp;31, 2021). In the event of a termination of
Mr.&nbsp;Klemt&rsquo;s&nbsp;employment due to death or disability or if Mr.&nbsp;Klemt resigns for Good Reason or upon a Change of Control
Termination, Mr.&nbsp;Klemt is entitled to accelerated vesting of options and performance share unit awards that remain unvested as of
the termination date. Additionally, if Mr.&nbsp;Klemt retires, he is entitled to accelerated vesting of options granted prior to June&nbsp;30,
2019. Furthermore, in the event of a Change of Control Termination, Mr.&nbsp;Klemt is entitled to accelerated vesting of restricted share
unit awards, and, to avoid duplication of severance payments, any amount to be paid per the above will be offset by severance amounts
paid pursuant to the Company&rsquo;s change of control guidelines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 59; Value: 1 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="font-size: 10pt; text-align: center; margin-top: 0pt; margin-bottom: 0pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->53<!-- Field: /Sequence --></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Alexander E. Kuta</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The following table discloses information about
the benefits the named executive officer would receive as of December&nbsp;31, 2021, at a share price of $20.74 per Ordinary Share upon
termination in certain circumstances, including in the event of change in control</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Termination<BR> without<BR>
    Cause<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Resignation<BR> for&nbsp;Good<BR>
    Reason<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Termination<BR> in&nbsp;Connection<BR>
    with&nbsp;a&nbsp;Change<BR> in&nbsp;Control<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Death<BR> ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Disability(4)<BR>
    ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Retirement(4)<BR>
    ($)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-indent: -10.1pt; padding-left: 10.1pt">Compensation</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="width: 22%; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Cash severance</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">622,738</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">622,738</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">934,107</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Pro-rata bonus (1)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">174,367</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">174,367</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">174,367</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Long term incentive</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Restricted share units &mdash; unvested&nbsp;&amp;
    accelerated</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">705,015</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="white-space: nowrap; font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Performance share units &mdash; unvested&nbsp;&amp;
    accelerated (2)</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">137,091</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">137,091</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">137,091</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">137,091</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">137,091</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; text-indent: -10pt; padding-left: 20pt">Stock options &mdash; unvested&nbsp;&amp; accelerated</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,022</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,022</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,022</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,022</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,022</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; text-align: left; text-indent: -10pt; padding-left: 10pt">Benefits and perquisites</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left; padding-bottom: 1pt; text-indent: -10pt; padding-left: 20pt">Health insurance (3)</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">22,370</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">22,370</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">33,556</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; text-align: right">&mdash;</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt; text-indent: -10pt; padding-left: 10pt">Total</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">956,567</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">958,589</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">1,986,158</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">139,114</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">139,114</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD><TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: right">2,022</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="border-top: Black 1pt solid; font-size: 1pt">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top; width: 3%">(1)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; width: 97%">Pro-rata bonus amount under the &ldquo;Termination without Cause
    or Resignation for Good Reason&rdquo; column is based on actual 2021 annual short-term incentive pay-out.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(2)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">PSU amounts reflect actual earned awards for all completed tranches.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(3)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">Health costs are based on individual elections and budgeted rates for 2021.</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD COLSPAN="2" STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; vertical-align: top">(4)</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif">The disclosure assumes the Compensation Committee did not exercise its discretion
    to award pro-rata short-term incentive amounts in the event of disability or retirement.</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Kuta Employment Agreement requires us to provide compensation
and/or other benefits to Dr.&nbsp;Kuta during his employment and in the event of that executive&rsquo;s termination of employment under
certain circumstances and in the event of termination because of a change in control. Those arrangements are described in greater detail
below. All severance payments and benefits described below (except for Accrued Benefits) are conditioned upon the execution and delivery
to the Company of a General Release of Claims.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Pursuant to the terms of the Kuta Employment Agreement, if Dr.&nbsp;Kuta&rsquo;s
employment is terminated due to the death or Disability of Dr.&nbsp;Kuta, then Dr.&nbsp;Kuta is entitled to Accrued Benefits. If the
Company terminates Dr.&nbsp;Kuta&rsquo;s employment without Cause or if Dr.&nbsp;Kuta resigns for Good Reason, then Dr.&nbsp;Kuta is
entitled to Accrued Benefits, twelve months of base salary plus target bonus, a bonus pro-rated to the date of termination and based
on the target bonus amount set by the Board (currently 40%), and continued coverage through COBRA for a period of 12 months. In the event
of a change of control termination then Dr.&nbsp;Kuta is entitled to Accrued Benefits, 18 months of base salary plus target bonus, a
bonus pro-rated to the date of termination and based on the target bonus amount set by the Board (currently 40%), and continued coverage
through COBRA for a period of 18 months. In the event of a termination of Dr.&nbsp;Kuta&rsquo;s employment due to death or disability
or if Dr.&nbsp;Kuta resigns for Good Reason or upon a Change of Control Termination, Dr.&nbsp;Kuta is entitled to accelerated vesting
of options and performance share unit awards that remain unvested as of the termination date. Additionally, if Dr.&nbsp;Kuta retires,
he is entitled to accelerated vesting of options granted prior to June&nbsp;30, 2019. Furthermore, in the event of a Change of Control
Termination, Dr.&nbsp;Kuta is entitled to accelerated vesting of restricted share unit awards, and, to avoid duplication of severance
payments, any amount to be paid per the above will be offset by severance amounts paid pursuant to the Company&rsquo;s change of control
guidelines.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><B><A NAME="va_002"></A>DIRECTOR COMPENSATION</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Overview of Director Compensation Program</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><I>Current Director Compensation Arrangements</I></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Our Remuneration Policy provides that our Board may determine compensation
paid to non-executive directors. Other than as noted below, our Board has determined that the compensation paid to our non-executive directors
will not increase in amount from that paid during the last fiscal year. The increases in compensation were based on information and recommendations
provided by Willis Towers Watson, the compensation consultant to the Board. Our Board-approved non-executive director compensation for
their services on our Board as follows:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
non-executive director received an annual retainer of $40,000.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">The
chair of the board receives an annual retainer totaling $75,000 (i.e., an annual retainer of $40,000 and an additional $35,000 as the
chair of the Board).</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 60; Options: NewSection; Value: 54 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->54<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
non-executive director who serves as member of a committee of our Board receives additional compensation as follows:</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Audit
Committee: the annual retainer for members was increased from $7,500 to $10,000; the annual retainer for the chair was increased from
$15,000 to $20,000.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Compensation
Committee:&nbsp;the annual retainer for members was increased from $5,000 to $7,500; the annual retainer for the chair was increased
from $10,000 to $15,000.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Nominating
and Corporate Governance Committee:&nbsp;members receive an annual retainer of $5,000; the chair receives an annual retainer of $10,000.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Research
 &amp; Development Committee: the annual retainer for members was increased from $10,000 to $15,000; the annual retainer for the chair
was increased from $5,000 to $7,500.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; margin-top: 0; margin-bottom: 0; width: 100%"><TR STYLE="vertical-align: top; text-align: justify">
<TD STYLE="width: 0.75in"></TD><TD STYLE="width: 0.25in; text-align: left"><FONT STYLE="font-family: Symbol">&middot;</FONT></TD><TD STYLE="text-align: justify"><FONT STYLE="font-family: Times New Roman, Times, Serif">Each
non-executive director receives an annual equity grant consisting of one-half options and one-half RSUs with a one-year vesting period
for each.</FONT></TD>
</TR></TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The size of the annual equity grant is determined by reference to our
peer group companies. In reviewing Board of Director compensation, the Compensation Committee&rsquo;s independent consultant provides
an analysis of cash and equity compensation practices and levels within the same compensation peer group used for the named executive
officers.&nbsp; To remain in line with the practice of peer companies, for 2021 it was determined that Directors would receive an equity
award of a fixed number of shares provided that the value of the shares remained within a reasonable range. As a result, the value of
the uniQure award will be consistent with our peers who predominantly use fixed share awards. Because such awards can vary in value from
year-to-year, the Board will assess the grants to ensure they remain within a reasonable range.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each annual retainer for Board and committee service is payable semi-annually.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Each member of our Board is also entitled to be reimbursed for reasonable
travel and other expenses incurred in connection with attending meetings of the Board and any committee of the Board on which she or he
serves.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_006"></A><B>DIRECTOR COMPENSATION TABLE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">The following table summarizes the annual compensation
paid to those persons who served as our non-executive directors during the fiscal year ended December 31, 2021.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.5in">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="border-collapse: collapse; width: 94%; font: 10pt Times New Roman, Times, Serif; margin-left: 0.5in">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid">Name</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Fees&nbsp;Earned<BR> ($)</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Option&nbsp;Awards<BR> ($)(3)</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Restricted&nbsp;Stock<BR> Unit&nbsp;Awards&nbsp;($)(3)</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD><TD STYLE="white-space: nowrap; font: bold 10pt Times New Roman, Times, Serif; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="white-space: nowrap; border-bottom: Black 1pt solid; font: bold 10pt Times New Roman, Times, Serif; text-align: center">Total<BR> ($)</TD><TD STYLE="white-space: nowrap; padding-bottom: 1pt; font: bold 10pt Times New Roman, Times, Serif">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 48%; font: 10pt Times New Roman, Times, Serif; text-align: left">Robert Gut, Ph.D.</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">46,134</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">79,676</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">88,134</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="width: 10%; font: 10pt Times New Roman, Times, Serif; text-align: right">213,944</TD><TD STYLE="width: 1%; font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jack Kaye</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">60,263</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">79,676</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">88,134</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">228,073</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Madhavan Balachandran</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">50,221</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">79,676</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">88,134</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">218,031</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Jeremy Springhorn</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">62,773</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">79,676</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">88,134</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">230,538</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Paula Soteropoulos</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">54,289</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">79,676</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">88,134</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">222,099</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">David Meek</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">66,898</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">79,676</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">88,134</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">234,708</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Leonard Post (1)</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">50,221</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">79,676</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">88,134</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">218,031</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Rachelle Jacques</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">7,890</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">158,600</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">-</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">166,490</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">Phillip Astley-Spark</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">40,413</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">79,676</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">69,912</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif">&nbsp;</TD>
    <TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: right">190,001</TD><TD STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left">&nbsp;</TD></TR>
  </TABLE>


<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 0; margin-bottom: 0; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><FONT STYLE="font-size: 2pt">&nbsp;</FONT></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>Dr. Post was elected on June 17, 2020.</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                                                    </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(2)</TD><TD>Ms. Jacques was elected on October 21, 2021 and received our standard new director grant (an option to purchase 10,000 shares vesting over three years).</TD></TR><TR STYLE="vertical-align: top">
<TD>&nbsp;</TD><TD>&nbsp;</TD><TD>&nbsp;</TD></TR>
                                                                                                                          </TABLE>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%; font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt"><TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(3)</TD><TD>The value of stock awards and stock options as reported in their respective columns is calculated using the grant date accounting
fair value determined in accordance with Accounting Standards Codification 718, Compensation-Stock Compensation (&ldquo;ASC 718&rdquo;).</TD></TR></TABLE>

<P STYLE="margin: 0pt 0; font: 10pt Times New Roman, Times, Serif">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 61; Value: 54 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->55<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; text-align: left; margin: 0pt 0; text-indent: 0.25in">The following table sets forth
information relating to the aggregate number of RSUs and stock options to our Ordinary Shares outstanding on December&nbsp;31, 2021 for
each of our non-executive directors.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%">
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold">Name</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Award<BR> Type</TD><TD STYLE="font-size: 10pt; font-weight: bold; padding-bottom: 1pt">&nbsp;</TD>
    <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; font-size: 10pt; font-weight: bold; text-align: center">Aggregate&nbsp;Number<BR>
    of&nbsp;Awards<BR> Outstanding<BR> (#)(1)</TD><TD STYLE="padding-bottom: 1pt; font-size: 10pt; font-weight: bold">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="width: 65%; font-size: 10pt; text-align: left">Jack Kaye</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 16%; font-size: 10pt">Option</TD><TD STYLE="width: 1%; font-size: 10pt">&nbsp;</TD>
    <TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="width: 15%; font-size: 10pt; text-align: right">40,412</TD><TD STYLE="width: 1%; font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">RSU</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,382</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Paula Soteropoulos</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Option</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">43,412</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">RSU</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,382</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Madhavan Balachandran</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Option</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">29,412</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">RSU</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,382</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Jeremy Springhorn</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Option</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">29,412</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">RSU</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,382</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">David Meek</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Option</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">23,022</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">RSU</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,382</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Robert Gut</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Option</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">95,828</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">RSU</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">12,351</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">PSU</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">5,610</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt; text-align: left">Leonard Post</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Option</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">14,107</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: rgb(204,238,255)">
    <TD STYLE="font-size: 10pt">&nbsp;</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">RSU</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">2,382</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  <TR STYLE="vertical-align: bottom; background-color: White">
    <TD STYLE="font-size: 10pt; text-align: left">Rachelle Jacques</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt">Option</TD><TD STYLE="font-size: 10pt">&nbsp;</TD>
    <TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD><TD STYLE="font-size: 10pt; text-align: right">10,000</TD><TD STYLE="font-size: 10pt; text-align: left">&nbsp;</TD></TR>
  </TABLE>

<P STYLE="margin-top: 0; margin-bottom: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV STYLE="margin-top: 3pt; margin-bottom: 3pt; width: 25%"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin-top: 0; margin-bottom: 0"></P>

<TABLE CELLPADDING="0" CELLSPACING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; margin-top: 0pt; margin-bottom: 0pt">
<TR STYLE="vertical-align: top">
<TD STYLE="width: 0.25in"></TD><TD STYLE="width: 0.25in">(1)</TD><TD>This table includes unexercised option awards (whether or not exercisable) and unvested stock awards (including unvested stock units).</TD></TR>
</TABLE>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: center"><A NAME="a_007"></A><B>GENERAL MATTERS</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Availability of Certain Documents</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">This Proxy Statement, a copy of our 2021 Annual Report on
Form&nbsp;10-K and our other filings have been posted on our website at <I>http://www.uniqure.com/investors-newsroom/sec-filings.php.</I>
 &nbsp;A copy of our 2021 Dutch Statutory Annual Accounts and our Dutch Statutory Board Report is available on our website at <I>www.uniqure.com</I>
or may be obtained free of charge by written request.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Please send a written request to investor relations at the Company&rsquo;s
principal executive offices below:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">uniQure N.V.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Paasheuvelweg 25a&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">1105 BP Amsterdam&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Netherlands</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Email: investors@uniQure.com</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">or to the Company&rsquo;s administrative offices:</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">uniQure N.V.&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">113 Hartwell Avenue</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Lexington, MA 02421&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">United States</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Attention: Investor Relations</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Shareholder Communications</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">The Company has a process for shareholders who wish to communicate
with the Board.&nbsp; Shareholders who wish to communicate with the Board may write to the Board at the address of the Company&rsquo;s
principal executive office given above. These communications will be received by Investor Relations and will be presented to the Board
in the discretion of investor relations. Certain items that are unrelated to the Board&rsquo;s duties and responsibilities may be excluded,
such as spam, junk mail and mass mailings, resumes and other forms of job inquiries, surveys and business solicitations or advertisements.
Any communication determined in good faith to be frivolous, unduly hostile, threatening, illegal or similarly unsuitable will not be
forwarded to the Board.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Proposals for the 2023 Annual General Meeting of Shareholders</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">If any shareholder wishes to propose a matter for consideration at
our 2023 Annual General Meeting of shareholders, the proposal should be delivered to investor relations at the address above.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">To be eligible under the SEC&rsquo;s shareholder proposal rule&nbsp;(Rule&nbsp;14a-8(e)&nbsp;of
the Exchange Act) for inclusion in our proxy statement and form of proxy for our 2023 Annual General Meeting of shareholders, a proposal
must be received by investor relations on or before February&nbsp;21, 2023, unless the date of the 2023 Annual General Meeting is changed
by more than 30 days from the date of the 2022 Annual General Meeting of shareholders, and must satisfy the proxy rules&nbsp;promulgated
by the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 62; Value: 54 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->56<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Any other shareholder proposals and nominations to be presented at
our 2023 Annual General Meeting of shareholders, must be received by the Company no later than 60 days before the date of the annual
general meeting and must otherwise be given pursuant to the requirements of Dutch law.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">Proposals and nominations that are not received by the dates specified
above will be considered untimely. In addition, proposals must comply with the laws of the Netherlands, our Articles of Association and
the rules&nbsp;and regulations of the SEC.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><B>Other Matters</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">At the date of the Proxy Statement, management is not aware of any
matters to be presented for action at the 2022 Annual Meeting other than those described above.&nbsp; However, if any other matters should
properly come before the 2022 Annual Meeting, it is the intention of the persons named in the accompanying Proxy Card to vote such Proxy
Card in accordance with their judgment on such matters.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse">
  <TR STYLE="vertical-align: top">
    <TD STYLE="width: 50%">May&nbsp;17, 2022</TD>
    <TD STYLE="width: 50%">By Order of the Board of Directors,</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>&nbsp;</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD STYLE="border-bottom: black 1pt solid">/s/ Matthew Kapusta</TD></TR>
  <TR STYLE="vertical-align: top">
    <TD>&nbsp;</TD>
    <TD>Matthew Kapusta, Chief Executive Officer, and Executive Director</TD></TR>
  </TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"></P>

<!-- Field: Page; Sequence: 63; Value: 54 -->
    <DIV STYLE="margin-top: 12pt; margin-bottom: 6pt; border-bottom: Black 1pt solid"><P STYLE="text-align: center; margin-top: 0pt; margin-bottom: 0pt"><FONT STYLE="font-size: 10pt"><!-- Field: Sequence; Type: Arabic; Name: PageNo -->57<!-- Field: /Sequence --></FONT></P></DIV>
    <DIV STYLE="break-before: page; margin-top: 6pt; margin-bottom: 12pt"><P STYLE="margin: 0pt">&nbsp;</P></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><A NAME="va_001"></A>&nbsp;</P>

<div  align="center"><p align="right" style="margin: 0in 0in 0pt; text-align: right;"><b><font face="Times New Roman" size="2" style="font-size: 10pt; font-weight: bold;"></font></b></p></div><div><div align="center"><div align="center"><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td width="92.3%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;"><p align="center" style="margin:0in 0in .0001pt;text-align:center;"><img width="850" height="1100"src="tm223584d1_pre14acvr01.jpg" alt="GRAPHIC"></p></td><td width="7.7%" valign="middle" style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;"><p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Arial" style="color:white;font-size:1.0pt;">1UPX
uniQure N.V.
Using a black ink pen, mark your votes with an X as shown in this example.
Please do not write outside the designated areas.
03MVZB
+
+
Please sign exactly as name(s) appears hereon. Joint owners should each sign. When signing as attorney, executor, administrator, corporate officer, trustee, guardian, or custodian, please give full title.
Signature 1 &#x2014; Please keep signature within the box. Signature 2 &#x2014; Please keep signature within the box. Date (mm/dd/yyyy) &#x2014; Please print date below.
Authorized Signatures &#x2014; This section must be completed for your vote to count. Please date and sign below. B
q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. q
Annual General Meeting Proxy Card
Proposals &#x2014; The Board recommends a vote FOR Proposals 1-9. A
1. Resolution to adopt the 2021 Dutch statutory annual accounts
and treatment of the results.
2. Resolution to discharge liability of the members of the Board.
For Against Abstain
3. Resolution to reappoint Matthew Kapusta as executive director. 4. Resolution to reappoint Robert Gut as non-executive director.
5. Resolution to renew the designation of the Board as the
competent body to issue ordinary shares and grant rights to
subscribe for ordinary shares.
6. Resolution to reauthorize the Board to exclude or limit
preemptive rights upon the issuance of ordinary shares.
7. Resolution to reauthorize the Board to repurchase ordinary
shares.
8. Resolution to appoint KPMG as external auditor of the Company
for the 2022 financial year.
9. Resolution to approve, on an advisory basis, the compensation
of the named executive officers of the Company.
For Against Abstain
000004
MR A SAMPLE
DESIGNATION (IF ANY)
ADD 1
ADD 2
ADD 3
ADD 4
ADD 5
ADD 6
ENDORSEMENT_LINE______________ SACKPACK_____________
1234  5678  9012  345
MMMMMMMMM
MMMMMMMMMMMMMMM
541457
MR A SAMPLE (THIS AREA IS SET UP TO ACCOMMODATE
140 CHARACTERS) MR A SAMPLE AND MR A SAMPLE AND
MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND
MR A SAMPLE AND MR A SAMPLE AND MR A SAMPLE AND
C 1234567890                   J N T
C123456789
MMMMMMMMMMMM
MMMMMMM
000000000.000000 ext
000000000.000000 ext
000000000.000000 ext
000000000.000000 ext
000000000.000000 ext
000000000.000000 ext
If no electronic voting,
delete QR code and control #
 &#x394;&#x2248;
You may vote online or by phone instead of mailing this card.
Online
Go to www.investorvote.com/QURE or scan
the QR code &#x2014; login details are located in
the shaded bar below.
Save paper, time and money!
Sign up for electronic delivery at
www.investorvote.com/QURE
Phone
Call toll free 1-800-652-VOTE (8683) within
the USA, US territories and Canada
Your vote matters &#x2013; here&#x2019;s how to vote!</font></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:always;" ><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div><div align="center"><table border="0" cellspacing="0" cellpadding="0" style="width:100%;border-collapse:collapse;"><tr style="page-break-inside:avoid;"><td width="92.3%" valign="top" style="padding:0in 5.4pt 0in 5.4pt;width:92.3%;"><p align="center" style="margin:0in 0in .0001pt;text-align:center;"><img width="850" height="1100"src="tm223584d1_pre14acvr02.jpg" alt="GRAPHIC"></p></td><td width="7.7%" valign="middle" style="padding:0in 5.4pt 0in 5.4pt;width:7.7%;"><p style="margin:0in 0in .0001pt;"><font size="1" color="white" face="Arial" style="color:white;font-size:1.0pt;">Small steps make an impact.
Help the environment by consenting to receive electronic
delivery, sign up at www.investorvote.com/QURE
2022 ANNUAL GENERAL MEETINGOF SHAREHOLDERS
This proxy is solicited by the Board of Directors for use at the Annual General Meeting on June 14, 2022.
Proxy and Power of Attorney of Shareholders
The undersigned shareholder of uniQure N.V. (the &#x201C;Company&#x201D;) hereby constitutes and appoints each of Matthew Kapusta and David Cerveny as the attorney
and proxy of the undersigned, with full power of substitution and revocation, to vote for and in the name, place and stead of the undersigned at the Annual
General Meeting of Shareholders of the Company to be held exclusively over the internet via live audio webcast at meetnow.global/M79DCD7, at
3:30 p.m. Central European Summer Time on June 14, 2022 and at any adjournments thereof, including on any matters that may properly come before the
Annual General Meeting, the number of votes the undersigned would be entitled to cast if present.
WHEN PROPERLY EXECUTED, THIS PROXY WILL BE VOTED IN THE MANNER DIRECTED HEREIN BY THE UNDERSIGNED SHAREHOLDER. IF NO DIRECTION IS MADE,
THIS PROXY WILL BE VOTED FOR PROPOSALS 1-9.
(Items to be voted appear on reverse side)
Proxy &#x2014; uniQure N.V.
q IF VOTING BY MAIL, SIGN, DETACH AND RETURN THE BOTTOM PORTION IN THE ENCLOSED ENVELOPE. q
Non-Voting Items C
+
+
Change of Address &#x2014; Please print new address below.
You will be able to attend and participate in the Annual Meeting online and submit your questions prior to and
during the meeting by visiting: meetnow.global/M79DCD7</font></p></td></tr></table></div><div style="margin-left:2.6515151515151%;margin-right:2.65151515151515%;page-break-after:avoid;" ><div style="background-color:#000000;clear:both;height:2pt;border:0;margin:30pt 0pt 30pt 0pt;"></div></div></div></div>

<P STYLE="margin: 0pt">&nbsp;</P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>tm223584d1_pre14aimg0001.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm223584d1_pre14aimg0001.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $U B$# 2(  A$! Q$!_\0
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M!E0T#EE8$DYY P>>E1+I5Y>2:O;ZE;V@LKX<&*=G<84*,@H!VSG/!]>M;U%
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MZFM8+RWEN(?];$DJL\?^\ <C\: +-%,\V/SO)\Q?-V[MF><=,X]*?0 4444
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M -!%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MJ%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MHHO]9/\ [X_]!%2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MM3-JYGQ\L"$_B>!_7\J[N@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M !_77_ /Y4 6:*** (HO]9/_ +X_]!%2U%%_K)_]\?\ H(J6@ HHHH ****
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MBBB@"*+_ %D_^^/_ $$5+447^LG_ -\?^@BI: "BBB@ HHHH **** "BBB@
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M@*,*,9]SW[UN8&)X<LH)Y-59XUW0ZG((R!RJ@+\H_P!GD\>]6/"T4:?VL54
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M* ()+.WE<N\>6/4Y--_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\
MCQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_Y
MY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L
M^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_
MQH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7
M_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M
M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH
M/[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_Q
MHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\
MCQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_Y
MY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L
M^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_
MQH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7
M_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M
M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH
M/[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_Q
MHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\
MCQ_QHHH /[/M?^>7_CQ_QH_L^U_YY?\ CQ_QHHH /[/M?^>7_CQ_QJ2&WB@S
0Y2[=W7DFBB@"6BBB@#__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>tm223584d1_pre14asp4img02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm223584d1_pre14asp4img02.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !G +,# 2(  A$! Q$!_\0
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MLHGNPR"RM*>I[U_:%I_S]0_]_!1_:%I_S]0_]_!7@OFO_??_ +ZH\U_[[_\
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M=%W#-&:**7R'8,T9HHHN(****5PU#^?K7H7PVF9DNX-QV!@P'I7GM=]\-/\
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( !1110!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>tm223584d1_pre14asp4img03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm223584d1_pre14asp4img03.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" !] +$# 2(  A$! Q$!_\0
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M (3S1/\ GN?^^:/^$\T3_GN?^^:\BS1FC^V:O\J#^PJ/\S/7?^$\T3_GN?\
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+*6BBK("BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>5
<FILENAME>tm223584d1_pre14acvr01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm223584d1_pre14acvr01.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" 1, U(# 2(  A$! Q$!_\0
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%0:G>V>FZ;<:AJ-W!:6=I$TUQ<7$@CC
MAC4$L[LV J@ DD\ "@">BH[6>&YMH[BWECFAF0/')&P974C(((X(([U)0 44
M44 %%%% !1110 4444 %%%% !1110!Q?[0G_ "2;4/\ KXL__2N&O%?$_P![
MX2_]E#U+_P!.LE>\?%_1[_7OA_>:7ID2R74TULR*SA00EQ&[<GC[JFO--<^&
M_BVY/P_\FPB/]@>,+W4[_-P@\NWDOWF1AS\Q*,#@<]J]#"U(1@DWU?\ Z2S[
MKAO&X:CA(1JU%%^TF]6EHZ,DG\WIZZ'D?PK_ .2<VG_7E?\ _IXTNNUUCI\'
M_P#L=]1_]+Y*E\!_"'QUIG@VWT^\TR%+B.VNXV47<9&Z34;&=>0?^><$I_#'
M4BNEU+X<^*YO^%=;+&(_\(]XGO-0U#_2$_=PR73R*PY^8E6!P.:ZZE:FY:26
M[_)GU&/S;+YXERC7BU[2J_B6SIU$G\VTEZH\@^"__))=*_ZYR_\ IYTNNOUS
M_C\^#?\ V.6I_P#IP:K?PU^$/CK1_A_8:5?Z9#'=0)()$%W&P!.I6,XY!Q_J
MX)3^&.I%=%JGPW\6S7/PW>.PB(\.^)+Z^U'_ $A/W4,MV948<_,2IS@<BG4K
M4W-VDMY?DQX[-LOGBY2C7BU[2J_B6SIU$G\VTEYM'D?P=_Y);H__ %Y/_P"G
MW3ZZ_7/]7\&_^QBU/_TI:K?PY^$/CK2/ FG:9?:9#'<V]LT<BB[C8!CJMI<=
M0<?ZJ&0_ACJ:Z+5/AOXMF7X;B.PB/_".ZQ?76H_Z0G[J.68LA'/S9!Z#I14K
M4W-OF6\OR88[-LOGBY2C7BU[2J_B6SIU$G\VTEYM'E'P7_Y)/H?_ &R_]/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MT$\H8#;QC[.1CON]J-?^-5KI?PNU+QFWA^:2/3?L&;870!?[5!!,/FV\;?/
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MHHHK$\D**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%U'*S,DBIG)'DJG_ 'PV.%. 70]_HHHH$%%%% !1110 4444 %%%% !1110
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MX+U+2="72HF33S-+_K;AV8-O  99]N,=CSS7._\ #/'[47_1VFH?^"@__'*
M/K"BF6ZND")(^]E4!F_O''6GT %%%% !1110 4444 %%%% !7R;J7_)J_C#_
M +%WPW_Z+AKZRKY2U*UNC^R[XOB%M-YC>'O#@5?+.21'#D >U>A@=WZQ_,^X
MX,:4Y7_Y^4/_ $ZB+P-_R6'7_P#L(^'?_1!J'7O^34?%_P#V O"_\H*M^"+6
MZ7XO:\[6TP4ZAX>()C.#B Y_*HM>M+H_LK^+HA;3>8VA^&0J>6<D@09P/:O0
MO[\?^W/T/NI2C]<HZ]<+^=(A\-?\E,\1?]A7PY_Z1RU-XF_Y-/\ &'_8&\+?
M^B+*CPW:W0^)/B%C;3!6U3P\0?+.#BTES^52^)+6Z/[*OB^(6TQD;1_# 5/+
M.21!9YP/;!HNN>/_ &Y_[:$I1^N4->N%_.B1>$/^2L^*_P#L,Z+_ .DEQ1XQ
M_P"31_$O_8.\-?\ I)95+X1M;H?%;Q4YMI@K:QHQ!*'! M;C-'C"UNC^R;XD
MB%M,9&T_PWA!&=QQ:66>/;!HNO:1_P"W/T)<H_7Z&O7#?^XBIH?_ "4/Q=_V
M'=%_](+VIO&__)K?C/\ Z]_#?_I'8T:+:W0^(/BUC;3;6US12#Y9P0+"\!(_
M,5+XVM;IOV7_ !C$+:8R-;^'-JB,Y.+.QS@>V#^5%U[2/_;O_MI3E'Z_0UZX
M;\Z)%X9_Y*CXW_[&+3?_ $AU"CXA?\FI^)_^Y>_]-]A4OANUNA\3O&S&VF"M
MXATTJ?+."!8WX)'YC\Z/B!:W3?LL>)HEMIC(W_"/X01G)Q86(/'M@_E2O^]C
M_P!N_H3S1_M*AKUPW_N(J6?_ "/?C+_L9K+_ --FH5-\2/\ DV7QK_U\>'__
M $W:?19VEU_PG/C!OLTV&\2V14^6>1_9M^,C\2/SJ7XC6MTW[-?C.);:8NUQ
MH&U1&<G&G:>#@>Q!_*G?]Y'_ +=_0:E'Z_A]?^@?\Z1%I/\ R4GQW_V-47_I
MMU.H?B1_R:QXK_["NC?^FVPJWI5K=#XC>.6-M-M;Q3$5/EG!']G:D,C\2/SJ
M+XBVETW[+OBJ);:8R-JFCD*(SDXTVP!X^H/Y4)_O(_\ ;OZ#A*/]HT-?^@?\
MZ94M_P#D;O&__8Y2?^FO5*E^+W_)M?BK_L.Z3_Z:[*EM[2Z_X2SQL?LTV&\8
MR,I\L\C^S-4&1[9(_.I?BW:73_LX>*(TMIF=M<TDA1&22!IEF#Q]0:=U[6/_
M &[^A<9Q_M+#Z_\ /G\Z9#'_ ,E.\=_]C=>?^FO5*/BK_P FL>)_^QFT_P#]
M-MC4R6EU_P +,\<M]FFVMXMNV4^6<$?V7J8R/Q(_.CXI6ET_[+OB:);:9I&\
M2Z>0HC.2!IMD,X^H/Y4D_P!Y#_MW]!0G'^T,+K_SX_.)4;_D;O'W_8Y:G_Z:
M]3JW\7?^3>?$'_8Y:?\ ^FRSJ)K2Z_X2SQX?LTV'\8ZFRGRSR#IFI@$>V2/S
MJU\6K6Z?]GW7XTMIF=O&-@P41DDC^S;,9QZ9!HO^]A\OT$I1_M##:_\ /K\X
M&?;_ /)0?'G_ &-6L_\ IJU*K?Q9_P"3;M:_['*S_P#2&VJ*WM+K_A/_ !TW
MV:;#>*=9*GRSR#I6I $?B1^=6OBM:W3_ +.>LQK;3,Y\8V;!1&<D?8K89QZ4
M77M8?]NAS1_M#"Z_\^OS1E+_ ,C!X_\ ^QN\0_\ IJU*M7XP_P#)#]2_['^T
M_P#2&"J"VEW_ &_X]/V6;Y_%OB!E_=GD'2]1 (^I(_.M3XO6MR_P3U)$MIF8
M^/;1@H0DX^PP#/TH;_>P^0Y3C_:&&U_D_-&+;_\ (T?$+_L9O$?_ *;KZMKX
MG?\ )$9O^RAVW_I/'67;VEW_ ,)-\0#]EFP_B7Q$5/EGY@=.O0"/7)(_.MGX
MF6MRWP5F1;>5F_X6#;-M"'.W[/'S]*)/]Y'Y$U91^NX;7^0YJ+[OC[_L8O$W
M_IJNZ]J^&/\ R$H?^Q[N?_33)7CD5I=X\>?Z+-\_B'Q*5_=GD'2[L CZDBO9
M?AG%*NI0EHG7_BN;EN5/3^RI!GZ9K'%?#\CR>))1>'>OV'^1ZY1117BGY&5+
MK5=+M=3M]-N=2M(;RZ!-O;23JLLP'78A.6_"G7FH6%K#<375];01VH#7#RRJ
MJP@]"Y)^7\:XB_-I9>+M<M-4\.WVIW>K:G9SZ<T=E(\;1+% BDSA2D0BECED
M(9@1G< 2XS3UI++PQ>>+=1;0I[T7.I6=Q;QM#-,LMR4!$C%0S;$8 G .T( H
MX45NJ2=OZ['M4\LA/E2;NU%K;6[C>VO3FMZIZ[I>A1ZGILEQ;V\>H6K37<7G
M6\:SJ6FC_OH,Y9>1R.*CU/6='TZWDN-0U6QM(891%+)<7*1JCD!@K$G 8@@X
M/."#7FLEJ+<>&8_#=E=W>H6K1S"2YTN2"'4%VS YEV[K<1EY6V-CAPN&# UF
MZ?I.LVFGWW_"26^IZ9-!XC^VF\TJW&I&:X?3%1W9&A/[LLQ VH<,P0;=N:M4
M(]SIADM&3;=33L])/6VV_;9/?NFEZU-KNB0LPEUC3XRMM]J8/=(,0_\ /4Y/
MW/\ :Z4RS\2>';NUCN;37M,GAEG^SQRQ7D;*\N ?+!!P6P0=O7FO./!L>OCQ
M]$VN6,IN+FX%Q?6O]F@VUO"=-13*D^SEO.7R=F_D9^3C<<WQ/H6HMX-T>[BT
MRZMKW5--OKR\BM[!YC+=7'D.+-]J_N@0/+$O!00@!AW/81NDW_6I4<EP_M8T
MI5-6D[K5:J3[?W=_-'LEO?65Q>3V<%Y;RW%KCSX4E5GBR,C<HY7/;-6*\W\"
MZ;J,'Q6G9$<6-HNJ&1I-.DAD+W%W%*H:5B5E'ROL*=$ W8)Q7I%8U(J+T9XV
M.PT,/4482NFK_P!>N_H^NX4445F<84444 %%%% !1110 4444 %%%% !1110
M 5YO\6O@)\)_B7XFB\0>,_"4>H:A'"(#.EW-;M(@S@/Y3KNQG@GGMG'%>D44
M >>:5\#/A7INIV6H67A1([C3]%?0[9_MUPP2R<.K18,A!)$CC>06YZTGACX%
M?"KP]?>'+W1_"BV\_A+SO[%?[?<O]E\UF:3.Z0^9DLQ^?=C/&*]$HH \E\8?
MLU?!SQ)X[;QE>^%6M]:DO$O);JROIK?S)58-N*HX4%B.2 "22<Y.:N?%+]GO
MX0?$7Q@WBCQ?X/BOM4DA6&:=+N>W,RJ-JEQ$Z[F X#=< #. ,>G44 <5X.^$
MGP\\*^,(/%.@>'5L]6MM(BT>*Y%W.^VTC5%2/:[E20(T&XC<<<GDUC^(OV>_
M@[KOQ)_X3O5? ]E<:TTPGDD,LHAFE&")'A#"-VX.<J=Q)+9/->FT4 8OQ#\)
M>'_'/@V]\*^*M.&H:1J*HMU;&5X_,"NKK\R,K##*IX(Z5CW_ ,*/A]>MX1>Y
M\.1R-X$$:^'6^T2@V(C5%09#_O !&GW]WW<]:[*B@#S6S^ /PAM/!.N^$K?P
M9;1:/XDNTNM3MH[F9?.D1@R8<.&15(X5" ,D8P3G7;X3_#X_$+1?&X\.0KK?
MAZP%AIEPDLBK;P!655\L-L.U78 D$C/LN.SHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@!EQ##<6\D$\22Q2J4DC=0RNI
M&""#P01VKDO^%3_"S_HFG@__ ,$-M_\ $5V%% ''_P#"I_A9_P!$T\'_ /@A
MMO\ XBC_ (5/\+/^B:>#_P#P0VW_ ,17844 87A?P3X,\-7TE[X<\(Z%H]S+
M'Y4DVGZ;#;NZ9!VED4$C(!Q["MVBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **CNIX;6UDN;F:.&&%"\DDC!510,DDG@ #O6?)XE\.1^'X]=D\0:
M6FES$"*_:]C%N^3@8DSM.2".M-1;V1I"E4G\,6];;=>WJ:E%4;S6=(M+ZTLK
MO5;&"YOSBSAEN$5[D_\ 3-2<OU'3-.@U?29M:FT>'4[.34;:,23V:7"F:)#T
M9D!W '(Y(HY7V#V-2U^5VM?;IM?TOH7**S;3Q#H%UI]U?VVN:;-:V+,MW<1W
M:-';LO+!V!PI'?/2FW'B3P[;Z-;ZO/K^EQ:?=.J6]X]Y&L,S-]T(Y.UB<' !
MYQ3Y9=BOJ]:]N1WO;9[]O4U**I76KZ3;:M;Z7<ZI90WUX"UM:R7"K-.!U*(3
MEL8["EM=7TFZU:XTJVU2SFO[10UQ:1W"M-"#T+H#E0<CJ*7*^Q/L:EK\KM:^
MW3:_I?0N453N=7TFWUB#2;C5+.+4+I"]O:27"K-,HZE4)W,!@\@4EGK&D7>I
M76GVNJ64]Y8X^U6\5PC26^>F]0<K^-'*^P>QJ6ORNUK[=-K^E]"[167!XE\.
M3:'-K<.OZ7)IENQ6:^2\C,$9!P0T@.T$$CJ>]/NO$&@VMK9W-SK>G0P:@RK9
MRR7:*MRS?=$9)PY/;&<T^678KZO6O;D=[VV>_;U-&BJ<FKZ3'KD>C2:I9IJ4
MT9ECLFN%$[H.K"/.X@8/.,5<J;-&<H2C;F5KA11389$EB66)U='4,K*<A@>A
M![B@D=1110 4444 %%4]6U?2=+DMTU/5+.R:\E$5LMS<+&9W/1$#$;F]AS2-
MK&DKKBZ*VJ62ZE)$94LC<+Y[(/XA'G<5]\8I\K[&BHU&KJ+MOMT6_P!Q=HJA
M9ZYHMW->Q6NKV$\FFMMODBN49K4XSB0 _(< _>QTJ+_A)O#G_"/_ -O?\)!I
M?]E9Q]O^VQ_9\YV_ZS.WKQUZT^678KZO6O;D?3H^NWW].YJ450O-<T6SDLDN
M]8L(&U)@MBLMRBFZ8C($8)^<X(^[GK3UU?26UQM%75+,ZDD7FM9"X7SU3^^8
M\[MO(YQBEROL3[&K:_*[;[=%N7**S[/7M#O([R2TUG3YTTUBMZT5TC"U8#)$
MA!^0@ YSCI4^CZCI^K:;%J&EWUM?6DPS%<6TRRQR#.,JRD@\CM0XM= E1J03
M<HM6\OF6:*SK3Q!H-U:WES:ZWITT.GLRWDL=VC+;%>6$A!PA&#G.,4R;Q+X<
MAT&'6YM?TN/3+@@0WSWL8@D). %D)VG)!Z'M3Y9=BOJ]:]N1WO;9[]O4U**I
M7FLZ1::C:Z?=:K907=]G[);RW"+)<8Z[%)RWX4MOJ^DW&L3Z1!JEG+J%J@>X
MLTN%::%3T9D!W*#D<D4N5]B?8U+7Y7:U]NFU_2^A<HJGHNKZ3K,$DVD:I9ZA
M'#(8I'M+A951QU4E2<$>G6KE)IK<F<)0DXR5F%%-DD2/;O=5W,%7<<9)Z >]
M.H)"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** .3^-14>"8_._X]3K&F"[S]WR#?0>9NS_#MSN_V<UR>DBU
M/QHNHIEA.E?VY?\ D+(!Y7VG^SK+?M[9YN\^_FUZEJ%O:WEC-:WT$,]K-&4F
MBF0-&Z$8(8'@@CJ#63<>'?!\OA6'2)]"T-]$A8/#:/9Q&U0Y."J$; <D\@=3
M713JJ,;/S_$]K 9A3H8=TI)Z\RT_O)*_JN7;JGNCQOPSAOACK!N IO$\.Z3_
M &07'S"/S)?LOEYY_P!;C&.^VM'6&F'A>UETW<->_P"$D\2!RF/.XAU' ..=
MO%ICZ1>U>NZAHWA^YU2PO+[2M-FOK'/]GS36T;2V_KY3$97H/N^E%KI&@P>(
M[C5;;3--CU>XC"W-W';HMS(G& [@;B.!U/85H\2G=V_JUCTI\04IN4_9N[;E
M;I?EY+?X>K??2W4\EUD:<OBC1UTU;<:,^G^'_MHA'[HH;M_LV[MC/3/:KV@C
M3_\ A;-Q%J2P?V+NUTVXD \C?_H'G=>,Y-WGZR^]>BV/A[PG;:/?:?9:'HT.
MGWCO]OMX;2)89F(^;S5 VL<==U-O/#OA&X\/VFF7>A:)+I5JRM:6LMG$UO$W
M.TQH1M4\G&!WH]O':S_I?F9O.:+O'EE:SC?2]G&W-_B_]MTN>/\ APRO\,IV
MOQNUA8?#/V0S?Z\96V\KWSYQGZ?Q;_>NE\$O;I>>$;A6C2]_M'6CJ3G <*'F
M\[>?03"'.?1:]$OM(T"XUZSU.\TO39=4ME*V=U+;HUQ$O.1&Y&Y1R<X/>FPZ
M%X;75M0NXM'TL7VH1B/495M8_-N4(P%E8#+C Z-FE+$*2>G]6L%?/*5:G).#
M7-=_?#V=O3[5^^ENIY[XF:"74/%4F8WOQXHT/[ W!;RC]B\O8>NW>;GIQ@O_
M +5<OKS8^&>GRV>1J;:/X@_M(I_K=NX_:=V.<^=M_''?%>U2:'X=_MNSOY-(
MTO\ M*SA,5E<-;1^?!& 1MC;&Y5P3P..:=I^C>'[76+Z]L=*TV&_O,?;YX;>
M-9I\]/-8#+?\"HCB%%+3^K6##YY2HPBE!OEL_NA[.WI]J_?2W4\UUH6B_&JW
M2V6 :.VHZ3YZQ >5YWV74?+SCY<Y%CC_ +9^U9.GC3?.\0IJJP_V6NC:]]@#
M@>6(?[0E\[9GC'$73C&WMBO5[7PYX/B\+SZ/;Z#HD>BS,6GLX[.(6KMD$ED
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MY<TQ]+%N/LH<B5]-+*]NUOZ\VPHHHK$\H**** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,?X@ZQ)X=\ ZYX
M@AA6:32=,N+Q(G.%<QQ,X4D=CMQ7)Z'XA\>6GBCPO:^(KKP[=V7B3S5"Z?I\
M]O+ RVS3@[GF<,/DQC ZYS74?$W2;K7OAOX@T.RV?:M3TFZM(-YPN^2)D7)[
M#+"N0T:S\8ZMXL\'OJGA%M(M/#GG//<2:C#-YA:U>$!50DYW.#SV!KHI<O([
MVZ_EI^)[^71P[P<W/EO[][N-_@]SEN[_ !?R_,S/$?CSX@6_A?Q7XNT]_#:Z
M7X:U"[MA8SV$[W$Z6\FTGS1.%!;!_@X]#73>*M<\87'Q._X1/PO/H=FL.CIJ
M,T^I64MP7+S/&$41RQ[<;,Y.<Y[8KC?$WAOQX_@CQIX*LO":W,?B/4[Z>VU/
M^TX4B1+B3<I9"=_R@\C';C-=9XIM/%&E_%X^*=&\-G6[6YT*/3W2.^B@:)TG
MDDR?,(R"''3T-;24.EKZVV\K7_'<]2K3P:M[/V?-[_+K"UK4^7FUM?X[<VM_
MD9D?C_Q1<?#?1KV"+2(];U/Q))H;RO!*UJA2XFB,HC$@?!$.=N_@MU.*OZ/X
ML\56&K>+-*\2?V/>7'A_1X=3@FTZVEMTD#B?Y&5Y)#P8!R"/O=*Q(?"/BVU^
M&.A!-'CFU73O%DNMS:<MX@/EO<W$FP2'Y"P69<\XX-:6EZ'XIUO7?&FKZIH2
MZ*=;T*#3;."6]CF9G07.68QY 7]\OOUHDJ5I;6_X*_05:GEW+6Y>3DYI=8W_
M (D;6UYK<E]M+#-'\5>/K6^\'7.O7'ANZT_Q5<+"8;'3YX9K<O:R3J=[SNK8
M\O!^7G/:M&7XAS67_"2S7U@DD.C^);31[=8259EG6U&]R<@D-<,> .% ]ZQM
M)TSQMJ=YX%L-1\(G2[;PO<I-=7DFI0RK($LY8,*B$MDM(#]*D^+?PBT[6WN-
M7T7^T8]6O=7LKNZ5-6FAA<)-")'\L,$W"*,X.,Y48YQ1:CSI3Z]O7_(4H96\
M7"GBN5*2WARM+]YUY9)*\-&]UV/4J***X3XX**** "BBB@ HHHH **** "BB
MB@#D_C3A_ ZVTG_'M>:MIMK=@]&@EOH(Y$;_ &61F4^S&N+T_1])NOB=-X2N
M=,LY?#MOK%Y);:>\*_9EE_L^R?:L>-I :XN6QV9F[BO5]8T^RU72Y].U&VCN
M+6Y0I+%(,A@?\]>U9$W@GPO+H$6C/I2FTAG,\>)I!()6R&?S0V\LP9@26R02
M#D'%=%.LHQL_/_ASW<OS2EAL.Z4N:[YMNG,DE+=>]&VGDWJNOC^AHNH_#W4M
M7U"-;C5-#T#3&T6XFP\L(#2M%)&YY!D90"1R^T DUH:KNL-%C\4Z;$B^(KK7
M_$-O<72(!-+''%J/EQLW4JGV:VP#Q\B>M>JWG@_PS=7]C>3:/;F734CCM=N5
M5$C.Z-2H(5@C<J&!"GD8-26OA?0+;Q'-KT.F1+?W ;S)<L1E@ S!"=JLP506
M !.!DFM7B8OI_5MOU/1J<08>3D^5ZW=M+:QY>7?X6_>>F_3J>3:EI6DZ9X@T
M_0M*L[>'1=6L]$.IPQJ/*N,W3JID &&,N C$_? P<CBKFB:/H^H_$=_"FIZ?
M:2^';-]9DL[*6-3;HX^P9*J>%V&XN0,?=WMC&*]$LO _A2TT>\TJWT6%;2^V
M">,LQR$.8U4DY0(>4"D!#]W%%WX'\*W.A6VCS:1&UG:.[PJ)'5@SYWDN&W-O
MW-NR3NR=V:7UB/G_ $M_4EY]0=]9]5?2^L;<_P 7Q+;?X>IY'H>_5/ ;>)M3
MC6X\0:?#X=^P7<H'GQ[DMG^4D97S))9@P'WMQ4YKI/ =M;1:WX6UN"")=4UC
M4=6CU6X50)9U#3,5D/5@DD<2C/W0 !@<5Z!>>%/#UUK5KJT^E0M=V2HL#C*J
M A)CR@.UMA)*Y!VDDC%,M_"'AN#5;W4HM*B6YU!)$N'W-AED(,FU<X3>0"Q4
M#<0"<FB6(BTU_6UO^"37SW#U:<H)25[]K*\.7EWV3][UTMU."\76UM-X@\2Z
MY+!$VKZ5XET>VTVX91YL,+"R.Q&ZA7:XN%('7<P-<SJP&F_#^U\0:<JV^L:M
MI.MMJMW$H260?,[N[#DF-PH4G[O08'%>R2>$O#DFN6NKOI41O+-$2&3<V $!
M"$KG:Q7<VTL"5R<$46/A+PY::I>ZA!I$"SZ@LBW);+*ZR'=( A)50[#+8 W'
MDY-$<1%)?UTM_P $*&>X>E3A%J3M;MK:'+R[[7][UZ=3S75-'TFQ^*<?A.RT
MRT@\-WE_IDEU8QQ*+9Y/LNHMADQM.6MK,D=R%)]\^STW3-1?6-*U6V@DTW1-
M+UG^R4D0%;4+?RH6B_NF,1QJI'*@  BO5+?P/X6AT&;1H])46EQ,LT@,TAD,
MB[=CB0MO!7:H4AOE  & *+_P1X4O=-L=/N=%@>VTY&2VC!90J-C>AP<NK%06
M5LAB 2#1]8CY_P!=?4I9]05M9Z65]+Z1:YOB^*6SU^'J]CS6Q0WD?_"47UM&
MWB.'Q7H]LMR5'GPPR0V2R1 XR$,<\[%>AWL:Z7XO>)_%%AXJM-"\-1W"O_9<
M^H2206L,[,4=$16$LB!8\L=Y!W<KC'6NOG\,:#-XFC\0R:;&VHQ ;9MS8R%*
MABN=I8*Q4,1N ) .*;XK\+>'_$OD'6],CNS;;Q$S,RLJN '3*D$JP W*>#@9
M!Q4^V@Y)M:(Y_P"UL)/$4JE2G>,4]&DTO=222O9Q35U=K=Z=^+T_QAXCO_B-
MIWA>2[LK+^U--AU1G51)):YA8-: \HSEU\Q6R<HLG' -=!\!?/\ ^%(^$6N+
MA[B1]"LW,C@9PT*D#CK@$#/4XR>:UU\-:"+DW"Z7;K,;M+SS N&$R1B-7![8
M0;<=-N1T)J?PWH^FZ!H\6E:/:K:V4!;RH$8E8]S%B%R3@9)P!P.@P*BI4@XV
MBK;?J<F,QV%JX;V5&'*_=Z+=*5W??[2^Z[U+U%%%8'C!1110!YG\6K#3M5\1
MZXFLPPRQ:9X0EN;%Y0";:5GDWS1Y^ZZ^5#AARO8C-8FE1FZF/BB\M(SXDC\8
M6=L)V4":.)H($:$-C*H8I)&*],L6QGFO4?$OAG0O$$UO+K&G1W3VNX1EF9?E
M8@LC8(W(2JY1LJ=HR.!22>%M ?Q2/$;:9$=37!$^6^\$V!]N=N\(2N_&[;QG
M'%=4:\5&W]?T^I])A\XHT\/&FU*Z5O+IIO\ #.UY>?1GBLD%O:>#?#%S9(D<
MOB;PD)/$,L:A&NR]UIXDEF8<[_\ 2;H9/(WOZ5T$FDZ7_P +83PE_9EI_P (
MXVN><=/\E?LOG_V87V>7C:1TDV]-WS8SS7H=CX+\+68U!8-%MPFJQM%=H^71
MXV+%D"L2%0EF)50!DDXIK>"/"[: -&;2P;47'VD$SR>;YV,>9YN[S-^WY=V[
M.WCIQ5O$Q\^OX_Y'5//\/+F7O:\ROI?WK-/?>&T>ZZQV/'_LUK=^!_$TM]'&
M\GAKPBTOA^210[692ZU 1RPD\AL6UJ,CGY$]:VK]#!N\4VUK&/$I\6WEOYZH
M#,\:PS(L)."=@BC1MO3*AL9YKTB^\%^%KL:>)M%MMNE1K%:(F41(U*E4*J0&
M0%5(5@1D XS5B/PSH2>*&\1)IT8U)^3-N;[VS9OVYVA]@"[\;MHQG'%)XF+Z
M?UV_S%4X@P\G)J,M>9VTMJDN7?X96YI>?1[GCDEAIVG:+H%OID$,5IX@T/2/
M[::,#_3%?4+-&>8C[Y=)[@,QY(9LGBNY\+@Z-I?Q!L]#A2"WTO4)#IT$"!8X
M&;3[>9E11P!YKNV .K&N@T_P/X3LM/OK*VT.W6WU*,17,9W,&C&2$7).Q 68
MA5P%)) !JUI'AK0],M[6&RL%C6RF>>$EV=A(ZLKNS,268AF!+$GFIG7C)6_K
MI_PWH88K.:%:$H^\];ZI:ZQ:;U>JY>7K[KOY/R&]TW2].;1]+TNW@CTS7-+T
M;^UEC4!+H-?Q('E_O&59)%8GE@2"36CI>CZ3>_%.3PC>Z9:3>&[:_P!3DM;"
M2)3;+)]ETYL+&1MX:ZO,8Z$MCV]#T_P/X4L=+O=.M=%@2UU!%2XCRS HN=B+
MDY15))55P%)RH%%UX'\*W.A6^CS:2C6EK*TT0\V02!WW;V,@;>2P9@Q).X$Y
MSFJ^L1\_ZZ^IN\^H.^L]>97TOK%)2^+XHVLM?AZK8\AT<#4?A_=:[J"K<:QI
M&DZ(=)NI0&FB'RNC(QY!D<L&(^]T.1Q5CQ-OTSP@/%6DQ+'XBN[[Q''=7<2@
M3R+'!?LJLP&2$DM[95!Z;5Q[^N7GA'PW=:I9:C-I%N;C3TC2V*Y546,[HP4!
M"L$8DJ"#M)R,&G6OA;P_;:]<ZS#I<(O+M669R2RG?C?A"=JEMJ[B "V!G-/Z
MS'M_5K6_4I\0X=N_(]V[:6^'EY=_AO[VV_3J<W\.-+TO0O'U]IF@6EO:Z?)X
M?TZX>*W4*AD+W*"0@=69$ +=3L'I6'X=\8>-=:\8?N8I;?2KS5+_ $Q3);0"
M&U$'GHDL;F3S))-\(+(4QACC 3+>A>%?#6A^&K>6'1-/2T68KOPS,2%&%7+$
MD*HX51PHZ 57/@KPL=6O-3_L: 75^LBW#AF ;S%VR,%SA68<,P 8]S6?M87D
MVKG!_:6$=6K.I%S<HI)R2;T5KM<VCO9WN]K=6>:Z+XHU[QKINA:I<:E;V@B\
M46UF;>SCW!REN[-*2PSME+!T'3RS&<Y)Q[16)>>$/#5TI$ND6X_X]\>7F/!@
MSY)!4C!7<0".W'3BMNHK5(RMRJQR9GC,/B7'V$.6*OI9:7MU6_7?UZA1116)
MY04444 %%%% !1110 4444 %%%>#_M$>(?%^F?$0VVB64$UK]DC;<_C=-,.X
M[L_N3.GM\V.?7BMJ-)U9<J=CT\IRR68XCV$9*+LW=M)?^3-+\3WBBODW_A,O
MB-_T#+7_ ,.C'_\ )5=9\#?$OC74/BEI=IJUC;Q6<GG>:Z>/4U C$,A'^CBX
M<OR!_"<?>XQFNB>!E&+ES+3S7^9[^*X.K8>A.LZT&HINRE#HK])M_<F?0U%%
M%<)\:%%%% !1110!F>--3?1/!NK:S%&DCZ=83W2HYPK&.-F ..W%<=>_$.>U
M\+/K-E<:3XB$>H06\D6DA]RHQ._ +'<^T$JO<C'>NW\2Z;%K/AS4-'FD>./4
M+26V=TQN170J2,\9&:S6\.W=RL*ZKKMS??9KR&ZAS!%'M:,DX^51D'(S].*V
MIN"7O(]7!5,%"DO;QN^;7?5:::+UZQ^9BR^,]4U'4ELO#T>FR>?JC6EO<3L[
M121"Q2Z#_*>^_'';FGV7BS7M86QT[2+'3[?5)%NS?FZD=X+<VT_V=U3: S;Y
M,[2<84$D9P"MG\.;/3%_XD>KWNG,FJ3:C"RI'((3)"(3&H=2-@4?*.V .@Q5
MQO!:VUK8'1]:O;&^L5N%-Z4CE>X$\@EG,BLNTEI%#Y &#T&,J;;HZ6_K?_@'
M9.IE:Y53MZM/>TM96W5^717V?31\UK'Q/N(5BVRZ'IDYT\S&VU*X;?/<K/+"
M]O"5P7.^(@$*2=P^7M6KJ7C;4X/%VG:6;2QL1>1VK"UU&5H9[HRM^\6!SB,O
M$.2G+,01A>"="W\ Z)'I\]C(UQ/;W.FBPF$CC<X\R20R[@ 1(7D9MPQ@X(Q3
M-3\%W%]<1"X\3ZDUHQMGO;5DC9;J2 J0X8KF/<47<$P#C(VG)+YJ-]BO;90Y
M6C"R5][];6VOY[^5I+=9F@^/9-0U+58#J.B>;IT]_'_9J[_M6VWEDC5F.['S
M"-6/'1J@TKXEW5Y9>$F_LN%9]=CNA?J)"1:200S-M7U#/ X!/9370Z;X4N+.
M.\M$U^Z;3[R>[F>T:"+Y3<222, ^W=@/*2.>P%4M.^&^D65\EU%>7>Z.6.15
M)7:-MG-;8 QP#Y\DA]6/IQ1S4-= ]KE'OWC_ (=^TDD]%U:EU^&UW<P]-^)5
M_>> )M>TZXT'6+Y8[,IIUD[HR23RI&$=F8X^^1G'45HZMX\O)_"NO:YX>BLY
M(='TV/44^U*^9HS!)(T9 (*."@'/3D$9K4L?!TT?AVWT.\\07=Y9VOV7R%:"
M)&3[/+'(G*J,Y\L Y[$TC> M)%GXJM8;BZBB\61NET@8$6Y>-E<Q CC)=W(.
M1N8GO1S4;[=?PT_X(Y5\IYI/E^U=;M<MX:/2/3FMIWNWHSHM*%^+%!J3V[W/
M.\VZ,L?7C 8D],=ZYZ;Q7<)\.]6\1BTC\W3[F^A2+<=KBWNI802?<1@GW-;>
MH2ZPEP%L;&QFAP,O->O$V>_RB)A^M8:^"V_L?5-'DUV[DT[4Y+J4V_DQ PM/
M.TS%7"Y.&=@,YX-91Y=Y=SS,.L/\5>R]Z+_[=UYE9;=-[&?;_$"4ZYK&DSZ<
MD,]AJUK:VC%SMN[>2XA@>0>C(TO([;HS_%3_ (=^-6\2:U-:/JNB>9#+<(VG
MP;S=1B.5HP6);'8$\=ZO:GX#TJ^NH;F6>Y6:WUM=6CD1@#O!0F(\<QDQH2/5
M5/4"I_#WA[4=!C>.RUF6[MUDFEBLKB..--TCL^#(J%@ 6/K5MTN5VW.VI4RR
M6'DJ4;3=M[]K.VCW>O35O5(Z*BLOS_$>W_D%:7NST_M.3&/KY%+Y_B'>!_9>
MF;<#)_M*3/3GCR/6L>5GC^PGW7_@2_S-.BLOS_$>PDZ5I>[(P/[3DQCOSY'T
MI?/\0Y3.EZ9@_?\ ^)E)QSV_<\\8]/ZT<K#V$^Z_\"7^9IT5EK/XCPV=*TL'
M'RXU.3DY[_N..]!G\1[1C2M+SW_XF<G'_D"CE8?5Y]U_X$O\S4HK-\_Q#YC#
M^R]-V\[3_:,F3Z9'D\?YZTWS_$>P$:5I>[)R/[3DQCMSY'UHY6'L)]U_X$O\
MS4HK,\_Q#N_Y!>F;=O7^TI.N.G^HZ9[_ /ZJL:;)J;L_]H6=I  !L,%TTV?7
M.8TQ^M+E8I4915VU]Z_S.6\'^,;S5?&5_I5V--@CM3<;K4RM'>6JQR;4DD1\
M;XY%^8.@VC@9;.:AT7Q[>:CX/FU!-+CCU&2^@MK*UDD*JZ7/EO!(YQD#RY07
MP,Y1P.E6+SP ;QIX[WQ+JEQ;_9[JWLXV$>^T6X&'Q)MW/A257<>!C.X@&GK\
M-_#5HUW_ &%:1:$ETEN3'IEM%"B302F6*<*%P7!.#D$,H .0*Z+T?Z_K^OQ/
M<E/*+WMK[NR=E9ZW>CU3Z+IO]IU?%'CB]\&Z;:W/C"VLX8Y+Z2W:XM9#LN$%
ML\RM&K'*L739M8\<G..:I>,_'VL>'?+AU&7PWI]V-*-_)!>W;*)GWD"")QRS
M8 &0IR3PO.*Z"U\'0M-:W6K:I=:I<PWKWDCW*ILD9K9K?8(P-J1A'/RCODDD
MDYL>%?"UOH=Q!-%?75Q]FL?L,/GL&(A$C.@)QDE00N3R0H)R<FCFI+I=DQQ&
M602DX<TEO:Z3>NU[V\]-;JRC8HZ=XR>?QTVBW%C]FM1:$F>1_F2Z6..62!AT
MXBF1@1_=?TK/_P"$O\2Q> [WQE/I6G_V8="GU:S19F$L.V+S(XYL\'<O)*_=
M((Y^]6A#\._#D6N1:[':0KK<>I27S:J+>,74@=GS"TFW)C\MS&%_NJO<9J'_
M (5_"^@W6AW&O:E-ICZ5/I=G:GRPMI!*@0\A<R,J@*I?.!UR222]$<:F5)QL
MM/=O=/6U^;EL^ONO5KKIT>GX%\1#Q1#=ZI8B!M'$S06,ZON>Y*,5DD('"KN&
M%'4A=W1@*WZPX='FTG5M0U'1(XY#JCQO/9SSF&%)%7:94*HQ#,HC!'0[ >#G
M-D3^(=RYTO3,'[__ !,I..>W[CGCZ5E))N\=CR\13ISJ.5"RAI9-JZTZW>K[
MO1/=);&G166L_B/#9TK2P<?+C4Y.3GO^XX[T-/XBVKC2M+W=P=2DP/H?(YJ>
M5F/U>?=?^!+_ #-2BLPS^(?,8#2],V\[3_:4F3Z9'D<=N_YTGG^(]@(TK2]V
M3D?VG)C';GR/K1RL/83[K_P)?YFI169Y_B'?@Z7IFW'7^TI,YQZ>3Z_Y[4GG
M^(]A)TK2]V1@?VG)C'?GR/I1RL/83[K_ ,"7^9J45F+/XAW+G2],VG[Q&I29
M'T'D<_I4VFRZN\Y%_8V4$>WAH+QY6+9'&#$O'7G/X4<K%*C)*]U]Z_S+M%%%
M29!1110 4444 %%%% !1110 4444 <O\899$\&+;I+)$E_JFGV,[QN480SWD
M,4@##D;D=ER.FZN*T_3[:]\?3> KKSY/#]EJETT%N+F10 ME92K$6#;BJO=S
M,!G PN/NC'J/B#2[+6M'GTS4(FDM[A0'"N48$$$,K*058$ @@Y! (K$D\!Z"
MVCQ6 ;44>&Z>[%['?RK=M*ZE78S!MQW*2I&<8  QM&.BE5C&-GY_\.>[EV8T
M,/AW3FVG[VRV;22ENM8V?R>C/+M+OK[5_ M]XAU"]NIM4\-Z+82:;-]H8$N&
MD8RD X8R[55LCY@,=S5[5+^\TO2U\:V4TYUB^UO7;.Y#2LRR0V\6H&&/83M&
MPV<...S?WSGT6Z\!>&9KJQE6TF@CT^W@MDMX+F2.&6*!MT*21@XD5&R0&SU/
M8D5-;>#-!@\1S:RL$SS3-*_D27#O;QO*,2.D1.Q6<=2!SEO[S9U>(I]OZMM^
MIZ4\\P4KVB[.[M96LXVY-]G+WWY]+ZGFU_:IHVNV?A>PN;L:7KMKI+WX:[D8
ML[W+K(^XMN!F50C$=<>N35C1].M]6\>-X&OI;HZ)IKZK+:1BZD4AD-CY>'#9
MQ%]KF"@GY<KC&T5VUG\//#5MHUWIJQ7LD=VL"&66_E>:%8&WP+'(6W((V)9<
M'@DGO3KKP!X>GT>WT\B_C^SO,XN8K^5+F0S?Z[?*&W,'SR">PQC:,'MX=W_2
MW)>=877WI7UULKWY;*?Q?$MO36]]#S/1]2O]9\%#QI?W-PVMZ7#H7V259V13
MYL=M)+\@.TB4SR*V1R,#^$8Z'P/N7Q!X;U])IVO?$-]J4.I;IV9713,Z*5)(
M'EF)$7 X!([G/8W7@CP[/K%IJ'V66(V:P*MO#</';R>0VZ O$#M8QGE<CC ]
M!@L?!.A6FL7>I6ZWB370GPHO9=EL9VW3-"N[$3.PW$K@YSC&32E7@TTOZTM;
M]2:^<8.I2E&*:O?HM$X<O+OLI>_VOTN<=XM+2>(/$'B#SIUU'0O$6E6-@5G9
M0D$@LV=-H.TB0W4RG(YX_NKCG-0U"^TCP7;^*M/O+J+5->TS5GU"3SW/S ,Z
M/@G"F$@*N!P"1TKU6X\%Z'/K]OJ\RWCSP>260WDGE3O#_JI)4W;9'0G(9@3D
M ]5&&6O@7PW!?7MR;2:9;Z*>%[>>X>2"))VW3K'&QVH)& +;0,T1KP22?]:;
M?J%#.<'3IPC)-VM?1:I1Y>7?;F]_UZ7.#O["VTWXC+X"M3.GA^^O=/>:W-U(
MP!:VU"1TW%MP5VLK<D9Y+-G.XU1M(3JS:IHU]>7@M?#>GZJ^ERB[D#1-'>RQ
MQR;@<LT*Q(JDY(Y]37HT/@#P_'HTVGYU%VGN([@WDFH2O=))& (RLQ;>-H&
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MRKR)<RJ67'1?[HQV7A6>70=)\=V6G;FMO#]\_P#9T3L7$(-A;W!C&X]!)(Y
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MF:!78QD8 8-(!QZXZ5V7CKQ':V'@S6;K3M5L_M]K8WC6RB5&;SH8F8C;W*D
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MZ-X#\(:9??OO*N]/UJ>>>/\ <OG:C6R Y&0<L, D\XP> _X2KQ+_ -!32O\
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M41CMU!.>%(&"223[FM:N:5N9V/G\0H*M+DVOI;_AW^;"BBBI,0HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *\._: E\%I\0"->\$^%=7
MN_LL?^DZGK$UO-MYPNQ+>08'.#N[]*]QKP#]I#Q#X@TSXD&VTVXT..#['$V+
MWQY<:3)D[L_N$NXAC_:V\^IQ77@U>K_P;'TW"=-U,QLK_"]I\G;K>/W7.6\_
MX8_]$O\  '_A1W/_ ,AUU7P3E\"M\3M,71O ?A#3+[]]Y5WI^M3SSQ_N7SM1
MK9 <C(.6& 2><8/ ?\)CXO\ ^?SPK_X=J[_^6-=?\!O$OB/4/BQI5I?W/A][
M>3SMZVGQ#N-2E.()"-ML][(LG(&<H<#+<8R/1K0?LY;[/[7_  3[[-,+*. K
MN\O@E_R_;Z/I[1W]+.^UCZ.HHHKPS\;"BBB@ HHHH YOXG2WJZ5I]M8ZE<Z>
M][JMO;R7%ML\Q49OF"[U8<_2N)OM2\42>+5\+KJ_B"^73[F\B:XTS[%%=7*K
M#8RH9#*%C^3[4Z': 3@''6O1_%VE:/J^BO!KJ_Z'"PN&?[0\'E%/FW^8K*5Q
MC.<US.NZ5\,+.WTJRU+4-.T_S!++IO\ Q.FM9;CS"K2,KK(K2[B$))+=JZ:,
MXI6M??H?097BJ$*<8RIN3][["ENM'>Z;M_+HNM[HI:IJ/B'3O%=B;K4]8ATN
M&2RMO.2.UN8@[[%>*^5<2)*Y=<21GRUW*W3(:GH^L^(-<TMS)X@U.Q_L[28;
MHMIUG%--<2S3SH'961MR((!\J@9R^<X&.@DT[X=?\)E::?+?V#:Y9)#Y5A)J
M[-,VP;HGD@,G[QE !5W5F&,@U?U;PEX2F@LK2\LTA6,-;VH2ZDA9PV7:+*L"
MZG:Q*$D<$XJO:025U^!L\;A(1@I4FI63OR1V5[M)MWOW;MU2NM>!_P"$^UM=
M2OV?4A)INIZKI4&D7*PB,(SQ6$DT.#S^]CN)'4')&R3GI5N/Q3J&NZ]XDT^/
M7;ZRA>">XTEK:)4:'[(YBE =XRKK(2D@QG@GD5WTWA3P[):-:MI%OY+7D%[Y
M:@JJS0K&L3J!]W:L,0 &!A<=SF3_ (1S1!86%D+!/(TR-H[1=[?NU:,QD9SD
MY1B#G/KU -+VU*WPZ_U_D2\TR[E7+1M*R5[1Z*-GZWBK[73D_M-'G=UK7B#1
M-*TF)/$-Y=2:KI=N[W5XD3M;R7%W:0&4!4"XC69V ((SUR*?XLUCQ?H/BRU\
M.:1J\^K/'=VMV!=1Q>=<0M;:@\EJ615'S&R!1L @OR2!7H-QX<T2X@6&?3H9
M8TLC8A'RR^0=N4P>WR+SUXJ/2_"NA:?)#+;V3&:"Y^U+/-/)-,9?*>+<TCL6
M;$<CJ-Q( /':CVU.WPZ^A,<UP2BW*DG+WOLQLV]O-6VT[G/:9XJFU+X<WNM:
M=>^?]LU(VNG7&T819KA88FQCHOF*<'TYK!OM4\2:EXT72H+_ ,0- DVIY32'
MM$D BFMTCW&XP"H$C#CGFN]NO#.F_P#",WVC:="EA'>22SAHESY=P[F3S0N>
MHD.['3-6K'0]+L]2.HP6B)=-YNZ4%N?-9&DX)QRT:'\*E5(1NTNYG3S#!T7.
M<*=[N5DTG9-65_\ @')_&KQ+?>&]-TR'3+F;[7NDO)56 RO<P6Z;GCX4X,CM
M$A.!C>>16+>>-]6@\5ZQ%_:"OI-_K.GVVBW"JO[MFALI9(<XY$D<TCKGILDY
M^[7IWV&T.J?VD80;KR/($A)R(]VXJ!T&3C/K@>@K+M?!OAFWTD:9%I$(M%N;
M>Z6(EB%E@6)8F!)R"JPQ 8[+[G)"I322<?ZN+!X_ 4J485:5VEJ[+6\D[^5D
MK+NFUHF<O%?>+C)K.FMJ#(WA>WG=;LA#_:+NOF6V\8X"1\2<#<QR,"N]TRZ2
M]TVWO8P52XA650>H# $?SJCK.A6M[I^JP0G[--K$/DW4ZY+%=FS(&< A20#V
M.#@]*TXD2.-8XU"J@"J!V [5G.49)61Q8S$4JT(N,4GY*W17^^5[=EIHK(=1
M1169YX4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7AW[0#^$E^(!&M?
M#S0]=NOLL?\ I=[=W<<FWG"XBM95P/\ >SST%>XU\\_M,:IJEI\3##:)X<,?
MV.(YU#QQ-I<N?F_Y8)=Q#'^UMY]3BNO!*]7_ (-O\CZ?A&G[3,;7:]U[2Y'T
MZ\T?NN<[YGP\_P"B-^%?_!CJ'_R!75?!-_!I^)VF#2OAIX?T>\_?>5?6E[>/
M+#^Y?.U9+2-3D94Y<<$]3P?-?[=UW_GGX+_\.G<__+"NR_9_U;5KGXN:3!<I
MX8$3>?N-EX^GU&;B"0C;;M>2!^0,Y0X&6XQD>E6A^[EJ]G]K_@GW^:811P%=
M\T](2WK-]'T]H[^EG?L?2U%%%>$?C(4444 %%%% '-?%>+5+SPF=(T>T6XN=
M4N([5A(66%82=TWFNJDHIB1USCJZCJ0*X?PRUYHEY;:?XJ\.7]Q!IVEWFE^7
M9:7<7MO/'YT+PHK"/#+Y)5=S #*/G&#CT_Q)J<6C:#=ZI,C2+:PM)Y:GYI"!
MPB^[' 'N17.2^.+JX72CHGANYU-M2TUM0>);J.)X44HK)AR 7#/C&1R#R*Z*
M4I<EDM/N/?RZM7^K>RC23A=Z\W*[\O=Z+W?^'.(TG2M3L_!=]X2OM)U.76YV
MTQ;2<6$TL,4T=G:(9_M.WRQY;QN=Q<$E.,D@'T#QUI"W?BSPEJB6<LTUAJKY
ME4,RP1-:SAF('"Y;8-Q'<#/.*S8?B3%<+)J5IHES/H$/V4S:FLR*8UGBBE5S
M"<-M59D+=P W!QBM[Q=XBDT*2%CI%U=6QVFYN8RJI;J9%0=3EVR^=J\X4]]H
M:IRJ.2TU_P"!_6AMBJV.E7A>GRRDI=5O*"BUY:6]UZZ^:-RBBBN4^:"BBB@
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MWH/A&S^(]U:ZSX<UZ;5[#78=+VF-I1&"HB\[((,2,&W]5KI+O]FNY/QK\/\
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M;S6/[8N/""08A,^#PL@<!5^8J#LW!/ER3\PZ'Q[^RYH7BKXX>*/B)=Z^8_\
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MRRD;,  '/S"K7[0GPWUOQ3XP\57]KX:CU%+S3_#%O92R+$Q;[/K$LUVB[CD
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M*G R>",CT:U-JG)Z[/J??9IE\H8"O*\M(2_Y>-]'TOKZ'TM1117AGXV%%%%
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M@X/4$5:I&$HRA)QDK-'%:Y\7/AOHWQ/M/AWJ?BZQMO$U]M\C3WW9+/\ <1G
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MBW<F1N<Y&>*^D?VB-+TW6?@[K&FZQIWB#4+*?R/-MO#T"RW\F)XV'E(P(."
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MENI0@'K3=2^,_P >[3QE=?#Y/&>N27UI</X:\_[8_F-<&^+"0M_SU.#'NZA
M0#@4%<I^GU9=]XE\/V?BRQ\,76LV4.LZE#)/9V#S 37$:??95ZD#G\CZ''YL
M_$+XR_'CPS\0M<\'P>-_$-PFBW]YH/G^>S-*\D\OEN6_YZ87Y#U 7C KU?\
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MPM?TQW^&_BK5;V+2='U2#Q3H>GW&AVMJ;>P1%MIQ'<LI)!$FPDG_ &G/1@*
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MG&0HXQZ4#L>BT444""BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M/9#3KG9$_FAB9"RA@V0!]W SDG)_:.UWQ/K7Q FTB+5K>ST'POXI\*QRZ?\
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MS;XKU?Q%X)OCXKU2:77]*O#;ZO9W>EK82Z9+Y4;F)E5F61/FWI*IPR,O<$D
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M;9%"QAF++GA017-0>)_&O@;2OB)?:9JS7UUK7Q171[1(-)226T>6.W+S(C2
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M9%\$O&?_  L+X8Z9XO\ [-_L[^T?._T7S_.\ORYGB^_M7.=F>@ZX]ZZJN?\
MA;X0TWP%X$L?">CSW<]EI_F>5)=NK2G?(\AW%54=7., <8KH*YY6YG;8_/\
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MM^/-"UC6O&OB%-*EU#5O"GAR32K*SANI;2R^WWEPJF2)6:21T#_-Y7,GEJ%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110!Q6O?"OPAK.M:YJ5_!?
M,WB,VK:E E_*D$TELT312^6&VAQY$0W==JXZ$YAU_P"$7@S56FF,6I6-Y-K,
MNLB_T_4IK:YBN98EAD*2HP95>- I4<$=L\UW=% &+K_ABPU;P>OAN:[U:WMD
MCC2.XM-4G@ND\L@HWGJXD+94$DL=W\6<FN:7X,?#\:%/I']EW!MKG19]&GW7
MTS/+;3S&>;<Y8L7>5F<OG=ECS7?T4 <-_P *C\$GX@?\)@UG?-??:IKP6[:E
M.;,3S6[6\THMBWE;GC8ACM]^"3G*T7X!?#G3-"U/2(K75I[?5+2WLW-UK%S,
M]M#;2&2V2!V?,(B8Y381C ZUZ=10!Y_XD^#GA#7_  [I>D:Q<>(+K^R?M BO
M7UZZ%Y(EP")XY)P^]HY!C*9VX50   *UO$WP[\+Z]\/M/\%W]O=KI.EFU-FM
MM>RP30FV*F%EE1@X92BG(.<C-=510!YGJGP%^'>H>';;1Y[;5UCA@O()[B'6
M;F*XOX[MQ)<K<RJX:82.JN0Y(RN.F0>P\'^$M#\,76I7&CVSPR:O-%-=EI6?
M>\<$<"$9/&(XD''IGJ:W** .&E^$G@R7XER>.9+?4'U*6]COY(6U*?[&]U'"
M(8YS;[O+,B1C"MMR,YZXQ%IOP=\&66A:QH<0UAM(UA2KZ9)J]PUK:H9/-*V\
M1?;$"Y)^4<9P,#BN^HH XJ'X5>#8OB8?'26=U_:7VAKM8#>R_8UNFB\EKD6^
M[RQ,8QM+XSCWYJII'P6^'FE-8/INCRVDNF0:C#:30W<JR0K?-NG(8-G)).T]
M4_AQ7H%% %70]/ATG1+/2[9YY(;&WCMXWN)FED944*"[L2S-@<L3DGDU:HHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %<?^T)_R0+QQ_P!BSJ/_
M *325V%<?^T)_P D"\<?]BSJ/_I-)0!H?";_ ))7X9_[ MI_Z)2N@KG_ (3?
M\DK\,_\ 8%M/_1*5T% 'E_[:W_)H_P 1O^Q9O/\ T4U>@>$_^15TS_KRA_\
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M!]2:U\2O"NE^)KG0;JXN!>VE_IVGRJMNQ7S[YB(%![_=))Z >_%7_%?B_2]
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MFK>!?%P\>>-&\:MHVBR>)]);P_XKMH#+;V^H6UFF)"2I0Q!F,;%\(<E=P)%
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MU.59;R51\T[K&L:EC[(BC\*MT4 )M42%PHW, "V.2!G _4_G0JJI8A0"QRQ
MZG&.?R%+10 F!NW8&2,$T*H50J@*JC  ' %+10 4THA!!53N.3QU_P XIU%
M!2,JEE)4$J<@D=/I2T4 (J@$D #<<G ZG_(HP-V[ R1@FEHH 1E#*58!E88(
M(X(I:** $VK\WRCYNO'7ZTM%% !@9SCGUI%55R54#<<G ZFEHH   !@# '04
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MOI_"OA&-AN2".$XO;M,\;Y9BT>\<[(=O(->VUXU_P3[P?V1?",A $LWVV6X
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M&;XC:Q^V3H*>+/%MPL=[+_8.IW26$2I=A);@PQ&/;LA,DJHI* -P>>IKZO\
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M9$;OB@9XU\,]8\=7MO<_LX6%S=V>H^$)S9:QXH1@'@T4A6M&@/:ZEA98P?\
MEGY;OR0!7T)X1T'2/"_AJST#0;&.RTZPB$5O!'T4>I)Y))R23R222237BOB#
MX=7/PDTW1OB=X?:YUC7-#\U_&LRK_I'B&SG8/=2E>[Q.!+&N>%0H.HKW+0]3
MT_6=%M-7TJ[BO+&^@2>VN(6W)+&P!5E/<$$4"/)_&G_)\'@;_L4M5_\ 1L%>
MQ5X[XT_Y/@\#?]BEJO\ Z-@KV*@ HHHH **** "BBB@ HHHH **** "BBB@
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MA!)QYF,]Z LSZ,7X:_!_QIK&D_$*+POH&L7,<$;:=JD2"1)(U $;?*=LFT
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M [X1^&]7GU/1/ &C6EU<QS1RNL&X-',NV1-K$@(RDC:!C!(QS70?#CP1X3\
MZ#)HO@[0K71["6X:YD@M@</*P +DDDDX51] !T%=!10 4444 %%%% !1110
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M,BE59L<D DD#/;)^M/HHH **** "BBB@ HHHH **** "BBB@#P7]J[Q5X?\
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MRVX_97_9]FN'E_X5?I,7F,#)';R30Q28.0&C1PK#/8C%>P44 <M\-_AK\/\
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M!<^0_B1^S)\6_&FH^*=:UOQ1X5NM7\3>#;#2)IPTT*M>0W=E/([*L) 0K:N
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MB%(<:A-IJLML\F3S&& .,8Z@<YX%;=%% @HHHH **** "BBB@ HHHH ****
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M_P#::]QCUW0Y->;0X]9T]M41-[6*W2&X5?4QYW <CG%:%'*%UV/G[_AO)?\
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M>M_^#'_[37T#11RAS+L?/W_#>2_]$;UO_P &/_VFC_AO)?\ HC>M_P#@Q_\
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MQE*,I<VC4FW&#;=TM$_=71JUM5(X[]J35I]+^&<<5M>75I)J.IV]KYMHS"8
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M-.3NG&6MXG"PZ4NC?M-?;]/*0P>*?#,\FIPI&O[^XLKBV2&4G&<B.\D7@X(
MSG QZ!7G?PYU"W\=_$O4/'FG3/)H>D6LNA:/,I/EW[-)')=W"Y7#Q[X8(D=6
M()BFR/NFO1*XCXP**** "BBB@ HHHH *[;PW_P @.W_W/ZFN)KMO#?\ R [?
M_<_J:F0T7J***D84444 %%%% !7SW\4/VA/A!X7^(&J^']=\7?9=1T^X,5S!
M_9EV_EL .-R1%3U[$U]"5PWB+X,_"C7]<N=9UOX>>';_ %"\D\RXNKC3XWDE
M;U9B,DT)V \5_P"&HO@5_P!#S_Y2+W_XS1_PU%\"O^AY_P#*1>__ !FO7?\
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M (S1_P -1? K_H>?_*1>_P#QFO7?^% _!/\ Z)9X5_\ !7'_ (4?\*!^"?\
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M\-1? K_H>?\ RD7O_P 9KUW_ (4#\$_^B6>%?_!7'_A1_P *!^"?_1+/"O\
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M_P#*1>__ !FC_AJ+X%?]#S_Y2+W_ .,UZ[_PH'X)_P#1+/"O_@KC_P */^%
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MB_X:B^!7_0\_^4B]_P#C-'_#47P*_P"AY_\ *1>__&:]=_X4#\$_^B6>%?\
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M<KX[_P#!7'_\K:/^%O?"3_HY7QW_ ."N/_Y6U],?\*!^"?\ T2SPK_X*X_\
M"C_A0/P3_P"B6>%?_!7'_A1<-#YG_P"%O?"3_HY7QW_X*X__ )6T?\+>^$G_
M $<KX[_\%<?_ ,K:^F/^% _!/_HEGA7_ ,%<?^%'_"@?@G_T2SPK_P""N/\
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M%_PU%\"O^AY_\I%[_P#&:/\ AJ+X%?\ 0\_^4B]_^,UZ[_PH'X)_]$L\*_\
M@KC_ ,*/^% _!/\ Z)9X5_\ !7'_ (4<S"R/(O\ AJ+X%?\ 0\_^4B]_^,T?
M\-1? K_H>?\ RD7O_P 9KUW_ (4#\$_^B6>%?_!7'_A1_P *!^"?_1+/"O\
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M2M.\(V.B75E'H=SK.IQ:A')YDT4,BADC=6&UMI)&0>?7I6=XJ_9(M+59-?\
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M15WAV_'_ (!U.>%UM"73[2^?V>O3MYG._P#"<>'_ /A%_P#A(,ZK]A\_R/\
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M*[5.#M:2-0Y] I)/;-,TWQQX?O\ 0[W5[8ZK]ET_'G^9HMY')STV1M$'D_X
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M;:0E>R^TM^K^'9]%T[LYW3?''A^_T.]U>V.J_9=/QY_F:+>1R<]-D;1!Y/\
M@"G%'_"<>'_^$7_X2#.J_8?/\C_D"WGG;_\ KCY7F8_VMN/>NBHIWAV?W_\
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M ( W/":VA+I]I?/['7IM;S.5_P"%A:#_ ,^'BK_PD-4_^1Z*ZJBG>GV?W_\
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M]$_9Q^./Q-\<?'!8+_3KFX\,:C=7-MY46E@0Z9Y:;D87"C<SD@!Q(<#<".H
M- LSZQO/B#:V=\ME=ZCI$%RV-L$LX60YZ84MGFI_^$T;=.OG:?NM1NG&[F$8
MSEOF^7CGFOBKXC>%/^$I_;?\9)+X&@\3VMC9V<\[2ZB]L;#%G$5E54=3*2P
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MBBR VO\ A)K_ /YXV_\ WRW^-'_"37__ #QM_P#OEO\ &L6BBR VO^$FO_\
MGC;_ /?+?XT?\)-?_P#/&W_[Y;_&L6BBR VO^$FO_P#GC;_]\M_C1_PDU_\
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M6/RAY?[L@,3D=SGK6G^PC\,OB3H'[1&GZEKWP]\5:79)97*M<WVBW$$2DQD
M%W0 $GWK]):* N>2^(?A]I^M^,-#\3ZCH]Y)J7ATS'3I09%6/S5"OE1PW '4
M<57G^%^@S^+=8\27'AV>>_U_3QIVI&42-'/;@8V%#\HR !P*]BHJN81\D_$#
M]E#0;KPA8>'O!VDMID+^(H-1U6>Z,TLLMLD<RF*-N3QYW R!U).:ZG5/V:?A
MK?\ A?2M G\&W M='=V@:.25)9-Y!D$C@Y?<0,YZ8P,"OHVBE<-3YW_X9O\
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M*X_[]-_A1_9]_P#\^5Q_WZ;_  KO**.8+'!_V??_ //E<?\ ?IO\*/[/O_\
MGRN/^_3?X5WE%',%C@_[/O\ _GRN/^_3?X4?V??_ //E<?\ ?IO\*[RBCF"Q
MP?\ 9]__ ,^5Q_WZ;_"C^S[_ /Y\KC_OTW^%=Y11S!8X/^S[_P#Y\KC_ +]-
M_A1_9]__ ,^5Q_WZ;_"N\HHY@L<'_9]__P ^5Q_WZ;_"C^S[_P#Y\KC_ +]-
M_A7>44<P6.#_ +/O_P#GRN/^_3?X4?V??_\ /E<?]^F_PKO**.8+'!_V??\
M_/E<?]^F_P */[/O_P#GRN/^_3?X5WE%',%C@_[/O_\ GRN/^_3?X4?V??\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\6:)\3?ASK>O_";Q(VEZ;XIO%GNI(Y8[HDK"UK=7$)E*Q1QS;G+*0CA""&.
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M** "BBB@ KA_%E]>V/QT\+H=9N8=,N=&U-KFR9T6V+Q-:E96XR6 D8<L0!T
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M*@O+.&^CTKR(=0E25[I@/#$6HF<GS!F3SW<;^F ."02?48=5^$<6@^$?&/\
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M^V6L$AG*\0+/N!W8W?('Z;N.M5=5F^'/BG7$^'NJ6&AZQ)9V,&J0Z==VD5Q
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MGR22S&XN3$20!M1LA"*]XT31? .E>%[G1]'TGPW8Z+?S207-G:6T$=K<2O\
M(Z.B@(S-C:002<8-8FK>'?@]X?\ "T>FR>$/"<>DRZQ;!;"VTBW:+[;+<QV<
M<OE*N-XED2,OC*]"1B@#SRUU?7_$.H:KK&E^+-;L+BQ\)&37XSJ"F&'4)+&&
M:."TMF4JC1@^8\F./-"Y8Y\O6\<WVH:CX)^%<%WXJU;2(M8@>35-0L[]K>5M
MFCSS[W<'D"1%<@Y!QR"*['PA:?"7Q+>'QOHVA^%Y[_5I9[1M3_L^ 75VPW1R
M(TFW>^54Y!/*X[5T6O>$?">N:79Z;K7AC1M2LM.97LK:\T^*:*U91M4QHRD(
M0.!@# XH$>$:?\8_'>H?#_2K&9M,L]8U*RBCFN);5S-$S^&I=1:;8LBX;[1'
MCC "Y&,\U>U'QUX_;X9Z[:?VUHL?]B> 1>SWRQS17]Y<S6%Q-'-;DRL%"&)<
MD[BQ$C KMQ7M5UX3\+77B2/Q%<^&M'FUB&,Q1:C)81-<HA5D*K*5W ;7=< ]
M&8=":JKX!\"K';HO@KPZJV=G)8VRC2H,06T@(D@0;?EC8,P*#@Y.1S0,Y3P-
MXN\:WGPK\52O8Z7J/B;PT[VMI'$SPV]]+]B@N8@QD<D$_:%0DL 2I.5!XXS0
M_B5XFF\67GB*[\261T^V\&K)+IZZ'<Q[=0%_<6I7R&N,K()HQ&RG/3:' ^8^
MX2:#H4FGWM@^BZ>UKJ1S?6[6J&.Z.Q8_WBXP_P B(O.?E51T JA_P@O@G[#!
M9?\ "':!]FMK.2Q@A_LN'RXK:0@O"J[<+&Q )0<''(H$>!P_%OXBS-J7C!KC
M3+<:%X0UB:YT>6QF$4MS9:C+;F4A;DB/B-"1E]HWJ'.0PV?$7Q-\8P_$Z?5H
MKFS;2O#NF^+&?2(()<ZC]@:R,8+>;CS3Y@ ;8=H\T;3O!3V.V\"^";>VMK>W
M\':!%#9Q7$5M''I<*K D^?/1 %PJR9.\#AL\YI=-\#^"M.ALXM/\'Z#:QZ<\
MDEDD&F0QBU:1=DC1@+\A9?E8C&1P:!GF7@OXD?$+7?&]GX0\WPG]L@O+A-1U
M"WM)Y+>>&.VT^Y'D+YP*OMOF0[F890-C'RUN?!;XEZGXI\)Z_P"(?$=O8Z;9
M^'88K>^:&*3]W>Q6XDONK$M'&[A% &<HX))Z=QX?\*>%]!CMX]#\-Z1IB6OF
M_9ULK"*$0^:5,FP(HV[RJEL==HSG%-\(^&-,\/:+=:9:AYXKZ^N[VZ:X"LTT
MMS,\TF["@$9D( Q]T <XH$>#7OQX^(<.AZA<II>A+/H@U6YO!=Z?-";FWL]/
MLKY0D8N'\IW6[9,LS#A6VCE*UM2^-'C6P\5:I936.@R6:ZC<P6!2WF$D45MK
M%C8R-,3)AB8[TL"H4*8\D$' ]:T_P!X$L--DT^Q\$^';6SF29)+>'2H$C=9H
MUCE!4+@ATC16'\2HH.0!5JZ\)>%+E;A;GPSH\PNDGCN!)81-YR3NKS*^5^82
M,B,X/WBBDY(% SR=?C5K3>(O#]E#;6%PM[K\FG:G'%928A@?4[NRM91.9L*S
M"T<E=C[BK?<!%2:3\0M=T+]D3P/XCCNSJ'B/5]$M/):\M7O&O9_L;7$I<"6,
MY\N&5RY<8VGACA3Z5!X!\"07&G3P^"O#L<ND9_LV1-*@#669/,/DD+^[_>$O
M\N/F.>M6=2\(^%-0\-6WAV_\,:-=:/9>7]ETZ?3XI+:#RQA-D17:NT<# X[4
M"/*/^%P>+KCPWXA\36]GX?@L=*AM+>WL+CS?M1N;BWL9OM#L& ^SI]NY 4-B
M/.[YL";7/BAXWT7Q]8Z!=IX9O(K=],M]2:VCF62]EOI[F%9+4&0[$B-N"RMO
M)^<;EV9/IS>"_!S7CW;>$]#-Q+8C3Y)CIL.][4  0%MN3%@ ;/N\#BBR\%^#
MK.\TRZM/">AV\^BQ&'2Y8M-A5[",YRD+!<QJ<GA<#DT >)K\</'>I:-IDFC6
M_AE;J^TZPO'>XMIWB!ET:ZU"50%F!'SVZJO/"L<[CS4ME\0?B-:V/C[Q/8W%
MAJ%M;ZUIK16DMC--_9-I)I=G<3.J+.&E55DR4C"L6$L@W9\L>QZ7X$\$::'&
MG>#?#]F))6E<6^EPQ[W9'C9CM498I+(I/4AV'1C2:EX"\#:BDZ:AX,\/7:W0
MA6<3Z5#()1""L(;*_-Y8)"Y^Z"<8H&;.E7,=[I=M>131S1W$*2I)&"%<,H(8
M9YP<U8I(U5(U1%"JHPJ@8 'H*6@05\[^!?VC/B)XU\.IK_A/]GS6-4TN662*
M*ZC\0VR*Y1RC<,H/!!'2OHBO"/\ @F[_ ,FHZ1_V$=0_]*I*!D__  N#XS_]
M&S:Y_P"%)9_X5T'[/7Q<U#XC^(O%>@:SX(NO"NJ>$Y;6*[M;B_2Y8F='<<HH
M P$!ZG[WM7J%>$?LU_\ )UWQX_[".C_^DLE 'N]</^T?X]M/AE\%M;\;7^C?
MVQ;::L*2V'F!//6:>. @DJPQ^]R<@Y QWKN*\/\ ^"C_ /R9AXR_[</_ $X6
MU BGX?\ B?\ %/2=%M].T3]E?4;#3X$Q;VUIKMC##$IYPJ*H"CGL.]6+SXT?
M&&TLYKJX_9JUN.&"-I)'/B2T^50,D]/05[;I?_(-M_\ KBO\A5'QU_R)&L_]
M@Z?_ -%M0,QO@1XZB^)?PET7QS!IKZ='K$3R+:O*)&BVR.F"P S]S/3O775X
M[^P#_P F?^"?^O2;_P!*9:]BH$>6_M!_%W4OAUXL\)>&=#\#77BS5?%QO!:6
MMO?I;,IMDC=N74@Y60GJ/N]\U@_\+@^,_P#T;-KG_A26?^%0?M$?\GD? /\
MZ[>(/_2.*O=Z!GSSXT_:*^(7@[2$UCQ;^S]K&DZ8;F*W>[D\06SJC2.%7A%)
M/)]*^AJ\(_X*,_\ )M<O_8<T[_TH6O=Z "BBB@1Y?\'KUKSXA>*=8L?$VH7G
MAMK@V<*:GJ0G\V]2XD29[=#_ *F%6(@4# <QY QAGX[]HWQ!XJT[X[:79:)J
M>I6ENUII2)-'J30V5G-<:D\/F7$(!$RN (L$<%EY7[P];T_X<_#VQN[FZLO
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M!;ZA/?MX0T%KNZLQ97%P=,A\R:W  $+-MRT8"J-IXP!QQ3M2\%^#M0BGBO\
MPGH=TEUYGGK/IL+B;?*DK[@5^;=)'&YSU9%8\@&@9Y'X=^,?Q U+QIH.A1^%
M[.[S*(M:FM+64QR#^U+JP:>%S)B)$6T,^&$A99 H((W&]X/^)?Q FL/A]JWB
M*+P_#I/C"..2YN[/3KAEMI)Q"+>V(\XF-G9Y,3,&3.U"%)#-Z;'X*\&QW&DS
MQ^$M"6704*:0ZZ;"&TY3_# =O[H>R8I[>$/"1N=+N#X7T4S:&@32I#I\6[3U
M P%@.W,0QQA<4"//_B1\2?$^C_%7_A'M,BT:+3HGLK27[7%(]U+->+<>7-%A
MU7RXV@&Y2"7&_#)MYYG3[[QM;_LC?#/4;'Q:5US6;_0)[S4KU+FY,PN[B)F1
MPUP'(S*H91(%90RJL:LH3VV^\.>'K[Q#:Z_>Z%IESJUE$T5KJ$UG&]Q C9#*
MDA&Y5.3D X.31>>'/#UWX73PU=:#ID^BQQ1PIIDMG&UJL<>WRT$1&P*NU=HQ
M@;1CI0!X._Q;\;>%D\10316FKK+J6J-HQ:&66:WV:_'8;9AY@$D:"Z0JB;,+
M%MW<Y'1_$KQ-XUU']FG3=6N-.N](\1WVO:;8SV=G=O823!]5BMRJ299H%FC.
M>22@DY)Q7J%YX2\*W<,\-UX9T>>.ZCGBG26PB994GD$DRL"OS"20!W!X9@"<
MGFDN_"/A2Z\(KX4NO#&C3:"B*BZ3)I\36:JK!E A*[  0"!C@@&@9X9X'^+?
MC.PT;0K*X^Q7B6D\4.KG47>:\N?/UR;34AMYD8)(T 0%I2K"7"D!-^1H:%\9
M?&?B/Q0-"T"/1%%_JUFFF:C?:7.D<EE<VFH3HYB%QN8_Z"N&W)N#GY%X->QG
MPCX4,VES'PQHQDT/_D%/_9\6ZP[?N#M_=_\  <5'HO@KP;H]XUWI/A+0K"X>
MX^U--:Z;#$[38D'F%E4$OB:8;NN)'_O'(!YI\$O'7B'Q5\8-3N]:U*RCTJ;1
M@^FV%L718 -2NK=?-#.0\["%<L O7:%XR?:*Y^W\">![?5+C4K?P;X?BO+RZ
M2\N;E-+A66>='\Q)G<+EG5_F#$Y#<@YKH*!!7GO[2/Q0?X4^#],UF#PW-X@N
M-6UJ#2;:QANE@9I9E<J=S CJF.?[W6O0J\(_;X_Y%/X>?]E)T?\ G+0")_\
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M7?Q)U>[ACBL)9@8C($!RBD#YD;CVK[$HH \!_P"&SOV?_P#H:;[_ ,$]S_\
M$5SO[.WQ$\*_$_\ ;H\4>)_!U])>::?!,%OYLEN\)WI<IN&UP#W%?4%% PHH
MHH$%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M9P5VD @ YGQ!\:-.L?#E\]GITNHZK:QF.,6,L4UG<7']DMJ8,<Q==\)B7 ?
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M0!M?VUH__06L?_ E/\:\[_:VU;2I?V8_'D46I6<COX>NPJK.I)/EG@#-8/\
MPR!^SK_T3S_RMZA_\?H_X9 _9U_Z)Y_Y6]0_^/T#T.__ &=_^3?_  +_ -BQ
MIW_I+'78U3\.Z58:%X?L=$TJ#[/8:;:QVMI#O9O+BC4(B[F))PH R22>]7*!
M'A5Y=6UI_P %(!)=7$4"'X3[0TKA03_:W3)^AKV?^VM'_P"@M8_^!*?XUP_Q
M>^ _PI^*'B2#7_'7A7^U=1MK1;.*?^T;J#;"KNX7;%(JGYI'.2,\]>!7*_\
M#('[.O\ T3S_ ,K>H?\ Q^@97_:IO[&[^*'P92TO;>=E\;QDB*56('DOZ&O>
M*\B\%_LP_ WPGXJL/$GA_P #_8]4TR=9[2X_M:]D\N0=#M>8J?H017KM @KY
M_P#V*]0L+35OC%'=7MO S?%/6"%EE521N3G!-?0%>.^)_P!ECX#>(?$FH:_K
M'@3[3J.JW<MY>3_VQ?)YLTCEW;:LP499B<  #/ H ]4_MK1_^@M8_P#@2G^-
M>(^"[FWNO^"B7BB6VGCFC_X0*U&Z-PPS]I7N*N?\,@?LZ_\ 1//_ "MZA_\
M'ZZ[X/\ P-^%OPMURZU?P)X7_LF]O+?[-/+_ &A<S[X]P;;B61@.5!R!GB@9
MZ%1110(**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>?"+X@ZIX;O-!U?_ (1UHK?PG::+H=[#JTX>T:)(6E!A-MC$\T0#R!R1''&
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MOPLUW79M+@T*V?4+*[;7I8);2:"2.6>:6-I\.%XDDMI<CHVP-@@J3MWOP_\
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M91/)KFH6HP5CW81($ ;;EE500#S7L*^ /!:Z'=:.OANP6PO;."SN+98]J/#
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M HHHH **** "BBB@ HHHH KW%C93WUO>SV=O)=6F_P"SSO$&DAW##;&/*Y
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M/3=+_P"0;;_]<5_D*H^.O^1(UG_L'3_^BVKQ.V^(W[44-O'$/V;;$^6@7/\
MPF=ES@8_O5!KGC[]J'4=%O-/;]F^RC%W;O"7'C.R.W<I7.-W/6@9TW[ /_)G
M_@G_ *])O_2F6O8J\U_9!\*Z]X)_9O\ "WA;Q/8?8=6TVWE2ZMO.27RR9Y&
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MJ:_X3_9\UC5-+EEDBBNH_$-LBN4<HW#*#P01TH ^B**\/_X7!\9_^C9M<_\
M"DL_\*Z#]GKXN:A\1_$7BO0-9\$77A75/"<MK%=VMQ?I<L3.CN.44 8" ]3]
M[VH"QZA117%_M#?$*'X5?![6/'MQI<FIQZ3Y&ZTCF$32>;/'#PQ!QCS,].U
M':45X;'\8_C+)&KI^S/KA5@"#_PDEGR/RIMY\:/C#:6<UU<?LU:W'#!&TDCG
MQ):?*H&2>GH*!V/=**Y'X$>.HOB7\)=%\<P::^G1ZQ$\BVKRB1HMLCI@L ,_
M<ST[UUU @HKRW]H/XNZE\.O%GA+PSH?@:Z\6:KXN-X+2UM[]+9E-LD;MRZD'
M*R$]1]WOFL'_ (7!\9_^C9M<_P#"DL_\* L>X45\\^-/VBOB%X.TA-8\6_L_
M:QI.F&YBMWNY/$%LZHTCA5X123R?2OH:@ HHHH **** "BBB@ HHHH ****
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M,B+&DH!7 =4C10W4!% X K<HH H6>B:+9ZA]NM-(L+>ZS.?/BMD63,SH\WS
M9_>/'&S?WBBDY(%7Z** "O"/^";O_)J.D?\ 81U#_P!*I*]WKXM_8U_:4^$?
MPX^ ]CX3\6:]=6FJ6E]>/+%'ITTJ@/<.Z_,JD'@B@?0^TJ\(_9K_ .3KOCQ_
MV$='_P#262H/^&SOV?\ _H:;[_P3W/\ \167^Q'XMT/QU\>/C3XL\-W+W.EZ
MG?:2]M*\31LP6WF0Y5@".5/6@#Z2KP__ (*/_P#)F'C+_MP_].%M7N%>'_\
M!1__ ),P\9?]N'_IPMJ!+<]ITO\ Y!MO_P!<5_D*H^.O^1(UG_L'3_\ HMJ\
M1L?VR_@#'90QOXIO@R1JI']D7/4#_<JKXJ_;$^ M[X7U*RM_$]ZTUQ9RQ1J=
M(N1EF0@#.SCDT#LSJ_V ?^3/_!/_ %Z3?^E,M>Q5X[^P#_R9_P""?^O2;_TI
MEKV*@3W/"/VB/^3R/@'_ -=O$'_I'%7N]?-?[:GC#0? /[2'P2\7>)[I[72M
M-DUUKF9(6D90]M!&N%4$GYG7H*UO^&SOV?\ _H:;[_P3W/\ \10,G_X*,_\
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M3VG_ #[S?I_C7QUX;_:Z35M!N8H_!JMXBEOK:UTK3X=15XKGS]VTO+M 0KM
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M>I>$?C+H/P_TKPK#J<^L0QS-<76JI9)AY&C"1EUPS KG&<G( &31H&I]!?\
M"3VG_/O-^G^-'_"3VG_/O-^G^-?'NE?MB>'YO$VK07?AYTTJ&"YDTNYBNPTM
MRT0)59(\9C$@'!YP<#GJ*'Q-^+GQBO?^%>WEMX&N-#.J:]&T%M#K4836D9(W
MAA9N"BL)"&W<9'/((!H%F?:/_"3VG_/O-^G^-'_"3VG_ #[S?I_C7Q5X5_:
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M<QI=07BRS//!&68>7@81B"JL2,G'^T%- LSZZ_X2>T_Y]YOT_P :/^$GM/\
MGWF_3_&ODW]F'XD^,?'_ .T1X@F\0)/INGOX<M;NPT=;SSH((Y#&Z2#& 7=7
MW$D9^;!QC X?P#\9?B%I'Q \3W>H:3JNMZQKGB"31]%T277%-C:RQL3)$B;<
M*8P8UW@J&WY[$T:!9GW5_P )/:?\^\WZ?XT?\)/:?\^\WZ?XU\L_#W]HC7?'
MOC+0=%\(> 4NTU#3H[_4GFU5(FL(A<F"=@"N)%4[2,'<P8?+U T_CQ\?'^&?
MC34O#]YX=BN631H=0TE_MA4W\CW"PF+;L.TC,C<$\1^XHT#4^D_^$GM/^?>;
M]/\ &C_A)[3_ )]YOT_QKY%_X:IG2\O)I_!'EZ5LU"#3;T:@"+F\LX!+)&1M
MRJ'<@#8_B'7#!8]8_:HU2WN8K2R\!0W=U/'I!BB_M39O>]MO.VY,>!M)"@GZ
MG'2C0+,^OO\ A)[3_GWF_3_&C_A)[3_GWF_3_&O"/B)\3]>\"?#OPQXE\4^%
M8+.74]4M[+6[==0#KI:R;LR;U4J^-H[@9(&>]>71?M;:A<6(O[3X=M-:VT,F
MH7[#4ANAL!<+;K( 5R7,C %>V1[E30-3[(_X2>T_Y]YOT_QH_P"$GM/^?>;]
M/\:^&?!O[1?B?0-0^(?BC6].N-8T=]62#1Q)J06*UE<GR;=5Q\J&%9)"X4<Q
M 'ELCU30OC)?^.?V6O%7CCP[IOV+6M'M;N"6%;E'2":.(.9HW(PZJCAP".2I
M7GJ30+,^DO\ A)[3_GWF_3_&C_A)[3_GWF_3_&OBCP'^T3XR\/?"OP]87_@Z
MXUW5DTB35KNZN-6#--IR-M%PS$,=[,)1M/(" X.[CV'XH?%^'0/AIX9\1^'M
M%DUB^\9S6L&B6$DJPEWN$#)YC'(7&0"/4@9QD@T#4]V_X2>T_P"?>;]/\:/^
M$GM/^?>;]/\ &OE'Q9^TKK7A[5UL=1^&UQ#)H]I;W7BJ,ZBA?35FE6-!'@8D
M)$D3#D'YP"!@D0W?[4-Q';M/#X/@DC_M'7+13_:)&Y;"UAG1O]7_ ,M/. ([
M;<\YP#0+,^M/^$GM/^?>;]/\:/\ A)[3_GWF_3_&O@_XO?M'^-O$/PXGL],T
M&?POJ45YIT[7%EJH9WM9T9T 8*I&XA,X.<-@XP:^N_#=QJ-WX=L;K6-/73M0
MFMHWN[-9A*+:4J"\8<<-M.1D<'%&C#5':_\ "3VG_/O-^G^-'_"3VG_/O-^G
M^-?F[\/?BM\49=*O+C2_'/B'5KA]/U.36H+F,R0Z7&D3&"5)B#L8MZ;<%5'.
M[ ]6\#_M36FEWW@[PEJ6G27\+:7I=MJVLSWV9S<S6T;-)L(+.JL3N8G.<^HW
M&@69]F?\)/:?\^\WZ?XT?\)/:?\ /O-^G^-?($W[6+6NJ^*+.Y\%V\W]B6[3
M6K6&M)<I/B>.$;G1"H!WE\C. ,8.<TSQ9^UA<Z!X9\/W-UX,LVU+5[=[V2"/
M6XY(5M5D:-6215(+NR2C9U79SDG - LS["_X2>T_Y]YOT_QH_P"$GM/^?>;]
M/\:\*^)WQ=BT+X9^&?$GAS19-8OO&5Q:6^B6$DRP;WN%#)YC'A<9 /N1R!DC
MPKP%^TCXF\%_!?2=6UVTB\3W>IZG>R7,UYK2Q3HBR !$B*EMOS'!4;5VD8HT
M#4^ZO^$GM/\ GWF_3_&C_A)[3_GWF_3_ !KX<\*_M#^*?#?B+XD>)/$>EW6H
M:4FH00:7;S:DHCLYF+>3 J@'"O$LDC.!_P LL'EA7M_P'^+D'Q'^%&H>*QIL
M-C>:1)-#>6SWB>1OC0.&6?[HC((^8]/FZ@9)H&I[I_PD]I_S[S?I_C1_PD]I
M_P ^\WZ?XU\:Z?\ M;:G=Z7,(/ %K-J:ZS:Z?#;PZVKQ2"=9F'[T)MW Q*,]
M#N)XVX.?\0_VH=8\0_"V6R\)>'9]/UZ?2[FXU*X2^ _LN..0Q>9$Q4%V)!/8
MKVSUHT"S/MK_ (2>T_Y]YOT_QH_X2>T_Y]YOT_QKYM\6?%C4/AW^S/X'\3RZ
M:^NZCK%CI]NSW=YY2^;):AS++*P/)*GJ1G))(P:X&_\ CUK'A[XL:Y=7FDZC
M<7VI:5I,6F:"-=2XL([JX17&QEC"C*L27!.[![%=AH&I]H?\)/:?\^\WZ?XT
M?\)/:?\ /O-^G^-?&8_:R\0O;JL/PU@DNXIKY;J#^V /*6U5'D(;R\'Y6?\
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M D@#OP"?PHT#4^.O"7[+ESI.JV-_??$6349+'5M+OE+:.(R8[%'C2'B8]49
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MY]8?^_8H^QVG_/K#_P!^Q1=!J?(>@_LLZ#I]YKEG)XA\[P_JD%Q';:?_ &3
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M2VC>&) L?FJFS=]M5\)G<7QQ7U5'+')N\N17VG#;3G!QG!_ C\Z=0!\^>)M
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MPSQ*DC;8_FY?/6?\*P_:*_Z.B_\ ,?:?_P#%T?\ "L/VBO\ HZ+_ ,Q]I_\
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MJ6N1W316-[<VAB1Y(U38#:V\,*(Q0M@1]78DDG K_P#"L/VBO^CHO_,?:?\
M_%T?\*P_:*_Z.B_\Q]I__P 70!SL_P #/$-UX@T'4'L%TW3X]2O+@Z5I5Y:*
MNB"6\MYXVB::V< ?N69_)V-G #$$U=C^#WB\>,])OI-.TJ98[R"1;^2X!ET=
M(=;NK^4Q*5.[[3;S1PMM(^[AL@"M7_A6'[17_1T7_F/M/_\ BZ/^%8?M%?\
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MU#'M)\Q;FVG"J "!(#D<D=-JGPA\56FJ:MK&AZ3HHOM4@U>*\D=(':]CGO\
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M3YU95WX(P2*ZRZ^'&IQ?LRVO@VVT<ZC=)K-GJ4VDZM=VS))&FK17DUNS10I
M$*+(H18P@!"@$"L/_A6O[47_ $<I8_\ A%V7_P 31_PK7]J+_HY2Q_\ "+LO
M_B: */AOX.^+M.\1>&IYM TJ2*T-C/'=K=KYWAY(+^[NY;. ;?F22*XB@RI
M(0AOE"UV7[./A#Q7\/\ 2[C2]1T"P*:OJWVN6>UON-/@:U&VW"MDNL#QK;H
M0"FUNS5S?_"M?VHO^CE+'_PB[+_XFC_A6O[47_1REC_X1=E_\30![]17@/\
MPK7]J+_HY2Q_\(NR_P#B:/\ A6O[47_1REC_ .$79?\ Q- 'OU%> _\ "M?V
MHO\ HY2Q_P#"+LO_ (FF7/PY_:BAMY)3^TE8GRT+8_X0RRYP,_W: /H&BO*_
MV)_&'B/Q[^S)X9\6>+-1_M#6-0^U_:;GR(XO,V7D\:_)&JJ,(BC@#IGK7JE
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MUTWMN5D@SV-PI[&NUC54C5$4*JC"J!@ >@H 6BBB@ HHHH **** "BBCIR:
M.)^*LDFM:UHG@*U=E_M>8WFJLAP4T^W9&D7(Z>;(T$6.I224C[M=M7#_  ?_
M .)[=:M\0I?F'B&18M*)_ATV L("/:1GFG^DR@_=KN* "BBB@ HHHH ****
M"BBB@ HHHH **** "O#_  '_ ,G]>/?^Q2TW_P!#:O<*\/\  ?\ R?UX]_[%
M+3?_ $-J /<*\/\ ^<DG_=)?_<M7N%>'_P#.23_NDO\ [EJ /<**** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ J#5/^0;<?\ 7%OY&IZ@U3_D&W'_ %Q;^1H \6_X)P?\F8>#?^W_ /\
M3A<U[A7A_P#P3@_Y,P\&_P#;_P#^G"YKW"@'N>$?\$U?^3-_"W_7:^_]+)J]
MWKPC_@FK_P F;^%O^NU]_P"EDU>[T ]PHHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /"/VX/^0E\'?\
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M?]TE_P#<M0![A1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_HEGA7_P5Q_X4?\ "@?@G_T2SPK_ ."N/_"@-#<_X6=\-O\ HH7A7_P=6_\
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M ,%<?^%'_"@?@G_T2SPK_P""N/\ PH#0W/\ A9WPV_Z*%X5_\'5O_P#%T?\
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M .B6>%?_  5Q_P"% :&Y_P +.^&W_10O"O\ X.K?_P"+H_X6=\-O^BA>%?\
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M?_1+/"O_ (*X_P#"C_A0/P3_ .B6>%?_  5Q_P"% :&Y_P +.^&W_10O"O\
MX.K?_P"+H_X6=\-O^BA>%?\ P=6__P 76'_PH'X)_P#1+/"O_@KC_P */^%
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MH'X)_P#1+/"O_@KC_P */^% _!/_ *)9X5_\%<?^% :&Y_PL[X;?]%"\*_\
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M **RM-UZWO?%VJ>'XX95GTF"VFED;&QQ-YFT+WR/*.<^HK.T7QSH^I?$S6O
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M!^5QPPYX(Z]:GK(\^47%M/<****!!1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %<U\9O^2/^*_^P%>_^B'KI:YKXS?\D?\ %?\ V KW_P!$/5T_
MCCZG9E_^^4?\4?S1\KZY_P F=_"K_L9I?_2FYKUG_@H3_P D&A_[#,'_ *!+
M7DVN?\F=_"K_ +&:7_TIN:]9_P""A/\ R0:'_L,P?^@2U[4O]XI_XI?F?K6(
M_P"1]@/^PG$?^G3QSP+_ ,H^_&?_ &,T7\[*CX&_\F??$_\ ZZ0_^RT>!?\
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M[$U?_1=Q7FNG_P#*/:^_[&(?^AQUZ4O_ ">UX(_[$U?_ $7<4JO_ "\_[?\
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MH0_7Y5K%U7P;K3:=X9CLS")=)T^>SFQ+@1K/Y,;!#C)"1[V'3)B0<9IOP_\
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M"_BQH%WK/@C49KVSLKG[+.\MK)"5DVJV,. 3PPYH&T=G1110(**** "BBB@
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M]K6-M]EMKO!WQ0X8;![89OSI3QL)<VCUYOQ2_P B<5Q?A*WUBU.7[QU[;?\
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MRK?=5+A5QW\OG[QPZZ\$7I3[-;ZAI'V&'47OK6UN=',J1LZNI1P)E#J!(=N
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MZ4 >I45YE??&?3=.UZUTO5-!O;5[S5Y-+A<W5N5FD22VB8Q?O,R$272J53+
MQR\$H17IM !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !4-_:P7MC-9742RV]Q
M&T4L;='1A@@_4$U-10!PS_"CPQ)IRV,]QJ]Q;XE,L<U^[B9WB>'S'!ZNL;E5
M(QP%SG:N)]+^%O@O3EC2STORXX=9768HPYV)=C?AP.W,CG'J:[*B@#A+/X3^
M'H;?3X)=1UFZATZ25HTGNQ^\62:*=TD*J"ZM+!&YR<DYR2&(/=T44 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
G 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>tm223584d1_pre14acvr02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 tm223584d1_pre14acvr02.jpg
M_]C_X  02D9)1@ ! 0$!+ $L  #_VP!#  0" P,# @0# P,$! 0$!0D&!04%
M!0L(" 8)#0L-#0T+# P.$!01#@\3#PP,$A@2$Q46%Q<7#A$9&QD6&A06%Q;_
MVP!# 00$! 4%!0H&!@H6#PP/%A86%A86%A86%A86%A86%A86%A86%A86%A86
M%A86%A86%A86%A86%A86%A86%A86%A;_P  1" 1, U(# 2(  A$! Q$!_\0
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MX:T3QIH7A/4M2$.L>)&F&F6HB=C-Y2%Y"64%4 4=6(R>!FOF;P7XJ\4>&/\
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M?+\YMV'RC*&['/O47A76M9BM_"WA'PUXT\0#P_J\VE/JZVU\ZBQOFDDC,<;
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MT0J4.F&RC^RE2VXCRL;,;N>G7FM6N)_:1\1ZOX1^ WBSQ+H/RZGINE32VK[
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M0>PK\^_ _P 4?B;X=AT[7]+\;:R;/0-0\-Z;#H/G9LKB&ZL)W=#%]T#_ $0
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M4$<!U=Y%4,X((.23UJ2;PAX3FTV33I?"^BR6<UV;V6V?3XC$]P>LS*5P9/\
M://O7YT^'?BM\3OAWIUG?:#X^U;7/#OA>'2U-M+=>9;HU]IF\P-C/RP21M&J
M$X5D. "37T-\2-6^)7@/]B'P#X]D\3ZQ=ZSHE_8:OKSS7;^9>VUP[,;:8G[P
M!FACP<CY:!6/=$TGX2S>+E\&KHGA)]:L=-6==,%A;F6"T\[<I";?E3S3NP.
MQ!ZD&LSQY>_ C2[R^T3Q?'X'@FL\:S>6>HVMME&E81_:65EY=F*KN^\<KZBO
MA?0_%_Q:N=3O];7QZ;'7];\$?:VN]2U".UG:!M43;#;3R$>6Q0[D7<."0.<5
MROQ>\4:IXXM6O9/%.N:G':^&K-YY]2CC%Q*R7YC*2LGWU1I6VMGG:I."2 #L
M?I%H^C_"'Q!XHU.RTW0O"&H:OX?\FTU%(M/MY)K(",B*-_ERH"!E4=  RCH1
M732>'/#TFDV>ER:#IC6.G2))96K6<9AMG3[C1IC"%<\$ 8[5^<^K^)?&MG^T
M!KGA'PQ\5-:6TN]1CCDUNQNQYNI+'8';,\D9_>%@@(;)ZY%9]Q\??BUXHT.+
M6+OXGZEI=WH@TZRM["RN?LYU)9&?S9Y%4CS&!1<G!X;'KD"Q^D#>#?![6]Q
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M5<O*K(PR78J3U.:!V/O;]G/X0>&?@UX*E\/^')+FY:[N#<WEW=%?,GDP%Z*
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MR9C=000,>Q (],"M*B@#A-;^"_PHU@1C5/ &AW7DZ=%IL1EM03%;1D%(T/\
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MSQ5EOA5\.&T_2K!O!>C_ &70[>>VTZ'[*NRWBG4K,JCI\X)SG.<D]3FNPHH
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M(85)*QA?N[ 6.%(P,FNRHH YKQ!\/? VN^+-/\3ZSX3TF^UC2E5;*]GM5>2
M*=RX)'\+9*_W3R,&JW@?X6?#OP=X@N==\,>#M)TS4KS=YUW;VX$C!CE@&/W0
M3U P*ZZB@#(\#^%O#W@[P_'H?A?2+72M.B=Y$MK9-J!F8LQQ[DUKT44 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%9OC#7=/\,^%=0\
M0ZJTBV6FVSW$YCC+OM49.U1R3[5S/_"R?^I!\<?^";_[.@#N**X?_A9/_4@^
M./\ P3?_ &='_"R?^I!\<?\ @F_^SH [BBN'_P"%D_\ 4@^./_!-_P#9T?\
M"R?^I!\<?^";_P"SH [BBN'_ .%D_P#4@^./_!-_]G1_PLG_ *D'QQ_X)O\
M[.@#N**X?_A9/_4@^./_  3?_9T?\+)_ZD'QQ_X)O_LZ .XHKA_^%D_]2#XX
M_P#!-_\ 9T?\+)_ZD'QQ_P"";_[.@#N**X?_ (63_P!2#XX_\$W_ -G1_P +
M)_ZD'QQ_X)O_ +.@#N**X?\ X63_ -2#XX_\$W_V='_"R?\ J0?''_@F_P#L
MZ .XHKA_^%D_]2#XX_\ !-_]G1_PLG_J0?''_@F_^SH [BBN'_X63_U(/CC_
M ,$W_P!G1_PLG_J0?''_ ()O_LZ .XHKA_\ A9/_ %(/CC_P3?\ V='_  LG
M_J0?''_@F_\ LZ .XHKA_P#A9/\ U(/CC_P3?_9T?\+)_P"I!\<?^";_ .SH
M [BBN'_X63_U(/CC_P $W_V='_"R?^I!\<?^";_[.@#N**X?_A9/_4@^./\
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M?_A9/_4@^./_  3?_9T?\+)_ZD'QQ_X)O_LZ .XHKA_^%D_]2#XX_P#!-_\
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M;_&2+4O&$/@/Q_X9O? _C*>-GMM/OI5FM-4"_>:QNU^2? ()7"N,\KP37J%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &"/&W@X^-O\
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MC'XF:MKNJ6%Y;ZDMO8WT%[H]W!YWE>9%)'GRP#/%B+C!&2-PPO>Q?$CXP_\
M#4$&A>&/'5]K>F>';RQTZ!;K7;:.+5[0Q_/,8F(%S)*"9!(I9E!&#RN +'WY
M17YM^ /BK\7?['6WT?XOW%W?>)/#5S->-KFKJ(M%EBO&1-LTK;8))(T"J6V\
MSH3QM8?0'P=\?:MJW[ /B_7[;Q?XBO\ 7-'MK^"6^U&53=6<Z1*P2.9.9%4.
MI$A.XDGI@  6/J2L_P 5:[HWAKP_=:[X@U.UTW3;)-]Q=W4HCCC!( R3ZD@
M=22 .37YV^&_B;\6-$U[2-5N/BEXFU&"PUC0&DL[J[9X[E-1M#/*D@YW*NS:
M <]21@FN=^)GQ=\;^*=$\:V5UXEUO4/#?B'3TO+:SU6_AN'C6/5H%C81Q +;
MMA-I0 9'S<AE- ^4_4"UFBN;:.X@D62*9 \;J<AE(R"/PJ2OS/N_B_\ %>Z\
M >'-&TOQQX@MM0OM0U"74I)=5735MIX%016J2R$+'#'&4<QY4.92O4+CZD_:
M ^('BW0_V+_#NIZS?:CI?B[Q$;"P,^DWMO 6N9 69C<?-'$CI&YWKPI88P*!
M6/HRLOQ1XET#PVMDVOZQ9Z:-2O$LK,W,P3SYWSMC7/5C@\>U?F]9?%WXQZUH
M-J3\3_$%G)H6@7UWO@O-QNFM[D[!*PXE/(!<YRHQR":^F_VC?$VJ:Q\%_@3X
MDN)56\UGQ3H%Y<E8UQYDENTC8&,#ECTQ0%CZ:HK\PS\2?C%#X3M=5C^+WBS=
M)X<_X2 QO?,P\R/4YK,19)R4*IN(/!)P00!75Z;\<_'6B?%F7QAJ/Q'UFZMD
M\9W%C>>&4G,T::<1NDECA)(&P9"?+@%>.X(%C]$:R[SQ'H-IXJL_#-SJ]G'K
M&H0O-:6#3#SYHT^\X3KM&#STX/I7YOZ#^T!\7K:PU[25\=:Q]DUU;)CJ-[?)
M=SZ3'-( \T;H,095L;%QLW#&&&:].@TVULOVV/AI+<_'6Y\065OI$C+XBDOX
M0MP(KJX(LFE#$.'&V-\L6;<3QN  %C[FHJCX;UK2/$.AV^LZ#J=IJ6GW0)@N
M[2998I0"5.UE)!P00?0@BKU @HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBN'^,7Q4\._#UK'3[JWU#6?$&L%ETGP]H\'VB_ORHRS+'D!8UQ\
MTCE57N>U '<45XND'[3?C#%RVH^"OAG929:.U%G)KVH(,' E8O% #TX3=_O'
MI3Y/!W[2.DC[5I?QH\+^()$((LM<\'"UBDXY!FMI]RCTPAQ[]* /9:*\A\-_
M&;4M%\367A/XR^$F\&:IJ,XM]-U:"Z^U:)JDI'"176%,4C8.(IE0G'!:O7J
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M&!52ZTUM._;>T_5+?='%X@^'U['>*/NS265_9^4Q]65;Z09]&'I0!ZO1110
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M:O8QWU\ADM;5[E!+<*.K(A.6'N!0!Q^K?!'X2:G#=17_ ,/M"F6]O/ML^ZU
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MY;;\N=RE@K 'BM6\\0:#9ZS%I%WK>G6^H3[?*LY;M%FDW'"[4)W')! P.<4
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M+X<@T.WUF;7]+CTV[95M[U[R-8)BWW0DA.UB<'&#SB@!?!OAW0_"?ANU\/\
MAO2[;3-,LP1;VELFV./+%C@>I9B2>Y)K3JF=7TD:XNC'4[/^TFA\];+[0OGF
M/.-XCSNVY[XQ63X5\::+J_A2'6[B\LM.S:Q7-U!-J-O(;1920AD>-V3#%3@A
MB#@X/% '1453L]7TF[U2ZTRTU.SGO;+'VJUBN%:6#/3>@.5SVR*+C5]*@UF#
M2)]3LXM0ND:2WLWN%6:95ZLJ$[F P<D"@"Y17,>$_'WAO6_#-GKC7T6FP:A?
MW%C:)J$T<+SRPW$D!51N^8EHF( )."..U:6M>)O#^DRW$&H:S807%K9O>RV\
METBRK @):382#M 4_-TXZT :M%<=X'^*'@KQ-X(T3Q-#K^FV4&O6R36L%Y?0
MI,"VS,3 ,1YBF1%903AF [BMUO$WAQ?[0W>(-+']D?\ (1S>Q_Z%_P!=N?W?
M0_>Q0!J45S]QXNTIGTAM*GM=6@U;46L1<6E_ 4B98I'8\N-Y'EX*)N;G., D
M:FEZOI6IS746FZG9WDEE*8;I+>X61H)!U1PI.UO8\T 7**** "BBB@ HHHH
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MBBB@ HHHH **** .'_:6_P"2!>+O^P3-_P"@UW%</^TL0/@#XN). -(FR?\
M@-=5_;6C_P#06L?_  )3_&@.A>KC_BY\+_!OQ)L[5/$VFN;S3G,FF:K9SM;7
M^G2'^."XC(=#D X!P<#(-=%_;6C_ /06L?\ P)3_ !H_MK1_^@M8_P#@2G^-
M 'FFA^ /C1X?F^SZ5\<[?5=-CP((_%'A%+VY51V:>WN+8O\ 4KGWI^O>"?CA
MK3>1<?&[2='M)#^^_P"$?\$B"XVXP0DMS=W 3/KL)&>,5Z1_;6C_ /06L?\
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MI\.KOQ[I#6^F7VG3PQ_)IMPMY(89%#+&9#&KL1M9PW)S7UA_;6C_ /06L?\
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M*?XT"+U%4?[:T?\ Z"UC_P"!*?XT?VUH_P#T%K'_ ,"4_P : +U%4?[:T?\
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M;6C_ /06L?\ P)3_ !H O5P]O_R<E=_]BE!_Z5S5U7]M:/\ ]!:Q_P# E/\
M&N/TN[M;O]H^\>TN89U7PG "8I P!^US>E '?4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 0ZA:VM]8S65[;0W-M<(8YH9HP\<B$8*LIX(([&N;_X
M5C\-O^B>^%?_  2V_P#\17544 <K_P *Q^&W_1/?"O\ X);?_P"(H_X5C\-O
M^B>^%?\ P2V__P 17544 <K_ ,*Q^&W_ $3WPK_X);?_ .(H_P"%8_#;_HGO
MA7_P2V__ ,17544 <K_PK'X;?]$]\*_^"6W_ /B*/^%8_#;_ *)[X5_\$MO_
M /$5U5% '*_\*Q^&W_1/?"O_ ();?_XBC_A6/PV_Z)[X5_\ !+;_ /Q%=510
M!RO_  K'X;?]$]\*_P#@EM__ (BC_A6/PV_Z)[X5_P#!+;__ !%=510!RO\
MPK'X;?\ 1/?"O_@EM_\ XBC_ (5C\-O^B>^%?_!+;_\ Q%=510!RO_"L?AM_
MT3WPK_X);?\ ^(H_X5C\-O\ HGOA7_P2V_\ \17544 <K_PK'X;?]$]\*_\
M@EM__B*/^%8_#;_HGOA7_P $MO\ _$5U5% '*_\ "L?AM_T3WPK_ ."6W_\
MB*/^%8_#;_HGOA7_ ,$MO_\ $5U5% '*_P#"L?AM_P!$]\*_^"6W_P#B*/\
MA6/PV_Z)[X5_\$MO_P#$5U5% '*_\*Q^&W_1/?"O_@EM_P#XBC_A6/PV_P"B
M>^%?_!+;_P#Q%=510!RO_"L?AM_T3WPK_P""6W_^(H_X5C\-O^B>^%?_  2V
M_P#\17544 <K_P *Q^&W_1/?"O\ X);?_P"(H_X5C\-O^B>^%?\ P2V__P 1
M7544 <K_ ,*Q^&W_ $3WPK_X);?_ .(H_P"%8_#;_HGOA7_P2V__ ,17544
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\>OV=M"^*4>E)J'B'4;#^R=&DTJ+R(T;>K-&=YR.H\H<>] :')_L\_'/Q_\
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M_LYW+>:5P 3O5B#R.0#VQ0/0XO2_VL?B/KC:AJ5KI?A?1;&W\)2:K96FIQ7
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M M%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M;R.3GILC:(/)_P  4XKHJ*=X=G]__ *<\)=VA+I]I?/['7IV\SG?^$X\/_\
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M / 'SX2_P2M?^9;6V^#>_7:VENISNM>-] TJTT^YO#JGEZG")K;R=%NYFVD
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M[T:KXX\/Z=HUCJET=5^S:B";?RM%O)9,#&=\:1%X^O\ &!FNBHHO#L_O_P"
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M]]:?_P#'Z/\ A.OVZ_\ H5=#_P"^M/\ _C]%F!]JT5\5?\)U^W7_ -"KH?\
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M%70_^^M/_P#C]%F!]JT5\5?\)U^W7_T*NA_]]:?_ /'Z/^$Z_;K_ .A5T/\
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M;6__  ,_^U4<R#E9]1T5\N?\-CM_T2;6_P#P,_\ M5'_  V.W_1)M;_\#/\
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M;6__  ,_^U4<R#E9]1T5\N?\-CM_T2;6_P#P,_\ M5'_  V.W_1)M;_\#/\
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M9K>7Y>6#Q.^?<'TKN?\ @I-NT;7OA+X[O%D_L?PYXJ#7[*,[0S0R#C_=MY*
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MS)PQ(9#U ^= 2&)50+,]MN/AKX"N-'T'29O"FFR6?AB9)]&A:'Y;%UY!3TY
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M&0XY H'8^UJ*^>(_VO\ P%-\([3Q?;Z)K,VIWVK-I-OX>C56NY;A0K-MP<%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M5B$^\0"<8KL:\_\ CQ9W=W?> S:6LTXM_&=I-,8HRWE1B&X!=L=%!(Y/'(H
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M]O8?">I6^@W\;1:F]^TEBB*P9X7C!15,C [$SG!Y],\$>'M6'[7,OA>^@/\
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M'*VX_.R6<=H-QR1YK8ZF@+'OE<3\'[GX?MI.N:GX(:22V?5)SJM_,MRQN;E
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M2\U?Q_K>DS^(=<N-=O)_%4'BW2&U*X$-GID44GV%TBW!85XM=DB!2_FOR>:
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MPDA35;"W:">&9$>[:6.:U56  <[UC;Y20,8;N*ZRODSXL)H%_KVO-K.M7_\
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MRP@8@#+!C@=* .KT_4M/OKJ\MK*^M[B;3YA!=QQ2AFMY"BN$<#[K;71L'G#
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M.'AF:-@CJ?4,01]*!&M5/4+[2]'M8GOKNUL89KB.WB,KK&KS2N$1%SU9W8
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M>;($9@5)&U@ >17B?PLT'P[K-SX/\#>.=,L9-&T\>+FO],D13IUOJ,5Y&K)
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M#C*@+V7M5^\?3+QIM'NVM+AIX#YUG*5<R1-\IW(>JG)!R,&O'/VC_#&@^/\
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MUG&9R-A3_68W?<9EZ]&(Z&OEWPW\6/C=J/P;U+Q=//?6=KJEAI]WI^JW.FV
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M#97L #T[2O@O\)M,AO8M/^'?AVUCU*V-I>+%I\:BXA+JYC? Y7=&AQZJ*W/
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M/4;((MO=75LKR1JCF15R>JAR6VGC/.*EA\#>#X?'LGC:+PWIR>(9H_+DU)8
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M+<Y/<Y[*B@#CY/A?X)?6+_4WTJ9IM2U>UUFX3[?<"(WMLRM%.L0?8C;D4MM
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MOC5J'P&\5?$@>,_!5TVB6\"MI,>GO]LLY)KZ*!))%P%VE#+CYCVR*]L_9X^
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M61O.1>I)PQXQ\WOO[46J^.= ^"NL^(_ %_I=GJ.AVTNHW+:C TJ/;0Q/)(B
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MSP1GU% ]#Z(^ OB'4?%OP7\+^)M7,37^JZ3!<W)B38AD9 6(7L,]J^0OAO\
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MQE6(/ER #!Q["@-#T;X]?&W6M*_8VL?B]X-AMK6^U**RF2&Z3STA\UAYD?\
M#NP=RYX]<"O(?B)^UAXNN&\77W@77]!_L6S\5:1IFD:C<Z>_EQVUS;7SRO(&
MPQP]JAR5R!NP.17LWQZ^"&IZY^R'9_"#P9=VAN=-BLX89[]VB241,-[L5#8+
M<M@#OBO,?BI^R[XVO=>\7W7A"S\(P6.I^+-(UC2M/F+1V_D6MM>I)')$D84
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MKIRO,A*+N8!L[F/& M?0?[/WA?4?!7P5\,^%-7>W:^TG38[>Y-NY:/>!SM)
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M.0O% M##U[]K[XBZS8ZQ?>$6TBTA%QHEK:)<61?[/+<6[&Y4DGY@)U8 D?=
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M]HC]GCXD^/?CMXDUC0]7T'3_  WXOTNRTS4IKEY'N88(I(9'\N-5P7W0+C+
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP%XK=)+-=0\377A/5[",S+:7@:*66&[@295<8,"$$J&"R2*<X!KWB@04444
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M[I=1=)+J:5V4EIF>,$-T&3QC 'H]% '-ZUX(T;5-#\/Z5<M="#PW>VE[9%)
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "O)?'7[37P0\'>
M+;[PQXD\;?8M5TV7RKNW_LF]D\ML XW)"5/!'0FO6J_)?]N;_D[7QS_V$_\
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M_P#(;?X4?V[I7_/U_P"0V_PKC**.4+G9_P!NZ5_S]?\ D-O\*/[=TK_GZ_\
M(;?X5QE%'*%SL_[=TK_GZ_\ (;?X4?V[I7_/U_Y#;_"N,HHY0N=G_;NE?\_7
M_D-O\*/[=TK_ )^O_(;?X5QE%'*%SL_[=TK_ )^O_(;?X4?V[I7_ #]?^0V_
MPKC**.4+G9_V[I7_ #]?^0V_PH_MW2O^?K_R&W^%<911RA<[/^W=*_Y^O_(;
M?X4?V[I7_/U_Y#;_  KC**.4+G9_V[I7_/U_Y#;_  H_MW2O^?K_ ,AM_A7&
M44<H7.S_ +=TK_GZ_P#(;?X4?V[I7_/U_P"0V_PKC**.4+G9_P!NZ5_S]?\
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MZ_\ (;?X5QE%'*%SL_[=TK_GZ_\ (;?X5>MYHYX5FB;<CC*G&,UY]7;^'?\
MD"6W^Y0U8"[1114C"BBB@ HHHH *_)?]N;_D[7QS_P!A/_VFE?K17DOCK]F7
MX(>,?%M]XG\2>"?MNJZE+YMW<?VM>Q^8V ,[4F"C@#H!0-.Q\5_M2?$[X(_$
M[P?/XTBTK5Y/B1K-E96SV[[X[72'A/[V12"%E$BDJ,[C\JG"'.>>_P""=_\
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M ([_ &=_&>CZ'-XMO]3T:!/#.@V,ZXDED#36@4R*P6/.W:'((SD@=,DCT/\
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M .1&_P :.8+'&45V?]A:5_SZ_P#D1O\ &C^PM*_Y]?\ R(W^-',%CC**[/\
ML+2O^?7_ ,B-_C1_86E?\^O_ )$;_&CF"QQE%=G_ &%I7_/K_P"1&_QH_L+2
MO^?7_P B-_C1S!8XRBNS_L+2O^?7_P B-_C1_86E?\^O_D1O\:.8+'&45V?]
MA:5_SZ_^1&_QH_L+2O\ GU_\B-_C1S!8XRBNS_L+2O\ GU_\B-_C1_86E?\
M/K_Y$;_&CF"QQE%=G_86E?\ /K_Y$;_&C^PM*_Y]?_(C?XT<P6.,HKL_["TK
M_GU_\B-_C1_86E?\^O\ Y$;_ !HY@L<9179_V%I7_/K_ .1&_P :/["TK_GU
M_P#(C?XT<P6.,HKL_P"PM*_Y]?\ R(W^-']A:5_SZ_\ D1O\:.8+'&45V?\
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M=2\2_%*#P3+X>AM[DZB^GSRB1B%DMX[E[S /9#':*/>X&>E6_B7\<'\)^/\
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M %WQ)\8O$>J6?B>'2?#]YIUCIY:&UU;R)MT4L<]NC+*7B$0,@FD*A'8@1_,
M6&)M5^/=YI<=WJ>I:!91:/'<3/!,EZSS"T@U,:=,\J[ J-YCQR##,-K,#@H2
M<NX^-G[)\^L:EJDOBC16O-855OY?L5T#<!2A&X>7C/[J/GJ=BYZ5"WQA_9#:
M76I#KWA[=XA_Y"I_LVX_TOYR_P W[ONY+'&,L23D\T >E?L]_$#5/B'X?U"_
MU/1H]+FTRYCT^Y@5RQ2\6"-[E.>R22%!_NG/->@5X'I?Q[_9:TW6O[6L/&&C
MV][YEU)Y\=E<ABURZ23D_N^2[1H3[J*VO^&J?V?_ /HI%C_X"7/_ ,;H ]BH
MKQW_ (:I_9__ .BD6/\ X"7/_P ;H_X:I_9__P"BD6/_ ("7/_QN@5F>Q45X
M[_PU3^S_ /\ 12+'_P !+G_XW1_PU3^S_P#]%(L?_ 2Y_P#C= 69[%17CO\
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M= 69[%17CO\ PU3^S_\ ]%(L?_ 2Y_\ C='_  U3^S__ -%(L?\ P$N?_C=
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MS_\ ]%(L?_ 2Y_\ C='_  U3^S__ -%(L?\ P$N?_C= 69[%17CO_#5/[/\
M_P!%(L?_  $N?_C='_#5/[/_ /T4BQ_\!+G_ .-T!9GL5%>._P##5/[/_P#T
M4BQ_\!+G_P"-T?\ #5/[/_\ T4BQ_P# 2Y_^-T!9GL5%>._\-4_L_P#_ $4B
MQ_\  2Y_^-T?\-4_L_\ _12+'_P$N?\ XW0%F>Q45X[_ ,-4_L__ /12+'_P
M$N?_ (W1_P -4_L__P#12+'_ ,!+G_XW0%F>Q45X[_PU3^S_ /\ 12+'_P !
M+G_XW1_PU3^S_P#]%(L?_ 2Y_P#C= 69[%17CO\ PU3^S_\ ]%(L?_ 2Y_\
MC='_  U3^S__ -%(L?\ P$N?_C= 69[%17CO_#5/[/\ _P!%(L?_  $N?_C=
M'_#5/[/_ /T4BQ_\!+G_ .-T!9GL5%>._P##5/[/_P#T4BQ_\!+G_P"-T?\
M#5/[/_\ T4BQ_P# 2Y_^-T!9GL5%>._\-4_L_P#_ $4BQ_\  2Y_^-UZAX/\
M0:/XJ\,V7B'P_?+?:9J$0EM;E%91*G3(# $=#U% &E1110 4444 %%%% !7@
M_P"S%8V-W\:OC4UW9V\[+XLC"F6)6Q_HZ],BO>*\/_95_P"2T?&S_L;8_P#T
MG6@#V+^Q='_Z!-C_ . R?X4?V+H__0)L?_ 9/\*O44 4?[%T?_H$V/\ X#)_
MA1_8NC_] FQ_\!D_PJ]10!1_L71_^@38_P#@,G^%']BZ/_T";'_P&3_"KU%
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M&3_"KU% %'^Q='_Z!-C_ . R?X4?V+H__0)L?_ 9/\*O44 4?[%T?_H$V/\
MX#)_A1_8NC_] FQ_\!D_PJ]10!1_L71_^@38_P#@,G^%']BZ/_T";'_P&3_"
MKU% %'^Q='_Z!-C_ . R?X4?V+H__0)L?_ 9/\*O44 4?[%T?_H$V/\ X#)_
MA1_8NC_] FQ_\!D_PJ]10!1_L71_^@38_P#@,G^%']BZ/_T";'_P&3_"KU%
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M3_\ 1+O _P#X4+__ !-'_"4?M3_]$N\#_P#A0O\ _$T >X45X?\ \)1^U/\
M]$N\#_\ A0O_ /$T?\)1^U/_ -$N\#_^%"__ ,30![A17A__  E'[4__ $2[
MP/\ ^%"__P 31_PE'[4__1+O _\ X4+_ /Q- 'N%%>'_ /"4?M3_ /1+O __
M (4+_P#Q-'_"4?M3_P#1+O __A0O_P#$T >X45X?_P )1^U/_P!$N\#_ /A0
MO_\ $T?\)1^U/_T2[P/_ .%"_P#\30![A17A_P#PE'[4_P#T2[P/_P"%"_\
M\31_PE'[4_\ T2[P/_X4+_\ Q- 'N%%>'_\ "4?M3_\ 1+O _P#X4+__ !-'
M_"4?M3_]$N\#_P#A0O\ _$T >X45X?\ \)1^U/\ ]$N\#_\ A0O_ /$T?\)1
M^U/_ -$N\#_^%"__ ,30![A17A__  E'[4__ $2[P/\ ^%"__P 31_PE'[4_
M_1+O _\ X4+_ /Q- 'N%%>'_ /"4?M3_ /1+O __ (4+_P#Q-'_"4?M3_P#1
M+O __A0O_P#$T >X45X?_P )1^U/_P!$N\#_ /A0O_\ $T?\)1^U/_T2[P/_
M .%"_P#\30![A17A_P#PE'[4_P#T2[P/_P"%"_\ \31_PE'[4_\ T2[P/_X4
M+_\ Q- 'N%%>'_\ "4?M3_\ 1+O _P#X4+__ !-'_"4?M3_]$N\#_P#A0O\
M_$T >X45X?\ \)1^U/\ ]$N\#_\ A0O_ /$T?\)1^U/_ -$N\#_^%"__ ,30
M![A17A__  E'[4__ $2[P/\ ^%"__P 31_PE'[4__1+O _\ X4+_ /Q- 'N%
M%>'_ /"4?M3_ /1+O __ (4+_P#Q-'_"4?M3_P#1+O __A0O_P#$T >X45X?
M_P )1^U/_P!$N\#_ /A0O_\ $T?\)1^U/_T2[P/_ .%"_P#\30![A17A_P#P
ME'[4_P#T2[P/_P"%"_\ \31_PE'[4_\ T2[P/_X4+_\ Q- 'N%%>'_\ "4?M
M3_\ 1+O _P#X4+__ !-'_"4?M3_]$N\#_P#A0O\ _$T >X45X?\ \)1^U/\
M]$N\#_\ A0O_ /$T?\)1^U/_ -$N\#_^%"__ ,30![A17A__  E'[4__ $2[
MP/\ ^%"__P 31_PE'[4__1+O _\ X4+_ /Q- 'N%%>'_ /"4?M3_ /1+O __
M (4+_P#Q-'_"4?M3_P#1+O __A0O_P#$T >X45X?_P )1^U/_P!$N\#_ /A0
MO_\ $T?\)1^U/_T2[P/_ .%"_P#\30![A17A_P#PE'[4_P#T2[P/_P"%"_\
M\31_PE'[4_\ T2[P/_X4+_\ Q- 'N%%>'_\ "4?M3_\ 1+O _P#X4+__ !-'
M_"4?M3_]$N\#_P#A0O\ _$T >X45X?\ \)1^U/\ ]$N\#_\ A0O_ /$T?\)1
M^U/_ -$N\#_^%"__ ,30![A17A__  E'[4__ $2[P/\ ^%"__P 31_PE'[4_
M_1+O _\ X4+_ /Q- 'N%%>'_ /"4?M3_ /1+O __ (4+_P#Q-'_"4?M3_P#1
M+O __A0O_P#$T >X45X?_P )1^U/_P!$N\#_ /A0O_\ $T?\)1^U/_T2[P/_
M .%"_P#\30![A17A_P#PE'[4_P#T2[P/_P"%"_\ \31_PE'[4_\ T2[P/_X4
M+_\ Q- 'N%%>'_\ "4?M3_\ 1+O _P#X4+__ !-'_"4?M3_]$N\#_P#A0O\
M_$T >X45X?\ \)1^U/\ ]$N\#_\ A0O_ /$T?\)1^U/_ -$N\#_^%"__ ,30
M![A17A__  E'[4__ $2[P/\ ^%"__P 31_PE'[4__1+O _\ X4+_ /Q- 'N%
M%>'_ /"4?M3_ /1+O __ (4+_P#Q-'_"4?M3_P#1+O __A0O_P#$T >X45X?
M_P )1^U/_P!$N\#_ /A0O_\ $T?\)1^U/_T2[P/_ .%"_P#\30![A17A_P#P
ME'[4_P#T2[P/_P"%"_\ \31_PE'[4_\ T2[P/_X4+_\ Q- 'N%%>'_\ "4?M
M3_\ 1+O _P#X4+__ !-'_"4?M3_]$N\#_P#A0O\ _$T >X45X?\ \)1^U/\
M]$N\#_\ A0O_ /$T?\)1^U/_ -$N\#_^%"__ ,30![A17A__  E'[4__ $2[
MP/\ ^%"__P 31_PE'[4__1+O _\ X4+_ /Q- 'N%%>'_ /"4?M3_ /1+O __
M (4+_P#Q-'_"4?M3_P#1+O __A0O_P#$T >X45X?_P )1^U/_P!$N\#_ /A0
MO_\ $T?\)1^U/_T2[P/_ .%"_P#\30![A17A_P#PE'[4_P#T2[P/_P"%"_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MD*A2Q ZG"J,^PK;H&%%%% @HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
)HHH **** /_9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
